data_2mdx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mdx _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--O 1.236 0.365 0 CA-C-O 121.281 0.563 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 84.5 t80 -153.15 97.34 2.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.738 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.7 ttt -124.69 137.25 54.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.396 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.683 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.2 pt-20 -134.93 147.97 49.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.522 . . . . 0.0 112.205 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.734 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 155.21 166.34 15.33 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.523 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.9 133.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.413 0.625 . . . . 0.0 111.825 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 83' ' ' ALA . 4.7 tp -118.34 120.05 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -74.52 93.11 2.44 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.14 0.576 . . . . 0.0 110.89 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 29.4 mtmt . . . . . 0 C--N 1.32 -0.696 0 CA-C-O 121.681 0.753 . . . . 0.0 112.412 -168.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.449 -1.142 0 N-CA-C 109.941 -0.831 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -124.26 142.87 50.9 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.734 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 67.7 t-105 -74.11 129.03 37.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.68 142.2 50.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.197 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.683 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -151.06 133.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 122.161 0.981 . . . . 0.0 112.557 172.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -92.98 119.72 32.54 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.694 -174.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -131.3 111.0 11.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 57.17 26.68 12.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.716 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.585 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.54 -28.34 15.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.368 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.578 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.01 108.78 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.932 0.872 . . . . 0.0 110.463 178.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.416 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -94.81 107.6 19.61 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.47 179.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 m -103.25 160.36 14.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.45 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -108.43 133.21 52.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.345 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.451 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 22.8 m-85 -139.82 165.34 27.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.992 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.33 6.75 22.62 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.394 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 t -173.6 164.55 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.172 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -77.28 -13.62 59.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.086 0.469 . . . . 0.0 111.181 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.48 -16.93 28.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.501 0.667 . . . . 0.0 109.996 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.521 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 26.6 t0 -79.7 -15.05 58.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.757 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.608 HG21 ' NE1' ' A' ' 27' ' ' TRP . 94.3 t -45.62 -29.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 p -69.82 -37.14 76.13 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HB3' ' HZ1' ' A' ' 49' ' ' LYS . 68.4 mmtt -122.79 -58.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.851 0.358 . . . . 0.0 110.665 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -148.33 49.51 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.315 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 50' ' ' GLY . 71.0 m -89.08 2.31 54.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' A' ' 46' ' ' LYS . 9.8 mptt 75.29 -34.66 0.26 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.762 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -63.91 141.3 44.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.002 176.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 p -147.11 150.0 34.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.359 0.599 . . . . 0.0 111.431 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.474 ' CG2' HG22 ' A' ' 73' ' ' ILE . 10.8 mt -87.63 123.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.321 176.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.578 ' HE3' HD11 ' A' ' 34' ' ' ILE . 30.8 mtpt -96.05 88.08 4.76 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.735 172.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.585 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -79.53 -9.6 59.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.748 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -80.81 -38.4 28.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.11 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -86.26 -17.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.246 1.022 . . . . 0.0 109.619 -174.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.468 ' HB3' HD12 ' A' ' 72' ' ' ILE . 96.3 m -128.69 -153.09 0.55 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.659 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.6 tp10 -120.81 142.98 49.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 119.247 0.931 . . . . 0.0 112.982 -168.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.64 115.84 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 170.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HG3' HG21 ' A' ' 72' ' ' ILE . 20.8 mmmt -94.29 130.73 40.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.496 HG13 ' HG ' ' A' ' 93' ' ' LEU . 1.8 m . . . . . 0 C--N 1.317 -0.827 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.631 ' CA ' ' HD3' ' A' ' 89' ' ' ARG . 80.4 p . . . . . 0 CA--C 1.554 1.102 0 CA-C-O 120.836 0.351 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -140.08 117.13 11.13 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.609 -0.682 . . . . 0.0 111.704 174.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.727 ' SD ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -172.38 153.68 3.02 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -159.65 164.79 33.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.595 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.445 ' HG ' ' CG2' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -133.09 130.32 39.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.192 0.52 . . . . 0.0 111.265 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.527 HG21 ' HG3' ' A' ' 60' ' ' LYS . 2.2 pp -115.96 120.49 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.706 ' HB ' ' CD ' ' A' ' 74' ' ' PRO . 2.5 pp -137.1 176.85 2.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.706 ' CD ' ' HB ' ' A' ' 73' ' ' ILE . 50.0 Cg_exo -54.79 137.03 73.98 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.004 3.136 . . . . 0.0 114.426 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.14 -46.56 3.0 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.887 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.403 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 13.6 pt-20 -139.46 106.36 5.41 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.595 0.712 . . . . 0.0 110.884 -177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.84 97.18 8.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.939 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.403 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -177.62 86.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.49 -178.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -140.42 96.45 3.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.172 0.511 . . . . 0.0 109.635 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -101.75 121.56 42.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.9 ptt? -151.08 137.57 18.66 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.161 -172.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 89' ' ' ARG . 35.5 ttpt -102.41 177.98 4.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -124.06 169.72 11.39 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.274 -175.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.713 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.66 -38.02 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 123.793 0.683 . . . . 0.0 110.983 173.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -157.66 -170.07 3.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.584 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.36 -48.91 9.88 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.995 -172.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -67.59 -17.87 64.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.554 0.692 . . . . 0.0 109.487 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.713 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.35 -54.4 29.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.475 -1.239 . . . . 0.0 107.739 171.273 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.727 ' HG3' ' SD ' ' A' ' 69' ' ' MET . 3.4 ttt180 -58.49 -34.51 71.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.765 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.48 ' O ' HG22 ' A' ' 94' ' ' VAL . 47.7 tp60 -62.91 -56.94 12.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.437 0.695 . . . . 0.0 111.044 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.738 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 65.3 mtt180 -34.71 -47.06 0.32 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.685 1.194 . . . . 0.0 113.149 174.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.509 ' HB2' ' CE ' ' A' ' 69' ' ' MET . 97.0 m95 -66.56 -53.63 32.51 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -49.97 -40.86 45.42 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.612 0.72 . . . . 0.0 109.96 175.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 52.5 t -55.85 -64.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.088 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 -50.49 71.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.37 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.474 HD23 ' HG2' ' A' ' 54' ' ' MET . 70.2 mt -52.65 -62.78 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.117 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.31 -1.81 65.59 Favored Glycine 0 C--O 1.222 -0.642 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.799 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.9 t -90.33 -32.65 16.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.564 0.682 . . . . 0.0 109.67 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.8 t -83.56 -28.09 28.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.032 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 17.8 tttt . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.629 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 9.7 tp10 . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 30.4 t80 -150.87 98.54 2.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.749 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 4.0 tpt -123.91 129.68 51.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.885 0.374 . . . . 0.0 111.355 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.702 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.0 pt-20 -134.84 143.73 47.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.365 0.602 . . . . 0.0 112.56 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.687 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 160.41 170.18 24.66 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.497 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -73.49 141.18 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.353 0.597 . . . . 0.0 112.276 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.491 HD23 ' SD ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -121.96 118.57 29.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.16 116.53 21.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.263 0.625 . . . . 0.0 112.103 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.637 ' HG2' ' C ' ' A' ' 80' ' ' TYR . 25.5 tptt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo . . . . . 0 N--CA 1.459 -0.537 0 N-CA-C 110.72 -0.531 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -112.13 149.39 32.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.687 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -80.4 130.84 35.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.468 0.652 . . . . 0.0 111.444 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.583 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -124.86 145.17 49.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.49 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.702 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.5 p -156.76 132.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 122.329 1.062 . . . . 0.0 112.798 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.1 tm? -94.36 118.29 31.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.725 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.18 130.22 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 109.914 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.52 22.15 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.841 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.644 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 97.21 -22.82 38.68 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.273 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.5 HD12 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -80.54 120.09 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.465 0.65 . . . . 0.0 111.157 177.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.585 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.67 106.84 18.82 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.162 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 8.3 t -105.16 162.38 13.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.013 0.435 . . . . 0.0 111.973 -167.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.458 ' OH ' ' HD1' ' A' ' 79' ' ' PHE . 39.3 m-85 -106.81 137.59 44.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.593 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' HE2' ' CG1' ' A' ' 29' ' ' VAL . 22.0 m-85 -149.28 164.47 34.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -98.0 -39.98 8.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.431 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -130.5 166.35 20.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.8 -5.82 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.24 -18.29 23.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.274 0.559 . . . . 0.0 110.109 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.7 -14.8 59.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.943 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.541 HG21 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -44.39 -22.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 2.7 p -83.0 -57.69 3.18 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.413 -0.805 . . . . 0.0 112.273 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 39.8 mmtm -133.58 27.78 4.01 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.59 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 49' ' ' LYS . . . -84.85 132.77 11.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.762 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.9 m 74.04 -34.0 0.27 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 47' ' ' GLY . 7.2 mptt 68.54 6.43 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.68 0.792 . . . . 0.0 112.727 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 137.54 13.43 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.882 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 12.0 p -146.83 142.67 27.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 35' ' ' LEU . 9.8 mt -89.24 136.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.465 1.106 . . . . 0.0 111.197 172.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' HE3' HD12 ' A' ' 34' ' ' ILE . 31.4 mtpt -106.73 89.78 3.12 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 120.993 0.425 . . . . 0.0 110.669 173.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.644 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.17 -1.16 31.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.621 -177.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.31 -48.47 8.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.04 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG21 ' HD3' ' A' ' 74' ' ' PRO . 1.7 m -80.7 -15.95 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.177 0.989 . . . . 0.0 109.501 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.578 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 54.1 m -131.64 -155.39 0.69 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.956 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.548 ' O ' HG13 ' A' ' 72' ' ' ILE . 7.8 tp10 -123.11 146.4 47.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.463 1.029 . . . . 0.0 113.194 -165.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.504 HD13 HG12 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -88.22 121.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.155 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 5.6 mttt -96.41 135.61 38.03 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.106 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.504 HG12 HD13 ' A' ' 59' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.315 -0.892 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 121.107 0.479 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -123.12 124.4 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.052 0.453 . . . . 0.0 111.357 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.543 ' HG2' ' H ' ' A' ' 70' ' ' GLU . 5.1 ttm -155.76 160.88 40.66 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.543 ' H ' ' HG2' ' A' ' 69' ' ' MET . 4.9 mt-10 -152.4 168.03 26.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -129.72 140.1 51.18 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.828 0.347 . . . . 0.0 110.269 171.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 58' ' ' GLU . 1.7 pp -120.87 117.05 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.699 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 1.7 pp -136.36 168.87 15.19 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.073 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.699 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 87.5 Cg_exo -29.79 117.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 124.94 3.76 . . . . 0.0 116.185 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.4 -21.38 6.2 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.273 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 14.9 pt-20 -151.76 115.33 4.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 112.322 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 3.0 pt20 -103.13 97.26 7.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 110.103 173.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.454 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 1.2 p80 -175.47 87.15 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.674 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 96.6 m-85 -138.2 97.02 3.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.637 ' C ' ' HG2' ' A' ' 15' ' ' LYS . 69.0 m-85 -87.99 140.61 29.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.311 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.586 ' HA ' ' HB2' ' A' ' 15' ' ' LYS . 8.3 ptt? -170.53 142.31 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 171.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.497 ' HA ' HH12 ' A' ' 89' ' ' ARG . 37.5 ttmt -104.64 170.17 8.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' A' ' 88' ' ' GLU . . . -119.55 165.49 14.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 118.514 0.597 . . . . 0.0 110.994 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.722 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.81 -42.2 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.57 0.544 . . . . 0.0 111.082 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -148.82 -172.27 4.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.86 -40.51 15.88 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.656 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.0 -18.8 63.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.608 0.718 . . . . 0.0 109.14 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.722 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -68.61 -52.15 34.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.573 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -48.07 -47.59 33.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.876 170.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.527 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.4 tp60 -55.78 -55.51 31.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.671 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.749 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 8.1 mtp180 -35.51 -44.84 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 124.599 1.187 . . . . 0.0 113.614 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.583 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 97.2 m95 -76.1 -51.03 13.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -53.16 -35.87 60.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.641 0.734 . . . . 0.0 109.889 175.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 19.6 t -55.86 -65.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.857 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.43 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -63.11 -55.77 22.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.002 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.486 ' CD1' HD11 ' A' ' 59' ' ' ILE . 83.3 mt -50.44 -60.21 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.525 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.39 -1.67 83.51 Favored Glycine 0 C--O 1.221 -0.71 0 CA-C-O 119.23 -0.761 . . . . 0.0 114.331 -173.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -90.04 -37.56 14.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.427 1.113 . . . . 0.0 109.517 169.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.7 t -72.81 -41.76 64.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.966 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 21.1 tttt . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.25 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 7.6 tp10 . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 120.913 0.387 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 81.2 t80 -150.57 99.0 2.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.037 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.659 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 3.7 tpt -127.48 120.5 28.47 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.291 0.567 . . . . 0.0 110.795 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -126.86 155.73 42.5 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.851 -173.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.74 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 143.87 167.31 11.76 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.725 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 27' ' ' TRP . 1.5 m -64.46 132.99 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.53 0.681 . . . . 0.0 111.208 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.1 tp -126.32 116.94 22.0 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 8.4 m-85 -66.25 161.07 23.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.6 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 67.6 mmtt . . . . . 0 C--N 1.318 -0.801 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 36.4 Cg_endo . . . . . 0 N--CA 1.464 -0.263 0 CA-C-O 121.291 0.454 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -113.75 135.75 53.6 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.74 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 49.5 t-105 -71.07 132.92 45.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.419 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -129.05 145.08 51.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.389 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.514 ' CG1' ' HE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -151.6 131.16 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.276 1.036 . . . . 0.0 112.654 170.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.7 tm? -93.69 113.09 25.09 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.784 -176.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.19 100.18 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.51 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.4 29.25 17.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.852 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.664 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.1 -23.29 32.5 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.131 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.514 HD13 ' HE3' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -82.3 100.21 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-O 122.138 0.971 . . . . 0.0 109.662 175.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -93.99 102.29 14.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.883 -177.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.4 t -105.33 155.4 19.13 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.443 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.564 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.7 p90 -114.04 141.24 47.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.132 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 38.7 m-85 -137.03 155.72 49.33 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.44 -4.26 59.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.766 0.317 . . . . 0.0 111.214 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -159.9 161.27 34.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.712 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -75.47 -17.44 60.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 110.643 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.16 -16.95 28.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.322 0.582 . . . . 0.0 109.984 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.0 -16.03 57.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.548 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.609 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 65.3 t -47.31 -43.41 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -51.85 -43.56 63.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.89 55.56 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.263 0.554 . . . . 0.0 111.83 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -121.5 0.73 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.815 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 50' ' ' GLY . 13.5 m -64.46 -30.65 71.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.865 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 29.6 mmmt 71.26 -25.07 0.17 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.999 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -54.93 134.62 47.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 175.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.483 ' HB2' HG21 ' A' ' 34' ' ' ILE . 32.5 p -140.87 150.62 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.948 0.88 . . . . 0.0 113.114 -171.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.513 HG23 HG23 ' A' ' 73' ' ' ILE . 12.7 mt -88.67 131.52 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.662 171.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.514 ' HE3' HD13 ' A' ' 34' ' ' ILE . 26.1 mtpt -101.23 89.56 3.83 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 172.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.664 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.46 3.8 14.92 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.354 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.04 -43.4 13.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.035 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 m -87.1 -18.35 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.724 0.773 . . . . 0.0 110.25 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.601 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 55.3 m -136.0 -173.36 3.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.921 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.548 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.9 tp10 -105.99 144.39 32.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -161.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.617 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -94.51 128.23 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 15.9 mmmt -109.87 144.29 38.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.644 ' CG1' ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 16.2 p . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.447 0.641 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -148.03 143.74 27.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.743 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.461 ' HG3' ' HG3' ' A' ' 81' ' ' MET . 4.5 ptm -170.29 154.99 5.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -148.57 166.9 26.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.025 0.44 . . . . 0.0 110.154 -176.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.5 ' HG ' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.94 124.53 23.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.276 0.56 . . . . 0.0 110.772 171.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 57' ' ' CYS . 2.0 pp -105.31 114.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.7 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 1.7 pp -136.38 163.35 50.61 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.067 -174.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.7 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 9.5 Cg_exo -14.6 -115.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.303 1 C-N-CA 126.857 5.038 . . . . 0.0 118.407 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.33 3.18 59.55 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.652 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -144.2 63.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.219 0.533 . . . . 0.0 111.395 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.403 ' HA ' ' H ' ' A' ' 73' ' ' ILE . 15.8 pt20 -78.02 96.55 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.396 0.617 . . . . 0.0 110.213 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 178.67 88.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.194 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 71.0 m-85 -137.36 96.23 3.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -98.46 132.48 43.86 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.443 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.461 ' HG3' ' HG3' ' A' ' 69' ' ' MET . 17.1 ptt? -157.58 165.59 35.15 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.309 0.576 . . . . 0.0 111.059 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 67' ' ' THR . 41.1 ttmt -131.2 157.91 41.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 88' ' ' GLU . . . -112.35 162.02 16.01 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.89 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.706 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.0 -41.27 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.259 175.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -147.02 -176.16 5.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.887 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -83.4 -36.82 23.99 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.622 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.23 -19.15 61.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.613 0.72 . . . . 0.0 109.173 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.706 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -67.77 -51.84 44.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 23.6 ttp180 -50.3 -45.72 54.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.914 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 8.0 tp60 -54.91 -59.19 5.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.563 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.659 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 14.6 mtt180 -36.33 -44.61 0.43 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.64 1.176 . . . . 0.0 113.466 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.553 ' CE2' ' HE2' ' A' ' 9' ' ' MET . 95.0 m95 -70.9 -55.43 8.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.644 ' HG ' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.03 -37.38 61.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.71 0.767 . . . . 0.0 110.15 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 98' ' ' SER . 19.0 t -56.97 -57.99 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.294 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -69.28 -43.55 73.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.938 -175.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.441 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 66.7 mt -54.06 -60.73 2.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.785 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.17 -1.18 73.45 Favored Glycine 0 C--O 1.203 -1.838 0 C-N-CA 119.259 -1.448 . . . . 0.0 112.106 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 39.4 t -75.1 -41.75 58.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.435 1.117 . . . . 0.0 108.615 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t -79.64 -37.79 35.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.603 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 34.5 tttt . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.832 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 43.2 mm-40 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 73.2 t80 -154.02 99.45 2.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.776 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.1 ttt -132.22 136.15 46.8 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.636 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.733 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.8 pt-20 -136.31 144.38 44.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.362 0.601 . . . . 0.0 112.294 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.688 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.5 168.16 22.99 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.399 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 m -67.06 140.83 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.646 0.736 . . . . 0.0 112.299 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 tp -125.12 118.93 27.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -67.37 87.76 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.31 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 43.2 tttm . . . . . 0 C--N 1.321 -0.673 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 N--CA 1.461 -0.435 0 CA-C-O 121.351 0.48 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.445 ' NH1' ' HA ' ' A' ' 39' ' ' ASP . 29.4 tpt180 -102.67 129.2 49.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.688 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 54.4 t-105 -72.02 129.69 39.15 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.683 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.483 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.6 m-85 -125.28 140.79 52.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.048 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.733 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -149.52 125.87 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 122.292 1.044 . . . . 0.0 112.27 171.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 1.9 tm? -92.81 113.3 25.54 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.96 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.26 131.73 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.068 0.461 . . . . 0.0 109.925 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 62.94 16.65 9.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.42 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.0 -28.43 14.61 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.891 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.541 HD13 ' HE3' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -77.4 122.21 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-O 121.446 0.641 . . . . 0.0 110.812 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.532 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.84 104.76 16.66 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 15.0 m -103.79 138.79 39.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.952 0.406 . . . . 0.0 110.388 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.4 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 9.5 p90 -110.79 137.5 48.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.5 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 53.3 m-85 -135.8 169.93 16.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.409 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.445 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 20.5 t70 -63.37 -61.66 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.493 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 18.3 m -139.9 -175.55 4.26 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.606 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.73 -17.28 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.161 0.505 . . . . 0.0 111.398 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 40' ' ' SER . 6.0 p-10 -86.37 -17.46 34.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.287 0.565 . . . . 0.0 110.571 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.523 ' OD1' ' HA3' ' A' ' 47' ' ' GLY . 26.0 t70 -85.23 -20.2 30.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.338 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 50.5 t -44.47 -44.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 124.329 1.052 . . . . 0.0 113.709 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 5.1 p -58.42 -57.76 11.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.234 -172.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -152.18 29.87 0.56 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 111.788 -173.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.523 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -86.16 -96.5 0.8 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.811 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 50' ' ' GLY . 14.3 m -62.44 -38.19 88.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.984 -173.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 28.1 mmmt 70.72 -30.43 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -53.36 129.03 39.81 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.322 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.1 p -136.51 140.92 43.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.862 0.839 . . . . 0.0 113.264 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 35' ' ' LEU . 12.6 mt -89.86 135.78 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.766 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.541 ' HE3' HD13 ' A' ' 34' ' ' ILE . 36.5 mtpt -109.27 93.06 4.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.834 171.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.84 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.22 -3.12 34.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.882 -176.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.01 -49.74 9.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 112.088 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.9 m -78.35 -17.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.271 1.034 . . . . 0.0 109.327 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 56.9 m -131.87 -149.73 0.39 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.305 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -132.09 145.27 51.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 120.093 1.315 . . . . 0.0 113.793 -168.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.88 112.4 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 168.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.529 ' HG3' HG23 ' A' ' 72' ' ' ILE . 18.0 mmmt -93.76 147.33 23.15 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.682 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.465 HG12 HD11 ' A' ' 59' ' ' ILE . 1.3 m . . . . . 0 C--N 1.311 -1.099 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.898 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -121.86 138.36 54.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.761 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.607 ' HE2' ' HB2' ' A' ' 92' ' ' TRP . 4.2 ptp -153.19 177.0 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -150.31 161.43 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.201 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.53 HD13 ' CG2' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -130.39 124.34 31.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.257 0.551 . . . . 0.0 111.021 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.529 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.2 pp -109.73 118.27 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.704 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 pp -138.39 167.06 21.23 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.704 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 39.0 Cg_endo -60.8 144.72 99.6 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.132 2.555 . . . . 0.0 113.987 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 -49.16 4.1 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.428 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 12.9 pt-20 -150.42 89.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.284 0.564 . . . . 0.0 111.3 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.44 97.0 10.22 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.336 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -170.1 87.25 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.748 0.785 . . . . 0.0 110.312 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.6 m-85 -139.02 98.08 3.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.591 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.464 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 46.5 m-85 -103.98 121.11 42.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.087 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 ptt? -149.37 142.4 24.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.695 0.76 . . . . 0.0 111.679 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -105.03 151.65 23.7 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.572 ' HB3' ' HB3' ' A' ' 88' ' ' GLU . . . -99.79 155.73 17.49 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.339 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.675 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.48 -40.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.721 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -146.43 -174.03 4.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.91 -44.64 14.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.895 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.02 -15.66 62.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.873 0.844 . . . . 0.0 109.361 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.675 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.06 -52.27 56.7 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.449 ' O ' HD22 ' A' ' 93' ' ' LEU . 10.0 ttp180 -54.42 -46.03 73.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.77 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.737 ' NE2' HG23 ' A' ' 94' ' ' VAL . 15.3 tm0? -49.12 -62.43 1.54 Allowed 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.557 0.743 . . . . 0.0 110.628 175.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.776 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 71.8 mtt180 -35.06 -48.13 0.4 Allowed 'General case' 0 N--CA 1.434 -1.27 0 O-C-N 124.75 1.281 . . . . 0.0 113.137 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.607 ' HB2' ' HE2' ' A' ' 69' ' ' MET . 95.6 m95 -71.46 -52.33 19.02 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HG ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.48 -38.67 55.04 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.793 0.806 . . . . 0.0 109.769 176.219 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.737 HG23 ' NE2' ' A' ' 90' ' ' GLN . 39.7 t -61.86 -63.04 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.783 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.1 86.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.484 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.2 mt -58.27 -58.89 6.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.247 0.546 . . . . 0.0 111.035 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.77 -0.98 90.05 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.02 -175.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.3 t -87.75 -31.41 19.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 166.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.424 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 30.3 t -81.73 -34.27 30.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.84 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 28.5 tttt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.199 0.523 . . . . 0.0 110.564 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 7.6 pt-20 . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.221 0.534 . . . . 0.0 112.039 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 32.2 t80 -151.51 97.58 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.78 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 5.8 tpt -130.12 128.84 42.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.749 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.57 158.16 40.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.347 0.594 . . . . 0.0 112.406 -173.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.784 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 139.96 162.42 9.11 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.983 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.7 136.32 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-O 121.265 0.555 . . . . 0.0 111.433 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 83' ' ' ALA . 3.9 tp -123.59 118.5 27.46 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.635 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 20.1 m-85 -74.63 93.69 2.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.532 0 C-N-CA 118.926 -1.11 . . . . 0.0 112.087 -171.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 62.4 Cg_endo . . . . . 0 N--CA 1.46 -0.454 0 CA-C-O 121.426 0.511 . . . . 0.0 112.098 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -110.86 146.84 35.78 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.784 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 56.3 t-105 -67.35 118.72 11.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.071 0.462 . . . . 0.0 109.783 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.633 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -108.5 144.48 36.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.984 -176.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -154.54 129.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.514 1.15 . . . . 0.0 112.667 167.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -93.64 124.58 37.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.647 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.9 141.58 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.982 0.42 . . . . 0.0 109.873 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.47 23.04 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.273 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.85 -13.24 37.97 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.23 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.496 HD13 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -90.71 141.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 123.445 0.698 . . . . 0.0 111.216 175.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.599 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -118.15 110.01 17.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.463 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.447 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 15.0 m -105.39 152.6 22.76 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.571 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.593 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.0 p90 -112.02 138.05 49.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.272 0.558 . . . . 0.0 111.55 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.447 ' OH ' ' HB2' ' A' ' 36' ' ' SER . 11.1 m-85 -134.46 178.4 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.011 -175.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.77 -63.89 1.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 110.441 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.7 t -146.76 -166.84 2.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.147 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.46 -11.74 61.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.972 0.415 . . . . 0.0 111.415 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -90.39 -17.16 27.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.462 0.648 . . . . 0.0 110.717 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.603 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 24.4 t70 -90.53 -14.51 32.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.854 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.656 HG23 ' NE1' ' A' ' 27' ' ' TRP . 59.7 t -43.49 -32.12 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.6 t -70.31 -38.68 74.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.725 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -123.2 -72.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.73 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.603 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -151.23 52.06 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.402 -176.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 50' ' ' GLY . 50.1 m -74.07 -11.04 60.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.312 0.577 . . . . 0.0 109.807 176.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.2 tptt 71.2 -9.92 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.466 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -66.04 141.56 41.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.42 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.7 p -146.56 142.32 27.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.243 0.544 . . . . 0.0 112.056 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.6 HG22 ' HG ' ' A' ' 71' ' ' LEU . 62.6 mt -89.16 144.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.764 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HE3' HD13 ' A' ' 34' ' ' ILE . 34.6 mtpt -113.56 90.46 3.35 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.331 173.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.599 ' CE ' HG21 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -73.09 -24.61 60.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -59.75 -36.61 76.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.441 HG23 ' HD3' ' A' ' 74' ' ' PRO . 2.0 m -94.97 -15.4 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.666 0.746 . . . . 0.0 111.07 -171.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.415 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 81.5 m -134.01 -145.76 0.25 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.544 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.611 ' O ' HG13 ' A' ' 72' ' ' ILE . 4.8 tp10 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.322 0.965 . . . . 0.0 112.313 -170.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -97.66 125.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.675 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 34.4 mtmt -104.71 97.76 7.6 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 -172.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.684 HG13 ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.276 0 CA-C-O 121.64 0.733 . . . . 0.0 110.814 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.4 p . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.715 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 3.2 ppt_? -123.56 134.89 53.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.045 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 81' ' ' MET . 1.7 ptm -171.49 158.06 5.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.063 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 4.8 mt-10 -150.25 167.12 27.89 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HG ' HG22 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -135.51 125.72 26.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 171.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.611 HG13 ' O ' ' A' ' 58' ' ' GLU . 2.1 pp -110.38 120.07 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.611 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 1.1 pp -133.72 163.39 51.45 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.61 -167.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.611 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 17.8 Cg_endo -53.77 -63.19 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.095 3.197 . . . . 0.0 115.253 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.93 -20.49 62.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.559 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 179.95 103.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.33 0.586 . . . . 0.0 111.162 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -84.39 97.55 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.942 -0.474 . . . . 0.0 111.051 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.47 87.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.211 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 82.9 m-85 -139.98 97.79 3.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.672 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -101.24 135.62 42.42 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 8.8 ptt? -156.26 151.15 26.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.933 0.873 . . . . 0.0 112.718 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -111.84 137.58 49.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.099 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -90.49 157.99 17.26 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.731 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.677 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -46.51 -49.06 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.134 175.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.425 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 12.0 m120 -134.88 -174.49 3.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.905 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.608 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -87.7 -37.15 16.95 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.825 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -76.51 -14.99 59.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.878 0.847 . . . . 0.0 109.249 171.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.677 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.02 -53.25 48.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.651 ' O ' HD13 ' A' ' 93' ' ' LEU . 32.7 ttp180 -47.72 -51.24 22.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.793 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.705 ' NE2' HG23 ' A' ' 94' ' ' VAL . 17.1 tm0? -49.1 -64.12 0.9 Allowed 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 123.701 0.8 . . . . 0.0 111.036 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.78 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 34.2 mtt180 -35.74 -45.13 0.37 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.633 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 94.2 m95 -70.65 -55.3 9.08 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.439 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.684 ' CD1' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -51.8 -41.0 61.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.949 0.88 . . . . 0.0 110.292 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.705 HG23 ' NE2' ' A' ' 90' ' ' GLN . 25.5 t -56.85 -51.56 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.007 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 -51.35 10.95 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.759 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.571 ' CD2' ' HE3' ' A' ' 54' ' ' MET . 92.3 mt -50.84 -55.78 15.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.674 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.31 -3.22 90.69 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.334 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.617 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 42.5 t -66.47 -57.06 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.885 0.842 . . . . 0.0 109.622 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 7' ' ' GLU . 13.9 t -79.77 -29.43 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.743 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.521 ' HD2' ' O ' ' A' ' 54' ' ' MET . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -173.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 6.0 tp10 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 75.4 t80 -150.45 99.59 2.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -172.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.751 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 2.9 tpt -122.79 133.34 54.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.308 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.684 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 5.4 pt-20 -135.67 149.94 49.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.544 0.688 . . . . 0.0 112.746 -173.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.755 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 151.31 162.98 11.08 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.206 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.11 132.14 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 121.361 0.601 . . . . 0.0 111.39 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 83' ' ' ALA . 3.5 tp -121.23 118.95 30.89 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.422 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 25' ' ' PRO . 85.4 m-85 -76.79 90.6 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.005 -175.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.784 0 CA-C-O 121.513 0.673 . . . . 0.0 112.686 -171.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.427 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 30.8 Cg_endo . . . . . 0 N--CA 1.455 -0.775 0 CA-C-O 121.488 0.537 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.518 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 1.4 tpm_? -112.34 129.28 56.35 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.755 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 62.4 t-105 -67.26 119.41 12.1 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.528 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.511 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -113.71 137.0 52.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.643 -177.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.684 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.9 p -150.53 130.85 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 122.409 1.099 . . . . 0.0 112.457 168.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.527 HD22 ' HE2' ' A' ' 54' ' ' MET . 2.7 tm? -93.37 117.98 30.74 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.756 -173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -141.28 124.44 16.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 58.21 31.23 20.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.425 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.562 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 91.55 -25.49 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.024 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.517 HD12 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -83.93 113.24 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-O 121.746 0.784 . . . . 0.0 111.238 -178.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -95.25 105.88 17.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.57 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.4 t -104.31 160.43 14.9 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.082 0.468 . . . . 0.0 111.279 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' OH ' HG13 ' A' ' 52' ' ' ILE . 1.6 m-85 -108.71 128.15 54.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.984 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.479 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 18.4 m-85 -131.47 160.39 35.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.13 -62.92 1.38 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.908 0.385 . . . . 0.0 110.084 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -142.9 -173.16 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.44 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -65.42 -19.91 66.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.16 -16.9 34.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.0 110.66 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.743 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 22.6 t0 -87.32 -14.24 41.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.096 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.6 HG22 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -41.47 -33.11 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.83 -36.84 85.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.87 0.366 . . . . 0.0 111.055 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -118.24 -76.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.001 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.743 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 71.11 -176.51 37.21 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.855 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -66.95 122.17 17.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -78.54 51.95 1.12 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.937 0.875 . . . . 0.0 111.59 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -134.92 159.75 24.06 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.488 ' OG ' HG22 ' A' ' 34' ' ' ILE . 4.5 t -159.78 158.51 31.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.151 0.977 . . . . 0.0 112.836 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.528 HG13 ' OH ' ' A' ' 37' ' ' TYR . 9.8 mt -90.49 128.2 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.409 171.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HE3' HD12 ' A' ' 34' ' ' ILE . 37.9 mtpt -104.37 88.7 3.03 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.235 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.96 -21.8 60.81 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.793 -177.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.565 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -65.71 -28.67 69.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.284 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 53' ' ' LYS . 1.5 m -98.56 -14.49 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.706 0.765 . . . . 0.0 110.931 -172.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.566 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 86.1 m -136.43 -142.99 0.18 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.576 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.5 tp10 -128.4 146.34 50.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.302 0.955 . . . . 0.0 112.376 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.563 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -93.91 135.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.568 ' CG ' HG23 ' A' ' 72' ' ' ILE . 9.7 mmtt -114.1 146.15 40.65 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.9 m . . . . . 0 C--N 1.316 -0.868 0 O-C-N 122.001 -0.437 . . . . 0.0 109.939 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 24.7 p . . . . . 0 C--O 1.223 -0.336 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -135.88 122.93 21.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.082 0.468 . . . . 0.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.573 ' HE2' ' HB2' ' A' ' 92' ' ' TRP . 1.3 mpp? -141.1 172.32 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -151.57 166.76 30.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 111.261 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.505 ' HG ' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -137.2 137.3 38.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 173.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 58' ' ' GLU . 1.9 pp -115.93 115.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.685 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 2.0 pp -135.72 164.98 39.52 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.814 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.685 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.29 132.25 45.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.513 2.809 . . . . 0.0 114.664 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.88 -29.81 7.63 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.539 170.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -156.97 58.41 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.987 0.423 . . . . 0.0 111.698 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -68.29 98.74 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.605 0.717 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -178.94 88.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.143 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.1 m-85 -138.32 99.0 3.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.826 0.346 . . . . 0.0 110.838 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.2 127.63 47.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 13.9 ptt? -151.58 142.42 22.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.665 0.745 . . . . 0.0 111.77 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 67' ' ' THR . 77.8 tttt -105.12 136.89 43.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.037 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 88' ' ' GLU . . . -89.41 155.82 19.08 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.705 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.677 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -47.56 -46.19 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.662 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.448 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 25.5 m-80 -139.16 -170.2 2.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.667 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -88.05 -40.26 13.98 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.361 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.26 -18.73 61.79 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.677 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -62.78 -53.16 58.48 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.706 ' O ' HD21 ' A' ' 93' ' ' LEU . 36.8 ttt-85 -45.13 -53.53 7.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.826 170.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.2 tp60 -54.46 -58.36 7.75 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.362 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.751 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 36.6 mtt180 -37.36 -41.86 0.45 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 124.562 1.164 . . . . 0.0 113.575 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.573 ' HB2' ' HE2' ' A' ' 69' ' ' MET . 91.8 m95 -72.89 -54.42 8.78 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.664 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.706 HD21 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.19 -38.2 62.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.434 0.635 . . . . 0.0 110.343 176.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 90' ' ' GLN . 25.4 t -54.4 -63.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.028 175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.08 -53.79 52.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.021 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 58.7 mt -53.38 -53.81 45.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.34 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.31 -1.07 79.16 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.808 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.2 t -89.98 -41.47 11.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.861 0.83 . . . . 0.0 109.818 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.451 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 8.8 t -75.81 -38.2 58.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.329 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.76 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 2.7 tttt . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.092 0.473 . . . . 0.0 110.908 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 C--O 1.236 0.357 0 CA-C-O 121.963 0.887 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 61.5 t80 -154.66 97.26 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.031 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.699 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 3.6 tpt -120.2 125.24 47.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.955 0.407 . . . . 0.0 111.163 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.685 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 8.2 pt-20 -131.87 151.78 51.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.532 0.682 . . . . 0.0 112.257 -173.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.728 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.97 159.73 8.72 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.309 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -60.08 131.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 83' ' ' ALA . 10.2 tp -122.58 118.61 28.61 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.607 ' O ' ' HB2' ' A' ' 81' ' ' MET . 10.1 m-30 -59.3 149.15 29.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 45.1 mmtm . . . . . 0 C--N 1.313 -1.007 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.669 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 CA--C 1.521 -0.153 0 CA-C-O 121.153 0.397 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.95 143.45 49.48 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.728 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -70.43 139.41 51.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.365 0.603 . . . . 0.0 111.345 -169.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.471 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -138.96 142.95 38.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.036 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.685 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.7 p -154.55 133.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 122.297 1.046 . . . . 0.0 112.67 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.3 tm? -94.42 126.0 39.41 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 113.117 -1.856 . . . . 0.0 109.97 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -138.27 113.38 9.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 58.06 30.91 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.237 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.438 ' CA ' ' HE2' ' A' ' 54' ' ' MET . . . 98.06 -29.81 10.58 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.53 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 0.8 OUTLIER -75.95 106.83 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 121.705 0.764 . . . . 0.0 110.075 177.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.36 108.94 20.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.177 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 14.8 t -103.4 155.17 18.68 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.92 -170.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -109.22 134.85 51.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.109 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.452 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 18.0 m-85 -143.73 169.14 18.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.132 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.74 -65.53 1.0 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.75 0.31 . . . . 0.0 110.547 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -123.78 179.92 4.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -73.5 -7.6 52.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.304 0.573 . . . . 0.0 111.109 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -84.57 -20.98 30.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.774 0.797 . . . . 0.0 110.298 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -78.84 -16.24 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.829 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.652 HG22 ' NE1' ' A' ' 27' ' ' TRP . 65.1 t -45.15 -39.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.2 p -61.7 -55.68 27.79 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.41 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -124.9 -76.83 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.552 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.86 -143.24 48.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.016 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -69.79 -21.54 63.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 0.0 110.8 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 tptt 62.73 13.72 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.34 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.78 129.51 9.18 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 12.3 p -128.98 141.4 51.27 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 35' ' ' LEU . 13.0 mt -89.01 133.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.965 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HG2' HG13 ' A' ' 34' ' ' ILE . 40.5 mtpt -111.69 89.47 3.07 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.819 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.03 -11.42 60.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 109.964 -176.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.14 -26.8 53.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.411 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 m -98.79 -16.13 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.748 0.785 . . . . 0.0 110.147 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 97.9 m -133.4 -142.71 0.21 Allowed 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.5 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.4 tp10 -131.06 146.18 52.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.802 1.183 . . . . 0.0 112.756 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.627 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -89.13 130.28 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.536 ' HG3' HG22 ' A' ' 72' ' ' ILE . 10.1 mmmt -105.01 136.04 45.23 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.187 0.517 . . . . 0.0 110.913 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.549 ' CG1' ' HG ' ' A' ' 93' ' ' LEU . 1.7 m . . . . . 0 C--N 1.315 -0.897 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 173.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.2 p . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.184 0.516 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -125.78 120.86 31.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.52 0.676 . . . . 0.0 110.476 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.455 ' CE ' ' HB2' ' A' ' 92' ' ' TRP . 8.2 ptm -155.07 152.4 29.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.919 -172.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.25 168.08 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.441 ' HG ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.29 134.13 39.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.461 . . . . 0.0 110.856 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.536 HG22 ' HG3' ' A' ' 60' ' ' LYS . 2.1 pp -116.82 119.21 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.72 ' HB ' ' CD ' ' A' ' 74' ' ' PRO . 2.6 pp -134.71 178.33 1.81 Allowed Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.731 -175.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.72 ' CD ' ' HB ' ' A' ' 73' ' ' ILE . 38.9 Cg_endo -76.37 143.38 24.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.197 1.931 . . . . 0.0 113.34 -170.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.74 -49.17 3.99 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.82 80.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.332 0.587 . . . . 0.0 111.048 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -84.39 96.44 9.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -171.8 87.55 0.09 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 110.352 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.499 ' CG ' HD12 ' A' ' 52' ' ' ILE . 92.7 m-85 -129.8 97.06 4.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.097 174.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -107.35 118.19 36.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.607 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 10.7 ptt? -143.23 176.79 8.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.283 0.564 . . . . 0.0 111.623 -171.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 41.7 ttmt -140.79 157.83 44.85 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -105.08 160.0 15.4 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.906 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.683 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -51.33 -31.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.042 176.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 13.0 t-20 -157.62 -175.75 5.56 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -77.45 -48.73 16.43 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.43 -14.55 62.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.624 0.726 . . . . 0.0 109.678 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.683 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 27.2 tp10 -65.6 -40.85 93.1 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 2.4 tmt_? -62.37 -44.21 96.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.261 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.738 ' NE2' HG22 ' A' ' 94' ' ' VAL . 15.8 tm0? -53.34 -62.66 1.51 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.103 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.699 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 69.0 mtt180 -33.11 -46.74 0.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.689 1.243 . . . . 0.0 113.857 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.52 ' CE2' ' HE3' ' A' ' 9' ' ' MET . 93.3 m95 -71.92 -54.37 10.24 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.549 ' HG ' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.2 -36.76 63.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.92 0.867 . . . . 0.0 109.611 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.738 HG22 ' NE2' ' A' ' 90' ' ' GLN . 31.3 t -59.32 -55.8 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.8 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.64 71.07 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.472 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 35' ' ' LEU . 78.0 mt -54.33 -55.67 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.059 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.23 -3.57 90.63 Favored Glycine 0 C--O 1.205 -1.718 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.241 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 48.3 t -67.72 -41.37 83.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.272 1.036 . . . . 0.0 108.826 173.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.406 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 9.7 t -80.49 -38.95 28.89 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.637 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.819 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 29.1 tttt . . . . . 0 C--O 1.226 -0.164 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.009 0.433 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 7.2 t80 -152.43 96.82 2.2 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.74 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 6.4 tpt -115.85 112.64 22.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.853 0.835 . . . . 0.0 110.306 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.633 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.85 137.94 52.53 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.957 -172.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.785 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.44 170.46 26.14 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.204 172.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -62.59 138.31 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 121.472 0.653 . . . . 0.0 111.729 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.463 ' HG ' ' HB2' ' A' ' 81' ' ' MET . 1.7 tp -128.24 116.93 20.63 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 62.4 m-85 -72.98 90.16 1.47 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.784 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 22.8 ttpp . . . . . 0 C--N 1.317 -0.839 0 CA-C-O 122.117 0.96 . . . . 0.0 112.326 -170.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.945 0 CA-C-O 121.364 0.485 . . . . 0.0 112.164 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -107.34 152.52 24.04 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.785 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 65.7 t-105 -74.23 105.43 5.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.084 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.9 OUTLIER -96.48 136.39 37.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.972 -177.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.633 ' HB ' ' CB ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -142.91 128.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.865 0.84 . . . . 0.0 111.994 172.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -96.13 123.45 39.76 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.239 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.24 140.49 14.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 110.379 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 61.25 27.73 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.421 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.517 ' HA2' ' HE3' ' A' ' 54' ' ' MET . . . 86.27 -22.49 12.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.114 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.523 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -86.3 134.15 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-O 121.342 0.591 . . . . 0.0 111.259 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -108.7 106.27 16.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 35.9 m -104.17 147.18 27.74 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.961 -0.462 . . . . 0.0 110.992 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.569 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 7.8 p90 -110.68 120.41 42.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.882 0.848 . . . . 0.0 110.995 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.485 ' HB3' ' CB ' ' A' ' 43' ' ' ASP . 57.4 m-85 -113.91 -174.13 2.41 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.293 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.03 -63.44 1.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.586 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.2 m -122.73 -179.57 4.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HG2' ' CE3' ' A' ' 27' ' ' TRP . 39.2 mt-30 -79.04 -1.26 34.8 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.76 -21.08 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.247 0.546 . . . . 0.0 110.341 170.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.485 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 6.4 m-20 -72.62 -16.8 61.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.418 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.64 HG23 ' NE1' ' A' ' 27' ' ' TRP . 49.1 t -44.62 -28.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.419 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 5.7 t -82.23 -52.22 7.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.878 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -141.23 17.21 2.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 49' ' ' LYS . . . -69.21 117.28 7.76 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.161 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m 72.19 -41.32 0.5 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.669 0.787 . . . . 0.0 113.046 175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.444 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 26.6 mmmt 67.8 11.19 8.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.865 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.19 131.8 10.73 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 34' ' ' ILE . 13.8 p -142.77 146.21 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.512 HG22 HG21 ' A' ' 73' ' ' ILE . 9.0 mt -87.52 134.87 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.919 168.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.523 ' HE3' HD11 ' A' ' 34' ' ' ILE . 40.8 mtpt -108.92 89.28 2.94 Favored 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.537 173.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.638 ' HB2' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -74.15 -21.36 59.89 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -63.32 -38.13 89.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.159 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 m -91.72 -15.19 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.783 0.801 . . . . 0.0 110.688 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.571 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 87.3 m -132.56 -145.27 0.25 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.243 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.7 tp10 -125.81 146.8 49.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.078 0.854 . . . . 0.0 112.221 -170.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.638 HG23 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -95.64 134.64 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 172.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.591 ' HG3' HG22 ' A' ' 72' ' ' ILE . 23.3 mtmt -117.16 147.35 42.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.014 0.435 . . . . 0.0 110.371 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.572 HG13 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m . . . . . 0 C--N 1.313 -1.0 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.49 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 44.3 p . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.576 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 59.0 ttt180 -159.28 109.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.492 . . . . 0.0 109.796 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.596 ' HE3' ' HB2' ' A' ' 92' ' ' TRP . 1.9 mpp? -130.08 171.22 13.05 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -148.58 155.31 40.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.035 0.445 . . . . 0.0 110.906 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -130.35 129.76 43.56 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.25 0.548 . . . . 0.0 111.461 174.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.591 HG22 ' HG3' ' A' ' 60' ' ' LYS . 1.5 pp -111.91 113.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.68 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 2.0 pp -133.67 166.27 30.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.706 -174.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 Cg_endo -59.63 130.03 33.55 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.294 2.662 . . . . 0.0 114.228 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 -25.04 9.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.594 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.83 69.53 0.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -80.85 97.22 7.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.522 0.677 . . . . 0.0 110.144 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -175.29 88.0 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.934 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.2 m-85 -144.97 97.23 2.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.722 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 88.3 m-85 -102.87 127.25 50.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -147.73 141.71 25.91 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.678 0.752 . . . . 0.0 112.833 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 67' ' ' THR . 39.6 ttpt -105.6 138.78 41.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.916 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' A' ' 88' ' ' GLU . . . -96.57 161.9 13.69 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.576 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.683 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -48.69 -45.36 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.79 176.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.51 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 38.3 m-80 -136.93 -175.79 4.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.589 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -79.66 -43.02 23.56 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.537 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.88 -17.71 62.7 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.56 173.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.683 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 26.6 tp10 -67.91 -44.13 77.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.734 ' O ' HD21 ' A' ' 93' ' ' LEU . 17.2 ttt180 -55.13 -52.3 63.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.69 171.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.463 ' O ' HG21 ' A' ' 94' ' ' VAL . 20.3 tp60 -51.6 -56.55 12.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.909 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.74 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 61.8 mtt180 -37.28 -42.36 0.46 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.591 1.157 . . . . 0.0 113.457 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.596 ' HB2' ' HE3' ' A' ' 69' ' ' MET . 93.0 m95 -72.43 -56.49 5.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.881 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.734 HD21 ' O ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -51.83 -37.37 51.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.5 176.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 90' ' ' GLN . 33.1 t -56.23 -63.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.17 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.63 79.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.867 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.1 mt -52.56 -55.25 23.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.37 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.59 -20.42 64.0 Favored Glycine 0 C--O 1.204 -1.741 0 C-N-CA 119.085 -1.531 . . . . 0.0 112.603 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -59.75 -34.68 73.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.91 1.355 . . . . 0.0 109.978 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -91.4 -32.73 15.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.187 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 1.1 tttt . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.406 ' HB2' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.355 0.598 . . . . 0.0 112.588 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.7 t80 -154.04 97.82 2.1 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.736 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 8.9 tpt -122.73 111.07 16.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 122.025 0.917 . . . . 0.0 110.838 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.45 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.36 147.93 45.68 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.44 -171.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.708 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.21 167.09 13.26 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.503 172.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 m -65.36 137.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.448 0.642 . . . . 0.0 111.575 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 82' ' ' LYS . 3.7 tp -124.05 119.05 28.37 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -73.46 87.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.4 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 15.1 tmtt? . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 0.0 111.629 -169.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 N--CA 1.46 -0.471 0 CA-C-O 121.276 0.448 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.44 ' HD3' ' OH ' ' A' ' 37' ' ' TYR . 98.8 mtt180 -123.16 157.09 33.74 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.708 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 74.0 t-105 -81.96 132.58 35.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.422 0.63 . . . . 0.0 111.546 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.497 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -129.44 142.47 50.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.137 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.472 ' CG1' ' HE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -151.6 132.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 122.581 1.181 . . . . 0.0 112.786 167.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.9 tm? -94.75 123.11 38.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.594 -2.093 . . . . 0.0 109.713 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -154.44 141.18 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 171.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.18 27.02 16.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.999 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 86.89 -28.74 5.34 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.133 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.527 HD12 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -77.14 124.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.532 0.682 . . . . 0.0 111.083 178.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.623 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -101.21 106.97 18.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 m -103.14 155.09 18.65 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.481 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.44 ' OH ' ' HD3' ' A' ' 26' ' ' ARG . 21.3 t80 -109.72 132.4 54.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.594 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.472 ' HE2' ' CG1' ' A' ' 29' ' ' VAL . 29.1 m-85 -139.66 179.55 6.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.27 -61.48 1.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.638 0.256 . . . . 0.0 110.916 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.3 m -132.41 -176.76 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' HG3' ' CE3' ' A' ' 27' ' ' TRP . 0.7 OUTLIER -73.29 -3.31 26.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.18 -20.47 23.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.257 0.551 . . . . 0.0 110.385 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.402 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 7.5 m-20 -82.29 -15.61 52.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.525 -175.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.673 HG23 ' NE1' ' A' ' 27' ' ' TRP . 70.3 t -41.16 -37.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -172.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 p -68.78 -51.82 36.87 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.079 -0.388 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -124.59 -68.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.073 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.63 -132.6 52.63 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.83 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.5 m -77.01 -8.49 57.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.747 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.8 tptt 73.93 -37.62 0.37 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.067 0.854 . . . . 0.0 112.485 176.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.99 129.91 42.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.195 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.1 p -139.7 139.07 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.367 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.623 ' HB ' ' O ' ' A' ' 35' ' ' LEU . 13.7 mt -88.51 133.77 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.41 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.527 ' HE3' HD12 ' A' ' 34' ' ' ILE . 38.1 mtpt -110.99 94.18 4.86 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.916 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.571 ' HB2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -76.66 -1.05 25.82 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.753 0.311 . . . . 0.0 110.439 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.01 -47.95 9.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.874 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.473 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.6 m -80.81 -16.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.034 0.921 . . . . 0.0 109.641 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.525 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 41.0 m -133.88 -154.84 0.62 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.835 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' ' HZ3' ' A' ' 100' ' ' LYS . 6.6 tp10 -124.35 144.37 50.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 113.23 -167.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.571 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -90.9 115.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 171.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.505 ' HG3' HG21 ' A' ' 72' ' ' ILE . 23.8 mmmt -97.47 139.08 33.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.568 -172.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.409 HG12 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m . . . . . 0 C--N 1.314 -0.939 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.733 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.1 p . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 121.46 0.648 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.69 120.12 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.437 ' HG2' ' O ' ' A' ' 81' ' ' MET . 9.4 ptm -170.16 151.95 4.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.735 -172.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -155.51 166.89 32.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.848 0.356 . . . . 0.0 110.325 -175.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.504 ' HG ' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -136.98 131.23 32.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.006 0.431 . . . . 0.0 111.102 175.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.524 ' O ' ' HB3' ' A' ' 57' ' ' CYS . 2.2 pp -115.5 118.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.692 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 1.9 pp -138.47 166.06 28.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.581 -174.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.692 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 37.3 Cg_endo -60.29 136.91 71.41 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.597 2.864 . . . . 0.0 114.437 -172.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.19 -45.07 2.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.664 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.79 80.04 1.01 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.106 0.479 . . . . 0.0 111.121 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.425 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 8.8 pt20 -81.43 95.87 7.19 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.399 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -166.61 87.41 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.303 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.8 m-85 -136.55 96.01 3.26 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 65.0 m-85 -103.83 117.06 33.47 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -142.52 147.6 36.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.384 0.611 . . . . 0.0 111.483 -172.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' A' ' 67' ' ' THR . 48.1 mtmt -110.53 176.69 4.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 88' ' ' GLU . . . -127.41 173.13 10.06 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.577 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.705 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -50.06 -39.52 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.609 0.719 . . . . 0.0 111.073 174.303 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -149.01 -176.17 5.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.383 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.609 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -86.14 -37.21 19.0 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.795 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -74.52 -15.15 60.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.113 0.959 . . . . 0.0 109.429 171.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.705 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.04 -52.46 55.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -47.99 -48.05 32.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.506 170.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.751 ' NE2' HG23 ' A' ' 94' ' ' VAL . 14.6 tm0? -51.74 -62.31 1.71 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.879 0.872 . . . . 0.0 111.127 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.736 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 69.7 mtt180 -35.17 -41.78 0.16 Allowed 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.57 1.169 . . . . 0.0 113.694 175.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.529 ' CE2' ' HE2' ' A' ' 9' ' ' MET . 96.9 m95 -73.36 -56.63 4.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.74 -36.42 57.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.792 0.806 . . . . 0.0 110.078 177.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.751 HG23 ' NE2' ' A' ' 90' ' ' GLN . 30.4 t -60.64 -53.58 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.621 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.85 46.08 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.624 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.423 ' CD1' HD13 ' A' ' 59' ' ' ILE . 77.3 mt -51.49 -53.59 35.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.774 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.83 -4.26 90.13 Favored Glycine 0 C--O 1.207 -1.535 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.624 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.556 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.7 t -69.09 -34.4 75.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.507 1.154 . . . . 0.0 109.243 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.3 t -89.51 -29.12 19.18 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.027 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 39.8 tttt . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 54.0 t80 -153.8 98.22 2.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.713 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 5.5 tpt -126.31 118.12 24.42 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.344 0.592 . . . . 0.0 111.017 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -126.2 153.13 45.09 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.533 -173.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.703 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 142.03 161.16 8.63 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.671 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.31 132.17 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.748 0.785 . . . . 0.0 111.12 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 83' ' ' ALA . 10.5 tp -122.03 118.65 29.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 8.8 m-30 -61.06 148.26 40.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 37.1 mtmt . . . . . 0 C--N 1.311 -1.075 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.832 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 44.3 Cg_endo . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.264 0.443 . . . . 0.0 112.966 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -116.46 139.67 50.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.703 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 64.3 t-105 -72.49 125.69 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.747 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.553 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.3 m-85 -121.15 143.16 49.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.045 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -152.47 129.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 122.445 1.117 . . . . 0.0 112.45 166.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -94.85 122.97 38.03 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 112.636 -2.074 . . . . 0.0 109.496 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -153.18 136.94 16.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.21 0.528 . . . . 0.0 110.301 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 61.12 24.26 14.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.207 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.634 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 91.76 -25.16 17.28 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.551 HD13 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.15 120.91 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-O 121.517 0.675 . . . . 0.0 111.064 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.703 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -100.21 108.21 20.25 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.417 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . 25.3 t -103.87 149.78 24.76 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.519 -0.738 . . . . 0.0 110.896 -172.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 22.8 p90 -113.58 130.55 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.492 0.663 . . . . 0.0 111.225 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 6.7 m-85 -130.36 179.06 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.144 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.88 -54.38 3.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.79 0.328 . . . . 0.0 110.235 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.5 p -131.56 178.33 6.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -72.36 -9.31 58.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.377 0.608 . . . . 0.0 110.595 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -85.69 -20.93 28.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.439 0.638 . . . . 0.0 110.335 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.09 -14.89 57.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.181 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.574 HG23 ' NE1' ' A' ' 27' ' ' TRP . 94.5 t -44.68 -27.14 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 t -73.16 -41.41 63.95 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.634 -0.666 . . . . 0.0 111.039 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -113.05 -71.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA3' ' CD2' ' A' ' 38' ' ' TYR . . . 65.44 52.4 40.11 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.231 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m 64.23 2.76 1.57 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.847 0.356 . . . . 0.0 111.921 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 31.4 mmmt 61.33 24.01 14.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.592 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 124.73 7.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.949 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.92 156.48 47.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.739 0.78 . . . . 0.0 111.729 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.703 ' HB ' ' O ' ' A' ' 35' ' ' LEU . 13.4 mt -92.0 131.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.293 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.551 ' HE3' HD13 ' A' ' 34' ' ' ILE . 33.5 mtpt -103.79 89.12 3.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.317 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.634 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -76.22 -3.7 37.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.65 -175.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.15 -41.81 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.204 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.4 m -83.92 -15.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.969 0.89 . . . . 0.0 109.466 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.567 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 51.9 m -133.47 -155.35 0.67 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.02 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.401 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.4 tp10 -121.54 144.01 48.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.621 1.1 . . . . 0.0 113.354 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.489 HD13 ' CD1' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -89.33 114.37 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 171.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HG3' HG23 ' A' ' 72' ' ' ILE . 22.0 mmmt -95.77 136.97 35.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.139 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.454 HG11 ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.317 -0.834 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.427 ' OG1' ' HE3' ' A' ' 82' ' ' LYS . 3.3 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.962 0.411 . . . . 0.0 111.815 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -135.99 131.28 34.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.188 0.518 . . . . 0.0 110.718 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.905 ' HG3' ' SD ' ' A' ' 81' ' ' MET . 8.2 ptm -170.16 153.95 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.164 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.49 167.54 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.048 0.451 . . . . 0.0 110.832 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.428 ' HG ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.84 134.7 39.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 175.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.508 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.3 pp -119.85 120.7 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.678 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 2.0 pp -139.43 165.98 27.69 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.077 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.678 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.51 146.23 95.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.27 2.647 . . . . 0.0 114.121 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.11 -45.63 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.806 -0.634 . . . . 0.0 113.122 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -148.05 66.8 1.09 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.272 0.558 . . . . 0.0 110.943 -176.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.54 95.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.446 0.641 . . . . 0.0 110.859 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 179.87 87.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.957 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CG ' HD13 ' A' ' 52' ' ' ILE . 91.9 m-85 -131.56 98.41 4.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.425 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -108.3 109.63 21.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.905 ' SD ' ' HG3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -128.82 171.43 12.26 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.748 -178.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 73.3 tttt -131.15 150.32 52.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 88' ' ' GLU . . . -98.48 158.69 15.44 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.276 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.678 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.1 t -50.8 -43.87 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.342 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -143.01 -171.46 3.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.573 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.46 -41.22 15.58 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.649 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.94 -16.68 61.54 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.168 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.678 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -66.23 -53.06 41.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 170.226 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.591 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 15.3 ttt180 -48.1 -49.17 32.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.924 171.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 51.6 tp60 -54.98 -58.39 7.84 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.848 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.713 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 41.9 mtt180 -37.8 -42.62 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 113.809 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CE2' ' HE3' ' A' ' 9' ' ' MET . 92.2 m95 -72.37 -53.77 11.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.381 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.464 HD11 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.84 -37.37 60.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.719 0.771 . . . . 0.0 110.246 176.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 98' ' ' SER . 24.5 t -60.05 -56.61 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.659 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.12 65.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.683 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.489 ' CD1' HD13 ' A' ' 59' ' ' ILE . 81.4 mt -52.99 -56.04 19.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.668 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.32 -2.92 88.26 Favored Glycine 0 C--O 1.205 -1.689 0 C-N-CA 119.695 -1.24 . . . . 0.0 112.473 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 21.7 t -68.29 -41.27 81.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.536 1.168 . . . . 0.0 108.931 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.7 t -80.7 -38.2 29.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.914 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 28.9 tttt . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -174.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.03 56.38 3.05 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.549 2.833 . . . . 0.0 112.714 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.42 ' C ' ' HB3' ' A' ' 102' ' ' CYS . 2.7 pt? -176.88 -26.83 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.44 -141.58 12.18 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.573 ' O ' ' HA ' ' A' ' 99' ' ' SER . 30.7 t -92.27 119.75 67.99 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.06 85.84 0.25 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.331 2.02 . . . . 0.0 111.771 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -87.69 165.31 15.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.364 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 84.5 t80 -153.15 97.34 2.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.738 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.7 ttt -124.69 137.25 54.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.396 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.683 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.2 pt-20 -134.93 147.97 49.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.522 . . . . 0.0 112.205 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.734 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 155.21 166.34 15.33 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.523 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.9 133.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.413 0.625 . . . . 0.0 111.825 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 83' ' ' ALA . 4.7 tp -118.34 120.05 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -74.52 93.11 2.44 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.14 0.576 . . . . 0.0 110.89 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 29.4 mtmt -92.98 146.0 23.95 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.681 0.753 . . . . 0.0 112.412 -168.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.549 ' CZ2' ' HA ' ' A' ' 19' ' ' TYR . 39.3 t-105 -93.61 98.6 11.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.355 175.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.2 p -86.77 -33.61 19.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.03 0.443 . . . . 0.0 110.558 -175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -159.08 165.88 32.89 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.549 ' HA ' ' CZ2' ' A' ' 16' ' ' TRP . 50.6 t80 -58.28 -41.95 85.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.018 0.437 . . . . 0.0 110.486 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.9 mt -64.47 -53.64 44.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.862 0.839 . . . . 0.0 110.758 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.0 p -107.31 89.42 2.99 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.707 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 23' ' ' TRP . . . -108.95 -174.31 21.37 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 172.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.474 ' HB3' ' O ' ' A' ' 22' ' ' GLY . 17.8 t90 73.84 -9.19 1.26 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 117.259 0.53 . . . . 0.0 112.202 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -49.56 102.32 0.31 Allowed Pre-proline 0 N--CA 1.472 0.645 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -171.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.86 107.84 2.51 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.173 1.249 . . . . 0.0 109.941 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -124.26 142.87 50.9 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.734 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 67.7 t-105 -74.11 129.03 37.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.68 142.2 50.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.197 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.683 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -151.06 133.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 122.161 0.981 . . . . 0.0 112.557 172.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -92.98 119.72 32.54 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.694 -174.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -131.3 111.0 11.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 57.17 26.68 12.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.716 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.585 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.54 -28.34 15.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.368 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.578 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.01 108.78 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.932 0.872 . . . . 0.0 110.463 178.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.416 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -94.81 107.6 19.61 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.47 179.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 m -103.25 160.36 14.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.45 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -108.43 133.21 52.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.345 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.451 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 22.8 m-85 -139.82 165.34 27.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.992 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.33 6.75 22.62 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.394 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 t -173.6 164.55 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.172 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -77.28 -13.62 59.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.086 0.469 . . . . 0.0 111.181 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.48 -16.93 28.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.501 0.667 . . . . 0.0 109.996 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.521 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 26.6 t0 -79.7 -15.05 58.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.757 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.608 HG21 ' NE1' ' A' ' 27' ' ' TRP . 94.3 t -45.62 -29.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 p -69.82 -37.14 76.13 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HB3' ' HZ1' ' A' ' 49' ' ' LYS . 68.4 mmtt -122.79 -58.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.851 0.358 . . . . 0.0 110.665 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -148.33 49.51 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.315 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 50' ' ' GLY . 71.0 m -89.08 2.31 54.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.404 ' HZ1' ' HB3' ' A' ' 46' ' ' LYS . 9.8 mptt 75.29 -34.66 0.26 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.762 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -63.91 141.3 44.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.002 176.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 p -147.11 150.0 34.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.359 0.599 . . . . 0.0 111.431 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.474 ' CG2' HG22 ' A' ' 73' ' ' ILE . 10.8 mt -87.63 123.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.321 176.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.578 ' HE3' HD11 ' A' ' 34' ' ' ILE . 30.8 mtpt -96.05 88.08 4.76 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.735 172.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.585 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -79.53 -9.6 59.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.748 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -80.81 -38.4 28.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.11 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.552 ' HA ' ' H ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -86.26 -17.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.246 1.022 . . . . 0.0 109.619 -174.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.468 ' HB3' HD12 ' A' ' 72' ' ' ILE . 96.3 m -128.69 -153.09 0.55 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.659 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.6 tp10 -120.81 142.98 49.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 119.247 0.931 . . . . 0.0 112.982 -168.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.64 115.84 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 170.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HG3' HG21 ' A' ' 72' ' ' ILE . 20.8 mmmt -94.29 130.73 40.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.496 HG13 ' HG ' ' A' ' 93' ' ' LEU . 1.8 m -141.17 128.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -145.37 -73.61 0.24 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.383 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 68' ' ' ARG . 44.2 m -16.56 109.99 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.079 1.487 . . . . 0.0 113.28 -167.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 57.66 0.7 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.423 -169.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -166.54 -159.35 0.36 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -69.49 152.46 44.83 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.631 ' CA ' ' HD3' ' A' ' 89' ' ' ARG . 80.4 p 54.72 95.97 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 O-C-N 123.405 0.44 . . . . 0.0 111.484 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -140.08 117.13 11.13 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.609 -0.682 . . . . 0.0 111.704 174.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.727 ' SD ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -172.38 153.68 3.02 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -159.65 164.79 33.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.595 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.445 ' HG ' ' CG2' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -133.09 130.32 39.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.192 0.52 . . . . 0.0 111.265 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.527 HG21 ' HG3' ' A' ' 60' ' ' LYS . 2.2 pp -115.96 120.49 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.706 ' HB ' ' CD ' ' A' ' 74' ' ' PRO . 2.5 pp -137.1 176.85 2.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.706 ' CD ' ' HB ' ' A' ' 73' ' ' ILE . 50.0 Cg_exo -54.79 137.03 73.98 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.004 3.136 . . . . 0.0 114.426 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.14 -46.56 3.0 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.887 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.403 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 13.6 pt-20 -139.46 106.36 5.41 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.595 0.712 . . . . 0.0 110.884 -177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.84 97.18 8.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.939 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.403 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -177.62 86.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.49 -178.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -140.42 96.45 3.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.172 0.511 . . . . 0.0 109.635 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -101.75 121.56 42.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.9 ptt? -151.08 137.57 18.66 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.161 -172.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 89' ' ' ARG . 35.5 ttpt -102.41 177.98 4.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -124.06 169.72 11.39 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.274 -175.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.713 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.66 -38.02 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 123.793 0.683 . . . . 0.0 110.983 173.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -157.66 -170.07 3.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.584 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.36 -48.91 9.88 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.995 -172.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -67.59 -17.87 64.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.554 0.692 . . . . 0.0 109.487 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.713 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.35 -54.4 29.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.475 -1.239 . . . . 0.0 107.739 171.273 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.727 ' HG3' ' SD ' ' A' ' 69' ' ' MET . 3.4 ttt180 -58.49 -34.51 71.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.765 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.48 ' O ' HG22 ' A' ' 94' ' ' VAL . 47.7 tp60 -62.91 -56.94 12.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.437 0.695 . . . . 0.0 111.044 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.738 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 65.3 mtt180 -34.71 -47.06 0.32 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.685 1.194 . . . . 0.0 113.149 174.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.509 ' HB2' ' CE ' ' A' ' 69' ' ' MET . 97.0 m95 -66.56 -53.63 32.51 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -49.97 -40.86 45.42 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.612 0.72 . . . . 0.0 109.96 175.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 52.5 t -55.85 -64.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.088 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 -50.49 71.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.37 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.474 HD23 ' HG2' ' A' ' 54' ' ' MET . 70.2 mt -52.65 -62.78 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.117 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.687 ' O ' ' HB1' ' A' ' 101' ' ' ALA . . . -75.31 -1.81 65.59 Favored Glycine 0 C--O 1.222 -0.642 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.799 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.9 t -90.33 -32.65 16.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.564 0.682 . . . . 0.0 109.67 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 5' ' ' SER . 31.8 t -83.56 -28.09 28.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.032 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 17.8 tttt -100.72 1.31 40.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.629 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.687 ' HB1' ' O ' ' A' ' 97' ' ' GLY . . . -56.77 -21.16 26.46 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -168.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.42 ' HB3' ' C ' ' A' ' 3' ' ' LEU . 45.2 t -90.89 -13.74 33.03 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.932 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 107' ' ' ARG . 1.1 mm? -90.26 100.93 13.67 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 110.015 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.0 p -89.24 -24.02 22.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.134 0.493 . . . . 0.0 110.267 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -111.1 -72.15 0.73 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.878 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.469 HG21 ' O ' ' A' ' 56' ' ' VAL . 85.4 m -160.03 131.79 6.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.116 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.552 ' H ' ' HA ' ' A' ' 56' ' ' VAL . 14.7 tpt180 -69.13 99.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.25 1.121 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.664 -178.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.35 78.24 2.35 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.873 2.382 . . . . 0.0 112.277 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.8 148.06 46.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.164 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.57 166.77 17.18 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.364 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 p -60.25 139.3 91.67 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 122.387 0.275 . . . . 0.0 111.06 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.56 93.73 0.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.613 2.209 . . . . 0.0 112.117 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 9.7 tp10 -77.24 168.56 19.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.656 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.537 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 30.4 t80 -150.87 98.54 2.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.749 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 4.0 tpt -123.91 129.68 51.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.885 0.374 . . . . 0.0 111.355 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.702 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.0 pt-20 -134.84 143.73 47.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.365 0.602 . . . . 0.0 112.56 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.687 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 160.41 170.18 24.66 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.497 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -73.49 141.18 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.353 0.597 . . . . 0.0 112.276 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.491 HD23 ' SD ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -121.96 118.57 29.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.08 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.16 116.53 21.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.263 0.625 . . . . 0.0 112.103 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.637 ' HG2' ' C ' ' A' ' 80' ' ' TYR . 25.5 tptt -153.98 168.48 26.28 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.495 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 35.9 t-105 -52.71 140.77 22.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.198 169.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -128.96 61.43 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 61.02 60.3 1.85 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.349 170.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 16' ' ' TRP . 80.7 t80 72.1 -63.29 0.43 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 168.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.1 mt -46.85 -56.72 5.82 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 123.334 0.654 . . . . 0.0 111.276 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.5 p -110.75 128.0 55.56 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.298 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 16' ' ' TRP . . . -65.74 -40.01 95.53 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.078 -173.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.614 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 39.5 p-90 -155.26 136.97 14.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.443 ' HB2' HG23 ' A' ' 17' ' ' THR . 84.4 mm-40 -145.99 119.82 5.31 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.614 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 19.9 Cg_endo -63.76 108.14 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.059 1.173 . . . . 0.0 110.72 167.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -112.13 149.39 32.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.687 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -80.4 130.84 35.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.468 0.652 . . . . 0.0 111.444 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.583 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -124.86 145.17 49.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.49 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.702 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.5 p -156.76 132.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 122.329 1.062 . . . . 0.0 112.798 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.1 tm? -94.36 118.29 31.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.725 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.18 130.22 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 109.914 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.52 22.15 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.841 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.644 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 97.21 -22.82 38.68 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.273 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.5 HD12 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -80.54 120.09 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.465 0.65 . . . . 0.0 111.157 177.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.585 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.67 106.84 18.82 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.162 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 8.3 t -105.16 162.38 13.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.013 0.435 . . . . 0.0 111.973 -167.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.458 ' OH ' ' HD1' ' A' ' 79' ' ' PHE . 39.3 m-85 -106.81 137.59 44.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.593 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' HE2' ' CG1' ' A' ' 29' ' ' VAL . 22.0 m-85 -149.28 164.47 34.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -98.0 -39.98 8.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.431 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -130.5 166.35 20.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.8 -5.82 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.24 -18.29 23.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.274 0.559 . . . . 0.0 110.109 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.7 -14.8 59.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.943 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.541 HG21 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -44.39 -22.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 2.7 p -83.0 -57.69 3.18 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.413 -0.805 . . . . 0.0 112.273 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 39.8 mmtm -133.58 27.78 4.01 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.59 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 49' ' ' LYS . . . -84.85 132.77 11.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.762 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.9 m 74.04 -34.0 0.27 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 47' ' ' GLY . 7.2 mptt 68.54 6.43 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.68 0.792 . . . . 0.0 112.727 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 137.54 13.43 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.882 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 12.0 p -146.83 142.67 27.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HB ' ' O ' ' A' ' 35' ' ' LEU . 9.8 mt -89.24 136.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.465 1.106 . . . . 0.0 111.197 172.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' HE3' HD12 ' A' ' 34' ' ' ILE . 31.4 mtpt -106.73 89.78 3.12 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 120.993 0.425 . . . . 0.0 110.669 173.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.644 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.17 -1.16 31.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.621 -177.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.31 -48.47 8.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.04 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.421 HG21 ' HD3' ' A' ' 74' ' ' PRO . 1.7 m -80.7 -15.95 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.177 0.989 . . . . 0.0 109.501 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.578 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 54.1 m -131.64 -155.39 0.69 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.956 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.548 ' O ' HG13 ' A' ' 72' ' ' ILE . 7.8 tp10 -123.11 146.4 47.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.463 1.029 . . . . 0.0 113.194 -165.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.504 HD13 HG12 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -88.22 121.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.155 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 5.6 mttt -96.41 135.61 38.03 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.106 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.504 HG12 HD13 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -138.31 158.27 31.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.24 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -138.2 94.78 2.91 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.108 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -78.62 78.06 5.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.197 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.62 33.93 0.27 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.756 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 16.9 t70 -170.61 -29.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.828 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 18.9 m120 83.29 -11.95 0.89 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.662 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p -135.72 44.2 2.53 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.107 0.479 . . . . 0.0 111.54 175.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -123.12 124.4 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.052 0.453 . . . . 0.0 111.357 176.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.543 ' HG2' ' H ' ' A' ' 70' ' ' GLU . 5.1 ttm -155.76 160.88 40.66 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.543 ' H ' ' HG2' ' A' ' 69' ' ' MET . 4.9 mt-10 -152.4 168.03 26.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 79' ' ' PHE . 0.2 OUTLIER -129.72 140.1 51.18 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.828 0.347 . . . . 0.0 110.269 171.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 58' ' ' GLU . 1.7 pp -120.87 117.05 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.699 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 1.7 pp -136.36 168.87 15.19 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.073 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.699 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 87.5 Cg_exo -29.79 117.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 124.94 3.76 . . . . 0.0 116.185 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.4 -21.38 6.2 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.273 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 14.9 pt-20 -151.76 115.33 4.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 112.322 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 3.0 pt20 -103.13 97.26 7.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 110.103 173.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.454 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 1.2 p80 -175.47 87.15 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.674 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 96.6 m-85 -138.2 97.02 3.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.637 ' C ' ' HG2' ' A' ' 15' ' ' LYS . 69.0 m-85 -87.99 140.61 29.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.311 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.586 ' HA ' ' HB2' ' A' ' 15' ' ' LYS . 8.3 ptt? -170.53 142.31 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 171.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.497 ' HA ' HH12 ' A' ' 89' ' ' ARG . 37.5 ttmt -104.64 170.17 8.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' A' ' 88' ' ' GLU . . . -119.55 165.49 14.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 118.514 0.597 . . . . 0.0 110.994 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.722 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.81 -42.2 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.57 0.544 . . . . 0.0 111.082 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -148.82 -172.27 4.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.86 -40.51 15.88 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.656 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.0 -18.8 63.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.608 0.718 . . . . 0.0 109.14 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.722 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -68.61 -52.15 34.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.573 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -48.07 -47.59 33.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.876 170.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.527 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.4 tp60 -55.78 -55.51 31.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.671 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.749 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 8.1 mtp180 -35.51 -44.84 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 124.599 1.187 . . . . 0.0 113.614 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.583 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 97.2 m95 -76.1 -51.03 13.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -53.16 -35.87 60.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.641 0.734 . . . . 0.0 109.889 175.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 19.6 t -55.86 -65.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.857 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.43 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -63.11 -55.77 22.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.002 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.486 ' CD1' HD11 ' A' ' 59' ' ' ILE . 83.3 mt -50.44 -60.21 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.525 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.738 ' O ' ' HB3' ' A' ' 101' ' ' ALA . . . -87.39 -1.67 83.51 Favored Glycine 0 C--O 1.221 -0.71 0 CA-C-O 119.23 -0.761 . . . . 0.0 114.331 -173.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -90.04 -37.56 14.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.427 1.113 . . . . 0.0 109.517 169.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.7 t -72.81 -41.76 64.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.966 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 21.1 tttt -88.22 -1.48 58.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.25 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -56.42 -35.44 67.82 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 121.882 -0.511 . . . . 0.0 112.227 -172.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 35.5 t -86.09 -17.1 36.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.099 0.476 . . . . 0.0 110.705 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.457 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 7.7 tp -78.72 -27.76 44.94 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 103' ' ' LEU . 68.3 p 60.87 -81.83 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.829 1.252 . . . . 0.0 112.836 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -121.41 -66.42 1.05 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.712 0.291 . . . . 0.0 110.983 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.2 p -95.52 150.79 19.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.812 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -81.35 165.95 20.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.132 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.048 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.511 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' A' ' 108' ' ' THR . 71.5 Cg_endo -76.25 65.09 7.16 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 123.056 2.504 . . . . 0.0 112.588 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.0 tp -177.38 152.27 0.83 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.52 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . -149.65 -101.53 0.24 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.29 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 99' ' ' SER . 14.7 m -71.11 114.69 29.45 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.556 0.217 . . . . 0.0 111.194 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.1 83.69 2.21 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.878 2.386 . . . . 0.0 110.74 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 7.6 tp10 -76.9 161.25 28.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.05 -174.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 81.2 t80 -150.57 99.0 2.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.037 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.659 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 3.7 tpt -127.48 120.5 28.47 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.291 0.567 . . . . 0.0 110.795 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -126.86 155.73 42.5 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.851 -173.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.74 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 143.87 167.31 11.76 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.725 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 27' ' ' TRP . 1.5 m -64.46 132.99 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.53 0.681 . . . . 0.0 111.208 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.1 tp -126.32 116.94 22.0 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 8.4 m-85 -66.25 161.07 23.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.6 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 67.6 mmtt -133.43 159.65 39.7 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.453 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 75.9 t-105 -117.58 102.13 8.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.0 p -74.4 -61.95 1.69 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.998 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -163.47 -68.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -152.76 -65.27 0.16 Allowed 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.694 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.3 mt -51.12 -67.64 0.23 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.647 0.737 . . . . 0.0 111.271 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.6 p -97.87 41.17 1.13 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.504 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 16' ' ' TRP . . . -44.52 -64.23 2.15 Favored Glycine 0 CA--C 1.5 -0.861 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.266 -174.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.61 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 36.5 p-90 -88.65 128.53 35.6 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -144.57 105.74 4.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.491 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 36.4 Cg_endo -70.46 109.6 2.49 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 120.919 1.079 . . . . 0.0 112.071 174.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -113.75 135.75 53.6 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.74 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 49.5 t-105 -71.07 132.92 45.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.419 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -129.05 145.08 51.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.389 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.514 ' CG1' ' HE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -151.6 131.16 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.276 1.036 . . . . 0.0 112.654 170.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.561 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.7 tm? -93.69 113.09 25.09 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.784 -176.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.19 100.18 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.51 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.4 29.25 17.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.852 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.664 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.1 -23.29 32.5 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.131 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.514 HD13 ' HE3' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -82.3 100.21 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-O 122.138 0.971 . . . . 0.0 109.662 175.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -93.99 102.29 14.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.883 -177.722 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.4 t -105.33 155.4 19.13 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.443 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.564 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.7 p90 -114.04 141.24 47.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.132 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 38.7 m-85 -137.03 155.72 49.33 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.44 -4.26 59.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.766 0.317 . . . . 0.0 111.214 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -159.9 161.27 34.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.712 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -75.47 -17.44 60.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 110.643 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.16 -16.95 28.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.322 0.582 . . . . 0.0 109.984 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.0 -16.03 57.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.548 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.609 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 65.3 t -47.31 -43.41 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -51.85 -43.56 63.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.89 55.56 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.263 0.554 . . . . 0.0 111.83 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -121.5 0.73 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.815 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 50' ' ' GLY . 13.5 m -64.46 -30.65 71.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.865 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 29.6 mmmt 71.26 -25.07 0.17 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.999 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -54.93 134.62 47.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 175.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.483 ' HB2' HG21 ' A' ' 34' ' ' ILE . 32.5 p -140.87 150.62 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.948 0.88 . . . . 0.0 113.114 -171.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.513 HG23 HG23 ' A' ' 73' ' ' ILE . 12.7 mt -88.67 131.52 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.662 171.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.514 ' HE3' HD13 ' A' ' 34' ' ' ILE . 26.1 mtpt -101.23 89.56 3.83 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 172.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.664 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.46 3.8 14.92 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.354 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.04 -43.4 13.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.035 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 106' ' ' THR . 2.0 m -87.1 -18.35 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.724 0.773 . . . . 0.0 110.25 -173.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.601 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 55.3 m -136.0 -173.36 3.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.921 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.548 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.9 tp10 -105.99 144.39 32.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -161.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.617 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -94.51 128.23 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.573 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 15.9 mmmt -109.87 144.29 38.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.644 ' CG1' ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -141.61 142.3 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.595 ' CE1' ' HA ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER 67.52 -43.04 0.45 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 165.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.5 t 63.05 -80.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -170.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.595 ' HA ' ' CE1' ' A' ' 62' ' ' HIS . . . -153.45 16.82 0.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.08 0.467 . . . . 0.0 110.784 169.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.65 -179.72 3.78 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.789 177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.641 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 94.0 m-20 -84.0 -80.98 0.18 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 16.2 p -73.86 73.29 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.447 0.641 . . . . 0.0 111.113 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -148.03 143.74 27.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.743 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.461 ' HG3' ' HG3' ' A' ' 81' ' ' MET . 4.5 ptm -170.29 154.99 5.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -148.57 166.9 26.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.025 0.44 . . . . 0.0 110.154 -176.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.5 ' HG ' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.94 124.53 23.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.276 0.56 . . . . 0.0 110.772 171.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 57' ' ' CYS . 2.0 pp -105.31 114.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.7 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 1.7 pp -136.38 163.35 50.61 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.067 -174.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.7 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 9.5 Cg_exo -14.6 -115.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.303 1 C-N-CA 126.857 5.038 . . . . 0.0 118.407 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.33 3.18 59.55 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.652 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -144.2 63.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.219 0.533 . . . . 0.0 111.395 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.403 ' HA ' ' H ' ' A' ' 73' ' ' ILE . 15.8 pt20 -78.02 96.55 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.396 0.617 . . . . 0.0 110.213 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 178.67 88.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.194 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 71.0 m-85 -137.36 96.23 3.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -98.46 132.48 43.86 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.443 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.461 ' HG3' ' HG3' ' A' ' 69' ' ' MET . 17.1 ptt? -157.58 165.59 35.15 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.309 0.576 . . . . 0.0 111.059 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 67' ' ' THR . 41.1 ttmt -131.2 157.91 41.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 88' ' ' GLU . . . -112.35 162.02 16.01 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.89 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.706 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.0 -41.27 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.259 175.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -147.02 -176.16 5.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.887 177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -83.4 -36.82 23.99 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.622 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.23 -19.15 61.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.613 0.72 . . . . 0.0 109.173 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.706 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -67.77 -51.84 44.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.641 ' HD3' ' O ' ' A' ' 66' ' ' ASN . 23.6 ttp180 -50.3 -45.72 54.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.914 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 8.0 tp60 -54.91 -59.19 5.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.563 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.659 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 14.6 mtt180 -36.33 -44.61 0.43 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.64 1.176 . . . . 0.0 113.466 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.553 ' CE2' ' HE2' ' A' ' 9' ' ' MET . 95.0 m95 -70.9 -55.43 8.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.644 ' HG ' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.03 -37.38 61.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.71 0.767 . . . . 0.0 110.15 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 98' ' ' SER . 19.0 t -56.97 -57.99 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.294 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -69.28 -43.55 73.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.938 -175.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.441 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 66.7 mt -54.06 -60.73 2.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.785 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.782 ' O ' ' HB1' ' A' ' 101' ' ' ALA . . . -77.17 -1.18 73.45 Favored Glycine 0 C--O 1.203 -1.838 0 C-N-CA 119.259 -1.448 . . . . 0.0 112.106 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 39.4 t -75.1 -41.75 58.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.435 1.117 . . . . 0.0 108.615 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 5' ' ' SER . 8.6 t -79.64 -37.79 35.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.603 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 34.5 tttt -84.38 -7.93 59.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.832 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.782 ' HB1' ' O ' ' A' ' 97' ' ' GLY . . . -53.29 -26.26 17.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.651 0.739 . . . . 0.0 110.769 -176.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.52 ' SG ' ' HA3' ' A' ' 4' ' ' GLY . 56.1 m -101.94 5.33 40.76 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.283 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 100' ' ' LYS . 1.4 mm? -83.77 -79.47 0.2 Allowed 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.1 174.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.9 p 48.37 39.64 12.94 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.601 0.563 . . . . 0.0 111.643 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -166.16 -81.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.185 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 8.2 p -135.26 -90.57 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.413 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.476 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -174.86 178.93 1.74 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 178.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.437 ' HB ' ' O ' ' A' ' 2' ' ' PRO . 2.9 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.06 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.48 115.45 2.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.453 2.102 . . . . 0.0 112.065 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.9 mt 61.34 30.78 19.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.389 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.49 145.97 5.33 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.368 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -111.92 131.89 22.24 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.91 74.11 3.5 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.705 2.27 . . . . 0.0 112.997 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 43.2 mm-40 -81.96 162.66 22.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.975 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 73.2 t80 -154.02 99.45 2.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.776 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.1 ttt -132.22 136.15 46.8 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.636 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.733 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.8 pt-20 -136.31 144.38 44.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.362 0.601 . . . . 0.0 112.294 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.688 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.5 168.16 22.99 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.399 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 m -67.06 140.83 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.646 0.736 . . . . 0.0 112.299 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 tp -125.12 118.93 27.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -67.37 87.76 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.31 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 43.2 tttm -99.49 143.97 29.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -70.17 126.19 28.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.037 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 p -100.16 -57.99 2.01 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.15 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -165.73 158.19 15.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -60.05 -15.65 24.67 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 40.8 mt -73.14 -71.04 0.33 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.536 0.684 . . . . 0.0 111.306 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.2 p -83.2 -11.53 57.76 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.204 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.67 -107.98 2.36 Favored Glycine 0 CA--C 1.505 -0.571 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.561 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.811 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 29.5 p-90 -108.41 139.89 42.5 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -143.75 125.89 8.46 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.811 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 6.3 Cg_endo -53.52 109.04 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.71 1.607 . . . . 0.0 112.012 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.445 ' NH1' ' HA ' ' A' ' 39' ' ' ASP . 29.4 tpt180 -102.67 129.2 49.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.688 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 54.4 t-105 -72.02 129.69 39.15 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.683 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.483 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.6 m-85 -125.28 140.79 52.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.048 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.733 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -149.52 125.87 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 122.292 1.044 . . . . 0.0 112.27 171.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 1.9 tm? -92.81 113.3 25.54 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.96 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.26 131.73 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.068 0.461 . . . . 0.0 109.925 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 62.94 16.65 9.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.42 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.0 -28.43 14.61 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.891 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.541 HD13 ' HE3' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -77.4 122.21 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-O 121.446 0.641 . . . . 0.0 110.812 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.532 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.84 104.76 16.66 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 15.0 m -103.79 138.79 39.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.952 0.406 . . . . 0.0 110.388 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.4 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 9.5 p90 -110.79 137.5 48.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.5 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.586 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 53.3 m-85 -135.8 169.93 16.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.409 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.445 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 20.5 t70 -63.37 -61.66 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.493 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 18.3 m -139.9 -175.55 4.26 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.606 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.73 -17.28 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.161 0.505 . . . . 0.0 111.398 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 40' ' ' SER . 6.0 p-10 -86.37 -17.46 34.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.287 0.565 . . . . 0.0 110.571 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.523 ' OD1' ' HA3' ' A' ' 47' ' ' GLY . 26.0 t70 -85.23 -20.2 30.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.338 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.586 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 50.5 t -44.47 -44.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 124.329 1.052 . . . . 0.0 113.709 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 5.1 p -58.42 -57.76 11.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.234 -172.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -152.18 29.87 0.56 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 111.788 -173.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.523 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -86.16 -96.5 0.8 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.811 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 50' ' ' GLY . 14.3 m -62.44 -38.19 88.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.984 -173.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 28.1 mmmt 70.72 -30.43 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -53.36 129.03 39.81 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.322 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 13.1 p -136.51 140.92 43.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.862 0.839 . . . . 0.0 113.264 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 35' ' ' LEU . 12.6 mt -89.86 135.78 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.766 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.541 ' HE3' HD13 ' A' ' 34' ' ' ILE . 36.5 mtpt -109.27 93.06 4.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.834 171.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.84 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.22 -3.12 34.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.882 -176.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.01 -49.74 9.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 112.088 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.9 m -78.35 -17.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.271 1.034 . . . . 0.0 109.327 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 56.9 m -131.87 -149.73 0.39 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.305 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -132.09 145.27 51.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 120.093 1.315 . . . . 0.0 113.793 -168.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.88 112.4 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 168.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.529 ' HG3' HG23 ' A' ' 72' ' ' ILE . 18.0 mmmt -93.76 147.33 23.15 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.682 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.465 HG12 HD11 ' A' ' 59' ' ' ILE . 1.3 m -135.85 152.23 30.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.898 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 68' ' ' ARG . 53.8 t-80 -120.56 90.38 3.31 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.1 m -90.75 70.71 6.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.488 0.661 . . . . 0.0 111.413 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.38 28.45 0.98 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.592 175.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 4.4 p-10 -172.68 -13.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.496 -174.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 18.0 m120 80.37 -10.58 1.25 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.731 0.812 . . . . 0.0 113.036 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -130.58 13.26 5.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -172.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.44 ' HB3' ' HB3' ' A' ' 62' ' ' HIS . 4.9 tpp180 -121.86 138.36 54.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.761 -174.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.607 ' HE2' ' HB2' ' A' ' 92' ' ' TRP . 4.2 ptp -153.19 177.0 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -150.31 161.43 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.201 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.53 HD13 ' CG2' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -130.39 124.34 31.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.257 0.551 . . . . 0.0 111.021 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.529 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.2 pp -109.73 118.27 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.704 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 2.1 pp -138.39 167.06 21.23 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.704 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 39.0 Cg_endo -60.8 144.72 99.6 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.132 2.555 . . . . 0.0 113.987 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 -49.16 4.1 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.428 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 12.9 pt-20 -150.42 89.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.284 0.564 . . . . 0.0 111.3 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.44 97.0 10.22 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.336 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -170.1 87.25 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.748 0.785 . . . . 0.0 110.312 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.6 m-85 -139.02 98.08 3.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.591 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.464 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 46.5 m-85 -103.98 121.11 42.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.087 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 ptt? -149.37 142.4 24.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.695 0.76 . . . . 0.0 111.679 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -105.03 151.65 23.7 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.572 ' HB3' ' HB3' ' A' ' 88' ' ' GLU . . . -99.79 155.73 17.49 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.339 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.675 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.48 -40.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.721 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -146.43 -174.03 4.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.91 -44.64 14.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.895 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.02 -15.66 62.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.873 0.844 . . . . 0.0 109.361 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.675 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.06 -52.27 56.7 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.449 ' O ' HD22 ' A' ' 93' ' ' LEU . 10.0 ttp180 -54.42 -46.03 73.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.77 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.737 ' NE2' HG23 ' A' ' 94' ' ' VAL . 15.3 tm0? -49.12 -62.43 1.54 Allowed 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.557 0.743 . . . . 0.0 110.628 175.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.776 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 71.8 mtt180 -35.06 -48.13 0.4 Allowed 'General case' 0 N--CA 1.434 -1.27 0 O-C-N 124.75 1.281 . . . . 0.0 113.137 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.607 ' HB2' ' HE2' ' A' ' 69' ' ' MET . 95.6 m95 -71.46 -52.33 19.02 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HG ' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.48 -38.67 55.04 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.793 0.806 . . . . 0.0 109.769 176.219 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.737 HG23 ' NE2' ' A' ' 90' ' ' GLN . 39.7 t -61.86 -63.04 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.783 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.1 86.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.484 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.2 mt -58.27 -58.89 6.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.247 0.546 . . . . 0.0 111.035 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.695 ' O ' ' HB1' ' A' ' 101' ' ' ALA . . . -81.77 -0.98 90.05 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.02 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.3 t -87.75 -31.41 19.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 166.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.424 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 30.3 t -81.73 -34.27 30.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.84 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 28.5 tttt -91.33 0.8 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.199 0.523 . . . . 0.0 110.564 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.695 ' HB1' ' O ' ' A' ' 97' ' ' GLY . . . -59.74 -12.8 7.85 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -170.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.4 t -98.45 -12.67 21.11 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.27 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -102.37 138.36 39.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.868 0.366 . . . . 0.0 110.354 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.0 p -112.08 -36.76 5.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.113 0.482 . . . . 0.0 110.62 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -133.37 -61.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.3 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.8 p -101.88 158.45 16.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.667 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 20.0 ptt180 -81.07 107.47 13.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.543 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.052 177.92 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.811 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.63 5.94 5.97 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.983 2.455 . . . . 0.0 113.131 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp -102.38 -1.57 30.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.247 0.546 . . . . 0.0 109.546 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.3 48.88 0.41 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.905 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.464 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 10.8 m -80.08 170.77 14.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 119.089 -0.481 . . . . 0.0 109.706 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 5' ' ' SER . 78.4 Cg_exo -43.88 134.72 7.86 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.856 2.371 . . . . 0.0 112.694 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 7.6 pt-20 -144.39 70.66 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.221 0.534 . . . . 0.0 112.039 -170.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 32.2 t80 -151.51 97.58 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.78 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 5.8 tpt -130.12 128.84 42.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.749 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.57 158.16 40.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.347 0.594 . . . . 0.0 112.406 -173.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.784 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 139.96 162.42 9.11 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.983 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.7 136.32 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-O 121.265 0.555 . . . . 0.0 111.433 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 83' ' ' ALA . 3.9 tp -123.59 118.5 27.46 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.635 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 20.1 m-85 -74.63 93.69 2.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -94.08 134.38 36.57 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.926 -1.11 . . . . 0.0 112.087 -171.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -80.02 110.45 15.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 p -68.91 -56.19 8.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.622 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -175.71 -60.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.628 0.251 . . . . 0.0 111.24 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -168.62 -49.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.33 -175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.6 mt -55.52 -70.78 0.1 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.358 0.599 . . . . 0.0 112.354 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.7 p -84.16 -14.12 51.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.783 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.12 -85.08 0.59 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.027 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.667 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 37.6 p-90 -128.56 140.19 51.91 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -172.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -147.09 108.33 3.95 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.55 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.667 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 62.4 Cg_endo -75.53 109.67 2.95 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.314 1.343 . . . . 0.0 112.098 173.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -110.86 146.84 35.78 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.784 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 56.3 t-105 -67.35 118.72 11.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.071 0.462 . . . . 0.0 109.783 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.633 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -108.5 144.48 36.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.984 -176.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -154.54 129.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.514 1.15 . . . . 0.0 112.667 167.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -93.64 124.58 37.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.647 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.9 141.58 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.982 0.42 . . . . 0.0 109.873 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.47 23.04 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.273 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.85 -13.24 37.97 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.23 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.496 HD13 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -90.71 141.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 123.445 0.698 . . . . 0.0 111.216 175.149 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.599 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -118.15 110.01 17.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.463 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.447 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 15.0 m -105.39 152.6 22.76 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.571 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.593 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.0 p90 -112.02 138.05 49.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.272 0.558 . . . . 0.0 111.55 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.447 ' OH ' ' HB2' ' A' ' 36' ' ' SER . 11.1 m-85 -134.46 178.4 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.011 -175.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.77 -63.89 1.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 110.441 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.7 t -146.76 -166.84 2.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.147 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.46 -11.74 61.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.972 0.415 . . . . 0.0 111.415 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -90.39 -17.16 27.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.462 0.648 . . . . 0.0 110.717 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.603 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 24.4 t70 -90.53 -14.51 32.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.854 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.656 HG23 ' NE1' ' A' ' 27' ' ' TRP . 59.7 t -43.49 -32.12 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.6 t -70.31 -38.68 74.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.725 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -123.2 -72.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.73 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.603 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -151.23 52.06 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.402 -176.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 50' ' ' GLY . 50.1 m -74.07 -11.04 60.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.312 0.577 . . . . 0.0 109.807 176.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.2 tptt 71.2 -9.92 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.466 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -66.04 141.56 41.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.42 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.7 p -146.56 142.32 27.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.243 0.544 . . . . 0.0 112.056 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.6 HG22 ' HG ' ' A' ' 71' ' ' LEU . 62.6 mt -89.16 144.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.764 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HE3' HD13 ' A' ' 34' ' ' ILE . 34.6 mtpt -113.56 90.46 3.35 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.331 173.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.599 ' CE ' HG21 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -73.09 -24.61 60.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -59.75 -36.61 76.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.441 HG23 ' HD3' ' A' ' 74' ' ' PRO . 2.0 m -94.97 -15.4 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.666 0.746 . . . . 0.0 111.07 -171.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.415 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 81.5 m -134.01 -145.76 0.25 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.544 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.611 ' O ' HG13 ' A' ' 72' ' ' ILE . 4.8 tp10 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.322 0.965 . . . . 0.0 112.313 -170.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -97.66 125.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.675 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 34.4 mtmt -104.71 97.76 7.6 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 -172.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.684 HG13 ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -114.35 89.83 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.64 0.733 . . . . 0.0 110.814 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.474 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 21.1 t-80 -76.18 107.71 8.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.178 -173.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 t -61.41 122.58 15.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.234 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -165.85 -70.27 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.267 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -124.68 -164.77 1.3 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.091 173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.587 ' HA ' ' NH1' ' A' ' 89' ' ' ARG . 49.9 m-80 -95.07 167.44 11.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.026 0.441 . . . . 0.0 111.78 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.423 ' HG1' ' C ' ' A' ' 66' ' ' ASN . 54.4 p 52.13 44.48 29.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.824 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.715 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 3.2 ppt_? -123.56 134.89 53.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.045 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 81' ' ' MET . 1.7 ptm -171.49 158.06 5.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.063 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 4.8 mt-10 -150.25 167.12 27.89 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HG ' HG22 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -135.51 125.72 26.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 171.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.611 HG13 ' O ' ' A' ' 58' ' ' GLU . 2.1 pp -110.38 120.07 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.611 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 1.1 pp -133.72 163.39 51.45 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.61 -167.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.611 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 17.8 Cg_endo -53.77 -63.19 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.095 3.197 . . . . 0.0 115.253 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.93 -20.49 62.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.559 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 179.95 103.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.33 0.586 . . . . 0.0 111.162 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -84.39 97.55 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.942 -0.474 . . . . 0.0 111.051 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.47 87.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.211 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 82.9 m-85 -139.98 97.79 3.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.672 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -101.24 135.62 42.42 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.527 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 8.8 ptt? -156.26 151.15 26.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.933 0.873 . . . . 0.0 112.718 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -111.84 137.58 49.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.099 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -90.49 157.99 17.26 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.731 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.677 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -46.51 -49.06 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.134 175.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.425 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 12.0 m120 -134.88 -174.49 3.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.905 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.608 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -87.7 -37.15 16.95 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.825 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -76.51 -14.99 59.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.878 0.847 . . . . 0.0 109.249 171.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.677 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.02 -53.25 48.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.651 ' O ' HD13 ' A' ' 93' ' ' LEU . 32.7 ttp180 -47.72 -51.24 22.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.793 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.705 ' NE2' HG23 ' A' ' 94' ' ' VAL . 17.1 tm0? -49.1 -64.12 0.9 Allowed 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 123.701 0.8 . . . . 0.0 111.036 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.78 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 34.2 mtt180 -35.74 -45.13 0.37 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.633 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 94.2 m95 -70.65 -55.3 9.08 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.439 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.684 ' CD1' HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -51.8 -41.0 61.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.949 0.88 . . . . 0.0 110.292 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.705 HG23 ' NE2' ' A' ' 90' ' ' GLN . 25.5 t -56.85 -51.56 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.007 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 -51.35 10.95 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.759 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.571 ' CD2' ' HE3' ' A' ' 54' ' ' MET . 92.3 mt -50.84 -55.78 15.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.674 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.751 ' O ' ' HB1' ' A' ' 101' ' ' ALA . . . -81.31 -3.22 90.69 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.334 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.617 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 42.5 t -66.47 -57.06 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.885 0.842 . . . . 0.0 109.622 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.513 ' HB2' ' HB3' ' A' ' 7' ' ' GLU . 13.9 t -79.77 -29.43 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.743 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.547 ' HG2' ' HB3' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -100.22 0.91 41.29 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -173.599 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.751 ' HB1' ' O ' ' A' ' 97' ' ' GLY . . . -45.87 -53.81 9.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.1 m -106.62 19.34 20.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.547 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 9.2 tp -80.09 -141.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.641 -173.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.409 ' HG1' ' C ' ' A' ' 103' ' ' LEU . 40.0 p 53.26 26.59 5.29 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.614 0.766 . . . . 0.0 111.742 -172.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -120.84 -55.24 2.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.521 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.5 p -82.74 -42.17 18.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.245 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.467 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 2.9 mmp_? -104.65 109.75 21.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.794 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.251 1.176 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.469 -179.715 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.9 -41.22 38.65 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.592 2.195 . . . . 0.0 112.172 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 tp -78.07 94.61 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.49 -80.21 0.47 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.346 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 99' ' ' SER . 18.5 m -82.84 118.64 72.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -175.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -87.83 104.57 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.966 2.444 . . . . 0.0 112.28 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 6.0 tp10 -107.55 159.31 16.53 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.149 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 75.4 t80 -150.45 99.59 2.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -172.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.751 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 2.9 tpt -122.79 133.34 54.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.308 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.684 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 5.4 pt-20 -135.67 149.94 49.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.544 0.688 . . . . 0.0 112.746 -173.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.755 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 151.31 162.98 11.08 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.206 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.11 132.14 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 121.361 0.601 . . . . 0.0 111.39 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 83' ' ' ALA . 3.5 tp -121.23 118.95 30.89 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.422 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 25' ' ' PRO . 85.4 m-85 -76.79 90.6 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.005 -175.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -95.7 158.49 15.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.513 0.673 . . . . 0.0 112.686 -171.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -81.96 131.54 35.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.192 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 p -101.76 -175.46 2.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.763 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.4 91.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.0 t80 71.64 -57.47 0.61 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.976 0.91 . . . . 0.0 112.478 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.41 167.16 21.83 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.468 ' C ' ' H ' ' A' ' 23' ' ' TRP . 19.8 p 39.08 100.11 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 125.07 1.481 . . . . 0.0 114.12 177.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.21 25.34 0.85 Allowed Glycine 0 C--N 1.329 0.186 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.293 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.595 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 17.6 p-90 -170.89 125.9 0.69 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -145.32 109.99 4.6 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.595 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 30.8 Cg_endo -68.77 107.93 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 120.807 1.005 . . . . 0.0 111.506 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.518 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 1.4 tpm_? -112.34 129.28 56.35 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.755 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 62.4 t-105 -67.26 119.41 12.1 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.528 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.511 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -113.71 137.0 52.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.643 -177.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.684 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.9 p -150.53 130.85 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 122.409 1.099 . . . . 0.0 112.457 168.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.527 HD22 ' HE2' ' A' ' 54' ' ' MET . 2.7 tm? -93.37 117.98 30.74 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.756 -173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -141.28 124.44 16.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 58.21 31.23 20.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.425 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.562 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 91.55 -25.49 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.024 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.517 HD12 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -83.93 113.24 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-O 121.746 0.784 . . . . 0.0 111.238 -178.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -95.25 105.88 17.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.57 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.4 t -104.31 160.43 14.9 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.082 0.468 . . . . 0.0 111.279 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' OH ' HG13 ' A' ' 52' ' ' ILE . 1.6 m-85 -108.71 128.15 54.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.984 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.479 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 18.4 m-85 -131.47 160.39 35.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.13 -62.92 1.38 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.908 0.385 . . . . 0.0 110.084 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -142.9 -173.16 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.44 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -65.42 -19.91 66.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.16 -16.9 34.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.0 110.66 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.743 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 22.6 t0 -87.32 -14.24 41.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.096 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.6 HG22 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -41.47 -33.11 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.83 -36.84 85.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.87 0.366 . . . . 0.0 111.055 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -118.24 -76.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.001 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.743 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 71.11 -176.51 37.21 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.855 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -66.95 122.17 17.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -78.54 51.95 1.12 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.937 0.875 . . . . 0.0 111.59 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -134.92 159.75 24.06 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.488 ' OG ' HG22 ' A' ' 34' ' ' ILE . 4.5 t -159.78 158.51 31.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.151 0.977 . . . . 0.0 112.836 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.528 HG13 ' OH ' ' A' ' 37' ' ' TYR . 9.8 mt -90.49 128.2 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.409 171.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HE3' HD12 ' A' ' 34' ' ' ILE . 37.9 mtpt -104.37 88.7 3.03 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.235 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.96 -21.8 60.81 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.793 -177.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.565 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -65.71 -28.67 69.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.284 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 53' ' ' LYS . 1.5 m -98.56 -14.49 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.706 0.765 . . . . 0.0 110.931 -172.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.566 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 86.1 m -136.43 -142.99 0.18 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.576 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.5 tp10 -128.4 146.34 50.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.302 0.955 . . . . 0.0 112.376 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.563 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -93.91 135.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.568 ' CG ' HG23 ' A' ' 72' ' ' ILE . 9.7 mmtt -114.1 146.15 40.65 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.9 m -141.43 128.42 20.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 122.001 -0.437 . . . . 0.0 109.939 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -80.15 99.85 7.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.9 m -82.91 48.24 1.32 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.561 -171.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.05 15.18 1.17 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.58 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -145.7 160.04 42.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.851 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 97.8 m-20 -91.74 -23.78 19.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.668 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 24.7 p -138.39 46.89 2.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -176.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -135.88 122.93 21.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.082 0.468 . . . . 0.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.573 ' HE2' ' HB2' ' A' ' 92' ' ' TRP . 1.3 mpp? -141.1 172.32 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -151.57 166.76 30.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 111.261 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.505 ' HG ' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -137.2 137.3 38.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 173.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 58' ' ' GLU . 1.9 pp -115.93 115.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.685 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 2.0 pp -135.72 164.98 39.52 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.814 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.685 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.29 132.25 45.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.513 2.809 . . . . 0.0 114.664 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.88 -29.81 7.63 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.539 170.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -156.97 58.41 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.987 0.423 . . . . 0.0 111.698 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -68.29 98.74 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.605 0.717 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -178.94 88.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.143 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.1 m-85 -138.32 99.0 3.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.826 0.346 . . . . 0.0 110.838 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.2 127.63 47.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 13.9 ptt? -151.58 142.42 22.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.665 0.745 . . . . 0.0 111.77 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 67' ' ' THR . 77.8 tttt -105.12 136.89 43.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.037 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 88' ' ' GLU . . . -89.41 155.82 19.08 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.705 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.677 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -47.56 -46.19 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.662 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.448 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 25.5 m-80 -139.16 -170.2 2.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.667 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -88.05 -40.26 13.98 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.361 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.26 -18.73 61.79 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.677 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -62.78 -53.16 58.48 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.706 ' O ' HD21 ' A' ' 93' ' ' LEU . 36.8 ttt-85 -45.13 -53.53 7.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.826 170.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.438 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.2 tp60 -54.46 -58.36 7.75 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.362 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.751 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 36.6 mtt180 -37.36 -41.86 0.45 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 124.562 1.164 . . . . 0.0 113.575 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.573 ' HB2' ' HE2' ' A' ' 69' ' ' MET . 91.8 m95 -72.89 -54.42 8.78 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.664 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.706 HD21 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.19 -38.2 62.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.434 0.635 . . . . 0.0 110.343 176.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 90' ' ' GLN . 25.4 t -54.4 -63.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.028 175.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.08 -53.79 52.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.021 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 58.7 mt -53.38 -53.81 45.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.34 -177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.755 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -89.31 -1.07 79.16 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.808 -175.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.2 t -89.98 -41.47 11.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.861 0.83 . . . . 0.0 109.818 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.451 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 8.8 t -75.81 -38.2 58.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.329 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.76 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 2.7 tttt -88.47 -1.82 58.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.092 0.473 . . . . 0.0 110.908 177.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -56.91 -25.29 56.88 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.973 -0.454 . . . . 0.0 111.803 -175.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 35.3 t -83.46 -13.67 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.273 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -92.85 133.22 36.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.181 0.515 . . . . 0.0 110.609 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.6 p -111.07 -30.05 7.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.295 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -123.73 -71.75 0.71 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.41 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -140.53 173.86 11.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.067 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -106.53 32.16 4.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 111.064 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.4 p . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.558 178.129 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.598 ' O ' HD13 ' A' ' 103' ' ' LEU . 30.0 Cg_exo -62.34 -43.13 24.34 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.731 2.287 . . . . 0.0 112.358 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.425 HD22 HH11 ' A' ' 107' ' ' ARG . 50.0 mt -148.03 147.66 29.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.027 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.7 -32.7 45.0 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.9 t -166.03 145.69 5.21 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.39 -62.61 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 121.83 1.687 . . . . 0.0 111.25 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 69.16 142.01 0.04 OUTLIER 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.963 0.887 . . . . 0.0 112.344 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 61.5 t80 -154.66 97.26 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.031 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.699 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 3.6 tpt -120.2 125.24 47.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.955 0.407 . . . . 0.0 111.163 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.685 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 8.2 pt-20 -131.87 151.78 51.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.532 0.682 . . . . 0.0 112.257 -173.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.728 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.97 159.73 8.72 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.309 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -60.08 131.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 83' ' ' ALA . 10.2 tp -122.58 118.61 28.61 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.607 ' O ' ' HB2' ' A' ' 81' ' ' MET . 10.1 m-30 -59.3 149.15 29.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 45.1 mmtm -119.57 151.58 38.41 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.669 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -95.82 99.37 11.19 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.6 p -88.05 -47.4 8.54 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.374 -172.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -166.61 165.83 16.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -55.84 -39.43 71.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.201 0.524 . . . . 0.0 110.645 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.24 -66.03 0.6 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.31 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.5 p -78.01 -18.03 56.39 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.533 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.87 -109.25 2.11 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.864 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.839 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 33.6 p-90 -100.65 144.19 29.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.861 -0.67 . . . . 0.0 110.877 -170.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -143.45 111.57 5.44 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.275 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.839 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 42.8 Cg_endo -70.04 114.7 3.83 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 121.758 1.639 . . . . 0.0 112.597 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.95 143.45 49.48 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.728 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -70.43 139.41 51.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.365 0.603 . . . . 0.0 111.345 -169.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.471 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -138.96 142.95 38.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.036 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.685 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.7 p -154.55 133.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 122.297 1.046 . . . . 0.0 112.67 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.3 tm? -94.42 126.0 39.41 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 113.117 -1.856 . . . . 0.0 109.97 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -138.27 113.38 9.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 58.06 30.91 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.237 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.438 ' CA ' ' HE2' ' A' ' 54' ' ' MET . . . 98.06 -29.81 10.58 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.53 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.418 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 0.8 OUTLIER -75.95 106.83 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 121.705 0.764 . . . . 0.0 110.075 177.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.528 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.36 108.94 20.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.177 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 14.8 t -103.4 155.17 18.68 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.92 -170.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -109.22 134.85 51.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.109 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.452 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 18.0 m-85 -143.73 169.14 18.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.132 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.74 -65.53 1.0 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.75 0.31 . . . . 0.0 110.547 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -123.78 179.92 4.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -73.5 -7.6 52.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.304 0.573 . . . . 0.0 111.109 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -84.57 -20.98 30.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.774 0.797 . . . . 0.0 110.298 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -78.84 -16.24 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.829 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.652 HG22 ' NE1' ' A' ' 27' ' ' TRP . 65.1 t -45.15 -39.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.2 p -61.7 -55.68 27.79 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.41 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -124.9 -76.83 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.552 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.86 -143.24 48.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.016 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -69.79 -21.54 63.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 0.0 110.8 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 tptt 62.73 13.72 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.34 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.78 129.51 9.18 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 12.3 p -128.98 141.4 51.27 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 35' ' ' LEU . 13.0 mt -89.01 133.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.965 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.417 ' HG2' HG13 ' A' ' 34' ' ' ILE . 40.5 mtpt -111.69 89.47 3.07 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.819 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.03 -11.42 60.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 109.964 -176.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.14 -26.8 53.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.411 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.0 m -98.79 -16.13 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.748 0.785 . . . . 0.0 110.147 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 73' ' ' ILE . 97.9 m -133.4 -142.71 0.21 Allowed 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.5 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.4 tp10 -131.06 146.18 52.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.802 1.183 . . . . 0.0 112.756 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.627 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -89.13 130.28 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.536 ' HG3' HG22 ' A' ' 72' ' ' ILE . 10.1 mmmt -105.01 136.04 45.23 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.187 0.517 . . . . 0.0 110.913 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.549 ' CG1' ' HG ' ' A' ' 93' ' ' LEU . 1.7 m -140.29 126.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 173.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -97.74 121.88 40.17 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.545 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.8 p -84.95 73.06 10.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.669 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -142.45 -83.27 0.18 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -86.41 136.01 33.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.575 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 10.9 t-20 -53.7 -54.53 36.64 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.92 -171.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.468 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.2 p -75.21 53.49 0.64 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.184 0.516 . . . . 0.0 112.315 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -125.78 120.86 31.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.52 0.676 . . . . 0.0 110.476 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.455 ' CE ' ' HB2' ' A' ' 92' ' ' TRP . 8.2 ptm -155.07 152.4 29.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.919 -172.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.25 168.08 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 -175.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.441 ' HG ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.29 134.13 39.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.461 . . . . 0.0 110.856 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.536 HG22 ' HG3' ' A' ' 60' ' ' LYS . 2.1 pp -116.82 119.21 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.72 ' HB ' ' CD ' ' A' ' 74' ' ' PRO . 2.6 pp -134.71 178.33 1.81 Allowed Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.731 -175.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.72 ' CD ' ' HB ' ' A' ' 73' ' ' ILE . 38.9 Cg_endo -76.37 143.38 24.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.197 1.931 . . . . 0.0 113.34 -170.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.74 -49.17 3.99 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.82 80.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.332 0.587 . . . . 0.0 111.048 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -84.39 96.44 9.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -171.8 87.55 0.09 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 110.352 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.499 ' CG ' HD12 ' A' ' 52' ' ' ILE . 92.7 m-85 -129.8 97.06 4.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.097 174.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -107.35 118.19 36.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.607 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 10.7 ptt? -143.23 176.79 8.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.283 0.564 . . . . 0.0 111.623 -171.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 41.7 ttmt -140.79 157.83 44.85 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -105.08 160.0 15.4 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.906 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.683 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -51.33 -31.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.042 176.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 13.0 t-20 -157.62 -175.75 5.56 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.575 ' HB2' ' OD1' ' A' ' 66' ' ' ASN . . . -77.45 -48.73 16.43 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.552 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.43 -14.55 62.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.624 0.726 . . . . 0.0 109.678 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.683 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 27.2 tp10 -65.6 -40.85 93.1 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.528 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 2.4 tmt_? -62.37 -44.21 96.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.261 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.738 ' NE2' HG22 ' A' ' 94' ' ' VAL . 15.8 tm0? -53.34 -62.66 1.51 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.103 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.699 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 69.0 mtt180 -33.11 -46.74 0.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.689 1.243 . . . . 0.0 113.857 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.52 ' CE2' ' HE3' ' A' ' 9' ' ' MET . 93.3 m95 -71.92 -54.37 10.24 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' HG ' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.2 -36.76 63.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.92 0.867 . . . . 0.0 109.611 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.738 HG22 ' NE2' ' A' ' 90' ' ' GLN . 31.3 t -59.32 -55.8 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.8 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.64 71.07 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.472 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 35' ' ' LEU . 78.0 mt -54.33 -55.67 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.059 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.67 ' O ' ' HB3' ' A' ' 101' ' ' ALA . . . -81.23 -3.57 90.63 Favored Glycine 0 C--O 1.205 -1.718 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.241 177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 48.3 t -67.72 -41.37 83.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.272 1.036 . . . . 0.0 108.826 173.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.415 ' OG ' HD21 ' A' ' 3' ' ' LEU . 9.7 t -80.49 -38.95 28.89 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.637 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.819 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 29.1 tttt -87.19 1.66 52.39 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -60.74 -22.88 64.47 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 121.607 -0.683 . . . . 0.0 111.441 -174.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 48.8 t -100.24 6.19 44.69 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.52 0.676 . . . . 0.0 110.286 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 2' ' ' PRO . 7.9 mp -110.51 111.5 22.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.415 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.4 p -93.32 -34.08 13.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.692 0.282 . . . . 0.0 111.547 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -127.85 -69.23 0.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.157 0.504 . . . . 0.0 111.547 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.1 m -152.86 128.03 9.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.216 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.425 HH11 HD22 ' A' ' 3' ' ' LEU . 59.9 ttp180 -64.97 130.37 43.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.858 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.249 1.029 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.99 179.19 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.44 -36.87 92.61 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.873 2.382 . . . . 0.0 111.937 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.58 165.59 27.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 99' ' ' SER . . . -99.27 103.59 2.74 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.309 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.403 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 29.3 m -73.35 -49.86 6.58 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 5' ' ' SER . 62.6 Cg_endo -71.88 0.61 6.86 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.166 1.911 . . . . 0.0 113.489 -175.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.66 122.24 20.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.009 0.433 . . . . 0.0 110.822 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 7.2 t80 -152.43 96.82 2.2 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.74 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 6.4 tpt -115.85 112.64 22.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.853 0.835 . . . . 0.0 110.306 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.633 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.85 137.94 52.53 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.957 -172.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.785 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.44 170.46 26.14 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.204 172.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -62.59 138.31 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 121.472 0.653 . . . . 0.0 111.729 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.463 ' HG ' ' HB2' ' A' ' 81' ' ' MET . 1.7 tp -128.24 116.93 20.63 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 62.4 m-85 -72.98 90.16 1.47 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.784 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 22.8 ttpp -94.06 135.5 35.35 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.117 0.96 . . . . 0.0 112.326 -170.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.516 ' CZ2' ' HA ' ' A' ' 19' ' ' TYR . 74.7 t-105 -80.12 98.23 7.2 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.91 -1.496 . . . . 0.0 109.838 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.507 ' H ' ' HA2' ' A' ' 22' ' ' GLY . 25.5 p -83.93 60.39 5.8 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.012 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 69.44 165.11 0.26 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.978 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.516 ' HA ' ' CZ2' ' A' ' 16' ' ' TRP . 29.4 p90 -68.65 -6.47 26.13 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.734 -171.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.0 mt -67.39 -55.29 14.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.564 0.697 . . . . 0.0 110.597 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.5 p -116.15 -81.02 0.61 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.011 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 17' ' ' THR . . . 79.0 176.67 48.69 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.382 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.478 ' HB3' ' O ' ' A' ' 22' ' ' GLY . 27.5 t90 75.67 -17.35 0.52 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -55.16 104.77 0.45 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -168.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 72.8 Cg_endo -81.89 108.75 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.037 1.825 . . . . 0.0 112.164 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -107.34 152.52 24.04 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.785 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 65.7 t-105 -74.23 105.43 5.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.084 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.9 OUTLIER -96.48 136.39 37.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.972 -177.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.633 ' HB ' ' CB ' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -142.91 128.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.865 0.84 . . . . 0.0 111.994 172.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -96.13 123.45 39.76 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.239 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.24 140.49 14.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 110.379 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 61.25 27.73 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.421 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.517 ' HA2' ' HE3' ' A' ' 54' ' ' MET . . . 86.27 -22.49 12.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.114 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.523 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -86.3 134.15 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-O 121.342 0.591 . . . . 0.0 111.259 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -108.7 106.27 16.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 35.9 m -104.17 147.18 27.74 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.961 -0.462 . . . . 0.0 110.992 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.569 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 7.8 p90 -110.68 120.41 42.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.882 0.848 . . . . 0.0 110.995 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.485 ' HB3' ' CB ' ' A' ' 43' ' ' ASP . 57.4 m-85 -113.91 -174.13 2.41 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.293 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.03 -63.44 1.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.586 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.2 m -122.73 -179.57 4.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HG2' ' CE3' ' A' ' 27' ' ' TRP . 39.2 mt-30 -79.04 -1.26 34.8 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.76 -21.08 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.247 0.546 . . . . 0.0 110.341 170.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.485 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 6.4 m-20 -72.62 -16.8 61.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.418 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.64 HG23 ' NE1' ' A' ' 27' ' ' TRP . 49.1 t -44.62 -28.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.419 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 5.7 t -82.23 -52.22 7.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.878 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -141.23 17.21 2.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 49' ' ' LYS . . . -69.21 117.28 7.76 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.161 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m 72.19 -41.32 0.5 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.669 0.787 . . . . 0.0 113.046 175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.444 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 26.6 mmmt 67.8 11.19 8.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.865 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.19 131.8 10.73 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.461 ' HB2' HG21 ' A' ' 34' ' ' ILE . 13.8 p -142.77 146.21 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.512 HG22 HG21 ' A' ' 73' ' ' ILE . 9.0 mt -87.52 134.87 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.919 168.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.523 ' HE3' HD11 ' A' ' 34' ' ' ILE . 40.8 mtpt -108.92 89.28 2.94 Favored 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.537 173.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.638 ' HB2' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -74.15 -21.36 59.89 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -63.32 -38.13 89.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.159 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.7 m -91.72 -15.19 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.783 0.801 . . . . 0.0 110.688 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.571 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 87.3 m -132.56 -145.27 0.25 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.243 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.542 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.7 tp10 -125.81 146.8 49.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.078 0.854 . . . . 0.0 112.221 -170.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.638 HG23 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -95.64 134.64 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 172.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.591 ' HG3' HG22 ' A' ' 72' ' ' ILE . 23.3 mtmt -117.16 147.35 42.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.014 0.435 . . . . 0.0 110.371 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.572 HG13 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m -141.79 127.65 18.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -86.63 129.23 34.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.967 0.413 . . . . 0.0 111.431 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 t -85.17 176.65 8.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.052 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.47 11.72 5.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.236 0.614 . . . . 0.0 111.962 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -168.49 173.0 7.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -117.14 167.78 10.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.302 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.49 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 44.3 p 48.69 57.07 6.72 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.576 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 59.0 ttt180 -159.28 109.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.492 . . . . 0.0 109.796 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.596 ' HE3' ' HB2' ' A' ' 92' ' ' TRP . 1.9 mpp? -130.08 171.22 13.05 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -148.58 155.31 40.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.035 0.445 . . . . 0.0 110.906 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.463 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -130.35 129.76 43.56 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.25 0.548 . . . . 0.0 111.461 174.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.591 HG22 ' HG3' ' A' ' 60' ' ' LYS . 1.5 pp -111.91 113.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.68 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 2.0 pp -133.67 166.27 30.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.706 -174.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 Cg_endo -59.63 130.03 33.55 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.294 2.662 . . . . 0.0 114.228 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 -25.04 9.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.594 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.83 69.53 0.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -80.85 97.22 7.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.522 0.677 . . . . 0.0 110.144 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -175.29 88.0 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.934 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.2 m-85 -144.97 97.23 2.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.722 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 88.3 m-85 -102.87 127.25 50.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -147.73 141.71 25.91 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.678 0.752 . . . . 0.0 112.833 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 67' ' ' THR . 39.6 ttpt -105.6 138.78 41.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.916 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' A' ' 88' ' ' GLU . . . -96.57 161.9 13.69 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.576 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.683 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -48.69 -45.36 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.79 176.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.51 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 38.3 m-80 -136.93 -175.79 4.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.589 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -79.66 -43.02 23.56 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.537 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.88 -17.71 62.7 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.56 173.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.683 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 26.6 tp10 -67.91 -44.13 77.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.734 ' O ' HD21 ' A' ' 93' ' ' LEU . 17.2 ttt180 -55.13 -52.3 63.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.69 171.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.463 ' O ' HG21 ' A' ' 94' ' ' VAL . 20.3 tp60 -51.6 -56.55 12.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.909 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.74 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 61.8 mtt180 -37.28 -42.36 0.46 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.591 1.157 . . . . 0.0 113.457 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.596 ' HB2' ' HE3' ' A' ' 69' ' ' MET . 93.0 m95 -72.43 -56.49 5.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.881 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.734 HD21 ' O ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -51.83 -37.37 51.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.5 176.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 90' ' ' GLN . 33.1 t -56.23 -63.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.17 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.63 79.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.867 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.1 mt -52.56 -55.25 23.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.37 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.609 ' O ' ' HB1' ' A' ' 101' ' ' ALA . . . -81.59 -20.42 64.0 Favored Glycine 0 C--O 1.204 -1.741 0 C-N-CA 119.085 -1.531 . . . . 0.0 112.603 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -59.75 -34.68 73.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.91 1.355 . . . . 0.0 109.978 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.451 ' HA ' ' HA3' ' A' ' 4' ' ' GLY . 1.9 p -91.4 -32.73 15.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.187 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 1.1 tttt -101.46 1.33 38.11 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -176.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 97' ' ' GLY . . . -54.38 -42.26 70.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.433 0.635 . . . . 0.0 111.095 -175.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.7 m -93.68 14.85 17.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.16 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 55' ' ' ALA . 2.2 tp -98.71 -78.48 0.49 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.344 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.8 p 50.21 36.25 12.12 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.104 0.562 . . . . 0.0 112.062 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -160.3 171.31 19.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.9 m -79.72 82.67 5.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.256 0.55 . . . . 0.0 110.049 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 107' ' ' ARG . 15.5 ttp85 -66.01 130.23 42.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.25 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.045 -0.978 . . . . 0.0 112.42 178.201 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.89 -12.13 14.86 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.986 2.457 . . . . 0.0 112.085 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.44 ' H ' HD22 ' A' ' 3' ' ' LEU . 1.9 pt? -103.58 -176.15 3.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.722 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.79 -113.84 2.84 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.98 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.0 m -104.44 165.88 12.56 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 122.389 0.276 . . . . 0.0 110.926 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.83 140.97 46.71 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.001 2.467 . . . . 0.0 111.248 171.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' HB2' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -134.87 125.91 27.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.355 0.598 . . . . 0.0 112.588 -169.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.7 t80 -154.04 97.82 2.1 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.736 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 8.9 tpt -122.73 111.07 16.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 122.025 0.917 . . . . 0.0 110.838 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.45 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.36 147.93 45.68 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.44 -171.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.708 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.21 167.09 13.26 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.503 172.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 m -65.36 137.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.448 0.642 . . . . 0.0 111.575 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 82' ' ' LYS . 3.7 tp -124.05 119.05 28.37 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -73.46 87.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.4 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 15.1 tmtt? -101.62 143.06 32.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 0.0 111.629 -169.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -70.22 118.32 12.89 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.705 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 p -76.61 -165.91 0.59 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.513 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.17 -52.06 46.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.274 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.7 p90 177.76 -19.99 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.344 0.403 . . . . 0.0 111.72 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mp -46.13 -69.29 0.14 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.7 p -105.14 -6.75 19.58 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.185 0.517 . . . . 0.0 111.474 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.24 -88.45 1.37 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.979 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.652 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 54.2 p-90 -100.38 141.72 32.84 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.318 -0.441 . . . . 0.0 109.984 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -149.06 115.37 3.7 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.883 -0.144 . . . . 0.0 111.147 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.652 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 35.3 Cg_endo -68.94 108.58 1.95 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.354 1.369 . . . . 0.0 111.271 170.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.44 ' HD3' ' OH ' ' A' ' 37' ' ' TYR . 98.8 mtt180 -123.16 157.09 33.74 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.708 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 74.0 t-105 -81.96 132.58 35.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.422 0.63 . . . . 0.0 111.546 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.497 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -129.44 142.47 50.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.137 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.472 ' CG1' ' HE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -151.6 132.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 122.581 1.181 . . . . 0.0 112.786 167.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.9 tm? -94.75 123.11 38.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.594 -2.093 . . . . 0.0 109.713 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -154.44 141.18 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 171.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.18 27.02 16.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.999 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 86.89 -28.74 5.34 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.133 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.527 HD12 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -77.14 124.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.532 0.682 . . . . 0.0 111.083 178.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.623 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -101.21 106.97 18.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 m -103.14 155.09 18.65 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.481 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.44 ' OH ' ' HD3' ' A' ' 26' ' ' ARG . 21.3 t80 -109.72 132.4 54.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.594 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.472 ' HE2' ' CG1' ' A' ' 29' ' ' VAL . 29.1 m-85 -139.66 179.55 6.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.27 -61.48 1.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.638 0.256 . . . . 0.0 110.916 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.3 m -132.41 -176.76 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' HG3' ' CE3' ' A' ' 27' ' ' TRP . 0.7 OUTLIER -73.29 -3.31 26.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.18 -20.47 23.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.257 0.551 . . . . 0.0 110.385 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.402 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 7.5 m-20 -82.29 -15.61 52.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.525 -175.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.673 HG23 ' NE1' ' A' ' 27' ' ' TRP . 70.3 t -41.16 -37.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -172.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 p -68.78 -51.82 36.87 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.079 -0.388 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -124.59 -68.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.073 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.63 -132.6 52.63 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.83 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.5 m -77.01 -8.49 57.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.747 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.8 tptt 73.93 -37.62 0.37 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.067 0.854 . . . . 0.0 112.485 176.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.99 129.91 42.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.195 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.1 p -139.7 139.07 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.367 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.623 ' HB ' ' O ' ' A' ' 35' ' ' LEU . 13.7 mt -88.51 133.77 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.41 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.527 ' HE3' HD12 ' A' ' 34' ' ' ILE . 38.1 mtpt -110.99 94.18 4.86 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.916 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.571 ' HB2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -76.66 -1.05 25.82 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.753 0.311 . . . . 0.0 110.439 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.01 -47.95 9.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.874 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.473 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.6 m -80.81 -16.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.034 0.921 . . . . 0.0 109.641 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.525 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 41.0 m -133.88 -154.84 0.62 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.835 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' ' HZ3' ' A' ' 100' ' ' LYS . 6.6 tp10 -124.35 144.37 50.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 113.23 -167.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.571 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -90.9 115.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 171.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.505 ' HG3' HG21 ' A' ' 72' ' ' ILE . 23.8 mmmt -97.47 139.08 33.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.568 -172.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.409 HG12 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m -139.89 126.07 22.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.74 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 23.6 t-80 -87.76 170.7 11.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 p -118.35 -166.0 1.17 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 76.7 -79.06 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.709 0.804 . . . . 0.0 112.265 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.65 178.43 4.75 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 111.21 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.412 ' C ' ' HG1' ' A' ' 67' ' ' THR . 12.0 m120 -99.75 163.31 12.53 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.733 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.1 p 50.4 56.22 8.27 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.46 0.648 . . . . 0.0 110.813 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.74 ' HD3' ' O ' ' A' ' 62' ' ' HIS . 0.3 OUTLIER -122.69 120.12 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.873 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.437 ' HG2' ' O ' ' A' ' 81' ' ' MET . 9.4 ptm -170.16 151.95 4.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.735 -172.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -155.51 166.89 32.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.848 0.356 . . . . 0.0 110.325 -175.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.504 ' HG ' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -136.98 131.23 32.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.006 0.431 . . . . 0.0 111.102 175.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.524 ' O ' ' HB3' ' A' ' 57' ' ' CYS . 2.2 pp -115.5 118.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.692 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 1.9 pp -138.47 166.06 28.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.581 -174.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.692 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 37.3 Cg_endo -60.29 136.91 71.41 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.597 2.864 . . . . 0.0 114.437 -172.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.19 -45.07 2.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.664 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.79 80.04 1.01 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.106 0.479 . . . . 0.0 111.121 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.425 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 8.8 pt20 -81.43 95.87 7.19 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.399 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -166.61 87.41 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.303 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.8 m-85 -136.55 96.01 3.26 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 65.0 m-85 -103.83 117.06 33.47 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -142.52 147.6 36.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.384 0.611 . . . . 0.0 111.483 -172.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.733 ' HG2' ' O ' ' A' ' 67' ' ' THR . 48.1 mtmt -110.53 176.69 4.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.485 ' HB3' ' HB3' ' A' ' 88' ' ' GLU . . . -127.41 173.13 10.06 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.577 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.705 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -50.06 -39.52 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.609 0.719 . . . . 0.0 111.073 174.303 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -149.01 -176.17 5.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.383 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.609 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -86.14 -37.21 19.0 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.795 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.605 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -74.52 -15.15 60.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.113 0.959 . . . . 0.0 109.429 171.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.705 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.04 -52.46 55.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.609 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -47.99 -48.05 32.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.506 170.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.751 ' NE2' HG23 ' A' ' 94' ' ' VAL . 14.6 tm0? -51.74 -62.31 1.71 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.879 0.872 . . . . 0.0 111.127 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.736 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 69.7 mtt180 -35.17 -41.78 0.16 Allowed 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.57 1.169 . . . . 0.0 113.694 175.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.529 ' CE2' ' HE2' ' A' ' 9' ' ' MET . 96.9 m95 -73.36 -56.63 4.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.74 -36.42 57.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.792 0.806 . . . . 0.0 110.078 177.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.751 HG23 ' NE2' ' A' ' 90' ' ' GLN . 30.4 t -60.64 -53.58 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.621 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.85 46.08 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.624 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.423 ' CD1' HD13 ' A' ' 59' ' ' ILE . 77.3 mt -51.49 -53.59 35.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.774 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -82.83 -4.26 90.13 Favored Glycine 0 C--O 1.207 -1.535 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.624 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.556 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.7 t -69.09 -34.4 75.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.507 1.154 . . . . 0.0 109.243 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.3 t -89.51 -29.12 19.18 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.027 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 39.8 tttt -99.31 -2.28 36.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -55.46 -28.99 57.85 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.612 -0.68 . . . . 0.0 112.086 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 45.0 t -110.54 5.62 21.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.025 0.44 . . . . 0.0 110.941 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.493 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 11.7 tp -84.55 150.21 25.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.152 0.501 . . . . 0.0 111.928 -169.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.5 p -68.03 149.1 50.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.491 173.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -52.96 -51.95 59.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.01 0.433 . . . . 0.0 111.143 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 m -104.7 81.03 1.72 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.762 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -91.94 74.55 5.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.085 0.469 . . . . 0.0 110.267 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.675 177.537 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 37.0 Cg_exo -57.32 124.34 15.92 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.706 2.27 . . . . 0.0 111.855 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' A' ' 2' ' ' PRO . 7.7 mp 72.17 -56.43 0.65 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.794 0.684 . . . . 0.0 110.671 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.86 62.22 4.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.704 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 m -88.21 133.27 37.25 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.26 105.62 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.72 2.28 . . . . 0.0 112.048 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 120.3 37.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 54.0 t80 -153.8 98.22 2.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.713 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 5.5 tpt -126.31 118.12 24.42 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.344 0.592 . . . . 0.0 111.017 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -126.2 153.13 45.09 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.533 -173.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.703 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 142.03 161.16 8.63 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.671 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.31 132.17 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.748 0.785 . . . . 0.0 111.12 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 83' ' ' ALA . 10.5 tp -122.03 118.65 29.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 8.8 m-30 -61.06 148.26 40.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 37.1 mtmt -111.99 141.03 46.15 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.832 170.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.402 ' H ' ' HA ' ' A' ' 81' ' ' MET . 70.1 t-105 -85.57 104.4 15.29 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.011 0.434 . . . . 0.0 109.976 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.3 p -80.65 152.53 28.43 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.97 83.82 0.68 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.668 0.271 . . . . 0.0 111.327 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 t80 74.48 -51.63 0.68 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.572 173.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.0 mt -47.43 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -170.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.6 p -91.26 4.21 52.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.068 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.72 -92.17 0.15 Allowed Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.01 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.861 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 42.4 p-90 -119.85 145.08 46.99 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -173.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -142.26 112.66 6.13 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.861 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 44.3 Cg_endo -69.41 117.94 5.37 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.059 1.839 . . . . 0.0 112.966 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -116.46 139.67 50.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.703 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 64.3 t-105 -72.49 125.69 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.747 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.553 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.3 m-85 -121.15 143.16 49.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.045 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -152.47 129.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 122.445 1.117 . . . . 0.0 112.45 166.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -94.85 122.97 38.03 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 112.636 -2.074 . . . . 0.0 109.496 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -153.18 136.94 16.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.21 0.528 . . . . 0.0 110.301 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 61.12 24.26 14.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.207 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.634 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 91.76 -25.16 17.28 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.551 HD13 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.15 120.91 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-O 121.517 0.675 . . . . 0.0 111.064 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.703 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -100.21 108.21 20.25 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.417 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . 25.3 t -103.87 149.78 24.76 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.519 -0.738 . . . . 0.0 110.896 -172.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.411 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 22.8 p90 -113.58 130.55 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.492 0.663 . . . . 0.0 111.225 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.533 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 6.7 m-85 -130.36 179.06 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.144 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.88 -54.38 3.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.79 0.328 . . . . 0.0 110.235 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.5 p -131.56 178.33 6.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -72.36 -9.31 58.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.377 0.608 . . . . 0.0 110.595 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -85.69 -20.93 28.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.439 0.638 . . . . 0.0 110.335 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.09 -14.89 57.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.181 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.574 HG23 ' NE1' ' A' ' 27' ' ' TRP . 94.5 t -44.68 -27.14 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 t -73.16 -41.41 63.95 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.634 -0.666 . . . . 0.0 111.039 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -113.05 -71.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' HA3' ' CD2' ' A' ' 38' ' ' TYR . . . 65.44 52.4 40.11 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.231 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m 64.23 2.76 1.57 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.847 0.356 . . . . 0.0 111.921 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 31.4 mmmt 61.33 24.01 14.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.592 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 124.73 7.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.949 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.92 156.48 47.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.739 0.78 . . . . 0.0 111.729 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.703 ' HB ' ' O ' ' A' ' 35' ' ' LEU . 13.4 mt -92.0 131.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.293 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.551 ' HE3' HD13 ' A' ' 34' ' ' ILE . 33.5 mtpt -103.79 89.12 3.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.317 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.634 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -76.22 -3.7 37.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.65 -175.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 107' ' ' ARG . . . -88.15 -41.81 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.204 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.424 ' HA ' ' HB ' ' A' ' 106' ' ' THR . 1.4 m -83.92 -15.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.969 0.89 . . . . 0.0 109.466 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.567 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 51.9 m -133.47 -155.35 0.67 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.02 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.401 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.4 tp10 -121.54 144.01 48.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.621 1.1 . . . . 0.0 113.354 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.489 HD13 ' CD1' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -89.33 114.37 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 171.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HG3' HG23 ' A' ' 72' ' ' ILE . 22.0 mmmt -95.77 136.97 35.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.139 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.454 HG11 ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -140.36 148.8 21.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -149.26 162.94 39.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.504 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.8 p -79.78 -79.06 0.15 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.409 ' CB ' ' HG3' ' A' ' 68' ' ' ARG . . . 67.19 -61.79 0.33 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.628 0.771 . . . . 0.0 110.791 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -152.23 -65.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.489 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.497 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 7.1 p30 -160.65 -17.29 0.05 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.467 HG22 ' OD1' ' A' ' 66' ' ' ASN . 3.3 p -128.61 70.66 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.962 0.411 . . . . 0.0 111.815 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.409 ' HG3' ' CB ' ' A' ' 64' ' ' ALA . 18.5 mmt180 -135.99 131.28 34.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.188 0.518 . . . . 0.0 110.718 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.905 ' HG3' ' SD ' ' A' ' 81' ' ' MET . 8.2 ptm -170.16 153.95 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.164 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.49 167.54 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.048 0.451 . . . . 0.0 110.832 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.428 ' HG ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.84 134.7 39.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 175.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.508 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.3 pp -119.85 120.7 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.678 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 2.0 pp -139.43 165.98 27.69 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.077 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.678 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.51 146.23 95.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.27 2.647 . . . . 0.0 114.121 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.11 -45.63 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.806 -0.634 . . . . 0.0 113.122 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -148.05 66.8 1.09 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.272 0.558 . . . . 0.0 110.943 -176.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.54 95.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.446 0.641 . . . . 0.0 110.859 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 179.87 87.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.957 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.427 ' CG ' HD13 ' A' ' 52' ' ' ILE . 91.9 m-85 -131.56 98.41 4.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.425 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -108.3 109.63 21.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.905 ' SD ' ' HG3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -128.82 171.43 12.26 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.748 -178.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 73.3 tttt -131.15 150.32 52.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 88' ' ' GLU . . . -98.48 158.69 15.44 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.276 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.678 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.1 t -50.8 -43.87 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.342 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -143.01 -171.46 3.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.573 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.46 -41.22 15.58 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.649 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.94 -16.68 61.54 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.168 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.678 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -66.23 -53.06 41.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 170.226 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.591 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 15.3 ttt180 -48.1 -49.17 32.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.924 171.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 51.6 tp60 -54.98 -58.39 7.84 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.848 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.713 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 41.9 mtt180 -37.8 -42.62 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 113.809 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.558 ' CE2' ' HE3' ' A' ' 9' ' ' MET . 92.2 m95 -72.37 -53.77 11.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.381 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.464 HD11 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.84 -37.37 60.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.719 0.771 . . . . 0.0 110.246 176.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 98' ' ' SER . 24.5 t -60.05 -56.61 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.659 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.12 65.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.683 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.489 ' CD1' HD13 ' A' ' 59' ' ' ILE . 81.4 mt -52.99 -56.04 19.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.668 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.667 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -79.32 -2.92 88.26 Favored Glycine 0 C--O 1.205 -1.689 0 C-N-CA 119.695 -1.24 . . . . 0.0 112.473 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 21.7 t -68.29 -41.27 81.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.536 1.168 . . . . 0.0 108.931 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.7 t -80.7 -38.2 29.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.914 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 28.9 tttt -91.81 0.85 57.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -174.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -57.21 -35.1 69.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.058 0.456 . . . . 0.0 111.379 -174.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.5 m -107.91 15.68 24.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.209 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.497 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 1.1 mp -86.35 74.46 9.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.751 -177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.2 p -72.95 -37.66 67.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.993 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.59 36.57 4.08 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.84 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' A' ' 56' ' ' VAL . 82.5 p 54.99 -169.35 0.07 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.966 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.453 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . 77.7 ttt180 -142.2 109.84 5.74 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.212 -0.305 . . . . 0.0 110.212 -174.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.0 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.556 -0.735 . . . . 0.0 111.151 -178.675 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--O 1.236 0.365 0 CA-C-O 121.281 0.563 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 84.5 t80 -153.15 97.34 2.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.773 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.7 ttt -124.69 137.25 54.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.396 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.2 pt-20 -134.93 147.97 49.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.522 . . . . 0.0 112.205 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.727 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 155.21 166.34 15.33 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.523 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.9 133.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.413 0.625 . . . . 0.0 111.825 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 83' ' ' ALA . 4.7 tp -118.34 120.05 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -74.52 93.11 2.44 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.14 0.576 . . . . 0.0 110.89 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 29.4 mtmt . . . . . 0 C--N 1.32 -0.696 0 CA-C-O 121.681 0.753 . . . . 0.0 112.412 -168.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.449 -1.142 0 N-CA-C 109.941 -0.831 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -124.26 142.87 50.9 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.727 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 67.7 t-105 -74.11 129.03 37.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -129.68 142.2 50.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.197 -177.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.699 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -151.06 133.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 122.161 0.981 . . . . 0.0 112.557 172.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -92.98 119.72 32.54 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.694 -174.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -131.3 111.0 11.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 57.17 26.68 12.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.716 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.604 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.54 -28.34 15.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.368 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.64 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.01 108.78 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.932 0.872 . . . . 0.0 110.463 178.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -94.81 107.6 19.61 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.47 179.146 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 m -103.25 160.36 14.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.45 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -108.43 133.21 52.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.345 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.456 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 22.8 m-85 -139.82 165.34 27.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.992 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.33 6.75 22.62 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.394 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 t -173.6 164.55 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.172 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -77.28 -13.62 59.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.086 0.469 . . . . 0.0 111.181 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.48 -16.93 28.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.501 0.667 . . . . 0.0 109.996 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.533 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 26.6 t0 -79.7 -15.05 58.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.757 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.622 HG22 ' NE1' ' A' ' 27' ' ' TRP . 94.3 t -45.62 -29.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 p -69.82 -37.14 76.13 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -122.79 -58.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.851 0.358 . . . . 0.0 110.665 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.533 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -148.33 49.51 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.315 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.0 m -89.08 2.31 54.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 75.29 -34.66 0.26 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.762 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.91 141.3 44.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.002 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 p -147.11 150.0 34.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.359 0.599 . . . . 0.0 111.431 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.069 HG23 HG21 ' A' ' 73' ' ' ILE . 10.8 mt -87.63 123.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.321 176.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.64 ' HE3' HD11 ' A' ' 34' ' ' ILE . 30.8 mtpt -96.05 88.08 4.76 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.735 172.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.604 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -79.53 -9.6 59.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.748 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -80.81 -38.4 28.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.11 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 74' ' ' PRO . 1.0 OUTLIER -86.26 -17.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.246 1.022 . . . . 0.0 109.619 -174.248 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.652 ' HB3' HD12 ' A' ' 72' ' ' ILE . 96.3 m -128.69 -153.09 0.55 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.659 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.447 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.6 tp10 -120.81 142.98 49.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 119.247 0.931 . . . . 0.0 112.982 -168.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.425 HD11 HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -92.64 115.84 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 170.436 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.57 ' HG3' HG23 ' A' ' 72' ' ' ILE . 20.8 mmmt -94.29 130.73 40.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.8 m . . . . . 0 C--N 1.317 -0.827 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.639 ' CA ' ' HD3' ' A' ' 89' ' ' ARG . 80.4 p . . . . . 0 CA--C 1.554 1.102 0 CA-C-O 120.836 0.351 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -140.08 117.13 11.13 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.609 -0.682 . . . . 0.0 111.704 174.575 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.731 ' SD ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -172.38 153.68 3.02 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -159.65 164.79 33.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.595 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.859 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -133.09 130.32 39.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.192 0.52 . . . . 0.0 111.265 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.2 pp -115.96 120.49 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.069 HG21 HG23 ' A' ' 52' ' ' ILE . 2.5 pp -137.1 176.85 2.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.744 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 50.0 Cg_exo -54.79 137.03 73.98 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.004 3.136 . . . . 0.0 114.426 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.14 -46.56 3.0 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.887 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 13.6 pt-20 -139.46 106.36 5.41 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.595 0.712 . . . . 0.0 110.884 -177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.84 97.18 8.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.939 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.404 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -177.62 86.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.49 -178.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CG ' HD11 ' A' ' 52' ' ' ILE . 87.6 m-85 -140.42 96.45 3.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.172 0.511 . . . . 0.0 109.635 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -101.75 121.56 42.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.526 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.9 ptt? -151.08 137.57 18.66 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.161 -172.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 89' ' ' ARG . 35.5 ttpt -102.41 177.98 4.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -124.06 169.72 11.39 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.274 -175.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.802 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.66 -38.02 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 123.793 0.683 . . . . 0.0 110.983 173.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -157.66 -170.07 3.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.584 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.36 -48.91 9.88 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.995 -172.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 90' ' ' GLN . . . -67.59 -17.87 64.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.554 0.692 . . . . 0.0 109.487 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.802 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.35 -54.4 29.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.475 -1.239 . . . . 0.0 107.739 171.273 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.731 ' HG3' ' SD ' ' A' ' 69' ' ' MET . 3.4 ttt180 -58.49 -34.51 71.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.765 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.49 ' HA ' HD22 ' A' ' 93' ' ' LEU . 47.7 tp60 -62.91 -56.94 12.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.437 0.695 . . . . 0.0 111.044 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.773 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 65.3 mtt180 -34.71 -47.06 0.32 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.685 1.194 . . . . 0.0 113.149 174.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.524 ' HB2' ' CE ' ' A' ' 69' ' ' MET . 97.0 m95 -66.56 -53.63 32.51 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.607 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -49.97 -40.86 45.42 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.612 0.72 . . . . 0.0 109.96 175.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 52.5 t -55.85 -64.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.088 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 -50.49 71.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.37 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.463 ' CD2' ' HG2' ' A' ' 54' ' ' MET . 70.2 mt -52.65 -62.78 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.117 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.31 -1.81 65.59 Favored Glycine 0 C--O 1.222 -0.642 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.799 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.9 t -90.33 -32.65 16.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.564 0.682 . . . . 0.0 109.67 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.8 t -83.56 -28.09 28.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.032 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 17.8 tttt . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.629 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 9.7 tp10 . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 30.4 t80 -150.87 98.54 2.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.857 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 4.0 tpt -123.91 129.68 51.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.885 0.374 . . . . 0.0 111.355 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.721 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.0 pt-20 -134.84 143.73 47.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.365 0.602 . . . . 0.0 112.56 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.679 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 160.41 170.18 24.66 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.497 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -73.49 141.18 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.353 0.597 . . . . 0.0 112.276 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.553 HD11 HH21 ' A' ' 89' ' ' ARG . 0.3 OUTLIER -121.96 118.57 29.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.08 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.16 116.53 21.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.263 0.625 . . . . 0.0 112.103 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HG2' ' C ' ' A' ' 80' ' ' TYR . 25.5 tptt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo . . . . . 0 N--CA 1.459 -0.537 0 N-CA-C 110.72 -0.531 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -112.13 149.39 32.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.679 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -80.4 130.84 35.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.468 0.652 . . . . 0.0 111.444 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.599 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -124.86 145.17 49.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.49 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.721 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.5 p -156.76 132.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 122.329 1.062 . . . . 0.0 112.798 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.1 tm? -94.36 118.29 31.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.725 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.18 130.22 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 109.914 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.52 22.15 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.841 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.664 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 97.21 -22.82 38.68 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.273 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.525 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -80.54 120.09 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.465 0.65 . . . . 0.0 111.157 177.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.604 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.67 106.84 18.82 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.162 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 8.3 t -105.16 162.38 13.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.013 0.435 . . . . 0.0 111.973 -167.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.694 ' HH ' ' HD1' ' A' ' 79' ' ' PHE . 39.3 m-85 -106.81 137.59 44.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.593 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.524 ' HE2' HG13 ' A' ' 29' ' ' VAL . 22.0 m-85 -149.28 164.47 34.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -98.0 -39.98 8.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.431 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -130.5 166.35 20.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.8 -5.82 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.24 -18.29 23.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.274 0.559 . . . . 0.0 110.109 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.7 -14.8 59.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.943 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.575 HG22 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -44.39 -22.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 2.7 p -83.0 -57.69 3.18 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.413 -0.805 . . . . 0.0 112.273 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 39.8 mmtm -133.58 27.78 4.01 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.59 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.85 132.77 11.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.762 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.9 m 74.04 -34.0 0.27 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mptt 68.54 6.43 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.68 0.792 . . . . 0.0 112.727 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 137.54 13.43 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.882 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 34' ' ' ILE . 12.0 p -146.83 142.67 27.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.124 HG23 HG21 ' A' ' 73' ' ' ILE . 9.8 mt -89.24 136.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.465 1.106 . . . . 0.0 111.197 172.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.525 ' HE3' HD11 ' A' ' 34' ' ' ILE . 31.4 mtpt -106.73 89.78 3.12 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 120.993 0.425 . . . . 0.0 110.669 173.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.664 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.17 -1.16 31.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.621 -177.344 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.31 -48.47 8.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.04 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.7 m -80.7 -15.95 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.177 0.989 . . . . 0.0 109.501 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.586 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 54.1 m -131.64 -155.39 0.69 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.956 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.564 ' O ' HG13 ' A' ' 72' ' ' ILE . 7.8 tp10 -123.11 146.4 47.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.463 1.029 . . . . 0.0 113.194 -165.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.565 HD13 HD13 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -88.22 121.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.155 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 5.6 mttt -96.41 135.61 38.03 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.106 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.532 HG12 HD11 ' A' ' 59' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.315 -0.892 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 121.107 0.479 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 89' ' ' ARG . 12.5 mmm180 -123.12 124.4 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.052 0.453 . . . . 0.0 111.357 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.601 ' HE3' ' NH2' ' A' ' 89' ' ' ARG . 5.1 ttm -155.76 160.88 40.66 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 4.9 mt-10 -152.4 168.03 26.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.907 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -129.72 140.1 51.18 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.828 0.347 . . . . 0.0 110.269 171.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 58' ' ' GLU . 1.7 pp -120.87 117.05 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.124 HG21 HG23 ' A' ' 52' ' ' ILE . 1.7 pp -136.36 168.87 15.19 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.073 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.774 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 87.5 Cg_exo -29.79 117.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 124.94 3.76 . . . . 0.0 116.185 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.4 -21.38 6.2 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.273 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 14.9 pt-20 -151.76 115.33 4.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 112.322 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 22.2 pt20 -103.13 97.26 7.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 110.103 173.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.46 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 1.2 p80 -175.47 87.15 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.674 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.694 ' HD1' ' HH ' ' A' ' 37' ' ' TYR . 96.6 m-85 -138.2 97.02 3.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.642 ' C ' ' HG2' ' A' ' 15' ' ' LYS . 69.0 m-85 -87.99 140.61 29.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.311 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.597 ' HA ' ' HB2' ' A' ' 15' ' ' LYS . 8.3 ptt? -170.53 142.31 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 171.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HA ' HH12 ' A' ' 89' ' ' ARG . 37.5 ttmt -104.64 170.17 8.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.461 ' H ' ' HG2' ' A' ' 82' ' ' LYS . . . -119.55 165.49 14.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 118.514 0.597 . . . . 0.0 110.994 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.81 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.81 -42.2 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.57 0.544 . . . . 0.0 111.082 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.456 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 67.0 m-20 -148.82 -172.27 4.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.86 -40.51 15.88 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.656 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.0 -18.8 63.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.608 0.718 . . . . 0.0 109.14 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.81 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -68.61 -52.15 34.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.61 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -48.07 -47.59 33.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.876 170.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.4 tp60 -55.78 -55.51 31.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.671 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.857 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 8.1 mtp180 -35.51 -44.84 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 124.599 1.187 . . . . 0.0 113.614 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.599 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 97.2 m95 -76.1 -51.03 13.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -53.16 -35.87 60.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.641 0.734 . . . . 0.0 109.889 175.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 19.6 t -55.86 -65.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.857 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -63.11 -55.77 22.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.002 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.565 HD13 HD13 ' A' ' 59' ' ' ILE . 83.3 mt -50.44 -60.21 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.525 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.39 -1.67 83.51 Favored Glycine 0 C--O 1.221 -0.71 0 CA-C-O 119.23 -0.761 . . . . 0.0 114.331 -173.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -90.04 -37.56 14.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.427 1.113 . . . . 0.0 109.517 169.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.7 t -72.81 -41.76 64.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.966 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 21.1 tttt . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.25 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 7.6 tp10 . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 120.913 0.387 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 81.2 t80 -150.57 99.0 2.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.037 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.94 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 3.7 tpt -127.48 120.5 28.47 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.291 0.567 . . . . 0.0 110.795 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -126.86 155.73 42.5 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.851 -173.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.737 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 143.87 167.31 11.76 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.725 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 27' ' ' TRP . 1.5 m -64.46 132.99 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.53 0.681 . . . . 0.0 111.208 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 83' ' ' ALA . 8.1 tp -126.32 116.94 22.0 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 8.4 m-85 -66.25 161.07 23.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.6 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 67.6 mmtt . . . . . 0 C--N 1.318 -0.801 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 36.4 Cg_endo . . . . . 0 N--CA 1.464 -0.263 0 CA-C-O 121.291 0.454 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -113.75 135.75 53.6 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.737 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 49.5 t-105 -71.07 132.92 45.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.419 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -129.05 145.08 51.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.389 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -151.6 131.16 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.276 1.036 . . . . 0.0 112.654 170.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.7 tm? -93.69 113.09 25.09 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.784 -176.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.19 100.18 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.51 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.4 29.25 17.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.852 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.684 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.1 -23.29 32.5 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.131 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.554 HG23 ' HB2' ' A' ' 51' ' ' SER . 0.9 OUTLIER -82.3 100.21 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-O 122.138 0.971 . . . . 0.0 109.662 175.192 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -93.99 102.29 14.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.883 -177.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.4 t -105.33 155.4 19.13 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.443 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.577 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.7 p90 -114.04 141.24 47.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.132 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 38.7 m-85 -137.03 155.72 49.33 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.44 -4.26 59.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.766 0.317 . . . . 0.0 111.214 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -159.9 161.27 34.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.712 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -75.47 -17.44 60.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 110.643 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.16 -16.95 28.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.322 0.582 . . . . 0.0 109.984 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.0 -16.03 57.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.548 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.59 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 65.3 t -47.31 -43.41 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -51.85 -43.56 63.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.89 55.56 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.263 0.554 . . . . 0.0 111.83 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -121.5 0.73 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.815 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 m -64.46 -30.65 71.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.865 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HA ' ' HD2' ' A' ' 49' ' ' LYS . 29.6 mmmt 71.26 -25.07 0.17 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.999 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.93 134.62 47.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 34' ' ' ILE . 32.5 p -140.87 150.62 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.948 0.88 . . . . 0.0 113.114 -171.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.069 HG23 HG21 ' A' ' 73' ' ' ILE . 12.7 mt -88.67 131.52 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.662 171.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HE3' HD11 ' A' ' 34' ' ' ILE . 26.1 mtpt -101.23 89.56 3.83 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 172.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.84 ' HE3' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -78.46 3.8 14.92 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.354 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.04 -43.4 13.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.035 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.434 HG22 ' HD3' ' A' ' 74' ' ' PRO . 2.0 m -87.1 -18.35 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.724 0.773 . . . . 0.0 110.25 -173.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 55.3 m -136.0 -173.36 3.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.921 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.563 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.9 tp10 -105.99 144.39 32.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -161.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.618 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -94.51 128.23 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.295 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 15.9 mmmt -109.87 144.29 38.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.689 ' CG1' ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 16.2 p . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.447 0.641 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -148.03 143.74 27.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.743 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.523 ' HG3' ' HG3' ' A' ' 81' ' ' MET . 4.5 ptm -170.29 154.99 5.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -148.57 166.9 26.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.025 0.44 . . . . 0.0 110.154 -176.414 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.945 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.94 124.53 23.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.276 0.56 . . . . 0.0 110.772 171.373 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 57' ' ' CYS . 2.0 pp -105.31 114.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.069 HG21 HG23 ' A' ' 52' ' ' ILE . 1.7 pp -136.38 163.35 50.61 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.067 -174.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 9.5 Cg_exo -14.6 -115.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.303 1 C-N-CA 126.857 5.038 . . . . 0.0 118.407 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.33 3.18 59.55 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.652 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 73' ' ' ILE . 1.6 pm0 -144.2 63.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.219 0.533 . . . . 0.0 111.395 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.457 ' HA ' ' H ' ' A' ' 73' ' ' ILE . 15.8 pt20 -78.02 96.55 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.396 0.617 . . . . 0.0 110.213 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 178.67 88.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.194 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 71.0 m-85 -137.36 96.23 3.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -98.46 132.48 43.86 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.443 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.523 ' HG3' ' HG3' ' A' ' 69' ' ' MET . 17.1 ptt? -157.58 165.59 35.15 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.309 0.576 . . . . 0.0 111.059 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 67' ' ' THR . 41.1 ttmt -131.2 157.91 41.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -112.35 162.02 16.01 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.89 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.796 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.0 -41.27 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.259 175.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.435 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 2.4 m120 -147.02 -176.16 5.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.887 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -83.4 -36.82 23.99 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.622 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.589 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.23 -19.15 61.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.613 0.72 . . . . 0.0 109.173 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.796 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -67.77 -51.84 44.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 23.6 ttp180 -50.3 -45.72 54.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.914 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 8.0 tp60 -54.91 -59.19 5.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.563 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.94 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 14.6 mtt180 -36.33 -44.61 0.43 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.64 1.176 . . . . 0.0 113.466 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.482 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 95.0 m95 -70.9 -55.43 8.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.689 ' HG ' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.03 -37.38 61.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.71 0.767 . . . . 0.0 110.15 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 98' ' ' SER . 19.0 t -56.97 -57.99 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.294 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -69.28 -43.55 73.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.938 -175.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.482 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 66.7 mt -54.06 -60.73 2.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.785 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.17 -1.18 73.45 Favored Glycine 0 C--O 1.203 -1.838 0 C-N-CA 119.259 -1.448 . . . . 0.0 112.106 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 39.4 t -75.1 -41.75 58.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.435 1.117 . . . . 0.0 108.615 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t -79.64 -37.79 35.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.603 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.84 ' HB2' ' HE3' ' A' ' 54' ' ' MET . 34.5 tttt . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.832 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 43.2 mm-40 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 73.2 t80 -154.02 99.45 2.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.813 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.1 ttt -132.22 136.15 46.8 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.636 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.751 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.8 pt-20 -136.31 144.38 44.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.362 0.601 . . . . 0.0 112.294 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.677 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.5 168.16 22.99 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.399 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 12' ' ' VAL . 2.0 m -67.06 140.83 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.646 0.736 . . . . 0.0 112.299 -175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 tp -125.12 118.93 27.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -67.37 87.76 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.31 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 43.2 tttm . . . . . 0 C--N 1.321 -0.673 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 N--CA 1.461 -0.435 0 CA-C-O 121.351 0.48 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' NH1' ' HA ' ' A' ' 39' ' ' ASP . 29.4 tpt180 -102.67 129.2 49.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.677 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 54.4 t-105 -72.02 129.69 39.15 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.683 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.6 m-85 -125.28 140.79 52.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.048 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.751 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -149.52 125.87 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 122.292 1.044 . . . . 0.0 112.27 171.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.9 tm? -92.81 113.3 25.54 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.96 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.26 131.73 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.068 0.461 . . . . 0.0 109.925 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 62.94 16.65 9.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.42 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.0 -28.43 14.61 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.891 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -77.4 122.21 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-O 121.446 0.641 . . . . 0.0 110.812 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.544 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.84 104.76 16.66 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 15.0 m -103.79 138.79 39.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.952 0.406 . . . . 0.0 110.388 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 9.5 p90 -110.79 137.5 48.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.5 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 53.3 m-85 -135.8 169.93 16.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.409 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 20.5 t70 -63.37 -61.66 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.508 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 18.3 m -139.9 -175.55 4.26 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.606 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.73 -17.28 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.161 0.505 . . . . 0.0 111.398 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.508 ' OD1' ' HB2' ' A' ' 40' ' ' SER . 6.0 p-10 -86.37 -17.46 34.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.287 0.565 . . . . 0.0 110.571 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.537 ' OD1' ' HA3' ' A' ' 47' ' ' GLY . 26.0 t70 -85.23 -20.2 30.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.338 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.582 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 50.5 t -44.47 -44.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 124.329 1.052 . . . . 0.0 113.709 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 5.1 p -58.42 -57.76 11.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.234 -172.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -152.18 29.87 0.56 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 111.788 -173.355 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -86.16 -96.5 0.8 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.811 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.3 m -62.44 -38.19 88.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.984 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt 70.72 -30.43 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.36 129.03 39.81 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.322 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.471 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.1 p -136.51 140.92 43.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.862 0.839 . . . . 0.0 113.264 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.085 HG23 HG21 ' A' ' 73' ' ' ILE . 12.6 mt -89.86 135.78 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.766 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.574 ' HE3' HD11 ' A' ' 34' ' ' ILE . 36.5 mtpt -109.27 93.06 4.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.834 171.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.862 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.22 -3.12 34.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.882 -176.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.01 -49.74 9.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 112.088 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.494 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.9 m -78.35 -17.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.271 1.034 . . . . 0.0 109.327 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.696 ' HB3' HD12 ' A' ' 72' ' ' ILE . 56.9 m -131.87 -149.73 0.39 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.305 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.2 tp10 -132.09 145.27 51.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 120.093 1.315 . . . . 0.0 113.793 -168.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.88 112.4 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 168.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.601 ' HG3' HG23 ' A' ' 72' ' ' ILE . 18.0 mmmt -93.76 147.33 23.15 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.682 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.55 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.3 m . . . . . 0 C--N 1.311 -1.099 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.898 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 4.9 tpp180 -121.86 138.36 54.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.761 -174.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 61' ' ' VAL . 4.2 ptp -153.19 177.0 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -150.31 161.43 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.201 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.92 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -130.39 124.34 31.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.257 0.551 . . . . 0.0 111.021 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.696 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.2 pp -109.73 118.27 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.085 HG21 HG23 ' A' ' 52' ' ' ILE . 2.1 pp -138.39 167.06 21.23 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 39.0 Cg_endo -60.8 144.72 99.6 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.132 2.555 . . . . 0.0 113.987 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 -49.16 4.1 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.428 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 12.9 pt-20 -150.42 89.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.284 0.564 . . . . 0.0 111.3 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.44 97.0 10.22 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.336 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -170.1 87.25 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.748 0.785 . . . . 0.0 110.312 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.6 m-85 -139.02 98.08 3.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.591 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.469 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 46.5 m-85 -103.98 121.11 42.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.087 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 ptt? -149.37 142.4 24.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.695 0.76 . . . . 0.0 111.679 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -105.03 151.65 23.7 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -99.79 155.73 17.49 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.339 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.753 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.48 -40.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.721 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.434 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 10.7 t-20 -146.43 -174.03 4.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.91 -44.64 14.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.895 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.02 -15.66 62.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.873 0.844 . . . . 0.0 109.361 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.753 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.06 -52.27 56.7 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.421 ' O ' HD22 ' A' ' 93' ' ' LEU . 10.0 ttp180 -54.42 -46.03 73.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.77 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.588 ' OE1' HG21 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -49.12 -62.43 1.54 Allowed 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.557 0.743 . . . . 0.0 110.628 175.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.813 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 71.8 mtt180 -35.06 -48.13 0.4 Allowed 'General case' 0 N--CA 1.434 -1.27 0 O-C-N 124.75 1.281 . . . . 0.0 113.137 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.501 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 95.6 m95 -71.46 -52.33 19.02 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.55 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.48 -38.67 55.04 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.793 0.806 . . . . 0.0 109.769 176.219 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.588 HG21 ' OE1' ' A' ' 90' ' ' GLN . 39.7 t -61.86 -63.04 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.783 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.1 86.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.484 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 59' ' ' ILE . 69.2 mt -58.27 -58.89 6.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.247 0.546 . . . . 0.0 111.035 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.77 -0.98 90.05 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.02 -175.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.3 t -87.75 -31.41 19.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 166.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.552 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 30.3 t -81.73 -34.27 30.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.862 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 28.5 tttt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.199 0.523 . . . . 0.0 110.564 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 7.6 pt-20 . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.221 0.534 . . . . 0.0 112.039 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 32.2 t80 -151.51 97.58 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.814 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 5.8 tpt -130.12 128.84 42.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.749 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.57 158.16 40.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.347 0.594 . . . . 0.0 112.406 -173.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.779 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 139.96 162.42 9.11 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.983 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.7 136.32 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-O 121.265 0.555 . . . . 0.0 111.433 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 83' ' ' ALA . 3.9 tp -123.59 118.5 27.46 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.635 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 20.1 m-85 -74.63 93.69 2.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.532 0 C-N-CA 118.926 -1.11 . . . . 0.0 112.087 -171.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 62.4 Cg_endo . . . . . 0 N--CA 1.46 -0.454 0 CA-C-O 121.426 0.511 . . . . 0.0 112.098 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -110.86 146.84 35.78 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.779 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 56.3 t-105 -67.35 118.72 11.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.071 0.462 . . . . 0.0 109.783 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.65 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -108.5 144.48 36.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.984 -176.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.606 HG13 ' HE2' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -154.54 129.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.514 1.15 . . . . 0.0 112.667 167.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -93.64 124.58 37.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.647 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.9 141.58 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.982 0.42 . . . . 0.0 109.873 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.47 23.04 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.273 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.85 -13.24 37.97 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.23 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.527 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -90.71 141.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 123.445 0.698 . . . . 0.0 111.216 175.149 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.612 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -118.15 110.01 17.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.463 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.462 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 15.0 m -105.39 152.6 22.76 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.571 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.613 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.0 p90 -112.02 138.05 49.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.272 0.558 . . . . 0.0 111.55 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HE2' HG13 ' A' ' 29' ' ' VAL . 11.1 m-85 -134.46 178.4 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.011 -175.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.77 -63.89 1.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 110.441 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 27' ' ' TRP . 5.7 t -146.76 -166.84 2.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.147 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.46 -11.74 61.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.972 0.415 . . . . 0.0 111.415 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -90.39 -17.16 27.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.462 0.648 . . . . 0.0 110.717 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.621 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 24.4 t70 -90.53 -14.51 32.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.854 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.667 HG22 ' NE1' ' A' ' 27' ' ' TRP . 59.7 t -43.49 -32.12 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.6 t -70.31 -38.68 74.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.725 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -123.2 -72.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.73 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.621 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -151.23 52.06 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.402 -176.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 50' ' ' GLY . 50.1 m -74.07 -11.04 60.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.312 0.577 . . . . 0.0 109.807 176.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.2 tptt 71.2 -9.92 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.466 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -66.04 141.56 41.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.7 p -146.56 142.32 27.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.243 0.544 . . . . 0.0 112.056 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.073 HG23 HG21 ' A' ' 73' ' ' ILE . 62.6 mt -89.16 144.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.764 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.527 ' HE3' HD11 ' A' ' 34' ' ' ILE . 34.6 mtpt -113.56 90.46 3.35 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.331 173.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.09 -24.61 60.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -59.75 -36.61 76.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.486 HG22 ' HD3' ' A' ' 74' ' ' PRO . 2.0 m -94.97 -15.4 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.666 0.746 . . . . 0.0 111.07 -171.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 72' ' ' ILE . 81.5 m -134.01 -145.76 0.25 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.544 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.624 ' O ' HG13 ' A' ' 72' ' ' ILE . 4.8 tp10 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.322 0.965 . . . . 0.0 112.313 -170.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.619 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -97.66 125.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.518 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.705 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 34.4 mtmt -104.71 97.76 7.6 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 -172.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.276 0 CA-C-O 121.64 0.733 . . . . 0.0 110.814 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.4 p . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.725 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 3.2 ppt_? -123.56 134.89 53.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.045 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' A' ' 81' ' ' MET . 1.7 ptm -171.49 158.06 5.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.063 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 4.8 mt-10 -150.25 167.12 27.89 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.818 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -135.51 125.72 26.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 171.641 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.1 pp -110.38 120.07 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.073 HG21 HG23 ' A' ' 52' ' ' ILE . 1.1 pp -133.72 163.39 51.45 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.61 -167.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 17.8 Cg_endo -53.77 -63.19 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.095 3.197 . . . . 0.0 115.253 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.93 -20.49 62.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.559 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 179.95 103.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.33 0.586 . . . . 0.0 111.162 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HA ' ' H ' ' A' ' 73' ' ' ILE . 16.9 pt20 -84.39 97.55 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.942 -0.474 . . . . 0.0 111.051 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.47 87.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.211 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 82.9 m-85 -139.98 97.79 3.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.672 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -101.24 135.62 42.42 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.533 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 8.8 ptt? -156.26 151.15 26.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.933 0.873 . . . . 0.0 112.718 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 40.3 ttmt -111.84 137.58 49.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.099 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -90.49 157.99 17.26 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.731 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.755 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -46.51 -49.06 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.134 175.5 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.508 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 85.0 m-20 -134.88 -174.49 3.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.905 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.617 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -87.7 -37.15 16.95 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.825 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -76.51 -14.99 59.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.878 0.847 . . . . 0.0 109.249 171.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.755 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.02 -53.25 48.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.665 ' O ' HD13 ' A' ' 93' ' ' LEU . 32.7 ttp180 -47.72 -51.24 22.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.793 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.698 ' NE2' HG21 ' A' ' 94' ' ' VAL . 17.1 tm0? -49.1 -64.12 0.9 Allowed 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 123.701 0.8 . . . . 0.0 111.036 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.814 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 34.2 mtt180 -35.74 -45.13 0.37 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.65 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 94.2 m95 -70.65 -55.3 9.08 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.439 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.753 ' CD1' HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -51.8 -41.0 61.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.949 0.88 . . . . 0.0 110.292 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.698 HG21 ' NE2' ' A' ' 90' ' ' GLN . 25.5 t -56.85 -51.56 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.007 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 -51.35 10.95 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.759 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.676 HD22 ' HE2' ' A' ' 54' ' ' MET . 92.3 mt -50.84 -55.78 15.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.674 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.31 -3.22 90.69 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.334 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.634 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 42.5 t -66.47 -57.06 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.885 0.842 . . . . 0.0 109.622 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 7' ' ' GLU . 13.9 t -79.77 -29.43 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.743 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -173.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 6.0 tp10 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 75.4 t80 -150.45 99.59 2.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -172.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.787 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 2.9 tpt -122.79 133.34 54.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.308 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.7 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 5.4 pt-20 -135.67 149.94 49.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.544 0.688 . . . . 0.0 112.746 -173.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.738 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 151.31 162.98 11.08 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.206 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.11 132.14 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 121.361 0.601 . . . . 0.0 111.39 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 83' ' ' ALA . 3.5 tp -121.23 118.95 30.89 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.422 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 25' ' ' PRO . 85.4 m-85 -76.79 90.6 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.005 -175.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.784 0 CA-C-O 121.513 0.673 . . . . 0.0 112.686 -171.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 30.8 Cg_endo . . . . . 0 N--CA 1.455 -0.775 0 CA-C-O 121.488 0.537 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.56 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 1.4 tpm_? -112.34 129.28 56.35 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.738 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 62.4 t-105 -67.26 119.41 12.1 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.528 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.527 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -113.71 137.0 52.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.643 -177.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.7 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.9 p -150.53 130.85 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 122.409 1.099 . . . . 0.0 112.457 168.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.748 HD21 ' HE3' ' A' ' 54' ' ' MET . 2.7 tm? -93.37 117.98 30.74 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.756 -173.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -141.28 124.44 16.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 58.21 31.23 20.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.425 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.579 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 91.55 -25.49 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.024 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.552 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -83.93 113.24 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-O 121.746 0.784 . . . . 0.0 111.238 -178.149 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -95.25 105.88 17.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.57 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.4 t -104.31 160.43 14.9 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.082 0.468 . . . . 0.0 111.279 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.555 ' OH ' HG13 ' A' ' 52' ' ' ILE . 1.6 m-85 -108.71 128.15 54.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.984 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 18.4 m-85 -131.47 160.39 35.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.13 -62.92 1.38 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.908 0.385 . . . . 0.0 110.084 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -142.9 -173.16 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.44 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -65.42 -19.91 66.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.16 -16.9 34.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.0 110.66 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.757 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 22.6 t0 -87.32 -14.24 41.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.096 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.592 HG22 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -41.47 -33.11 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.83 -36.84 85.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.87 0.366 . . . . 0.0 111.055 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -118.24 -76.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.001 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.757 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 71.11 -176.51 37.21 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.855 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -66.95 122.17 17.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -78.54 51.95 1.12 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.937 0.875 . . . . 0.0 111.59 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -134.92 159.75 24.06 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.486 ' OG ' HG23 ' A' ' 34' ' ' ILE . 4.5 t -159.78 158.51 31.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.151 0.977 . . . . 0.0 112.836 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 73' ' ' ILE . 9.8 mt -90.49 128.2 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.409 171.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HE3' HD11 ' A' ' 34' ' ' ILE . 37.9 mtpt -104.37 88.7 3.03 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.235 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.783 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.96 -21.8 60.81 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.793 -177.162 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -65.71 -28.67 69.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.284 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 53' ' ' LYS . 1.5 m -98.56 -14.49 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.706 0.765 . . . . 0.0 110.931 -172.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.635 ' HB3' HD12 ' A' ' 72' ' ' ILE . 86.1 m -136.43 -142.99 0.18 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.5 tp10 -128.4 146.34 50.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.302 0.955 . . . . 0.0 112.376 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -93.91 135.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 9.7 mmtt -114.1 146.15 40.65 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.598 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.9 m . . . . . 0 C--N 1.316 -0.868 0 O-C-N 122.001 -0.437 . . . . 0.0 109.939 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 24.7 p . . . . . 0 C--O 1.223 -0.336 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -135.88 122.93 21.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.082 0.468 . . . . 0.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.644 ' HG2' HD11 ' A' ' 93' ' ' LEU . 1.3 mpp? -141.1 172.32 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -151.57 166.76 30.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 111.261 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.846 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -137.2 137.3 38.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 173.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 57' ' ' CYS . 1.9 pp -115.93 115.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.023 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -135.72 164.98 39.52 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.814 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.767 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.29 132.25 45.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.513 2.809 . . . . 0.0 114.664 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.88 -29.81 7.63 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.539 170.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -156.97 58.41 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.987 0.423 . . . . 0.0 111.698 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.29 98.74 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.605 0.717 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -178.94 88.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.143 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.1 m-85 -138.32 99.0 3.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.826 0.346 . . . . 0.0 110.838 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.2 127.63 47.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 13.9 ptt? -151.58 142.42 22.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.665 0.745 . . . . 0.0 111.77 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 67' ' ' THR . 77.8 tttt -105.12 136.89 43.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.037 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.66 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -89.41 155.82 19.08 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.705 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.767 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -47.56 -46.19 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.662 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.532 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 7.7 m120 -139.16 -170.2 2.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.667 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -88.05 -40.26 13.98 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.361 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.26 -18.73 61.79 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.767 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -62.78 -53.16 58.48 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.183 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.702 ' O ' HD22 ' A' ' 93' ' ' LEU . 36.8 ttt-85 -45.13 -53.53 7.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.826 170.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.2 tp60 -54.46 -58.36 7.75 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.362 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.787 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 36.6 mtt180 -37.36 -41.86 0.45 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 124.562 1.164 . . . . 0.0 113.575 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.527 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 91.8 m95 -72.89 -54.42 8.78 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.664 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.19 -38.2 62.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.434 0.635 . . . . 0.0 110.343 176.341 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 90' ' ' GLN . 25.4 t -54.4 -63.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.028 175.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -61.08 -53.79 52.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.021 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.521 ' HB3' HG21 ' A' ' 59' ' ' ILE . 58.7 mt -53.38 -53.81 45.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.34 -177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.31 -1.07 79.16 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.808 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.2 t -89.98 -41.47 11.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.861 0.83 . . . . 0.0 109.818 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 7' ' ' GLU . 8.8 t -75.81 -38.2 58.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.329 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.783 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 2.7 tttt . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.092 0.473 . . . . 0.0 110.908 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 C--O 1.236 0.357 0 CA-C-O 121.963 0.887 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 61.5 t80 -154.66 97.26 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.031 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.91 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 3.6 tpt -120.2 125.24 47.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.955 0.407 . . . . 0.0 111.163 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.702 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 8.2 pt-20 -131.87 151.78 51.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.532 0.682 . . . . 0.0 112.257 -173.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.714 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.97 159.73 8.72 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.309 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.7 m -60.08 131.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 83' ' ' ALA . 10.2 tp -122.58 118.61 28.61 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.62 ' O ' ' HB2' ' A' ' 81' ' ' MET . 10.1 m-30 -59.3 149.15 29.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 45.1 mmtm . . . . . 0 C--N 1.313 -1.007 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.669 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 CA--C 1.521 -0.153 0 CA-C-O 121.153 0.397 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.95 143.45 49.48 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.714 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -70.43 139.41 51.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.365 0.603 . . . . 0.0 111.345 -169.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.486 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -138.96 142.95 38.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.036 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.702 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.7 p -154.55 133.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 122.297 1.046 . . . . 0.0 112.67 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.3 tm? -94.42 126.0 39.41 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 113.117 -1.856 . . . . 0.0 109.97 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -138.27 113.38 9.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 58.06 30.91 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.237 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 98.06 -29.81 10.58 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.53 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.438 HG13 ' HG2' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -75.95 106.83 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 121.705 0.764 . . . . 0.0 110.075 177.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.36 108.94 20.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.177 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 14.8 t -103.4 155.17 18.68 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.92 -170.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -109.22 134.85 51.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.109 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.457 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 18.0 m-85 -143.73 169.14 18.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.132 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.74 -65.53 1.0 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.75 0.31 . . . . 0.0 110.547 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -123.78 179.92 4.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -73.5 -7.6 52.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.304 0.573 . . . . 0.0 111.109 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -84.57 -20.98 30.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.774 0.797 . . . . 0.0 110.298 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.423 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -78.84 -16.24 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.829 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.68 HG22 ' NE1' ' A' ' 27' ' ' TRP . 65.1 t -45.15 -39.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.2 p -61.7 -55.68 27.79 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.41 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -124.9 -76.83 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.552 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.86 -143.24 48.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.016 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -69.79 -21.54 63.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 0.0 110.8 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 tptt 62.73 13.72 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.34 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.78 129.51 9.18 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 12.3 p -128.98 141.4 51.27 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.045 HG23 HG21 ' A' ' 73' ' ' ILE . 13.0 mt -89.01 133.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.965 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.438 ' HG2' HG13 ' A' ' 34' ' ' ILE . 40.5 mtpt -111.69 89.47 3.07 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.823 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.03 -11.42 60.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 109.964 -176.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.14 -26.8 53.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.411 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.477 HG21 ' HG3' ' A' ' 74' ' ' PRO . 2.0 m -98.79 -16.13 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.748 0.785 . . . . 0.0 110.147 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.733 ' HB3' HD12 ' A' ' 72' ' ' ILE . 97.9 m -133.4 -142.71 0.21 Allowed 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.512 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.4 tp10 -131.06 146.18 52.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.802 1.183 . . . . 0.0 112.756 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.774 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -89.13 130.28 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.568 ' HG3' HG23 ' A' ' 72' ' ' ILE . 10.1 mmmt -105.01 136.04 45.23 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.187 0.517 . . . . 0.0 110.913 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.7 m . . . . . 0 C--N 1.315 -0.897 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 173.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.477 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.2 p . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.184 0.516 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -125.78 120.86 31.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.52 0.676 . . . . 0.0 110.476 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.47 ' CE ' ' HB2' ' A' ' 92' ' ' TRP . 8.2 ptm -155.07 152.4 29.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.919 -172.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HG2' ' C ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -157.25 168.08 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 -175.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.824 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.29 134.13 39.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.461 . . . . 0.0 110.856 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.733 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.1 pp -116.82 119.21 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.045 HG21 HG23 ' A' ' 52' ' ' ILE . 2.6 pp -134.71 178.33 1.81 Allowed Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.731 -175.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.757 ' CD ' ' HB ' ' A' ' 73' ' ' ILE . 38.9 Cg_endo -76.37 143.38 24.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.197 1.931 . . . . 0.0 113.34 -170.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.74 -49.17 3.99 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.82 80.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.332 0.587 . . . . 0.0 111.048 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -84.39 96.44 9.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -171.8 87.55 0.09 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 110.352 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CG ' HD11 ' A' ' 52' ' ' ILE . 92.7 m-85 -129.8 97.06 4.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.097 174.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -107.35 118.19 36.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 10.7 ptt? -143.23 176.79 8.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.283 0.564 . . . . 0.0 111.623 -171.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 41.7 ttmt -140.79 157.83 44.85 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -105.08 160.0 15.4 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.906 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.708 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -51.33 -31.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.042 176.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.56 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 13.0 t-20 -157.62 -175.75 5.56 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -77.45 -48.73 16.43 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.43 -14.55 62.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.624 0.726 . . . . 0.0 109.678 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.708 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 27.2 tp10 -65.6 -40.85 93.1 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.537 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 2.4 tmt_? -62.37 -44.21 96.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.261 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.776 ' NE2' HG21 ' A' ' 94' ' ' VAL . 15.8 tm0? -53.34 -62.66 1.51 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.103 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.91 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 69.0 mtt180 -33.11 -46.74 0.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.689 1.243 . . . . 0.0 113.857 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.486 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 93.3 m95 -71.92 -54.37 10.24 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.607 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.2 -36.76 63.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.92 0.867 . . . . 0.0 109.611 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.776 HG21 ' NE2' ' A' ' 90' ' ' GLN . 31.3 t -59.32 -55.8 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.8 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.64 71.07 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.472 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' A' ' 59' ' ' ILE . 78.0 mt -54.33 -55.67 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.059 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.23 -3.57 90.63 Favored Glycine 0 C--O 1.205 -1.718 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.241 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 48.3 t -67.72 -41.37 83.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.272 1.036 . . . . 0.0 108.826 173.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.412 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 9.7 t -80.49 -38.95 28.89 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.637 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.823 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 29.1 tttt . . . . . 0 C--O 1.226 -0.164 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.009 0.433 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 7.2 t80 -152.43 96.82 2.2 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.863 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 6.4 tpt -115.85 112.64 22.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.853 0.835 . . . . 0.0 110.306 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.664 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.85 137.94 52.53 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.957 -172.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.794 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.44 170.46 26.14 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.204 172.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.6 m -62.59 138.31 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 121.472 0.653 . . . . 0.0 111.729 -176.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 81' ' ' MET . 1.7 tp -128.24 116.93 20.63 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 62.4 m-85 -72.98 90.16 1.47 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.784 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 22.8 ttpp . . . . . 0 C--N 1.317 -0.839 0 CA-C-O 122.117 0.96 . . . . 0.0 112.326 -170.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.945 0 CA-C-O 121.364 0.485 . . . . 0.0 112.164 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -107.34 152.52 24.04 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.794 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 65.7 t-105 -74.23 105.43 5.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.084 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.9 OUTLIER -96.48 136.39 37.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.972 -177.592 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.681 HG13 ' CE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -142.91 128.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.865 0.84 . . . . 0.0 111.994 172.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -96.13 123.45 39.76 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.239 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.24 140.49 14.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 110.379 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 61.25 27.73 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.421 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 86.27 -22.49 12.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.114 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.552 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -86.3 134.15 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-O 121.342 0.591 . . . . 0.0 111.259 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.464 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -108.7 106.27 16.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.3 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 35.9 m -104.17 147.18 27.74 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.961 -0.462 . . . . 0.0 110.992 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.589 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 7.8 p90 -110.68 120.41 42.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.882 0.848 . . . . 0.0 110.995 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.681 ' CE2' HG13 ' A' ' 29' ' ' VAL . 57.4 m-85 -113.91 -174.13 2.41 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.293 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.03 -63.44 1.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.586 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.2 m -122.73 -179.57 4.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HG2' ' CE3' ' A' ' 27' ' ' TRP . 39.2 mt-30 -79.04 -1.26 34.8 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.76 -21.08 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.247 0.546 . . . . 0.0 110.341 170.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.498 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 6.4 m-20 -72.62 -16.8 61.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.418 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.679 HG22 ' NE1' ' A' ' 27' ' ' TRP . 49.1 t -44.62 -28.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.448 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 5.7 t -82.23 -52.22 7.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.878 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -141.23 17.21 2.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 43' ' ' ASP . . . -69.21 117.28 7.76 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.161 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m 72.19 -41.32 0.5 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.669 0.787 . . . . 0.0 113.046 175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 26.6 mmmt 67.8 11.19 8.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.865 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.19 131.8 10.73 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.512 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.8 p -142.77 146.21 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.093 HG23 HG21 ' A' ' 73' ' ' ILE . 9.0 mt -87.52 134.87 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.919 168.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HE3' HD11 ' A' ' 34' ' ' ILE . 40.8 mtpt -108.92 89.28 2.94 Favored 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.537 173.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.725 ' HB2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -74.15 -21.36 59.89 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.468 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -63.32 -38.13 89.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.159 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.7 m -91.72 -15.19 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.783 0.801 . . . . 0.0 110.688 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.584 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 87.3 m -132.56 -145.27 0.25 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.243 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.561 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.7 tp10 -125.81 146.8 49.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.078 0.854 . . . . 0.0 112.221 -170.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.725 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -95.64 134.64 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 172.481 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.622 ' HG3' HG23 ' A' ' 72' ' ' ILE . 23.3 mtmt -117.16 147.35 42.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.014 0.435 . . . . 0.0 110.371 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.604 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m . . . . . 0 C--N 1.313 -1.0 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 44.3 p . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.62 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 59.0 ttt180 -159.28 109.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.492 . . . . 0.0 109.796 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.619 ' HG2' HD11 ' A' ' 93' ' ' LEU . 1.9 mpp? -130.08 171.22 13.05 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -148.58 155.31 40.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.035 0.445 . . . . 0.0 110.906 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.848 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -130.35 129.76 43.56 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.25 0.548 . . . . 0.0 111.461 174.266 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.622 HG23 ' HG3' ' A' ' 60' ' ' LYS . 1.5 pp -111.91 113.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.093 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -133.67 166.27 30.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.706 -174.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.761 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 Cg_endo -59.63 130.03 33.55 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.294 2.662 . . . . 0.0 114.228 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 -25.04 9.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.594 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.83 69.53 0.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -80.85 97.22 7.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.522 0.677 . . . . 0.0 110.144 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -175.29 88.0 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.934 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.2 m-85 -144.97 97.23 2.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.722 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 88.3 m-85 -102.87 127.25 50.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -147.73 141.71 25.91 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.678 0.752 . . . . 0.0 112.833 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 67' ' ' THR . 39.6 ttpt -105.6 138.78 41.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.916 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 161.9 13.69 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.576 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.716 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -48.69 -45.36 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.79 176.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.61 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 11.3 m120 -136.93 -175.79 4.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.589 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -79.66 -43.02 23.56 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.537 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.88 -17.71 62.7 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.56 173.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.716 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 26.6 tp10 -67.91 -44.13 77.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.728 ' O ' HD22 ' A' ' 93' ' ' LEU . 17.2 ttt180 -55.13 -52.3 63.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.69 171.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 94' ' ' VAL . 20.3 tp60 -51.6 -56.55 12.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.909 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.863 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 61.8 mtt180 -37.28 -42.36 0.46 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.591 1.157 . . . . 0.0 113.457 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.552 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 93.0 m95 -72.43 -56.49 5.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.881 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -51.83 -37.37 51.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.5 176.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 90' ' ' GLN . 33.1 t -56.23 -63.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.17 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.63 79.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.867 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.494 ' HB3' HG21 ' A' ' 59' ' ' ILE . 83.1 mt -52.56 -55.25 23.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.37 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.59 -20.42 64.0 Favored Glycine 0 C--O 1.204 -1.741 0 C-N-CA 119.085 -1.531 . . . . 0.0 112.603 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -59.75 -34.68 73.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.91 1.355 . . . . 0.0 109.978 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -91.4 -32.73 15.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.187 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 1.1 tttt . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.355 0.598 . . . . 0.0 112.588 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.7 t80 -154.04 97.82 2.1 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.922 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 8.9 tpt -122.73 111.07 16.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 122.025 0.917 . . . . 0.0 110.838 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.36 147.93 45.68 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.44 -171.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.7 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.21 167.09 13.26 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.503 172.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.414 HG13 ' H ' ' A' ' 12' ' ' VAL . 2.0 m -65.36 137.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.448 0.642 . . . . 0.0 111.575 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 13' ' ' LEU . 3.7 tp -124.05 119.05 28.37 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -73.46 87.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.4 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 15.1 tmtt? . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 0.0 111.629 -169.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 N--CA 1.46 -0.471 0 CA-C-O 121.276 0.448 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HD3' ' OH ' ' A' ' 37' ' ' TYR . 98.8 mtt180 -123.16 157.09 33.74 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.715 ' NE1' HG22 ' A' ' 44' ' ' VAL . 74.0 t-105 -81.96 132.58 35.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.422 0.63 . . . . 0.0 111.546 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.514 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -129.44 142.47 50.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.137 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.63 HG13 ' HE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -151.6 132.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 122.581 1.181 . . . . 0.0 112.786 167.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.9 tm? -94.75 123.11 38.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.594 -2.093 . . . . 0.0 109.713 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -154.44 141.18 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 171.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.18 27.02 16.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.999 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 86.89 -28.74 5.34 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.133 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.554 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -77.14 124.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.532 0.682 . . . . 0.0 111.083 178.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.634 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -101.21 106.97 18.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 m -103.14 155.09 18.65 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.481 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.455 ' OH ' ' HD3' ' A' ' 26' ' ' ARG . 21.3 t80 -109.72 132.4 54.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.594 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.63 ' HE2' HG13 ' A' ' 29' ' ' VAL . 29.1 m-85 -139.66 179.55 6.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.27 -61.48 1.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.638 0.256 . . . . 0.0 110.916 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.3 m -132.41 -176.76 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' HG3' ' CE3' ' A' ' 27' ' ' TRP . 0.7 OUTLIER -73.29 -3.31 26.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.497 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.18 -20.47 23.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.257 0.551 . . . . 0.0 110.385 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 7.5 m-20 -82.29 -15.61 52.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.525 -175.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.715 HG22 ' NE1' ' A' ' 27' ' ' TRP . 70.3 t -41.16 -37.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -172.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 p -68.78 -51.82 36.87 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.079 -0.388 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -124.59 -68.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.073 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.63 -132.6 52.63 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.83 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.5 m -77.01 -8.49 57.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.747 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.8 tptt 73.93 -37.62 0.37 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.067 0.854 . . . . 0.0 112.485 176.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.99 129.91 42.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.195 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.1 p -139.7 139.07 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.367 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.013 HG23 HG21 ' A' ' 73' ' ' ILE . 13.7 mt -88.51 133.77 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.41 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.554 ' HE3' HD11 ' A' ' 34' ' ' ILE . 38.1 mtpt -110.99 94.18 4.86 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.916 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.893 ' HB2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -76.66 -1.05 25.82 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.753 0.311 . . . . 0.0 110.439 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.01 -47.95 9.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.874 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.6 m -80.81 -16.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.034 0.921 . . . . 0.0 109.641 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.614 ' HB3' HD12 ' A' ' 72' ' ' ILE . 41.0 m -133.88 -154.84 0.62 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.835 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.6 tp10 -124.35 144.37 50.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 113.23 -167.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.893 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -90.9 115.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 171.18 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HG3' HG23 ' A' ' 72' ' ' ILE . 23.8 mmmt -97.47 139.08 33.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.568 -172.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.452 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m . . . . . 0 C--N 1.314 -0.939 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.744 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.1 p . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 121.46 0.648 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.69 120.12 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.585 ' HE1' ' HB2' ' A' ' 92' ' ' TRP . 9.4 ptm -170.16 151.95 4.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.735 -172.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -155.51 166.89 32.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.848 0.356 . . . . 0.0 110.325 -175.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.91 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -136.98 131.23 32.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.006 0.431 . . . . 0.0 111.102 175.154 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.679 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.2 pp -115.5 118.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.013 HG21 HG23 ' A' ' 52' ' ' ILE . 1.9 pp -138.47 166.06 28.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.581 -174.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.787 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 37.3 Cg_endo -60.29 136.91 71.41 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.597 2.864 . . . . 0.0 114.437 -172.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.19 -45.07 2.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.664 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.79 80.04 1.01 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.106 0.479 . . . . 0.0 111.121 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.422 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 8.8 pt20 -81.43 95.87 7.19 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.399 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -166.61 87.41 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.303 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.8 m-85 -136.55 96.01 3.26 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.486 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 65.0 m-85 -103.83 117.06 33.47 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -142.52 147.6 36.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.384 0.611 . . . . 0.0 111.483 -172.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.744 ' HG2' ' O ' ' A' ' 67' ' ' THR . 48.1 mtmt -110.53 176.69 4.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -127.41 173.13 10.06 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.577 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.791 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -50.06 -39.52 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.609 0.719 . . . . 0.0 111.073 174.303 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.443 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 12.8 t-20 -149.01 -176.17 5.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.383 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -86.14 -37.21 19.0 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.795 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -74.52 -15.15 60.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.113 0.959 . . . . 0.0 109.429 171.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.791 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.04 -52.46 55.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.614 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -47.99 -48.05 32.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.506 170.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.618 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -51.74 -62.31 1.71 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.879 0.872 . . . . 0.0 111.127 177.285 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.922 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 69.7 mtt180 -35.17 -41.78 0.16 Allowed 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.57 1.169 . . . . 0.0 113.694 175.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.585 ' HB2' ' HE1' ' A' ' 69' ' ' MET . 96.9 m95 -73.36 -56.63 4.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.74 -36.42 57.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.792 0.806 . . . . 0.0 110.078 177.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.599 HG21 ' OE1' ' A' ' 90' ' ' GLN . 30.4 t -60.64 -53.58 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.621 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.85 46.08 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.624 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.427 ' CD1' HD13 ' A' ' 59' ' ' ILE . 77.3 mt -51.49 -53.59 35.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.774 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.83 -4.26 90.13 Favored Glycine 0 C--O 1.207 -1.535 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.624 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.572 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.7 t -69.09 -34.4 75.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.507 1.154 . . . . 0.0 109.243 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.3 t -89.51 -29.12 19.18 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.027 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 39.8 tttt . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 54.0 t80 -153.8 98.22 2.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.892 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 5.5 tpt -126.31 118.12 24.42 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.344 0.592 . . . . 0.0 111.017 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -126.2 153.13 45.09 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.533 -173.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.693 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 142.03 161.16 8.63 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.671 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.31 132.17 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.748 0.785 . . . . 0.0 111.12 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 83' ' ' ALA . 10.5 tp -122.03 118.65 29.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.557 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 8.8 m-30 -61.06 148.26 40.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 37.1 mtmt . . . . . 0 C--N 1.311 -1.075 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.832 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 44.3 Cg_endo . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.264 0.443 . . . . 0.0 112.966 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -116.46 139.67 50.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.693 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 64.3 t-105 -72.49 125.69 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.747 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.3 m-85 -121.15 143.16 49.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.045 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -152.47 129.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 122.445 1.117 . . . . 0.0 112.45 166.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -94.85 122.97 38.03 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 112.636 -2.074 . . . . 0.0 109.496 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -153.18 136.94 16.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.21 0.528 . . . . 0.0 110.301 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 61.12 24.26 14.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.207 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.654 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 91.76 -25.16 17.28 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.582 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.15 120.91 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-O 121.517 0.675 . . . . 0.0 111.064 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.715 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -100.21 108.21 20.25 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.446 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.423 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . 25.3 t -103.87 149.78 24.76 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.519 -0.738 . . . . 0.0 110.896 -172.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.429 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 22.8 p90 -113.58 130.55 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.492 0.663 . . . . 0.0 111.225 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.532 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 6.7 m-85 -130.36 179.06 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.144 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.88 -54.38 3.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.79 0.328 . . . . 0.0 110.235 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.5 p -131.56 178.33 6.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -72.36 -9.31 58.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.377 0.608 . . . . 0.0 110.595 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -85.69 -20.93 28.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.439 0.638 . . . . 0.0 110.335 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.09 -14.89 57.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.181 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.615 HG22 ' NE1' ' A' ' 27' ' ' TRP . 94.5 t -44.68 -27.14 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 t -73.16 -41.41 63.95 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.634 -0.666 . . . . 0.0 111.039 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -113.05 -71.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA3' ' CD2' ' A' ' 38' ' ' TYR . . . 65.44 52.4 40.11 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.231 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m 64.23 2.76 1.57 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.847 0.356 . . . . 0.0 111.921 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 31.4 mmmt 61.33 24.01 14.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.592 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 124.73 7.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.949 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.92 156.48 47.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.739 0.78 . . . . 0.0 111.729 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.094 HG23 HG21 ' A' ' 73' ' ' ILE . 13.4 mt -92.0 131.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.293 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HE3' HD11 ' A' ' 34' ' ' ILE . 33.5 mtpt -103.79 89.12 3.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.317 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.654 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -76.22 -3.7 37.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.65 -175.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.15 -41.81 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.204 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.4 m -83.92 -15.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.969 0.89 . . . . 0.0 109.466 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.643 ' HB3' HD12 ' A' ' 72' ' ' ILE . 51.9 m -133.47 -155.35 0.67 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.02 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.416 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.4 tp10 -121.54 144.01 48.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.621 1.1 . . . . 0.0 113.354 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.531 HD13 HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -89.33 114.37 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 171.033 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.693 ' HG3' HG23 ' A' ' 72' ' ' ILE . 22.0 mmmt -95.77 136.97 35.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.139 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.541 HG11 ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.317 -0.834 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.444 ' OG1' ' HE3' ' A' ' 82' ' ' LYS . 3.3 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.962 0.411 . . . . 0.0 111.815 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -135.99 131.28 34.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.188 0.518 . . . . 0.0 110.718 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.912 ' HG3' ' SD ' ' A' ' 81' ' ' MET . 8.2 ptm -170.16 153.95 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.164 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.49 167.54 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.048 0.451 . . . . 0.0 110.832 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.877 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.84 134.7 39.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 175.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.693 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.3 pp -119.85 120.7 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.094 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -139.43 165.98 27.69 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.077 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.765 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.51 146.23 95.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.27 2.647 . . . . 0.0 114.121 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.11 -45.63 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.806 -0.634 . . . . 0.0 113.122 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -148.05 66.8 1.09 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.272 0.558 . . . . 0.0 110.943 -176.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -72.54 95.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.446 0.641 . . . . 0.0 110.859 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 p80 179.87 87.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.957 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.461 ' CG ' HD11 ' A' ' 52' ' ' ILE . 91.9 m-85 -131.56 98.41 4.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.425 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -108.3 109.63 21.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.912 ' SD ' ' HG3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -128.82 171.43 12.26 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.748 -178.26 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 73.3 tttt -131.15 150.32 52.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -98.48 158.69 15.44 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.276 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.761 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.1 t -50.8 -43.87 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.342 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.444 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 14.9 m120 -143.01 -171.46 3.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.573 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.46 -41.22 15.58 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.649 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.94 -16.68 61.54 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.168 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.761 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -66.23 -53.06 41.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 170.226 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.598 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 15.3 ttt180 -48.1 -49.17 32.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.924 171.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 51.6 tp60 -54.98 -58.39 7.84 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.848 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.892 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 41.9 mtt180 -37.8 -42.62 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 113.809 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 92.2 m95 -72.37 -53.77 11.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.381 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.541 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.84 -37.37 60.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.719 0.771 . . . . 0.0 110.246 176.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 98' ' ' SER . 24.5 t -60.05 -56.61 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.659 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.12 65.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.683 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 59' ' ' ILE . 81.4 mt -52.99 -56.04 19.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.668 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.32 -2.92 88.26 Favored Glycine 0 C--O 1.205 -1.689 0 C-N-CA 119.695 -1.24 . . . . 0.0 112.473 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 21.7 t -68.29 -41.27 81.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.536 1.168 . . . . 0.0 108.931 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.7 t -80.7 -38.2 29.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.914 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 28.9 tttt . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -174.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.03 56.38 3.05 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.549 2.833 . . . . 0.0 112.714 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.443 ' C ' ' HB3' ' A' ' 102' ' ' CYS . 2.7 pt? -176.88 -26.83 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.44 -141.58 12.18 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 99' ' ' SER . 30.7 t -92.27 119.75 67.99 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.06 85.84 0.25 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.331 2.02 . . . . 0.0 111.771 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -87.69 165.31 15.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.364 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 84.5 t80 -153.15 97.34 2.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.773 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.7 ttt -124.69 137.25 54.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.396 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.2 pt-20 -134.93 147.97 49.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.522 . . . . 0.0 112.205 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.727 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 155.21 166.34 15.33 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.523 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.9 133.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.413 0.625 . . . . 0.0 111.825 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 83' ' ' ALA . 4.7 tp -118.34 120.05 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -74.52 93.11 2.44 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.14 0.576 . . . . 0.0 110.89 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 29.4 mtmt -92.98 146.0 23.95 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.681 0.753 . . . . 0.0 112.412 -168.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.559 ' CZ2' ' HA ' ' A' ' 19' ' ' TYR . 39.3 t-105 -93.61 98.6 11.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.355 175.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.2 p -86.77 -33.61 19.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.03 0.443 . . . . 0.0 110.558 -175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -159.08 165.88 32.89 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.559 ' HA ' ' CZ2' ' A' ' 16' ' ' TRP . 50.6 t80 -58.28 -41.95 85.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.018 0.437 . . . . 0.0 110.486 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.9 mt -64.47 -53.64 44.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.862 0.839 . . . . 0.0 110.758 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.0 p -107.31 89.42 2.99 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.707 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 23' ' ' TRP . . . -108.95 -174.31 21.37 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 172.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.479 ' HB3' ' O ' ' A' ' 22' ' ' GLY . 17.8 t90 73.84 -9.19 1.26 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 117.259 0.53 . . . . 0.0 112.202 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.403 ' HB3' ' HE ' ' A' ' 26' ' ' ARG . 86.8 mm-40 -49.56 102.32 0.31 Allowed Pre-proline 0 N--CA 1.472 0.645 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -171.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.86 107.84 2.51 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.173 1.249 . . . . 0.0 109.941 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HE ' ' HB3' ' A' ' 24' ' ' GLN . 22.6 mmt180 -124.26 142.87 50.9 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.727 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 67.7 t-105 -74.11 129.03 37.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -129.68 142.2 50.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.197 -177.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.699 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -151.06 133.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 122.161 0.981 . . . . 0.0 112.557 172.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -92.98 119.72 32.54 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.694 -174.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -131.3 111.0 11.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 57.17 26.68 12.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.716 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.604 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.54 -28.34 15.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.368 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.64 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.01 108.78 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.932 0.872 . . . . 0.0 110.463 178.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -94.81 107.6 19.61 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.47 179.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 m -103.25 160.36 14.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.45 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -108.43 133.21 52.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.345 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.456 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 22.8 m-85 -139.82 165.34 27.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.992 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.33 6.75 22.62 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.394 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 t -173.6 164.55 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.172 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -77.28 -13.62 59.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.086 0.469 . . . . 0.0 111.181 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.48 -16.93 28.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.501 0.667 . . . . 0.0 109.996 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.533 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 26.6 t0 -79.7 -15.05 58.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.757 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.622 HG22 ' NE1' ' A' ' 27' ' ' TRP . 94.3 t -45.62 -29.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 p -69.82 -37.14 76.13 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -122.79 -58.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.851 0.358 . . . . 0.0 110.665 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.533 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -148.33 49.51 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.315 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.0 m -89.08 2.31 54.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 75.29 -34.66 0.26 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.762 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.91 141.3 44.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.002 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 p -147.11 150.0 34.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.359 0.599 . . . . 0.0 111.431 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.069 HG23 HG21 ' A' ' 73' ' ' ILE . 10.8 mt -87.63 123.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.321 176.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.64 ' HE3' HD11 ' A' ' 34' ' ' ILE . 30.8 mtpt -96.05 88.08 4.76 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.735 172.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.604 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -79.53 -9.6 59.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.748 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -80.81 -38.4 28.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.11 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.624 ' HA ' ' H ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -86.26 -17.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.246 1.022 . . . . 0.0 109.619 -174.248 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.652 ' HB3' HD12 ' A' ' 72' ' ' ILE . 96.3 m -128.69 -153.09 0.55 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.659 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.447 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.6 tp10 -120.81 142.98 49.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 119.247 0.931 . . . . 0.0 112.982 -168.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.425 HD11 HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -92.64 115.84 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 170.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.57 ' HG3' HG23 ' A' ' 72' ' ' ILE . 20.8 mmmt -94.29 130.73 40.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.8 m -141.17 128.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -145.37 -73.61 0.24 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.383 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 68' ' ' ARG . 44.2 m -16.56 109.99 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.079 1.487 . . . . 0.0 113.28 -167.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 57.66 0.7 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.423 -169.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -166.54 -159.35 0.36 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 24.2 p-10 -69.49 152.46 44.83 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.639 ' CA ' ' HD3' ' A' ' 89' ' ' ARG . 80.4 p 54.72 95.97 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 O-C-N 123.405 0.44 . . . . 0.0 111.484 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 63' ' ' SER . 0.0 OUTLIER -140.08 117.13 11.13 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.609 -0.682 . . . . 0.0 111.704 174.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.731 ' SD ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -172.38 153.68 3.02 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -159.65 164.79 33.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.595 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.859 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -133.09 130.32 39.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.192 0.52 . . . . 0.0 111.265 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.2 pp -115.96 120.49 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.069 HG21 HG23 ' A' ' 52' ' ' ILE . 2.5 pp -137.1 176.85 2.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.744 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 50.0 Cg_exo -54.79 137.03 73.98 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.004 3.136 . . . . 0.0 114.426 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.14 -46.56 3.0 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.887 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 13.6 pt-20 -139.46 106.36 5.41 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.595 0.712 . . . . 0.0 110.884 -177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.84 97.18 8.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.939 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.404 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -177.62 86.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.49 -178.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CG ' HD11 ' A' ' 52' ' ' ILE . 87.6 m-85 -140.42 96.45 3.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.172 0.511 . . . . 0.0 109.635 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -101.75 121.56 42.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.526 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.9 ptt? -151.08 137.57 18.66 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.161 -172.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 89' ' ' ARG . 35.5 ttpt -102.41 177.98 4.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -124.06 169.72 11.39 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.274 -175.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.802 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.66 -38.02 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 123.793 0.683 . . . . 0.0 110.983 173.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -157.66 -170.07 3.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.584 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 66' ' ' ASN . . . -83.36 -48.91 9.88 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.995 -172.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 90' ' ' GLN . . . -67.59 -17.87 64.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.554 0.692 . . . . 0.0 109.487 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.802 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.35 -54.4 29.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.475 -1.239 . . . . 0.0 107.739 171.273 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.731 ' HG3' ' SD ' ' A' ' 69' ' ' MET . 3.4 ttt180 -58.49 -34.51 71.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.765 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.49 ' HA ' HD22 ' A' ' 93' ' ' LEU . 47.7 tp60 -62.91 -56.94 12.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.437 0.695 . . . . 0.0 111.044 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.773 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 65.3 mtt180 -34.71 -47.06 0.32 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.685 1.194 . . . . 0.0 113.149 174.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.524 ' HB2' ' CE ' ' A' ' 69' ' ' MET . 97.0 m95 -66.56 -53.63 32.51 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.607 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -49.97 -40.86 45.42 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.612 0.72 . . . . 0.0 109.96 175.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 52.5 t -55.85 -64.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.088 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 -50.49 71.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.37 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.463 ' CD2' ' HG2' ' A' ' 54' ' ' MET . 70.2 mt -52.65 -62.78 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.117 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.689 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -75.31 -1.81 65.59 Favored Glycine 0 C--O 1.222 -0.642 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.799 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.9 t -90.33 -32.65 16.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.564 0.682 . . . . 0.0 109.67 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 5' ' ' SER . 31.8 t -83.56 -28.09 28.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.032 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 17.8 tttt -100.72 1.31 40.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.629 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -56.77 -21.16 26.46 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -168.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.443 ' HB3' ' C ' ' A' ' 3' ' ' LEU . 45.2 t -90.89 -13.74 33.03 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.932 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' A' ' 107' ' ' ARG . 1.1 mm? -90.26 100.93 13.67 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 110.015 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.0 p -89.24 -24.02 22.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.134 0.493 . . . . 0.0 110.267 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -111.1 -72.15 0.73 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.878 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 56' ' ' VAL . 85.4 m -160.03 131.79 6.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.116 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.624 ' H ' ' HA ' ' A' ' 56' ' ' VAL . 14.7 tpt180 -69.13 99.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.25 1.121 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.664 -178.98 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.35 78.24 2.35 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.873 2.382 . . . . 0.0 112.277 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.8 148.06 46.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.164 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.57 166.77 17.18 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.364 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 p -60.25 139.3 91.67 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 122.387 0.275 . . . . 0.0 111.06 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.56 93.73 0.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.613 2.209 . . . . 0.0 112.117 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 9.7 tp10 -77.24 168.56 19.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.656 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 30.4 t80 -150.87 98.54 2.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.857 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 4.0 tpt -123.91 129.68 51.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.885 0.374 . . . . 0.0 111.355 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.721 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.0 pt-20 -134.84 143.73 47.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.365 0.602 . . . . 0.0 112.56 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.679 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 160.41 170.18 24.66 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.497 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -73.49 141.18 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.353 0.597 . . . . 0.0 112.276 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.553 HD11 HH21 ' A' ' 89' ' ' ARG . 0.3 OUTLIER -121.96 118.57 29.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.08 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.16 116.53 21.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.263 0.625 . . . . 0.0 112.103 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HG2' ' C ' ' A' ' 80' ' ' TYR . 25.5 tptt -153.98 168.48 26.28 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 35.9 t-105 -52.71 140.77 22.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.198 169.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.516 HG21 ' HB2' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -128.96 61.43 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 61.02 60.3 1.85 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.349 170.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.47 ' HA ' ' CZ2' ' A' ' 16' ' ' TRP . 80.7 t80 72.1 -63.29 0.43 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 168.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.1 mt -46.85 -56.72 5.82 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 123.334 0.654 . . . . 0.0 111.276 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.5 p -110.75 128.0 55.56 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.298 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' TRP . . . -65.74 -40.01 95.53 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.078 -173.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.647 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 39.5 p-90 -155.26 136.97 14.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.516 ' HB2' HG21 ' A' ' 17' ' ' THR . 84.4 mm-40 -145.99 119.82 5.31 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.647 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 19.9 Cg_endo -63.76 108.14 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.059 1.173 . . . . 0.0 110.72 167.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -112.13 149.39 32.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.679 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -80.4 130.84 35.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.468 0.652 . . . . 0.0 111.444 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.599 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -124.86 145.17 49.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.49 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.721 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.5 p -156.76 132.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 122.329 1.062 . . . . 0.0 112.798 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.1 tm? -94.36 118.29 31.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.725 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.18 130.22 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 109.914 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.52 22.15 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.841 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.664 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 97.21 -22.82 38.68 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.273 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.525 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -80.54 120.09 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.465 0.65 . . . . 0.0 111.157 177.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.604 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.67 106.84 18.82 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.162 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 8.3 t -105.16 162.38 13.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.013 0.435 . . . . 0.0 111.973 -167.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.694 ' HH ' ' HD1' ' A' ' 79' ' ' PHE . 39.3 m-85 -106.81 137.59 44.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.593 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.524 ' HE2' HG13 ' A' ' 29' ' ' VAL . 22.0 m-85 -149.28 164.47 34.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -98.0 -39.98 8.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.431 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -130.5 166.35 20.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.8 -5.82 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.24 -18.29 23.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.274 0.559 . . . . 0.0 110.109 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.7 -14.8 59.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.943 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.575 HG22 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -44.39 -22.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 2.7 p -83.0 -57.69 3.18 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.413 -0.805 . . . . 0.0 112.273 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 39.8 mmtm -133.58 27.78 4.01 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.59 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.85 132.77 11.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.762 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.9 m 74.04 -34.0 0.27 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mptt 68.54 6.43 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.68 0.792 . . . . 0.0 112.727 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 137.54 13.43 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.882 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 34' ' ' ILE . 12.0 p -146.83 142.67 27.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.124 HG23 HG21 ' A' ' 73' ' ' ILE . 9.8 mt -89.24 136.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.465 1.106 . . . . 0.0 111.197 172.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.525 ' HE3' HD11 ' A' ' 34' ' ' ILE . 31.4 mtpt -106.73 89.78 3.12 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 120.993 0.425 . . . . 0.0 110.669 173.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.664 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.17 -1.16 31.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.621 -177.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.31 -48.47 8.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.04 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.7 m -80.7 -15.95 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.177 0.989 . . . . 0.0 109.501 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.586 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 54.1 m -131.64 -155.39 0.69 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.956 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.564 ' O ' HG13 ' A' ' 72' ' ' ILE . 7.8 tp10 -123.11 146.4 47.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.463 1.029 . . . . 0.0 113.194 -165.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.565 HD13 HD13 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -88.22 121.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.155 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 5.6 mttt -96.41 135.61 38.03 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.106 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.532 HG12 HD11 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -138.31 158.27 31.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.24 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -138.2 94.78 2.91 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.108 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -78.62 78.06 5.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.197 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.62 33.93 0.27 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.756 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 16.9 t70 -170.61 -29.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.828 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 18.9 m120 83.29 -11.95 0.89 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.662 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p -135.72 44.2 2.53 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.107 0.479 . . . . 0.0 111.54 175.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 89' ' ' ARG . 12.5 mmm180 -123.12 124.4 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.052 0.453 . . . . 0.0 111.357 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.601 ' HE3' ' NH2' ' A' ' 89' ' ' ARG . 5.1 ttm -155.76 160.88 40.66 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 4.9 mt-10 -152.4 168.03 26.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.907 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -129.72 140.1 51.18 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.828 0.347 . . . . 0.0 110.269 171.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 58' ' ' GLU . 1.7 pp -120.87 117.05 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.124 HG21 HG23 ' A' ' 52' ' ' ILE . 1.7 pp -136.36 168.87 15.19 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.073 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.774 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 87.5 Cg_exo -29.79 117.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 124.94 3.76 . . . . 0.0 116.185 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.4 -21.38 6.2 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.273 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 14.9 pt-20 -151.76 115.33 4.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 112.322 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 22.2 pt20 -103.13 97.26 7.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 110.103 173.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.46 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 1.2 p80 -175.47 87.15 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.674 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.694 ' HD1' ' HH ' ' A' ' 37' ' ' TYR . 96.6 m-85 -138.2 97.02 3.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.642 ' C ' ' HG2' ' A' ' 15' ' ' LYS . 69.0 m-85 -87.99 140.61 29.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.311 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.597 ' HA ' ' HB2' ' A' ' 15' ' ' LYS . 8.3 ptt? -170.53 142.31 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 171.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HA ' HH12 ' A' ' 89' ' ' ARG . 37.5 ttmt -104.64 170.17 8.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.461 ' H ' ' HG2' ' A' ' 82' ' ' LYS . . . -119.55 165.49 14.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 118.514 0.597 . . . . 0.0 110.994 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.81 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.81 -42.2 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.57 0.544 . . . . 0.0 111.082 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.456 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 67.0 m-20 -148.82 -172.27 4.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -176.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.86 -40.51 15.88 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.656 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.0 -18.8 63.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.608 0.718 . . . . 0.0 109.14 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.81 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -68.61 -52.15 34.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.61 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -48.07 -47.59 33.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.876 170.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.4 tp60 -55.78 -55.51 31.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.671 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.857 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 8.1 mtp180 -35.51 -44.84 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 124.599 1.187 . . . . 0.0 113.614 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.599 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 97.2 m95 -76.1 -51.03 13.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -53.16 -35.87 60.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.641 0.734 . . . . 0.0 109.889 175.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 19.6 t -55.86 -65.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.857 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -63.11 -55.77 22.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.002 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.565 HD13 HD13 ' A' ' 59' ' ' ILE . 83.3 mt -50.44 -60.21 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.525 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.738 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -87.39 -1.67 83.51 Favored Glycine 0 C--O 1.221 -0.71 0 CA-C-O 119.23 -0.761 . . . . 0.0 114.331 -173.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -90.04 -37.56 14.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.427 1.113 . . . . 0.0 109.517 169.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.7 t -72.81 -41.76 64.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.966 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 21.1 tttt -88.22 -1.48 58.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.25 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -56.42 -35.44 67.82 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 121.882 -0.511 . . . . 0.0 112.227 -172.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 35.5 t -86.09 -17.1 36.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.099 0.476 . . . . 0.0 110.705 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.501 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 7.7 tp -78.72 -27.76 44.94 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.3 p 60.87 -81.83 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.829 1.252 . . . . 0.0 112.836 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -121.41 -66.42 1.05 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.712 0.291 . . . . 0.0 110.983 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.2 p -95.52 150.79 19.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.812 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -81.35 165.95 20.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.132 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.048 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.511 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.452 ' O ' ' HB ' ' A' ' 108' ' ' THR . 71.5 Cg_endo -76.25 65.09 7.16 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 123.056 2.504 . . . . 0.0 112.588 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.0 tp -177.38 152.27 0.83 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.524 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . -149.65 -101.53 0.24 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.29 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 99' ' ' SER . 14.7 m -71.11 114.69 29.45 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.556 0.217 . . . . 0.0 111.194 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 4.9 Cg_exo -79.1 83.69 2.21 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.878 2.386 . . . . 0.0 110.74 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 7.6 tp10 -76.9 161.25 28.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.05 -174.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 81.2 t80 -150.57 99.0 2.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.037 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.94 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 3.7 tpt -127.48 120.5 28.47 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.291 0.567 . . . . 0.0 110.795 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -126.86 155.73 42.5 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.851 -173.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.737 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 143.87 167.31 11.76 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.725 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 27' ' ' TRP . 1.5 m -64.46 132.99 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.53 0.681 . . . . 0.0 111.208 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 83' ' ' ALA . 8.1 tp -126.32 116.94 22.0 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 8.4 m-85 -66.25 161.07 23.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.6 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 67.6 mmtt -133.43 159.65 39.7 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.446 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 75.9 t-105 -117.58 102.13 8.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.0 p -74.4 -61.95 1.69 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.998 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -163.47 -68.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -152.76 -65.27 0.16 Allowed 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.694 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.3 mt -51.12 -67.64 0.23 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.647 0.737 . . . . 0.0 111.271 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.6 p -97.87 41.17 1.13 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.504 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 16' ' ' TRP . . . -44.52 -64.23 2.15 Favored Glycine 0 CA--C 1.5 -0.861 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.266 -174.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.623 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 36.5 p-90 -88.65 128.53 35.6 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -144.57 105.74 4.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.491 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.623 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 36.4 Cg_endo -70.46 109.6 2.49 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 120.919 1.079 . . . . 0.0 112.071 174.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -113.75 135.75 53.6 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.737 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 49.5 t-105 -71.07 132.92 45.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.419 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -129.05 145.08 51.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.389 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -151.6 131.16 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.276 1.036 . . . . 0.0 112.654 170.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.7 tm? -93.69 113.09 25.09 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.784 -176.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.19 100.18 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.51 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.4 29.25 17.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.852 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.684 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.1 -23.29 32.5 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.131 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.554 HG23 ' HB2' ' A' ' 51' ' ' SER . 0.9 OUTLIER -82.3 100.21 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-O 122.138 0.971 . . . . 0.0 109.662 175.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -93.99 102.29 14.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.883 -177.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.4 t -105.33 155.4 19.13 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.443 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.577 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.7 p90 -114.04 141.24 47.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.132 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 38.7 m-85 -137.03 155.72 49.33 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.44 -4.26 59.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.766 0.317 . . . . 0.0 111.214 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -159.9 161.27 34.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.712 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -75.47 -17.44 60.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 110.643 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.16 -16.95 28.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.322 0.582 . . . . 0.0 109.984 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.0 -16.03 57.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.548 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.59 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 65.3 t -47.31 -43.41 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -51.85 -43.56 63.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.89 55.56 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.263 0.554 . . . . 0.0 111.83 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -121.5 0.73 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.815 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 m -64.46 -30.65 71.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.865 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HA ' ' HD2' ' A' ' 49' ' ' LYS . 29.6 mmmt 71.26 -25.07 0.17 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.999 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.93 134.62 47.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 34' ' ' ILE . 32.5 p -140.87 150.62 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.948 0.88 . . . . 0.0 113.114 -171.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.069 HG23 HG21 ' A' ' 73' ' ' ILE . 12.7 mt -88.67 131.52 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.662 171.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HE3' HD11 ' A' ' 34' ' ' ILE . 26.1 mtpt -101.23 89.56 3.83 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 172.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.84 ' HE3' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -78.46 3.8 14.92 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.354 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.04 -43.4 13.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.035 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 106' ' ' THR . 2.0 m -87.1 -18.35 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.724 0.773 . . . . 0.0 110.25 -173.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 55.3 m -136.0 -173.36 3.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.921 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.563 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.9 tp10 -105.99 144.39 32.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -161.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.618 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -94.51 128.23 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.295 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 15.9 mmmt -109.87 144.29 38.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.689 ' CG1' ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -141.61 142.3 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.445 ' HB3' HG23 ' A' ' 61' ' ' VAL . 0.1 OUTLIER 67.52 -43.04 0.45 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 165.147 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.5 t 63.05 -80.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -170.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.45 16.82 0.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.08 0.467 . . . . 0.0 110.784 169.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.65 -179.72 3.78 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.789 177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.659 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 94.0 m-20 -84.0 -80.98 0.18 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 16.2 p -73.86 73.29 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.447 0.641 . . . . 0.0 111.113 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -148.03 143.74 27.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.743 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.523 ' HG3' ' HG3' ' A' ' 81' ' ' MET . 4.5 ptm -170.29 154.99 5.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -148.57 166.9 26.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.025 0.44 . . . . 0.0 110.154 -176.414 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.945 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.94 124.53 23.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.276 0.56 . . . . 0.0 110.772 171.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 57' ' ' CYS . 2.0 pp -105.31 114.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.069 HG21 HG23 ' A' ' 52' ' ' ILE . 1.7 pp -136.38 163.35 50.61 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.067 -174.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 9.5 Cg_exo -14.6 -115.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.303 1 C-N-CA 126.857 5.038 . . . . 0.0 118.407 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.33 3.18 59.55 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.652 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 73' ' ' ILE . 1.6 pm0 -144.2 63.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.219 0.533 . . . . 0.0 111.395 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.457 ' HA ' ' H ' ' A' ' 73' ' ' ILE . 15.8 pt20 -78.02 96.55 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.396 0.617 . . . . 0.0 110.213 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 178.67 88.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.194 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 71.0 m-85 -137.36 96.23 3.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -98.46 132.48 43.86 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.443 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.523 ' HG3' ' HG3' ' A' ' 69' ' ' MET . 17.1 ptt? -157.58 165.59 35.15 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.309 0.576 . . . . 0.0 111.059 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 67' ' ' THR . 41.1 ttmt -131.2 157.91 41.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -112.35 162.02 16.01 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.89 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.796 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.0 -41.27 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.259 175.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.435 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 2.4 m120 -147.02 -176.16 5.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.887 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -83.4 -36.82 23.99 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.622 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.589 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.23 -19.15 61.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.613 0.72 . . . . 0.0 109.173 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.796 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -67.77 -51.84 44.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.659 ' HD3' ' O ' ' A' ' 66' ' ' ASN . 23.6 ttp180 -50.3 -45.72 54.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.914 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 8.0 tp60 -54.91 -59.19 5.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.563 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.94 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 14.6 mtt180 -36.33 -44.61 0.43 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.64 1.176 . . . . 0.0 113.466 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.482 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 95.0 m95 -70.9 -55.43 8.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.689 ' HG ' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.03 -37.38 61.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.71 0.767 . . . . 0.0 110.15 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 98' ' ' SER . 19.0 t -56.97 -57.99 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.294 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -69.28 -43.55 73.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.938 -175.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.482 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 66.7 mt -54.06 -60.73 2.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.785 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.771 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -77.17 -1.18 73.45 Favored Glycine 0 C--O 1.203 -1.838 0 C-N-CA 119.259 -1.448 . . . . 0.0 112.106 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 39.4 t -75.1 -41.75 58.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.435 1.117 . . . . 0.0 108.615 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' SER . 8.6 t -79.64 -37.79 35.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.603 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.84 ' HB2' ' HE3' ' A' ' 54' ' ' MET . 34.5 tttt -84.38 -7.93 59.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.832 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -53.29 -26.26 17.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.651 0.739 . . . . 0.0 110.769 -176.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.524 ' SG ' ' HA3' ' A' ' 4' ' ' GLY . 56.1 m -101.94 5.33 40.76 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.283 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.713 HD23 ' HA ' ' A' ' 100' ' ' LYS . 1.4 mm? -83.77 -79.47 0.2 Allowed 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.1 174.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.9 p 48.37 39.64 12.94 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.601 0.563 . . . . 0.0 111.643 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -166.16 -81.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.185 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 8.2 p -135.26 -90.57 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.413 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.509 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -174.86 178.93 1.74 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 178.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 2' ' ' PRO . 2.9 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.06 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.48 115.45 2.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.453 2.102 . . . . 0.0 112.065 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.9 mt 61.34 30.78 19.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.389 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.49 145.97 5.33 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.368 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -111.92 131.89 22.24 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.91 74.11 3.5 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.705 2.27 . . . . 0.0 112.997 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 43.2 mm-40 -81.96 162.66 22.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.975 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 73.2 t80 -154.02 99.45 2.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.813 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.1 ttt -132.22 136.15 46.8 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.636 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.751 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.8 pt-20 -136.31 144.38 44.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.362 0.601 . . . . 0.0 112.294 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.677 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.5 168.16 22.99 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.399 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 12' ' ' VAL . 2.0 m -67.06 140.83 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.646 0.736 . . . . 0.0 112.299 -175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 tp -125.12 118.93 27.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -67.37 87.76 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.31 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 43.2 tttm -99.49 143.97 29.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -70.17 126.19 28.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.037 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 p -100.16 -57.99 2.01 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.15 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -165.73 158.19 15.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -60.05 -15.65 24.67 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 20' ' ' LEU . 40.8 mt -73.14 -71.04 0.33 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.536 0.684 . . . . 0.0 111.306 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.2 p -83.2 -11.53 57.76 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.204 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.67 -107.98 2.36 Favored Glycine 0 CA--C 1.505 -0.571 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.561 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.827 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 29.5 p-90 -108.41 139.89 42.5 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -143.75 125.89 8.46 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.827 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 6.3 Cg_endo -53.52 109.04 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.71 1.607 . . . . 0.0 112.012 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' NH1' ' HA ' ' A' ' 39' ' ' ASP . 29.4 tpt180 -102.67 129.2 49.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.677 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 54.4 t-105 -72.02 129.69 39.15 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.683 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.6 m-85 -125.28 140.79 52.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.048 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.751 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -149.52 125.87 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 122.292 1.044 . . . . 0.0 112.27 171.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.9 tm? -92.81 113.3 25.54 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.96 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.26 131.73 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.068 0.461 . . . . 0.0 109.925 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 62.94 16.65 9.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.42 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.0 -28.43 14.61 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.891 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -77.4 122.21 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-O 121.446 0.641 . . . . 0.0 110.812 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.544 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.84 104.76 16.66 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 15.0 m -103.79 138.79 39.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.952 0.406 . . . . 0.0 110.388 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 9.5 p90 -110.79 137.5 48.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.5 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 53.3 m-85 -135.8 169.93 16.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.409 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 20.5 t70 -63.37 -61.66 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.508 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 18.3 m -139.9 -175.55 4.26 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.606 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.73 -17.28 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.161 0.505 . . . . 0.0 111.398 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.508 ' OD1' ' HB2' ' A' ' 40' ' ' SER . 6.0 p-10 -86.37 -17.46 34.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.287 0.565 . . . . 0.0 110.571 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.537 ' OD1' ' HA3' ' A' ' 47' ' ' GLY . 26.0 t70 -85.23 -20.2 30.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.338 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.582 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 50.5 t -44.47 -44.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 124.329 1.052 . . . . 0.0 113.709 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 5.1 p -58.42 -57.76 11.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.234 -172.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -152.18 29.87 0.56 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 111.788 -173.355 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -86.16 -96.5 0.8 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.811 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.3 m -62.44 -38.19 88.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.984 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt 70.72 -30.43 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.36 129.03 39.81 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.322 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.471 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.1 p -136.51 140.92 43.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.862 0.839 . . . . 0.0 113.264 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.085 HG23 HG21 ' A' ' 73' ' ' ILE . 12.6 mt -89.86 135.78 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.766 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.574 ' HE3' HD11 ' A' ' 34' ' ' ILE . 36.5 mtpt -109.27 93.06 4.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.834 171.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.862 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.22 -3.12 34.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.882 -176.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.01 -49.74 9.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 112.088 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.494 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.9 m -78.35 -17.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.271 1.034 . . . . 0.0 109.327 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.696 ' HB3' HD12 ' A' ' 72' ' ' ILE . 56.9 m -131.87 -149.73 0.39 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.305 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.2 tp10 -132.09 145.27 51.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 120.093 1.315 . . . . 0.0 113.793 -168.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.88 112.4 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 168.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.601 ' HG3' HG23 ' A' ' 72' ' ' ILE . 18.0 mmmt -93.76 147.33 23.15 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.682 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.55 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.3 m -135.85 152.23 30.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.898 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 68' ' ' ARG . 53.8 t-80 -120.56 90.38 3.31 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.1 m -90.75 70.71 6.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.488 0.661 . . . . 0.0 111.413 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB3' ' CE1' ' A' ' 62' ' ' HIS . . . -147.38 28.45 0.98 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.592 175.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 4.4 p-10 -172.68 -13.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.496 -174.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 18.0 m120 80.37 -10.58 1.25 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.731 0.812 . . . . 0.0 113.036 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -130.58 13.26 5.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -172.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' HB3' ' HB3' ' A' ' 62' ' ' HIS . 4.9 tpp180 -121.86 138.36 54.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.761 -174.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 61' ' ' VAL . 4.2 ptp -153.19 177.0 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -150.31 161.43 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.201 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.92 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -130.39 124.34 31.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.257 0.551 . . . . 0.0 111.021 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.696 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.2 pp -109.73 118.27 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.085 HG21 HG23 ' A' ' 52' ' ' ILE . 2.1 pp -138.39 167.06 21.23 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 39.0 Cg_endo -60.8 144.72 99.6 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.132 2.555 . . . . 0.0 113.987 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 -49.16 4.1 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.428 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 12.9 pt-20 -150.42 89.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.284 0.564 . . . . 0.0 111.3 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.44 97.0 10.22 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.336 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -170.1 87.25 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.748 0.785 . . . . 0.0 110.312 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.6 m-85 -139.02 98.08 3.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.591 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.469 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 46.5 m-85 -103.98 121.11 42.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.087 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 ptt? -149.37 142.4 24.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.695 0.76 . . . . 0.0 111.679 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -105.03 151.65 23.7 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -99.79 155.73 17.49 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.339 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.753 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.48 -40.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.721 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.434 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 10.7 t-20 -146.43 -174.03 4.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.91 -44.64 14.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.895 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.02 -15.66 62.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.873 0.844 . . . . 0.0 109.361 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.753 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.06 -52.27 56.7 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.421 ' O ' HD22 ' A' ' 93' ' ' LEU . 10.0 ttp180 -54.42 -46.03 73.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.77 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.588 ' OE1' HG21 ' A' ' 94' ' ' VAL . 0.4 OUTLIER -49.12 -62.43 1.54 Allowed 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.557 0.743 . . . . 0.0 110.628 175.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.813 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 71.8 mtt180 -35.06 -48.13 0.4 Allowed 'General case' 0 N--CA 1.434 -1.27 0 O-C-N 124.75 1.281 . . . . 0.0 113.137 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.501 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 95.6 m95 -71.46 -52.33 19.02 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.55 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.48 -38.67 55.04 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.793 0.806 . . . . 0.0 109.769 176.219 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.588 HG21 ' OE1' ' A' ' 90' ' ' GLN . 39.7 t -61.86 -63.04 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.783 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.1 86.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.484 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 59' ' ' ILE . 69.2 mt -58.27 -58.89 6.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.247 0.546 . . . . 0.0 111.035 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.708 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -81.77 -0.98 90.05 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.02 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.3 t -87.75 -31.41 19.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 166.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.552 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 30.3 t -81.73 -34.27 30.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.862 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 28.5 tttt -91.33 0.8 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.199 0.523 . . . . 0.0 110.564 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -59.74 -12.8 7.85 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -170.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.4 t -98.45 -12.67 21.11 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.27 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -102.37 138.36 39.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.868 0.366 . . . . 0.0 110.354 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.0 p -112.08 -36.76 5.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.113 0.482 . . . . 0.0 110.62 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -133.37 -61.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.3 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.8 p -101.88 158.45 16.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.667 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 20.0 ptt180 -81.07 107.47 13.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.543 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.052 177.92 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.811 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.63 5.94 5.97 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.983 2.455 . . . . 0.0 113.131 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp -102.38 -1.57 30.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.247 0.546 . . . . 0.0 109.546 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.3 48.88 0.41 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.905 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.504 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 10.8 m -80.08 170.77 14.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 119.089 -0.481 . . . . 0.0 109.706 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 5' ' ' SER . 78.4 Cg_exo -43.88 134.72 7.86 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.856 2.371 . . . . 0.0 112.694 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 7.6 pt-20 -144.39 70.66 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.221 0.534 . . . . 0.0 112.039 -170.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 32.2 t80 -151.51 97.58 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.814 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 5.8 tpt -130.12 128.84 42.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.749 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.57 158.16 40.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.347 0.594 . . . . 0.0 112.406 -173.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.779 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 139.96 162.42 9.11 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.983 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.7 136.32 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-O 121.265 0.555 . . . . 0.0 111.433 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 83' ' ' ALA . 3.9 tp -123.59 118.5 27.46 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.635 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 20.1 m-85 -74.63 93.69 2.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -94.08 134.38 36.57 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.926 -1.11 . . . . 0.0 112.087 -171.68 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -80.02 110.45 15.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 p -68.91 -56.19 8.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.622 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -175.71 -60.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.628 0.251 . . . . 0.0 111.24 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -168.62 -49.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.33 -175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.6 mt -55.52 -70.78 0.1 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.358 0.599 . . . . 0.0 112.354 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.7 p -84.16 -14.12 51.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.783 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.12 -85.08 0.59 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.027 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.683 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 37.6 p-90 -128.56 140.19 51.91 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -172.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -147.09 108.33 3.95 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.55 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.683 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 62.4 Cg_endo -75.53 109.67 2.95 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.314 1.343 . . . . 0.0 112.098 173.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -110.86 146.84 35.78 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.779 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 56.3 t-105 -67.35 118.72 11.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.071 0.462 . . . . 0.0 109.783 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.65 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -108.5 144.48 36.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.984 -176.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.606 HG13 ' HE2' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -154.54 129.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.514 1.15 . . . . 0.0 112.667 167.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -93.64 124.58 37.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.647 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.9 141.58 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.982 0.42 . . . . 0.0 109.873 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.47 23.04 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.273 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.85 -13.24 37.97 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.23 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.527 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -90.71 141.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 123.445 0.698 . . . . 0.0 111.216 175.149 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.612 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -118.15 110.01 17.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.463 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.462 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 15.0 m -105.39 152.6 22.76 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.571 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.613 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.0 p90 -112.02 138.05 49.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.272 0.558 . . . . 0.0 111.55 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HE2' HG13 ' A' ' 29' ' ' VAL . 11.1 m-85 -134.46 178.4 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.011 -175.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.77 -63.89 1.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 110.441 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 27' ' ' TRP . 5.7 t -146.76 -166.84 2.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.147 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.46 -11.74 61.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.972 0.415 . . . . 0.0 111.415 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -90.39 -17.16 27.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.462 0.648 . . . . 0.0 110.717 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.621 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 24.4 t70 -90.53 -14.51 32.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.854 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.667 HG22 ' NE1' ' A' ' 27' ' ' TRP . 59.7 t -43.49 -32.12 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.6 t -70.31 -38.68 74.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.725 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -123.2 -72.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.73 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.621 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -151.23 52.06 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.402 -176.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 50' ' ' GLY . 50.1 m -74.07 -11.04 60.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.312 0.577 . . . . 0.0 109.807 176.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.2 tptt 71.2 -9.92 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.466 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -66.04 141.56 41.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.7 p -146.56 142.32 27.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.243 0.544 . . . . 0.0 112.056 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.073 HG23 HG21 ' A' ' 73' ' ' ILE . 62.6 mt -89.16 144.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.764 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.527 ' HE3' HD11 ' A' ' 34' ' ' ILE . 34.6 mtpt -113.56 90.46 3.35 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.331 173.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.09 -24.61 60.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -59.75 -36.61 76.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.486 HG22 ' HD3' ' A' ' 74' ' ' PRO . 2.0 m -94.97 -15.4 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.666 0.746 . . . . 0.0 111.07 -171.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 72' ' ' ILE . 81.5 m -134.01 -145.76 0.25 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.544 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.624 ' O ' HG13 ' A' ' 72' ' ' ILE . 4.8 tp10 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.322 0.965 . . . . 0.0 112.313 -170.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.619 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -97.66 125.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.518 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.705 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 34.4 mtmt -104.71 97.76 7.6 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 -172.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -114.35 89.83 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.64 0.733 . . . . 0.0 110.814 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.468 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 21.1 t-80 -76.18 107.71 8.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.178 -173.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 t -61.41 122.58 15.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.234 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -165.85 -70.27 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.267 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -124.68 -164.77 1.3 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.091 173.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.596 ' HA ' ' NH1' ' A' ' 89' ' ' ARG . 49.9 m-80 -95.07 167.44 11.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.026 0.441 . . . . 0.0 111.78 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.4 p 52.13 44.48 29.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.824 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.725 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 3.2 ppt_? -123.56 134.89 53.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.045 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' A' ' 81' ' ' MET . 1.7 ptm -171.49 158.06 5.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.063 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 4.8 mt-10 -150.25 167.12 27.89 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.818 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -135.51 125.72 26.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 171.641 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.1 pp -110.38 120.07 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.073 HG21 HG23 ' A' ' 52' ' ' ILE . 1.1 pp -133.72 163.39 51.45 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.61 -167.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 17.8 Cg_endo -53.77 -63.19 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.095 3.197 . . . . 0.0 115.253 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.93 -20.49 62.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.559 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 179.95 103.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.33 0.586 . . . . 0.0 111.162 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HA ' ' H ' ' A' ' 73' ' ' ILE . 16.9 pt20 -84.39 97.55 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.942 -0.474 . . . . 0.0 111.051 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.47 87.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.211 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 82.9 m-85 -139.98 97.79 3.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.672 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -101.24 135.62 42.42 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.533 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 8.8 ptt? -156.26 151.15 26.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.933 0.873 . . . . 0.0 112.718 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 40.3 ttmt -111.84 137.58 49.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.099 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -90.49 157.99 17.26 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.731 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.755 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -46.51 -49.06 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.134 175.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.508 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 85.0 m-20 -134.88 -174.49 3.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.905 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.617 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -87.7 -37.15 16.95 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.825 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -76.51 -14.99 59.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.878 0.847 . . . . 0.0 109.249 171.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.755 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.02 -53.25 48.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.665 ' O ' HD13 ' A' ' 93' ' ' LEU . 32.7 ttp180 -47.72 -51.24 22.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.793 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.698 ' NE2' HG21 ' A' ' 94' ' ' VAL . 17.1 tm0? -49.1 -64.12 0.9 Allowed 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 123.701 0.8 . . . . 0.0 111.036 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.814 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 34.2 mtt180 -35.74 -45.13 0.37 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.65 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 94.2 m95 -70.65 -55.3 9.08 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.439 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.753 ' CD1' HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -51.8 -41.0 61.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.949 0.88 . . . . 0.0 110.292 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.698 HG21 ' NE2' ' A' ' 90' ' ' GLN . 25.5 t -56.85 -51.56 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.007 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 -51.35 10.95 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.759 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.676 HD22 ' HE2' ' A' ' 54' ' ' MET . 92.3 mt -50.84 -55.78 15.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.674 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -81.31 -3.22 90.69 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.334 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.634 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 42.5 t -66.47 -57.06 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.885 0.842 . . . . 0.0 109.622 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 7' ' ' GLU . 13.9 t -79.77 -29.43 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.743 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -100.22 0.91 41.29 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -173.599 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -45.87 -53.81 9.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.1 m -106.62 19.34 20.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 9.2 tp -80.09 -141.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.641 -173.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.0 p 53.26 26.59 5.29 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.614 0.766 . . . . 0.0 111.742 -172.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -120.84 -55.24 2.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.521 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.5 p -82.74 -42.17 18.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.245 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.47 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 2.9 mmp_? -104.65 109.75 21.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.794 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.251 1.176 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.469 -179.715 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.9 -41.22 38.65 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.592 2.195 . . . . 0.0 112.172 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 tp -78.07 94.61 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.49 -80.21 0.47 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.346 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' SER . 18.5 m -82.84 118.64 72.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -175.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -87.83 104.57 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.966 2.444 . . . . 0.0 112.28 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 6.0 tp10 -107.55 159.31 16.53 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.149 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 75.4 t80 -150.45 99.59 2.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -172.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.787 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 2.9 tpt -122.79 133.34 54.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.308 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.7 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 5.4 pt-20 -135.67 149.94 49.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.544 0.688 . . . . 0.0 112.746 -173.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.738 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 151.31 162.98 11.08 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.206 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.11 132.14 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 121.361 0.601 . . . . 0.0 111.39 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 83' ' ' ALA . 3.5 tp -121.23 118.95 30.89 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.422 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 25' ' ' PRO . 85.4 m-85 -76.79 90.6 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.005 -175.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -95.7 158.49 15.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.513 0.673 . . . . 0.0 112.686 -171.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -81.96 131.54 35.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.192 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.442 HG21 ' HG3' ' A' ' 24' ' ' GLN . 13.4 p -101.76 -175.46 2.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.763 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.4 91.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.0 t80 71.64 -57.47 0.61 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.976 0.91 . . . . 0.0 112.478 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.41 167.16 21.83 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.428 ' C ' ' H ' ' A' ' 23' ' ' TRP . 19.8 p 39.08 100.11 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 125.07 1.481 . . . . 0.0 114.12 177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.21 25.34 0.85 Allowed Glycine 0 C--N 1.329 0.186 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.293 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.61 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 17.6 p-90 -170.89 125.9 0.69 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.442 ' HG3' HG21 ' A' ' 17' ' ' THR . 77.9 mm-40 -145.32 109.99 4.6 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 171.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 30.8 Cg_endo -68.77 107.93 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 120.807 1.005 . . . . 0.0 111.506 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.56 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 1.4 tpm_? -112.34 129.28 56.35 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.738 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 62.4 t-105 -67.26 119.41 12.1 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.528 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.527 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -113.71 137.0 52.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.643 -177.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.7 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.9 p -150.53 130.85 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 122.409 1.099 . . . . 0.0 112.457 168.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.748 HD21 ' HE3' ' A' ' 54' ' ' MET . 2.7 tm? -93.37 117.98 30.74 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.756 -173.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -141.28 124.44 16.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 58.21 31.23 20.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.425 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.579 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 91.55 -25.49 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.024 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.552 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -83.93 113.24 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-O 121.746 0.784 . . . . 0.0 111.238 -178.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -95.25 105.88 17.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.57 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.4 t -104.31 160.43 14.9 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.082 0.468 . . . . 0.0 111.279 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.555 ' OH ' HG13 ' A' ' 52' ' ' ILE . 1.6 m-85 -108.71 128.15 54.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.984 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 18.4 m-85 -131.47 160.39 35.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.13 -62.92 1.38 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.908 0.385 . . . . 0.0 110.084 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -142.9 -173.16 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.44 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -65.42 -19.91 66.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.16 -16.9 34.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.0 110.66 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.757 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 22.6 t0 -87.32 -14.24 41.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.096 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.592 HG22 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -41.47 -33.11 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.83 -36.84 85.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.87 0.366 . . . . 0.0 111.055 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -118.24 -76.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.001 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.757 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 71.11 -176.51 37.21 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.855 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -66.95 122.17 17.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -78.54 51.95 1.12 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.937 0.875 . . . . 0.0 111.59 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -134.92 159.75 24.06 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.486 ' OG ' HG23 ' A' ' 34' ' ' ILE . 4.5 t -159.78 158.51 31.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.151 0.977 . . . . 0.0 112.836 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 73' ' ' ILE . 9.8 mt -90.49 128.2 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.409 171.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HE3' HD11 ' A' ' 34' ' ' ILE . 37.9 mtpt -104.37 88.7 3.03 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.235 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.783 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.96 -21.8 60.81 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.793 -177.162 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -65.71 -28.67 69.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.284 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 53' ' ' LYS . 1.5 m -98.56 -14.49 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.706 0.765 . . . . 0.0 110.931 -172.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.635 ' HB3' HD12 ' A' ' 72' ' ' ILE . 86.1 m -136.43 -142.99 0.18 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.5 tp10 -128.4 146.34 50.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.302 0.955 . . . . 0.0 112.376 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -93.91 135.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 9.7 mmtt -114.1 146.15 40.65 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.598 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.9 m -141.43 128.42 20.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 122.001 -0.437 . . . . 0.0 109.939 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -80.15 99.85 7.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.9 m -82.91 48.24 1.32 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.561 -171.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.05 15.18 1.17 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.58 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -145.7 160.04 42.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.851 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 97.8 m-20 -91.74 -23.78 19.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.668 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 24.7 p -138.39 46.89 2.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -176.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -135.88 122.93 21.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.082 0.468 . . . . 0.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.644 ' HG2' HD11 ' A' ' 93' ' ' LEU . 1.3 mpp? -141.1 172.32 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -151.57 166.76 30.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 111.261 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.846 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -137.2 137.3 38.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 173.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 57' ' ' CYS . 1.9 pp -115.93 115.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.023 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -135.72 164.98 39.52 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.814 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.767 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.29 132.25 45.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.513 2.809 . . . . 0.0 114.664 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.88 -29.81 7.63 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.539 170.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -156.97 58.41 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.987 0.423 . . . . 0.0 111.698 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.29 98.74 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.605 0.717 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -178.94 88.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.143 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.1 m-85 -138.32 99.0 3.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.826 0.346 . . . . 0.0 110.838 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.2 127.63 47.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 13.9 ptt? -151.58 142.42 22.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.665 0.745 . . . . 0.0 111.77 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 67' ' ' THR . 77.8 tttt -105.12 136.89 43.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.037 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.66 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -89.41 155.82 19.08 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.705 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.767 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -47.56 -46.19 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.662 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.532 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 7.7 m120 -139.16 -170.2 2.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.667 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -88.05 -40.26 13.98 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.361 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.26 -18.73 61.79 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.767 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -62.78 -53.16 58.48 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.183 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.702 ' O ' HD22 ' A' ' 93' ' ' LEU . 36.8 ttt-85 -45.13 -53.53 7.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.826 170.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.2 tp60 -54.46 -58.36 7.75 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.362 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.787 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 36.6 mtt180 -37.36 -41.86 0.45 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 124.562 1.164 . . . . 0.0 113.575 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.527 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 91.8 m95 -72.89 -54.42 8.78 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.664 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.19 -38.2 62.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.434 0.635 . . . . 0.0 110.343 176.341 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 90' ' ' GLN . 25.4 t -54.4 -63.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.028 175.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -61.08 -53.79 52.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.021 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.521 ' HB3' HG21 ' A' ' 59' ' ' ILE . 58.7 mt -53.38 -53.81 45.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.34 -177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.764 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -89.31 -1.07 79.16 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.808 -175.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.2 t -89.98 -41.47 11.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.861 0.83 . . . . 0.0 109.818 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 7' ' ' GLU . 8.8 t -75.81 -38.2 58.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.329 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.783 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 2.7 tttt -88.47 -1.82 58.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.092 0.473 . . . . 0.0 110.908 177.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.764 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -56.91 -25.29 56.88 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.973 -0.454 . . . . 0.0 111.803 -175.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 35.3 t -83.46 -13.67 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.273 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.424 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 1.4 mm? -92.85 133.22 36.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.181 0.515 . . . . 0.0 110.609 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.6 p -111.07 -30.05 7.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.295 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -123.73 -71.75 0.71 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.41 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -140.53 173.86 11.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.067 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -106.53 32.16 4.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 111.064 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.4 p . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.558 178.129 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.604 ' O ' HD11 ' A' ' 103' ' ' LEU . 30.0 Cg_exo -62.34 -43.13 24.34 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.731 2.287 . . . . 0.0 112.358 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.452 HD21 HH11 ' A' ' 107' ' ' ARG . 50.0 mt -148.03 147.66 29.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.027 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.7 -32.7 45.0 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.9 t -166.03 145.69 5.21 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.39 -62.61 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 121.83 1.687 . . . . 0.0 111.25 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 69.16 142.01 0.04 OUTLIER 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.963 0.887 . . . . 0.0 112.344 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 61.5 t80 -154.66 97.26 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.031 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.91 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 3.6 tpt -120.2 125.24 47.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.955 0.407 . . . . 0.0 111.163 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.702 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 8.2 pt-20 -131.87 151.78 51.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.532 0.682 . . . . 0.0 112.257 -173.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.714 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.97 159.73 8.72 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.309 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.7 m -60.08 131.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 83' ' ' ALA . 10.2 tp -122.58 118.61 28.61 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.62 ' O ' ' HB2' ' A' ' 81' ' ' MET . 10.1 m-30 -59.3 149.15 29.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' TRP . 45.1 mmtm -119.57 151.58 38.41 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.669 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -95.82 99.37 11.19 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.6 p -88.05 -47.4 8.54 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.374 -172.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -166.61 165.83 16.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -55.84 -39.43 71.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.201 0.524 . . . . 0.0 110.645 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.24 -66.03 0.6 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.31 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.5 p -78.01 -18.03 56.39 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.533 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.87 -109.25 2.11 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.864 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.844 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 33.6 p-90 -100.65 144.19 29.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.861 -0.67 . . . . 0.0 110.877 -170.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -143.45 111.57 5.44 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.275 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.844 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 42.8 Cg_endo -70.04 114.7 3.83 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 121.758 1.639 . . . . 0.0 112.597 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.95 143.45 49.48 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.714 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -70.43 139.41 51.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.365 0.603 . . . . 0.0 111.345 -169.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.486 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -138.96 142.95 38.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.036 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.702 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.7 p -154.55 133.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 122.297 1.046 . . . . 0.0 112.67 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.3 tm? -94.42 126.0 39.41 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 113.117 -1.856 . . . . 0.0 109.97 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -138.27 113.38 9.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 58.06 30.91 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.237 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 98.06 -29.81 10.58 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.53 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.438 HG13 ' HG2' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -75.95 106.83 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 121.705 0.764 . . . . 0.0 110.075 177.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.36 108.94 20.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.177 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 14.8 t -103.4 155.17 18.68 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.92 -170.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -109.22 134.85 51.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.109 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.457 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 18.0 m-85 -143.73 169.14 18.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.132 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.74 -65.53 1.0 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.75 0.31 . . . . 0.0 110.547 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -123.78 179.92 4.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -73.5 -7.6 52.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.304 0.573 . . . . 0.0 111.109 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -84.57 -20.98 30.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.774 0.797 . . . . 0.0 110.298 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.423 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -78.84 -16.24 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.829 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.68 HG22 ' NE1' ' A' ' 27' ' ' TRP . 65.1 t -45.15 -39.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.2 p -61.7 -55.68 27.79 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.41 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -124.9 -76.83 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.552 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.86 -143.24 48.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.016 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -69.79 -21.54 63.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 0.0 110.8 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 tptt 62.73 13.72 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.34 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.78 129.51 9.18 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 12.3 p -128.98 141.4 51.27 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.045 HG23 HG21 ' A' ' 73' ' ' ILE . 13.0 mt -89.01 133.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.965 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.438 ' HG2' HG13 ' A' ' 34' ' ' ILE . 40.5 mtpt -111.69 89.47 3.07 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.823 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.03 -11.42 60.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 109.964 -176.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.14 -26.8 53.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.411 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.477 HG21 ' HG3' ' A' ' 74' ' ' PRO . 2.0 m -98.79 -16.13 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.748 0.785 . . . . 0.0 110.147 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.733 ' HB3' HD12 ' A' ' 72' ' ' ILE . 97.9 m -133.4 -142.71 0.21 Allowed 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.512 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.4 tp10 -131.06 146.18 52.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.802 1.183 . . . . 0.0 112.756 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.774 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -89.13 130.28 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.568 ' HG3' HG23 ' A' ' 72' ' ' ILE . 10.1 mmmt -105.01 136.04 45.23 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.187 0.517 . . . . 0.0 110.913 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.7 m -140.29 126.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 173.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -97.74 121.88 40.17 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.545 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.8 p -84.95 73.06 10.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.669 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -142.45 -83.27 0.18 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -86.41 136.01 33.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.53 ' OD1' ' HB1' ' A' ' 86' ' ' ALA . 10.9 t-20 -53.7 -54.53 36.64 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.92 -171.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.477 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.2 p -75.21 53.49 0.64 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.184 0.516 . . . . 0.0 112.315 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -125.78 120.86 31.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.52 0.676 . . . . 0.0 110.476 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.47 ' CE ' ' HB2' ' A' ' 92' ' ' TRP . 8.2 ptm -155.07 152.4 29.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.919 -172.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HG2' ' C ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -157.25 168.08 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 -175.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.824 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.29 134.13 39.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.461 . . . . 0.0 110.856 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.733 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.1 pp -116.82 119.21 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.045 HG21 HG23 ' A' ' 52' ' ' ILE . 2.6 pp -134.71 178.33 1.81 Allowed Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.731 -175.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.757 ' CD ' ' HB ' ' A' ' 73' ' ' ILE . 38.9 Cg_endo -76.37 143.38 24.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.197 1.931 . . . . 0.0 113.34 -170.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.74 -49.17 3.99 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.82 80.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.332 0.587 . . . . 0.0 111.048 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -84.39 96.44 9.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -171.8 87.55 0.09 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 110.352 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CG ' HD11 ' A' ' 52' ' ' ILE . 92.7 m-85 -129.8 97.06 4.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.097 174.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -107.35 118.19 36.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 10.7 ptt? -143.23 176.79 8.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.283 0.564 . . . . 0.0 111.623 -171.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 41.7 ttmt -140.79 157.83 44.85 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -105.08 160.0 15.4 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.906 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.708 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -51.33 -31.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.042 176.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.56 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 13.0 t-20 -157.62 -175.75 5.56 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -77.45 -48.73 16.43 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.43 -14.55 62.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.624 0.726 . . . . 0.0 109.678 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.708 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 27.2 tp10 -65.6 -40.85 93.1 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.537 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 2.4 tmt_? -62.37 -44.21 96.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.261 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.776 ' NE2' HG21 ' A' ' 94' ' ' VAL . 15.8 tm0? -53.34 -62.66 1.51 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.103 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.91 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 69.0 mtt180 -33.11 -46.74 0.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.689 1.243 . . . . 0.0 113.857 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.486 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 93.3 m95 -71.92 -54.37 10.24 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.607 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.2 -36.76 63.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.92 0.867 . . . . 0.0 109.611 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.776 HG21 ' NE2' ' A' ' 90' ' ' GLN . 31.3 t -59.32 -55.8 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.8 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.64 71.07 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.472 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' A' ' 59' ' ' ILE . 78.0 mt -54.33 -55.67 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.059 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.664 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -81.23 -3.57 90.63 Favored Glycine 0 C--O 1.205 -1.718 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.241 177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 48.3 t -67.72 -41.37 83.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.272 1.036 . . . . 0.0 108.826 173.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.451 ' OG ' HD22 ' A' ' 3' ' ' LEU . 9.7 t -80.49 -38.95 28.89 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.637 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.823 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 29.1 tttt -87.19 1.66 52.39 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -60.74 -22.88 64.47 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 121.607 -0.683 . . . . 0.0 111.441 -174.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 48.8 t -100.24 6.19 44.69 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.52 0.676 . . . . 0.0 110.286 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.604 HD11 ' O ' ' A' ' 2' ' ' PRO . 7.9 mp -110.51 111.5 22.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.415 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.4 p -93.32 -34.08 13.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.692 0.282 . . . . 0.0 111.547 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -127.85 -69.23 0.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.157 0.504 . . . . 0.0 111.547 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 56' ' ' VAL . 73.1 m -152.86 128.03 9.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.216 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.47 ' HB2' HD21 ' A' ' 103' ' ' LEU . 59.9 ttp180 -64.97 130.37 43.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.858 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.249 1.029 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.99 179.19 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.44 -36.87 92.61 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.873 2.382 . . . . 0.0 111.937 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.58 165.59 27.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 99' ' ' SER . . . -99.27 103.59 2.74 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.309 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.42 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 29.3 m -73.35 -49.86 6.58 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 5' ' ' SER . 62.6 Cg_endo -71.88 0.61 6.86 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.166 1.911 . . . . 0.0 113.489 -175.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.66 122.24 20.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.009 0.433 . . . . 0.0 110.822 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 7.2 t80 -152.43 96.82 2.2 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.863 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 6.4 tpt -115.85 112.64 22.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.853 0.835 . . . . 0.0 110.306 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.664 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.85 137.94 52.53 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.957 -172.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.794 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.44 170.46 26.14 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.204 172.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.6 m -62.59 138.31 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 121.472 0.653 . . . . 0.0 111.729 -176.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 81' ' ' MET . 1.7 tp -128.24 116.93 20.63 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 62.4 m-85 -72.98 90.16 1.47 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.784 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 22.8 ttpp -94.06 135.5 35.35 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.117 0.96 . . . . 0.0 112.326 -170.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.523 ' CZ2' ' HA ' ' A' ' 19' ' ' TYR . 74.7 t-105 -80.12 98.23 7.2 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.91 -1.496 . . . . 0.0 109.838 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.513 ' H ' ' HA2' ' A' ' 22' ' ' GLY . 25.5 p -83.93 60.39 5.8 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.012 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 69.44 165.11 0.26 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.978 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.523 ' HA ' ' CZ2' ' A' ' 16' ' ' TRP . 29.4 p90 -68.65 -6.47 26.13 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.734 -171.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.0 mt -67.39 -55.29 14.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.564 0.697 . . . . 0.0 110.597 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.5 p -116.15 -81.02 0.61 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.011 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.513 ' HA2' ' H ' ' A' ' 17' ' ' THR . . . 79.0 176.67 48.69 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.382 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.483 ' HB3' ' O ' ' A' ' 22' ' ' GLY . 27.5 t90 75.67 -17.35 0.52 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -55.16 104.77 0.45 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -168.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 72.8 Cg_endo -81.89 108.75 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.037 1.825 . . . . 0.0 112.164 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -107.34 152.52 24.04 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.794 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 65.7 t-105 -74.23 105.43 5.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.084 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.9 OUTLIER -96.48 136.39 37.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.972 -177.592 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.681 HG13 ' CE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -142.91 128.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.865 0.84 . . . . 0.0 111.994 172.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -96.13 123.45 39.76 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.239 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.24 140.49 14.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 110.379 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 61.25 27.73 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.421 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 86.27 -22.49 12.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.114 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.552 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -86.3 134.15 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-O 121.342 0.591 . . . . 0.0 111.259 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.464 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -108.7 106.27 16.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 35.9 m -104.17 147.18 27.74 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.961 -0.462 . . . . 0.0 110.992 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.589 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 7.8 p90 -110.68 120.41 42.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.882 0.848 . . . . 0.0 110.995 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.681 ' CE2' HG13 ' A' ' 29' ' ' VAL . 57.4 m-85 -113.91 -174.13 2.41 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.293 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.03 -63.44 1.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.586 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.2 m -122.73 -179.57 4.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HG2' ' CE3' ' A' ' 27' ' ' TRP . 39.2 mt-30 -79.04 -1.26 34.8 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.76 -21.08 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.247 0.546 . . . . 0.0 110.341 170.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.498 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 6.4 m-20 -72.62 -16.8 61.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.418 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.679 HG22 ' NE1' ' A' ' 27' ' ' TRP . 49.1 t -44.62 -28.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.448 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 5.7 t -82.23 -52.22 7.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.878 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -141.23 17.21 2.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 43' ' ' ASP . . . -69.21 117.28 7.76 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.161 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m 72.19 -41.32 0.5 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.669 0.787 . . . . 0.0 113.046 175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 26.6 mmmt 67.8 11.19 8.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.865 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.19 131.8 10.73 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.512 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.8 p -142.77 146.21 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.093 HG23 HG21 ' A' ' 73' ' ' ILE . 9.0 mt -87.52 134.87 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.919 168.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HE3' HD11 ' A' ' 34' ' ' ILE . 40.8 mtpt -108.92 89.28 2.94 Favored 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.537 173.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.725 ' HB2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -74.15 -21.36 59.89 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.468 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -63.32 -38.13 89.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.159 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.7 m -91.72 -15.19 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.783 0.801 . . . . 0.0 110.688 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.584 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 87.3 m -132.56 -145.27 0.25 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.243 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.561 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.7 tp10 -125.81 146.8 49.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.078 0.854 . . . . 0.0 112.221 -170.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.725 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -95.64 134.64 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 172.481 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.622 ' HG3' HG23 ' A' ' 72' ' ' ILE . 23.3 mtmt -117.16 147.35 42.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.014 0.435 . . . . 0.0 110.371 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.604 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m -141.79 127.65 18.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -86.63 129.23 34.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.967 0.413 . . . . 0.0 111.431 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 t -85.17 176.65 8.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.052 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.47 11.72 5.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.236 0.614 . . . . 0.0 111.962 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' ' 68' ' ' ARG . 2.9 p30 -168.49 173.0 7.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -117.14 167.78 10.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.302 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 44.3 p 48.69 57.07 6.72 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.62 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 59.0 ttt180 -159.28 109.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.492 . . . . 0.0 109.796 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.619 ' HG2' HD11 ' A' ' 93' ' ' LEU . 1.9 mpp? -130.08 171.22 13.05 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -148.58 155.31 40.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.035 0.445 . . . . 0.0 110.906 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.848 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -130.35 129.76 43.56 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.25 0.548 . . . . 0.0 111.461 174.266 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.622 HG23 ' HG3' ' A' ' 60' ' ' LYS . 1.5 pp -111.91 113.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.093 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -133.67 166.27 30.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.706 -174.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.761 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 Cg_endo -59.63 130.03 33.55 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.294 2.662 . . . . 0.0 114.228 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 -25.04 9.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.594 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.83 69.53 0.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -80.85 97.22 7.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.522 0.677 . . . . 0.0 110.144 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -175.29 88.0 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.934 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.2 m-85 -144.97 97.23 2.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.722 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 88.3 m-85 -102.87 127.25 50.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -147.73 141.71 25.91 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.678 0.752 . . . . 0.0 112.833 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 67' ' ' THR . 39.6 ttpt -105.6 138.78 41.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.916 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 161.9 13.69 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.576 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.716 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -48.69 -45.36 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.79 176.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.61 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 11.3 m120 -136.93 -175.79 4.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.589 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -79.66 -43.02 23.56 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.537 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.88 -17.71 62.7 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.56 173.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.716 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 26.6 tp10 -67.91 -44.13 77.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.728 ' O ' HD22 ' A' ' 93' ' ' LEU . 17.2 ttt180 -55.13 -52.3 63.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.69 171.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 94' ' ' VAL . 20.3 tp60 -51.6 -56.55 12.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.909 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.863 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 61.8 mtt180 -37.28 -42.36 0.46 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.591 1.157 . . . . 0.0 113.457 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.552 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 93.0 m95 -72.43 -56.49 5.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.881 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -51.83 -37.37 51.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.5 176.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 90' ' ' GLN . 33.1 t -56.23 -63.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.17 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.63 79.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.867 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.494 ' HB3' HG21 ' A' ' 59' ' ' ILE . 83.1 mt -52.56 -55.25 23.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.37 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.589 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -81.59 -20.42 64.0 Favored Glycine 0 C--O 1.204 -1.741 0 C-N-CA 119.085 -1.531 . . . . 0.0 112.603 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -59.75 -34.68 73.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.91 1.355 . . . . 0.0 109.978 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.457 ' HA ' ' HA3' ' A' ' 4' ' ' GLY . 1.9 p -91.4 -32.73 15.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.187 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 1.1 tttt -101.46 1.33 38.11 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -176.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -54.38 -42.26 70.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.433 0.635 . . . . 0.0 111.095 -175.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.7 m -93.68 14.85 17.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.16 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 55' ' ' ALA . 2.2 tp -98.71 -78.48 0.49 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.344 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.8 p 50.21 36.25 12.12 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.104 0.562 . . . . 0.0 112.062 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -160.3 171.31 19.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.9 m -79.72 82.67 5.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.256 0.55 . . . . 0.0 110.049 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 107' ' ' ARG . 15.5 ttp85 -66.01 130.23 42.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.25 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.045 -0.978 . . . . 0.0 112.42 178.201 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.89 -12.13 14.86 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.986 2.457 . . . . 0.0 112.085 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.9 pt? -103.58 -176.15 3.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.722 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.79 -113.84 2.84 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.98 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.0 m -104.44 165.88 12.56 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 122.389 0.276 . . . . 0.0 110.926 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.83 140.97 46.71 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.001 2.467 . . . . 0.0 111.248 171.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -134.87 125.91 27.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.355 0.598 . . . . 0.0 112.588 -169.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.7 t80 -154.04 97.82 2.1 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.922 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 8.9 tpt -122.73 111.07 16.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 122.025 0.917 . . . . 0.0 110.838 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.36 147.93 45.68 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.44 -171.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.7 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.21 167.09 13.26 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.503 172.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.414 HG13 ' H ' ' A' ' 12' ' ' VAL . 2.0 m -65.36 137.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.448 0.642 . . . . 0.0 111.575 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 13' ' ' LEU . 3.7 tp -124.05 119.05 28.37 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -73.46 87.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.4 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 15.1 tmtt? -101.62 143.06 32.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 0.0 111.629 -169.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -70.22 118.32 12.89 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.705 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 p -76.61 -165.91 0.59 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.513 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.17 -52.06 46.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.274 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.7 p90 177.76 -19.99 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.344 0.403 . . . . 0.0 111.72 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mp -46.13 -69.29 0.14 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.7 p -105.14 -6.75 19.58 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.185 0.517 . . . . 0.0 111.474 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.24 -88.45 1.37 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.979 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.678 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 54.2 p-90 -100.38 141.72 32.84 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.318 -0.441 . . . . 0.0 109.984 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -149.06 115.37 3.7 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.883 -0.144 . . . . 0.0 111.147 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.678 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 35.3 Cg_endo -68.94 108.58 1.95 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.354 1.369 . . . . 0.0 111.271 170.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HD3' ' OH ' ' A' ' 37' ' ' TYR . 98.8 mtt180 -123.16 157.09 33.74 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.715 ' NE1' HG22 ' A' ' 44' ' ' VAL . 74.0 t-105 -81.96 132.58 35.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.422 0.63 . . . . 0.0 111.546 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.514 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -129.44 142.47 50.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.137 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.63 HG13 ' HE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -151.6 132.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 122.581 1.181 . . . . 0.0 112.786 167.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.9 tm? -94.75 123.11 38.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.594 -2.093 . . . . 0.0 109.713 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -154.44 141.18 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 171.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.18 27.02 16.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.999 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 86.89 -28.74 5.34 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.133 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.554 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -77.14 124.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.532 0.682 . . . . 0.0 111.083 178.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.634 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -101.21 106.97 18.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 m -103.14 155.09 18.65 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.481 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.455 ' OH ' ' HD3' ' A' ' 26' ' ' ARG . 21.3 t80 -109.72 132.4 54.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.594 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.63 ' HE2' HG13 ' A' ' 29' ' ' VAL . 29.1 m-85 -139.66 179.55 6.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.27 -61.48 1.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.638 0.256 . . . . 0.0 110.916 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.3 m -132.41 -176.76 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' HG3' ' CE3' ' A' ' 27' ' ' TRP . 0.7 OUTLIER -73.29 -3.31 26.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.18 -20.47 23.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.257 0.551 . . . . 0.0 110.385 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 7.5 m-20 -82.29 -15.61 52.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.525 -175.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.715 HG22 ' NE1' ' A' ' 27' ' ' TRP . 70.3 t -41.16 -37.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -172.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 p -68.78 -51.82 36.87 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.079 -0.388 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -124.59 -68.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.073 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.63 -132.6 52.63 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.83 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.5 m -77.01 -8.49 57.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.747 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.8 tptt 73.93 -37.62 0.37 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.067 0.854 . . . . 0.0 112.485 176.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.99 129.91 42.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.195 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.1 p -139.7 139.07 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.367 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.013 HG23 HG21 ' A' ' 73' ' ' ILE . 13.7 mt -88.51 133.77 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.41 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.554 ' HE3' HD11 ' A' ' 34' ' ' ILE . 38.1 mtpt -110.99 94.18 4.86 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.916 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.893 ' HB2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -76.66 -1.05 25.82 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.753 0.311 . . . . 0.0 110.439 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.01 -47.95 9.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.874 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.6 m -80.81 -16.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.034 0.921 . . . . 0.0 109.641 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.614 ' HB3' HD12 ' A' ' 72' ' ' ILE . 41.0 m -133.88 -154.84 0.62 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.835 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.6 tp10 -124.35 144.37 50.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 113.23 -167.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.893 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -90.9 115.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 171.18 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HG3' HG23 ' A' ' 72' ' ' ILE . 23.8 mmmt -97.47 139.08 33.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.568 -172.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.452 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m -139.89 126.07 22.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.747 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 23.6 t-80 -87.76 170.7 11.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 p -118.35 -166.0 1.17 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 76.7 -79.06 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.709 0.804 . . . . 0.0 112.265 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.65 178.43 4.75 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 111.21 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -99.75 163.31 12.53 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.744 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.1 p 50.4 56.22 8.27 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.46 0.648 . . . . 0.0 110.813 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.747 ' HD3' ' O ' ' A' ' 62' ' ' HIS . 0.3 OUTLIER -122.69 120.12 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.873 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.585 ' HE1' ' HB2' ' A' ' 92' ' ' TRP . 9.4 ptm -170.16 151.95 4.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.735 -172.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -155.51 166.89 32.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.848 0.356 . . . . 0.0 110.325 -175.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.91 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -136.98 131.23 32.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.006 0.431 . . . . 0.0 111.102 175.154 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.679 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.2 pp -115.5 118.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.013 HG21 HG23 ' A' ' 52' ' ' ILE . 1.9 pp -138.47 166.06 28.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.581 -174.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.787 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 37.3 Cg_endo -60.29 136.91 71.41 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.597 2.864 . . . . 0.0 114.437 -172.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.19 -45.07 2.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.664 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.79 80.04 1.01 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.106 0.479 . . . . 0.0 111.121 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.422 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 8.8 pt20 -81.43 95.87 7.19 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.399 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -166.61 87.41 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.303 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.8 m-85 -136.55 96.01 3.26 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.486 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 65.0 m-85 -103.83 117.06 33.47 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -142.52 147.6 36.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.384 0.611 . . . . 0.0 111.483 -172.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.744 ' HG2' ' O ' ' A' ' 67' ' ' THR . 48.1 mtmt -110.53 176.69 4.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -127.41 173.13 10.06 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.577 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.791 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -50.06 -39.52 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.609 0.719 . . . . 0.0 111.073 174.303 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.443 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 12.8 t-20 -149.01 -176.17 5.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.383 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -86.14 -37.21 19.0 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.795 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -74.52 -15.15 60.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.113 0.959 . . . . 0.0 109.429 171.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.791 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.04 -52.46 55.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.614 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -47.99 -48.05 32.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.506 170.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.618 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -51.74 -62.31 1.71 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.879 0.872 . . . . 0.0 111.127 177.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.922 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 69.7 mtt180 -35.17 -41.78 0.16 Allowed 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.57 1.169 . . . . 0.0 113.694 175.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.585 ' HB2' ' HE1' ' A' ' 69' ' ' MET . 96.9 m95 -73.36 -56.63 4.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.74 -36.42 57.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.792 0.806 . . . . 0.0 110.078 177.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.599 HG21 ' OE1' ' A' ' 90' ' ' GLN . 30.4 t -60.64 -53.58 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.621 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.85 46.08 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.624 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.427 ' CD1' HD13 ' A' ' 59' ' ' ILE . 77.3 mt -51.49 -53.59 35.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.774 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -82.83 -4.26 90.13 Favored Glycine 0 C--O 1.207 -1.535 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.624 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.572 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.7 t -69.09 -34.4 75.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.507 1.154 . . . . 0.0 109.243 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.3 t -89.51 -29.12 19.18 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.027 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 39.8 tttt -99.31 -2.28 36.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -55.46 -28.99 57.85 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.612 -0.68 . . . . 0.0 112.086 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 45.0 t -110.54 5.62 21.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.025 0.44 . . . . 0.0 110.941 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 11.7 tp -84.55 150.21 25.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.152 0.501 . . . . 0.0 111.928 -169.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.5 p -68.03 149.1 50.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.491 173.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -52.96 -51.95 59.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.01 0.433 . . . . 0.0 111.143 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 m -104.7 81.03 1.72 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.762 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -91.94 74.55 5.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.085 0.469 . . . . 0.0 110.267 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.417 HG22 ' HB ' ' A' ' 56' ' ' VAL . 39.2 p . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.675 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 37.0 Cg_exo -57.32 124.34 15.92 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.706 2.27 . . . . 0.0 111.855 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 2' ' ' PRO . 7.7 mp 72.17 -56.43 0.65 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.794 0.684 . . . . 0.0 110.671 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.86 62.22 4.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.704 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 m -88.21 133.27 37.25 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.26 105.62 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.72 2.28 . . . . 0.0 112.048 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 120.3 37.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 54.0 t80 -153.8 98.22 2.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.892 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 5.5 tpt -126.31 118.12 24.42 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.344 0.592 . . . . 0.0 111.017 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -126.2 153.13 45.09 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.533 -173.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.693 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 142.03 161.16 8.63 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.671 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.31 132.17 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.748 0.785 . . . . 0.0 111.12 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 83' ' ' ALA . 10.5 tp -122.03 118.65 29.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.557 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 8.8 m-30 -61.06 148.26 40.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 37.1 mtmt -111.99 141.03 46.15 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.832 170.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.423 ' H ' ' HA ' ' A' ' 81' ' ' MET . 70.1 t-105 -85.57 104.4 15.29 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.011 0.434 . . . . 0.0 109.976 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.3 p -80.65 152.53 28.43 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.97 83.82 0.68 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.668 0.271 . . . . 0.0 111.327 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 t80 74.48 -51.63 0.68 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.572 173.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.0 mt -47.43 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -170.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.6 p -91.26 4.21 52.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.068 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.72 -92.17 0.15 Allowed Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.01 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.865 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 42.4 p-90 -119.85 145.08 46.99 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -173.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -142.26 112.66 6.13 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.865 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 44.3 Cg_endo -69.41 117.94 5.37 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.059 1.839 . . . . 0.0 112.966 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -116.46 139.67 50.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.693 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 64.3 t-105 -72.49 125.69 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.747 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.3 m-85 -121.15 143.16 49.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.045 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -152.47 129.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 122.445 1.117 . . . . 0.0 112.45 166.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -94.85 122.97 38.03 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 112.636 -2.074 . . . . 0.0 109.496 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -153.18 136.94 16.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.21 0.528 . . . . 0.0 110.301 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 61.12 24.26 14.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.207 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.654 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 91.76 -25.16 17.28 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.582 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.15 120.91 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-O 121.517 0.675 . . . . 0.0 111.064 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.715 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -100.21 108.21 20.25 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.423 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . 25.3 t -103.87 149.78 24.76 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.519 -0.738 . . . . 0.0 110.896 -172.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.429 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 22.8 p90 -113.58 130.55 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.492 0.663 . . . . 0.0 111.225 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.532 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 6.7 m-85 -130.36 179.06 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.144 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.88 -54.38 3.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.79 0.328 . . . . 0.0 110.235 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.5 p -131.56 178.33 6.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -72.36 -9.31 58.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.377 0.608 . . . . 0.0 110.595 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -85.69 -20.93 28.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.439 0.638 . . . . 0.0 110.335 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.09 -14.89 57.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.181 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.615 HG22 ' NE1' ' A' ' 27' ' ' TRP . 94.5 t -44.68 -27.14 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 t -73.16 -41.41 63.95 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.634 -0.666 . . . . 0.0 111.039 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -113.05 -71.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA3' ' CD2' ' A' ' 38' ' ' TYR . . . 65.44 52.4 40.11 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.231 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m 64.23 2.76 1.57 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.847 0.356 . . . . 0.0 111.921 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 31.4 mmmt 61.33 24.01 14.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.592 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 124.73 7.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.949 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.92 156.48 47.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.739 0.78 . . . . 0.0 111.729 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.094 HG23 HG21 ' A' ' 73' ' ' ILE . 13.4 mt -92.0 131.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.293 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HE3' HD11 ' A' ' 34' ' ' ILE . 33.5 mtpt -103.79 89.12 3.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.317 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.654 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -76.22 -3.7 37.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.65 -175.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' A' ' 107' ' ' ARG . . . -88.15 -41.81 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.204 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.431 ' HA ' ' HB ' ' A' ' 106' ' ' THR . 1.4 m -83.92 -15.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.969 0.89 . . . . 0.0 109.466 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.643 ' HB3' HD12 ' A' ' 72' ' ' ILE . 51.9 m -133.47 -155.35 0.67 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.02 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.416 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.4 tp10 -121.54 144.01 48.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.621 1.1 . . . . 0.0 113.354 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.531 HD13 HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -89.33 114.37 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 171.033 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.693 ' HG3' HG23 ' A' ' 72' ' ' ILE . 22.0 mmmt -95.77 136.97 35.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.139 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.541 HG11 ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -140.36 148.8 21.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -149.26 162.94 39.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.504 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.8 p -79.78 -79.06 0.15 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.431 ' CB ' ' HG3' ' A' ' 68' ' ' ARG . . . 67.19 -61.79 0.33 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.628 0.771 . . . . 0.0 110.791 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -152.23 -65.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.489 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.505 ' OD1' HG23 ' A' ' 67' ' ' THR . 7.1 p30 -160.65 -17.29 0.05 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.505 HG23 ' OD1' ' A' ' 66' ' ' ASN . 3.3 p -128.61 70.66 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.962 0.411 . . . . 0.0 111.815 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG3' ' CB ' ' A' ' 64' ' ' ALA . 18.5 mmt180 -135.99 131.28 34.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.188 0.518 . . . . 0.0 110.718 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.912 ' HG3' ' SD ' ' A' ' 81' ' ' MET . 8.2 ptm -170.16 153.95 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.164 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.49 167.54 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.048 0.451 . . . . 0.0 110.832 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.877 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.84 134.7 39.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 175.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.693 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.3 pp -119.85 120.7 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.094 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -139.43 165.98 27.69 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.077 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.765 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.51 146.23 95.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.27 2.647 . . . . 0.0 114.121 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.11 -45.63 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.806 -0.634 . . . . 0.0 113.122 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -148.05 66.8 1.09 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.272 0.558 . . . . 0.0 110.943 -176.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -72.54 95.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.446 0.641 . . . . 0.0 110.859 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 16.5 p80 179.87 87.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.957 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.461 ' CG ' HD11 ' A' ' 52' ' ' ILE . 91.9 m-85 -131.56 98.41 4.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.425 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -108.3 109.63 21.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.912 ' SD ' ' HG3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -128.82 171.43 12.26 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.748 -178.26 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 73.3 tttt -131.15 150.32 52.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -98.48 158.69 15.44 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.276 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.761 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.1 t -50.8 -43.87 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.342 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.444 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 14.9 m120 -143.01 -171.46 3.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.573 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.46 -41.22 15.58 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.649 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.94 -16.68 61.54 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.168 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.761 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -66.23 -53.06 41.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 170.226 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.598 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 15.3 ttt180 -48.1 -49.17 32.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.924 171.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 51.6 tp60 -54.98 -58.39 7.84 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.848 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.892 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 41.9 mtt180 -37.8 -42.62 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 113.809 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 92.2 m95 -72.37 -53.77 11.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.381 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.541 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.84 -37.37 60.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.719 0.771 . . . . 0.0 110.246 176.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 98' ' ' SER . 24.5 t -60.05 -56.61 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.659 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.12 65.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.683 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 59' ' ' ILE . 81.4 mt -52.99 -56.04 19.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.668 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -79.32 -2.92 88.26 Favored Glycine 0 C--O 1.205 -1.689 0 C-N-CA 119.695 -1.24 . . . . 0.0 112.473 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 21.7 t -68.29 -41.27 81.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.536 1.168 . . . . 0.0 108.931 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.7 t -80.7 -38.2 29.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.914 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 28.9 tttt -91.81 0.85 57.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -174.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -57.21 -35.1 69.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.058 0.456 . . . . 0.0 111.379 -174.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.5 m -107.91 15.68 24.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.209 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 1.1 mp -86.35 74.46 9.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.751 -177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.2 p -72.95 -37.66 67.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.993 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.59 36.57 4.08 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.84 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.431 ' HB ' ' HA ' ' A' ' 56' ' ' VAL . 82.5 p 54.99 -169.35 0.07 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.966 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 77.7 ttt180 -142.2 109.84 5.74 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.212 -0.305 . . . . 0.0 110.212 -174.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.0 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.556 -0.735 . . . . 0.0 111.151 -178.675 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--O 1.236 0.365 0 CA-C-O 121.281 0.563 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 84.5 t80 -153.15 97.34 2.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.773 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.7 ttt -124.69 137.25 54.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.396 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.2 pt-20 -134.93 147.97 49.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.522 . . . . 0.0 112.205 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.727 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 155.21 166.34 15.33 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.523 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.9 133.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.413 0.625 . . . . 0.0 111.825 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 83' ' ' ALA . 4.7 tp -118.34 120.05 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -74.52 93.11 2.44 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.14 0.576 . . . . 0.0 110.89 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 29.4 mtmt . . . . . 0 C--N 1.32 -0.696 0 CA-C-O 121.681 0.753 . . . . 0.0 112.412 -168.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.449 -1.142 0 N-CA-C 109.941 -0.831 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -124.26 142.87 50.9 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.727 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 67.7 t-105 -74.11 129.03 37.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -129.68 142.2 50.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.197 -177.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.699 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -151.06 133.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 122.161 0.981 . . . . 0.0 112.557 172.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -92.98 119.72 32.54 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.694 -174.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -131.3 111.0 11.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 57.17 26.68 12.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.716 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.604 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.54 -28.34 15.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.368 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.64 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.01 108.78 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.932 0.872 . . . . 0.0 110.463 178.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -94.81 107.6 19.61 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.47 179.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 m -103.25 160.36 14.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.45 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -108.43 133.21 52.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.345 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.456 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 22.8 m-85 -139.82 165.34 27.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.992 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.33 6.75 22.62 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.394 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 t -173.6 164.55 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.172 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -77.28 -13.62 59.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.086 0.469 . . . . 0.0 111.181 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.48 -16.93 28.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.501 0.667 . . . . 0.0 109.996 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.533 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 26.6 t0 -79.7 -15.05 58.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.757 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.622 HG22 ' NE1' ' A' ' 27' ' ' TRP . 94.3 t -45.62 -29.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 p -69.82 -37.14 76.13 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -122.79 -58.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.851 0.358 . . . . 0.0 110.665 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.533 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -148.33 49.51 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.315 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.0 m -89.08 2.31 54.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 75.29 -34.66 0.26 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.762 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.91 141.3 44.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.002 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 p -147.11 150.0 34.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.359 0.599 . . . . 0.0 111.431 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.069 HG23 HG21 ' A' ' 73' ' ' ILE . 10.8 mt -87.63 123.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.321 176.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.64 ' HE3' HD11 ' A' ' 34' ' ' ILE . 30.8 mtpt -96.05 88.08 4.76 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.735 172.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.604 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -79.53 -9.6 59.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.748 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -80.81 -38.4 28.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.11 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 74' ' ' PRO . 1.0 OUTLIER -86.26 -17.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.246 1.022 . . . . 0.0 109.619 -174.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.652 ' HB3' HD12 ' A' ' 72' ' ' ILE . 96.3 m -128.69 -153.09 0.55 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.659 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.447 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.6 tp10 -120.81 142.98 49.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 119.247 0.931 . . . . 0.0 112.982 -168.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.425 HD11 HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -92.64 115.84 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 170.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.57 ' HG3' HG23 ' A' ' 72' ' ' ILE . 20.8 mmmt -94.29 130.73 40.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.8 m . . . . . 0 C--N 1.317 -0.827 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.639 ' CA ' ' HD3' ' A' ' 89' ' ' ARG . 80.4 p . . . . . 0 CA--C 1.554 1.102 0 CA-C-O 120.836 0.351 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -140.08 117.13 11.13 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.609 -0.682 . . . . 0.0 111.704 174.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.731 ' SD ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -172.38 153.68 3.02 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -159.65 164.79 33.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.595 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.859 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -133.09 130.32 39.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.192 0.52 . . . . 0.0 111.265 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.2 pp -115.96 120.49 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.069 HG21 HG23 ' A' ' 52' ' ' ILE . 2.5 pp -137.1 176.85 2.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.744 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 50.0 Cg_exo -54.79 137.03 73.98 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.004 3.136 . . . . 0.0 114.426 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.14 -46.56 3.0 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.887 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 13.6 pt-20 -139.46 106.36 5.41 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.595 0.712 . . . . 0.0 110.884 -177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.84 97.18 8.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.939 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.404 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -177.62 86.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.49 -178.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CG ' HD11 ' A' ' 52' ' ' ILE . 87.6 m-85 -140.42 96.45 3.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.172 0.511 . . . . 0.0 109.635 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -101.75 121.56 42.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.526 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.9 ptt? -151.08 137.57 18.66 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.161 -172.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 89' ' ' ARG . 35.5 ttpt -102.41 177.98 4.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -124.06 169.72 11.39 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.274 -175.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.802 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.66 -38.02 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 123.793 0.683 . . . . 0.0 110.983 173.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -157.66 -170.07 3.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.584 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.36 -48.91 9.88 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.995 -172.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 90' ' ' GLN . . . -67.59 -17.87 64.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.554 0.692 . . . . 0.0 109.487 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.802 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.35 -54.4 29.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.475 -1.239 . . . . 0.0 107.739 171.273 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.731 ' HG3' ' SD ' ' A' ' 69' ' ' MET . 3.4 ttt180 -58.49 -34.51 71.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.765 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.49 ' HA ' HD22 ' A' ' 93' ' ' LEU . 47.7 tp60 -62.91 -56.94 12.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.437 0.695 . . . . 0.0 111.044 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.773 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 65.3 mtt180 -34.71 -47.06 0.32 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.685 1.194 . . . . 0.0 113.149 174.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.524 ' HB2' ' CE ' ' A' ' 69' ' ' MET . 97.0 m95 -66.56 -53.63 32.51 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.607 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -49.97 -40.86 45.42 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.612 0.72 . . . . 0.0 109.96 175.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 52.5 t -55.85 -64.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.088 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 -50.49 71.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.37 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.463 ' CD2' ' HG2' ' A' ' 54' ' ' MET . 70.2 mt -52.65 -62.78 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.117 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.31 -1.81 65.59 Favored Glycine 0 C--O 1.222 -0.642 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.799 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.9 t -90.33 -32.65 16.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.564 0.682 . . . . 0.0 109.67 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.8 t -83.56 -28.09 28.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.032 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 17.8 tttt . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.629 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 9.7 tp10 . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 30.4 t80 -150.87 98.54 2.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.857 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 4.0 tpt -123.91 129.68 51.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.885 0.374 . . . . 0.0 111.355 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.721 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.0 pt-20 -134.84 143.73 47.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.365 0.602 . . . . 0.0 112.56 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.679 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 160.41 170.18 24.66 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.497 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -73.49 141.18 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.353 0.597 . . . . 0.0 112.276 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.553 HD11 HH21 ' A' ' 89' ' ' ARG . 0.3 OUTLIER -121.96 118.57 29.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.16 116.53 21.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.263 0.625 . . . . 0.0 112.103 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HG2' ' C ' ' A' ' 80' ' ' TYR . 25.5 tptt . . . . . 0 C--O 1.234 0.249 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo . . . . . 0 N--CA 1.459 -0.537 0 N-CA-C 110.72 -0.531 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -112.13 149.39 32.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.679 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -80.4 130.84 35.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.468 0.652 . . . . 0.0 111.444 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.599 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -124.86 145.17 49.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.49 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.721 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.5 p -156.76 132.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 122.329 1.062 . . . . 0.0 112.798 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.1 tm? -94.36 118.29 31.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.725 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.18 130.22 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 109.914 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.52 22.15 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.841 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.664 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 97.21 -22.82 38.68 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.273 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.525 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -80.54 120.09 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.465 0.65 . . . . 0.0 111.157 177.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.604 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.67 106.84 18.82 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 8.3 t -105.16 162.38 13.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.013 0.435 . . . . 0.0 111.973 -167.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.694 ' HH ' ' HD1' ' A' ' 79' ' ' PHE . 39.3 m-85 -106.81 137.59 44.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.593 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.524 ' HE2' HG13 ' A' ' 29' ' ' VAL . 22.0 m-85 -149.28 164.47 34.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -98.0 -39.98 8.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.431 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -130.5 166.35 20.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.8 -5.82 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.24 -18.29 23.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.274 0.559 . . . . 0.0 110.109 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.7 -14.8 59.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.943 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.575 HG22 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -44.39 -22.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 2.7 p -83.0 -57.69 3.18 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.413 -0.805 . . . . 0.0 112.273 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 39.8 mmtm -133.58 27.78 4.01 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.59 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.85 132.77 11.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.762 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.9 m 74.04 -34.0 0.27 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mptt 68.54 6.43 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.68 0.792 . . . . 0.0 112.727 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 137.54 13.43 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.882 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 34' ' ' ILE . 12.0 p -146.83 142.67 27.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.124 HG23 HG21 ' A' ' 73' ' ' ILE . 9.8 mt -89.24 136.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.465 1.106 . . . . 0.0 111.197 172.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.525 ' HE3' HD11 ' A' ' 34' ' ' ILE . 31.4 mtpt -106.73 89.78 3.12 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 120.993 0.425 . . . . 0.0 110.669 173.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.664 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.17 -1.16 31.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.621 -177.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.31 -48.47 8.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.04 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.7 m -80.7 -15.95 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.177 0.989 . . . . 0.0 109.501 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.586 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 54.1 m -131.64 -155.39 0.69 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.956 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.564 ' O ' HG13 ' A' ' 72' ' ' ILE . 7.8 tp10 -123.11 146.4 47.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.463 1.029 . . . . 0.0 113.194 -165.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.565 HD13 HD13 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -88.22 121.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 5.6 mttt -96.41 135.61 38.03 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.106 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.532 HG12 HD11 ' A' ' 59' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.315 -0.892 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 121.107 0.479 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 89' ' ' ARG . 12.5 mmm180 -123.12 124.4 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.052 0.453 . . . . 0.0 111.357 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.601 ' HE3' ' NH2' ' A' ' 89' ' ' ARG . 5.1 ttm -155.76 160.88 40.66 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 4.9 mt-10 -152.4 168.03 26.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.907 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -129.72 140.1 51.18 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.828 0.347 . . . . 0.0 110.269 171.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 58' ' ' GLU . 1.7 pp -120.87 117.05 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.124 HG21 HG23 ' A' ' 52' ' ' ILE . 1.7 pp -136.36 168.87 15.19 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.073 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.774 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 87.5 Cg_exo -29.79 117.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 124.94 3.76 . . . . 0.0 116.185 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.4 -21.38 6.2 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.273 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 14.9 pt-20 -151.76 115.33 4.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 112.322 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 3.0 pt20 -103.13 97.26 7.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 110.103 173.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.46 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 1.2 p80 -175.47 87.15 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.674 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.694 ' HD1' ' HH ' ' A' ' 37' ' ' TYR . 96.6 m-85 -138.2 97.02 3.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.642 ' C ' ' HG2' ' A' ' 15' ' ' LYS . 69.0 m-85 -87.99 140.61 29.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.311 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.597 ' HA ' ' HB2' ' A' ' 15' ' ' LYS . 8.3 ptt? -170.53 142.31 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 171.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HA ' HH12 ' A' ' 89' ' ' ARG . 37.5 ttmt -104.64 170.17 8.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.461 ' H ' ' HG2' ' A' ' 82' ' ' LYS . . . -119.55 165.49 14.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 118.514 0.597 . . . . 0.0 110.994 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.81 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.81 -42.2 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.57 0.544 . . . . 0.0 111.082 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.456 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 6.2 m120 -148.82 -172.27 4.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.86 -40.51 15.88 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.656 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.0 -18.8 63.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.608 0.718 . . . . 0.0 109.14 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.81 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -68.61 -52.15 34.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.61 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -48.07 -47.59 33.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.876 170.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.4 tp60 -55.78 -55.51 31.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.671 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.857 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 8.1 mtp180 -35.51 -44.84 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 124.599 1.187 . . . . 0.0 113.614 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.599 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 97.2 m95 -76.1 -51.03 13.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -53.16 -35.87 60.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.641 0.734 . . . . 0.0 109.889 175.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 19.6 t -55.86 -65.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.857 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -63.11 -55.77 22.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.002 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.565 HD13 HD13 ' A' ' 59' ' ' ILE . 83.3 mt -50.44 -60.21 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.525 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.39 -1.67 83.51 Favored Glycine 0 C--O 1.221 -0.71 0 CA-C-O 119.23 -0.761 . . . . 0.0 114.331 -173.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -90.04 -37.56 14.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.427 1.113 . . . . 0.0 109.517 169.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.7 t -72.81 -41.76 64.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.966 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 21.1 tttt . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.25 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 7.6 tp10 . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 120.913 0.387 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 81.2 t80 -150.57 99.0 2.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.037 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.94 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 3.7 tpt -127.48 120.5 28.47 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.291 0.567 . . . . 0.0 110.795 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -126.86 155.73 42.5 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.851 -173.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.737 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 143.87 167.31 11.76 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.725 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 27' ' ' TRP . 1.5 m -64.46 132.99 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.53 0.681 . . . . 0.0 111.208 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 83' ' ' ALA . 8.1 tp -126.32 116.94 22.0 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 8.4 m-85 -66.25 161.07 23.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.6 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 67.6 mmtt . . . . . 0 C--N 1.318 -0.801 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 36.4 Cg_endo . . . . . 0 N--CA 1.464 -0.263 0 CA-C-O 121.291 0.454 . . . . 0.0 112.071 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -113.75 135.75 53.6 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.737 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 49.5 t-105 -71.07 132.92 45.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.419 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -129.05 145.08 51.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.389 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -151.6 131.16 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.276 1.036 . . . . 0.0 112.654 170.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.7 tm? -93.69 113.09 25.09 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.784 -176.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.19 100.18 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.51 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.4 29.25 17.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.852 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.684 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.1 -23.29 32.5 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.131 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.554 HG23 ' HB2' ' A' ' 51' ' ' SER . 0.9 OUTLIER -82.3 100.21 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-O 122.138 0.971 . . . . 0.0 109.662 175.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -93.99 102.29 14.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.883 -177.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.4 t -105.33 155.4 19.13 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.443 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.577 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.7 p90 -114.04 141.24 47.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.132 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 38.7 m-85 -137.03 155.72 49.33 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.44 -4.26 59.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.766 0.317 . . . . 0.0 111.214 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -159.9 161.27 34.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.712 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -75.47 -17.44 60.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 110.643 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.16 -16.95 28.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.322 0.582 . . . . 0.0 109.984 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.0 -16.03 57.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.548 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.59 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 65.3 t -47.31 -43.41 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -51.85 -43.56 63.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.89 55.56 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.263 0.554 . . . . 0.0 111.83 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -121.5 0.73 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.815 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 m -64.46 -30.65 71.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.865 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HA ' ' HD2' ' A' ' 49' ' ' LYS . 29.6 mmmt 71.26 -25.07 0.17 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.999 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.93 134.62 47.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 34' ' ' ILE . 32.5 p -140.87 150.62 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.948 0.88 . . . . 0.0 113.114 -171.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.069 HG23 HG21 ' A' ' 73' ' ' ILE . 12.7 mt -88.67 131.52 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.662 171.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HE3' HD11 ' A' ' 34' ' ' ILE . 26.1 mtpt -101.23 89.56 3.83 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 172.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.84 ' HE3' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -78.46 3.8 14.92 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.354 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.04 -43.4 13.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.035 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.434 HG22 ' HD3' ' A' ' 74' ' ' PRO . 2.0 m -87.1 -18.35 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.724 0.773 . . . . 0.0 110.25 -173.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 55.3 m -136.0 -173.36 3.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.921 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.563 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.9 tp10 -105.99 144.39 32.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -161.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.618 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -94.51 128.23 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 15.9 mmmt -109.87 144.29 38.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.689 ' CG1' ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 16.2 p . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.447 0.641 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -148.03 143.74 27.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.743 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.523 ' HG3' ' HG3' ' A' ' 81' ' ' MET . 4.5 ptm -170.29 154.99 5.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -148.57 166.9 26.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.025 0.44 . . . . 0.0 110.154 -176.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.945 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.94 124.53 23.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.276 0.56 . . . . 0.0 110.772 171.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 57' ' ' CYS . 2.0 pp -105.31 114.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.069 HG21 HG23 ' A' ' 52' ' ' ILE . 1.7 pp -136.38 163.35 50.61 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.067 -174.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 9.5 Cg_exo -14.6 -115.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.303 1 C-N-CA 126.857 5.038 . . . . 0.0 118.407 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.33 3.18 59.55 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.652 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 73' ' ' ILE . 1.6 pm0 -144.2 63.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.219 0.533 . . . . 0.0 111.395 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.457 ' HA ' ' H ' ' A' ' 73' ' ' ILE . 15.8 pt20 -78.02 96.55 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.396 0.617 . . . . 0.0 110.213 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 178.67 88.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.194 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 71.0 m-85 -137.36 96.23 3.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -98.46 132.48 43.86 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.443 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.523 ' HG3' ' HG3' ' A' ' 69' ' ' MET . 17.1 ptt? -157.58 165.59 35.15 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.309 0.576 . . . . 0.0 111.059 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 67' ' ' THR . 41.1 ttmt -131.2 157.91 41.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -112.35 162.02 16.01 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.89 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.796 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.0 -41.27 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.259 175.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.435 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 7.3 m-80 -147.02 -176.16 5.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.887 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -83.4 -36.82 23.99 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.622 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.589 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.23 -19.15 61.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.613 0.72 . . . . 0.0 109.173 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.796 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -67.77 -51.84 44.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 23.6 ttp180 -50.3 -45.72 54.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.914 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 8.0 tp60 -54.91 -59.19 5.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.563 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.94 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 14.6 mtt180 -36.33 -44.61 0.43 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.64 1.176 . . . . 0.0 113.466 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.482 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 95.0 m95 -70.9 -55.43 8.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.689 ' HG ' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.03 -37.38 61.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.71 0.767 . . . . 0.0 110.15 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 98' ' ' SER . 19.0 t -56.97 -57.99 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.294 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -69.28 -43.55 73.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.938 -175.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.482 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 66.7 mt -54.06 -60.73 2.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.785 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.17 -1.18 73.45 Favored Glycine 0 C--O 1.203 -1.838 0 C-N-CA 119.259 -1.448 . . . . 0.0 112.106 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 39.4 t -75.1 -41.75 58.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.435 1.117 . . . . 0.0 108.615 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.6 t -79.64 -37.79 35.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.603 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.84 ' HB2' ' HE3' ' A' ' 54' ' ' MET . 34.5 tttt . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.832 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 43.2 mm-40 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 73.2 t80 -154.02 99.45 2.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.813 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.1 ttt -132.22 136.15 46.8 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.636 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.751 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.8 pt-20 -136.31 144.38 44.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.362 0.601 . . . . 0.0 112.294 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.677 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.5 168.16 22.99 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.399 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 12' ' ' VAL . 2.0 m -67.06 140.83 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.646 0.736 . . . . 0.0 112.299 -175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 tp -125.12 118.93 27.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -67.37 87.76 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.31 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 43.2 tttm . . . . . 0 C--N 1.321 -0.673 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 N--CA 1.461 -0.435 0 CA-C-O 121.351 0.48 . . . . 0.0 112.012 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' NH1' ' HA ' ' A' ' 39' ' ' ASP . 29.4 tpt180 -102.67 129.2 49.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.677 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 54.4 t-105 -72.02 129.69 39.15 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.683 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.6 m-85 -125.28 140.79 52.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.048 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.751 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -149.52 125.87 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 122.292 1.044 . . . . 0.0 112.27 171.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.9 tm? -92.81 113.3 25.54 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.96 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.26 131.73 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.068 0.461 . . . . 0.0 109.925 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 62.94 16.65 9.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.42 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.0 -28.43 14.61 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.891 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -77.4 122.21 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-O 121.446 0.641 . . . . 0.0 110.812 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.544 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.84 104.76 16.66 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 15.0 m -103.79 138.79 39.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.952 0.406 . . . . 0.0 110.388 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 9.5 p90 -110.79 137.5 48.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.5 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 53.3 m-85 -135.8 169.93 16.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.409 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 20.5 t70 -63.37 -61.66 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.508 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 18.3 m -139.9 -175.55 4.26 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.606 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.73 -17.28 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.161 0.505 . . . . 0.0 111.398 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.508 ' OD1' ' HB2' ' A' ' 40' ' ' SER . 6.0 p-10 -86.37 -17.46 34.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.287 0.565 . . . . 0.0 110.571 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.537 ' OD1' ' HA3' ' A' ' 47' ' ' GLY . 26.0 t70 -85.23 -20.2 30.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.338 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.582 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 50.5 t -44.47 -44.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 124.329 1.052 . . . . 0.0 113.709 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 5.1 p -58.42 -57.76 11.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.234 -172.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -152.18 29.87 0.56 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 111.788 -173.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -86.16 -96.5 0.8 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.811 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.3 m -62.44 -38.19 88.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.984 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt 70.72 -30.43 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.36 129.03 39.81 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.322 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.471 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.1 p -136.51 140.92 43.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.862 0.839 . . . . 0.0 113.264 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.085 HG23 HG21 ' A' ' 73' ' ' ILE . 12.6 mt -89.86 135.78 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.766 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.574 ' HE3' HD11 ' A' ' 34' ' ' ILE . 36.5 mtpt -109.27 93.06 4.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.834 171.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.862 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.22 -3.12 34.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.882 -176.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.01 -49.74 9.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 112.088 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.494 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.9 m -78.35 -17.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.271 1.034 . . . . 0.0 109.327 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.696 ' HB3' HD12 ' A' ' 72' ' ' ILE . 56.9 m -131.87 -149.73 0.39 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.305 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.2 tp10 -132.09 145.27 51.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 120.093 1.315 . . . . 0.0 113.793 -168.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.88 112.4 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 168.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.601 ' HG3' HG23 ' A' ' 72' ' ' ILE . 18.0 mmmt -93.76 147.33 23.15 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.682 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.55 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.3 m . . . . . 0 C--N 1.311 -1.099 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.898 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 4.9 tpp180 -121.86 138.36 54.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.761 -174.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 61' ' ' VAL . 4.2 ptp -153.19 177.0 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -150.31 161.43 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.92 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -130.39 124.34 31.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.257 0.551 . . . . 0.0 111.021 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.696 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.2 pp -109.73 118.27 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.085 HG21 HG23 ' A' ' 52' ' ' ILE . 2.1 pp -138.39 167.06 21.23 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 39.0 Cg_endo -60.8 144.72 99.6 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.132 2.555 . . . . 0.0 113.987 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 -49.16 4.1 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.428 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 12.9 pt-20 -150.42 89.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.284 0.564 . . . . 0.0 111.3 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.44 97.0 10.22 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.336 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -170.1 87.25 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.748 0.785 . . . . 0.0 110.312 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.6 m-85 -139.02 98.08 3.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.591 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.469 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 46.5 m-85 -103.98 121.11 42.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.087 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 ptt? -149.37 142.4 24.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.695 0.76 . . . . 0.0 111.679 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -105.03 151.65 23.7 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -99.79 155.73 17.49 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.339 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.753 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.48 -40.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.721 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.434 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 10.7 t-20 -146.43 -174.03 4.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.91 -44.64 14.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.895 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.02 -15.66 62.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.873 0.844 . . . . 0.0 109.361 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.753 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.06 -52.27 56.7 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.421 ' O ' HD22 ' A' ' 93' ' ' LEU . 10.0 ttp180 -54.42 -46.03 73.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.77 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.73 ' NE2' HG21 ' A' ' 94' ' ' VAL . 15.3 tm0? -49.12 -62.43 1.54 Allowed 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.557 0.743 . . . . 0.0 110.628 175.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.813 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 71.8 mtt180 -35.06 -48.13 0.4 Allowed 'General case' 0 N--CA 1.434 -1.27 0 O-C-N 124.75 1.281 . . . . 0.0 113.137 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.501 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 95.6 m95 -71.46 -52.33 19.02 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.55 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.48 -38.67 55.04 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.793 0.806 . . . . 0.0 109.769 176.219 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.73 HG21 ' NE2' ' A' ' 90' ' ' GLN . 39.7 t -61.86 -63.04 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.783 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.1 86.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.484 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 59' ' ' ILE . 69.2 mt -58.27 -58.89 6.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.247 0.546 . . . . 0.0 111.035 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.77 -0.98 90.05 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.02 -175.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.3 t -87.75 -31.41 19.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 166.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.552 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 30.3 t -81.73 -34.27 30.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.862 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 28.5 tttt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.199 0.523 . . . . 0.0 110.564 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 7.6 pt-20 . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.221 0.534 . . . . 0.0 112.039 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 32.2 t80 -151.51 97.58 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.814 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 5.8 tpt -130.12 128.84 42.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.749 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.57 158.16 40.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.347 0.594 . . . . 0.0 112.406 -173.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.779 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 139.96 162.42 9.11 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.983 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.7 136.32 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-O 121.265 0.555 . . . . 0.0 111.433 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 83' ' ' ALA . 3.9 tp -123.59 118.5 27.46 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.635 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 20.1 m-85 -74.63 93.69 2.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.532 0 C-N-CA 118.926 -1.11 . . . . 0.0 112.087 -171.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 62.4 Cg_endo . . . . . 0 N--CA 1.46 -0.454 0 CA-C-O 121.426 0.511 . . . . 0.0 112.098 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -110.86 146.84 35.78 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.779 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 56.3 t-105 -67.35 118.72 11.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.071 0.462 . . . . 0.0 109.783 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.65 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -108.5 144.48 36.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.984 -176.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.606 HG13 ' HE2' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -154.54 129.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.514 1.15 . . . . 0.0 112.667 167.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -93.64 124.58 37.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.647 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.9 141.58 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.982 0.42 . . . . 0.0 109.873 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.47 23.04 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.273 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.85 -13.24 37.97 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.23 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.527 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -90.71 141.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 123.445 0.698 . . . . 0.0 111.216 175.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.612 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -118.15 110.01 17.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.463 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.462 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 15.0 m -105.39 152.6 22.76 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.571 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.613 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.0 p90 -112.02 138.05 49.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.272 0.558 . . . . 0.0 111.55 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HE2' HG13 ' A' ' 29' ' ' VAL . 11.1 m-85 -134.46 178.4 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.011 -175.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.77 -63.89 1.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 110.441 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 27' ' ' TRP . 5.7 t -146.76 -166.84 2.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.147 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.46 -11.74 61.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.972 0.415 . . . . 0.0 111.415 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -90.39 -17.16 27.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.462 0.648 . . . . 0.0 110.717 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.621 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 24.4 t70 -90.53 -14.51 32.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.854 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.667 HG22 ' NE1' ' A' ' 27' ' ' TRP . 59.7 t -43.49 -32.12 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.6 t -70.31 -38.68 74.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.725 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -123.2 -72.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.73 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.621 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -151.23 52.06 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.402 -176.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 50' ' ' GLY . 50.1 m -74.07 -11.04 60.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.312 0.577 . . . . 0.0 109.807 176.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.2 tptt 71.2 -9.92 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.466 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -66.04 141.56 41.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.7 p -146.56 142.32 27.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.243 0.544 . . . . 0.0 112.056 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.073 HG23 HG21 ' A' ' 73' ' ' ILE . 62.6 mt -89.16 144.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.764 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.527 ' HE3' HD11 ' A' ' 34' ' ' ILE . 34.6 mtpt -113.56 90.46 3.35 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.331 173.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.09 -24.61 60.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -59.75 -36.61 76.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.486 HG22 ' HD3' ' A' ' 74' ' ' PRO . 2.0 m -94.97 -15.4 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.666 0.746 . . . . 0.0 111.07 -171.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 72' ' ' ILE . 81.5 m -134.01 -145.76 0.25 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.544 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.624 ' O ' HG13 ' A' ' 72' ' ' ILE . 4.8 tp10 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.322 0.965 . . . . 0.0 112.313 -170.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.619 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -97.66 125.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.705 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 34.4 mtmt -104.71 97.76 7.6 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 -172.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.276 0 CA-C-O 121.64 0.733 . . . . 0.0 110.814 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.4 p . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.725 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 3.2 ppt_? -123.56 134.89 53.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.045 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' A' ' 81' ' ' MET . 1.7 ptm -171.49 158.06 5.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.063 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 4.8 mt-10 -150.25 167.12 27.89 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.818 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -135.51 125.72 26.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 171.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.1 pp -110.38 120.07 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.073 HG21 HG23 ' A' ' 52' ' ' ILE . 1.1 pp -133.72 163.39 51.45 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.61 -167.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 17.8 Cg_endo -53.77 -63.19 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.095 3.197 . . . . 0.0 115.253 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.93 -20.49 62.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.559 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 179.95 103.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.33 0.586 . . . . 0.0 111.162 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HA ' ' H ' ' A' ' 73' ' ' ILE . 16.9 pt20 -84.39 97.55 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.942 -0.474 . . . . 0.0 111.051 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.47 87.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.211 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 82.9 m-85 -139.98 97.79 3.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.672 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -101.24 135.62 42.42 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.533 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 8.8 ptt? -156.26 151.15 26.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.933 0.873 . . . . 0.0 112.718 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 40.3 ttmt -111.84 137.58 49.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.099 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -90.49 157.99 17.26 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.731 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.755 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -46.51 -49.06 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.134 175.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.508 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 12.0 m120 -134.88 -174.49 3.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.905 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.617 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -87.7 -37.15 16.95 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.825 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -76.51 -14.99 59.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.878 0.847 . . . . 0.0 109.249 171.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.755 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.02 -53.25 48.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.665 ' O ' HD13 ' A' ' 93' ' ' LEU . 32.7 ttp180 -47.72 -51.24 22.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.793 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.698 ' NE2' HG21 ' A' ' 94' ' ' VAL . 17.1 tm0? -49.1 -64.12 0.9 Allowed 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 123.701 0.8 . . . . 0.0 111.036 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.814 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 34.2 mtt180 -35.74 -45.13 0.37 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.65 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 94.2 m95 -70.65 -55.3 9.08 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.439 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.753 ' CD1' HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -51.8 -41.0 61.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.949 0.88 . . . . 0.0 110.292 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.698 HG21 ' NE2' ' A' ' 90' ' ' GLN . 25.5 t -56.85 -51.56 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.007 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 -51.35 10.95 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.759 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.676 HD22 ' HE2' ' A' ' 54' ' ' MET . 92.3 mt -50.84 -55.78 15.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.674 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.31 -3.22 90.69 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.334 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.634 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 42.5 t -66.47 -57.06 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.885 0.842 . . . . 0.0 109.622 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 7' ' ' GLU . 13.9 t -79.77 -29.43 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.743 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.569 ' HG3' ' HA ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -173.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 6.0 tp10 . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 75.4 t80 -150.45 99.59 2.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -172.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.787 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 2.9 tpt -122.79 133.34 54.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.308 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.7 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 5.4 pt-20 -135.67 149.94 49.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.544 0.688 . . . . 0.0 112.746 -173.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.738 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 151.31 162.98 11.08 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.206 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.11 132.14 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 121.361 0.601 . . . . 0.0 111.39 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 83' ' ' ALA . 3.5 tp -121.23 118.95 30.89 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.422 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 25' ' ' PRO . 85.4 m-85 -76.79 90.6 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.005 -175.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.784 0 CA-C-O 121.513 0.673 . . . . 0.0 112.686 -171.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.425 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 30.8 Cg_endo . . . . . 0 N--CA 1.455 -0.775 0 CA-C-O 121.488 0.537 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.56 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 1.4 tpm_? -112.34 129.28 56.35 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.738 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 62.4 t-105 -67.26 119.41 12.1 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.528 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.527 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -113.71 137.0 52.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.643 -177.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.7 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.9 p -150.53 130.85 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 122.409 1.099 . . . . 0.0 112.457 168.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.748 HD21 ' HE3' ' A' ' 54' ' ' MET . 2.7 tm? -93.37 117.98 30.74 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.756 -173.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -141.28 124.44 16.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 58.21 31.23 20.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.425 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.579 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 91.55 -25.49 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.024 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.552 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -83.93 113.24 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-O 121.746 0.784 . . . . 0.0 111.238 -178.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -95.25 105.88 17.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.57 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.4 t -104.31 160.43 14.9 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.082 0.468 . . . . 0.0 111.279 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.555 ' OH ' HG13 ' A' ' 52' ' ' ILE . 1.6 m-85 -108.71 128.15 54.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.984 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 18.4 m-85 -131.47 160.39 35.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.13 -62.92 1.38 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.908 0.385 . . . . 0.0 110.084 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -142.9 -173.16 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.44 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -65.42 -19.91 66.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.16 -16.9 34.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.0 110.66 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.757 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 22.6 t0 -87.32 -14.24 41.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.096 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.592 HG22 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -41.47 -33.11 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.83 -36.84 85.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.87 0.366 . . . . 0.0 111.055 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -118.24 -76.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.001 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.757 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 71.11 -176.51 37.21 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.855 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -66.95 122.17 17.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -78.54 51.95 1.12 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.937 0.875 . . . . 0.0 111.59 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -134.92 159.75 24.06 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.486 ' OG ' HG23 ' A' ' 34' ' ' ILE . 4.5 t -159.78 158.51 31.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.151 0.977 . . . . 0.0 112.836 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 73' ' ' ILE . 9.8 mt -90.49 128.2 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.409 171.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HE3' HD11 ' A' ' 34' ' ' ILE . 37.9 mtpt -104.37 88.7 3.03 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.235 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.783 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.96 -21.8 60.81 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.793 -177.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -65.71 -28.67 69.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.284 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 53' ' ' LYS . 1.5 m -98.56 -14.49 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.706 0.765 . . . . 0.0 110.931 -172.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.635 ' HB3' HD12 ' A' ' 72' ' ' ILE . 86.1 m -136.43 -142.99 0.18 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.5 tp10 -128.4 146.34 50.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.302 0.955 . . . . 0.0 112.376 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -93.91 135.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 9.7 mmtt -114.1 146.15 40.65 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.598 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.9 m . . . . . 0 C--N 1.316 -0.868 0 O-C-N 122.001 -0.437 . . . . 0.0 109.939 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 24.7 p . . . . . 0 C--O 1.223 -0.336 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -135.88 122.93 21.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.082 0.468 . . . . 0.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.644 ' HG2' HD11 ' A' ' 93' ' ' LEU . 1.3 mpp? -141.1 172.32 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -151.57 166.76 30.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 111.261 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.846 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -137.2 137.3 38.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 173.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 57' ' ' CYS . 1.9 pp -115.93 115.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.023 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -135.72 164.98 39.52 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.814 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.767 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.29 132.25 45.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.513 2.809 . . . . 0.0 114.664 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.88 -29.81 7.63 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.539 170.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -156.97 58.41 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.987 0.423 . . . . 0.0 111.698 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -68.29 98.74 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.605 0.717 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -178.94 88.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.143 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.1 m-85 -138.32 99.0 3.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.826 0.346 . . . . 0.0 110.838 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.2 127.63 47.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 13.9 ptt? -151.58 142.42 22.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.665 0.745 . . . . 0.0 111.77 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 67' ' ' THR . 77.8 tttt -105.12 136.89 43.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.037 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.66 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -89.41 155.82 19.08 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.705 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.767 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -47.56 -46.19 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.662 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.532 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 25.5 m-80 -139.16 -170.2 2.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.667 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -88.05 -40.26 13.98 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.361 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.26 -18.73 61.79 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.767 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -62.78 -53.16 58.48 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.702 ' O ' HD22 ' A' ' 93' ' ' LEU . 36.8 ttt-85 -45.13 -53.53 7.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.826 170.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.2 tp60 -54.46 -58.36 7.75 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.362 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.787 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 36.6 mtt180 -37.36 -41.86 0.45 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 124.562 1.164 . . . . 0.0 113.575 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.527 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 91.8 m95 -72.89 -54.42 8.78 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.664 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.19 -38.2 62.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.434 0.635 . . . . 0.0 110.343 176.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 90' ' ' GLN . 25.4 t -54.4 -63.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.028 175.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -61.08 -53.79 52.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.021 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.521 ' HB3' HG21 ' A' ' 59' ' ' ILE . 58.7 mt -53.38 -53.81 45.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.34 -177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.31 -1.07 79.16 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.808 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.2 t -89.98 -41.47 11.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.861 0.83 . . . . 0.0 109.818 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 7' ' ' GLU . 8.8 t -75.81 -38.2 58.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.329 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.783 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 2.7 tttt . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.092 0.473 . . . . 0.0 110.908 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 C--O 1.236 0.357 0 CA-C-O 121.963 0.887 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 61.5 t80 -154.66 97.26 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.031 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.91 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 3.6 tpt -120.2 125.24 47.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.955 0.407 . . . . 0.0 111.163 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.702 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 8.2 pt-20 -131.87 151.78 51.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.532 0.682 . . . . 0.0 112.257 -173.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.714 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.97 159.73 8.72 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.309 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.7 m -60.08 131.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 83' ' ' ALA . 10.2 tp -122.58 118.61 28.61 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.62 ' O ' ' HB2' ' A' ' 81' ' ' MET . 10.1 m-30 -59.3 149.15 29.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 45.1 mmtm . . . . . 0 C--N 1.313 -1.007 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.669 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 CA--C 1.521 -0.153 0 CA-C-O 121.153 0.397 . . . . 0.0 112.597 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.95 143.45 49.48 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.714 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -70.43 139.41 51.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.365 0.603 . . . . 0.0 111.345 -169.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.486 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -138.96 142.95 38.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.036 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.702 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.7 p -154.55 133.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 122.297 1.046 . . . . 0.0 112.67 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.3 tm? -94.42 126.0 39.41 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 113.117 -1.856 . . . . 0.0 109.97 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -138.27 113.38 9.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 58.06 30.91 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.237 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 98.06 -29.81 10.58 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.53 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.438 HG13 ' HG2' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -75.95 106.83 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 121.705 0.764 . . . . 0.0 110.075 177.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.36 108.94 20.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.177 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 14.8 t -103.4 155.17 18.68 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.92 -170.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -109.22 134.85 51.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.109 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.457 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 18.0 m-85 -143.73 169.14 18.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.132 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.74 -65.53 1.0 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.75 0.31 . . . . 0.0 110.547 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -123.78 179.92 4.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -73.5 -7.6 52.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.304 0.573 . . . . 0.0 111.109 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -84.57 -20.98 30.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.774 0.797 . . . . 0.0 110.298 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.423 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -78.84 -16.24 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.829 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.68 HG22 ' NE1' ' A' ' 27' ' ' TRP . 65.1 t -45.15 -39.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.2 p -61.7 -55.68 27.79 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.41 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -124.9 -76.83 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.552 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.86 -143.24 48.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.016 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -69.79 -21.54 63.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 0.0 110.8 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 tptt 62.73 13.72 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.34 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.78 129.51 9.18 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 12.3 p -128.98 141.4 51.27 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.045 HG23 HG21 ' A' ' 73' ' ' ILE . 13.0 mt -89.01 133.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.965 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.438 ' HG2' HG13 ' A' ' 34' ' ' ILE . 40.5 mtpt -111.69 89.47 3.07 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.823 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.03 -11.42 60.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 109.964 -176.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.14 -26.8 53.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.411 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.477 HG21 ' HG3' ' A' ' 74' ' ' PRO . 2.0 m -98.79 -16.13 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.748 0.785 . . . . 0.0 110.147 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.733 ' HB3' HD12 ' A' ' 72' ' ' ILE . 97.9 m -133.4 -142.71 0.21 Allowed 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.512 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.4 tp10 -131.06 146.18 52.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.802 1.183 . . . . 0.0 112.756 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.774 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -89.13 130.28 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.568 ' HG3' HG23 ' A' ' 72' ' ' ILE . 10.1 mmmt -105.01 136.04 45.23 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.187 0.517 . . . . 0.0 110.913 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.7 m . . . . . 0 C--N 1.315 -0.897 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 173.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.477 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.2 p . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 121.184 0.516 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -125.78 120.86 31.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.52 0.676 . . . . 0.0 110.476 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.47 ' CE ' ' HB2' ' A' ' 92' ' ' TRP . 8.2 ptm -155.07 152.4 29.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.919 -172.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HG2' ' C ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -157.25 168.08 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 -175.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.824 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.29 134.13 39.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.461 . . . . 0.0 110.856 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.733 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.1 pp -116.82 119.21 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.045 HG21 HG23 ' A' ' 52' ' ' ILE . 2.6 pp -134.71 178.33 1.81 Allowed Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.731 -175.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.757 ' CD ' ' HB ' ' A' ' 73' ' ' ILE . 38.9 Cg_endo -76.37 143.38 24.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.197 1.931 . . . . 0.0 113.34 -170.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.74 -49.17 3.99 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.82 80.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.332 0.587 . . . . 0.0 111.048 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -84.39 96.44 9.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -171.8 87.55 0.09 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 110.352 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CG ' HD11 ' A' ' 52' ' ' ILE . 92.7 m-85 -129.8 97.06 4.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.097 174.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -107.35 118.19 36.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 10.7 ptt? -143.23 176.79 8.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.283 0.564 . . . . 0.0 111.623 -171.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 41.7 ttmt -140.79 157.83 44.85 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -105.08 160.0 15.4 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.906 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.708 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -51.33 -31.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.042 176.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.56 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 13.0 t-20 -157.62 -175.75 5.56 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -77.45 -48.73 16.43 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.43 -14.55 62.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.624 0.726 . . . . 0.0 109.678 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.708 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 27.2 tp10 -65.6 -40.85 93.1 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.537 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 2.4 tmt_? -62.37 -44.21 96.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.261 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.776 ' NE2' HG21 ' A' ' 94' ' ' VAL . 15.8 tm0? -53.34 -62.66 1.51 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.103 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.91 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 69.0 mtt180 -33.11 -46.74 0.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.689 1.243 . . . . 0.0 113.857 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.486 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 93.3 m95 -71.92 -54.37 10.24 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.607 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.2 -36.76 63.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.92 0.867 . . . . 0.0 109.611 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.776 HG21 ' NE2' ' A' ' 90' ' ' GLN . 31.3 t -59.32 -55.8 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.8 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.64 71.07 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.472 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' A' ' 59' ' ' ILE . 78.0 mt -54.33 -55.67 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.059 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.23 -3.57 90.63 Favored Glycine 0 C--O 1.205 -1.718 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.241 177.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 48.3 t -67.72 -41.37 83.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.272 1.036 . . . . 0.0 108.826 173.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.412 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 9.7 t -80.49 -38.95 28.89 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.637 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.823 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 29.1 tttt . . . . . 0 C--O 1.226 -0.164 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 121.009 0.433 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 7.2 t80 -152.43 96.82 2.2 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.863 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 6.4 tpt -115.85 112.64 22.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.853 0.835 . . . . 0.0 110.306 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.664 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.85 137.94 52.53 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.957 -172.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.794 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.44 170.46 26.14 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.204 172.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.6 m -62.59 138.31 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 121.472 0.653 . . . . 0.0 111.729 -176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 81' ' ' MET . 1.7 tp -128.24 116.93 20.63 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 62.4 m-85 -72.98 90.16 1.47 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.784 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 22.8 ttpp . . . . . 0 C--N 1.317 -0.839 0 CA-C-O 122.117 0.96 . . . . 0.0 112.326 -170.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.945 0 CA-C-O 121.364 0.485 . . . . 0.0 112.164 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -107.34 152.52 24.04 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.794 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 65.7 t-105 -74.23 105.43 5.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.084 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.9 OUTLIER -96.48 136.39 37.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.972 -177.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.681 HG13 ' CE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -142.91 128.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.865 0.84 . . . . 0.0 111.994 172.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -96.13 123.45 39.76 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.239 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.24 140.49 14.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 110.379 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 61.25 27.73 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.421 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 86.27 -22.49 12.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.114 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.552 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -86.3 134.15 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-O 121.342 0.591 . . . . 0.0 111.259 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.464 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -108.7 106.27 16.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 35.9 m -104.17 147.18 27.74 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.961 -0.462 . . . . 0.0 110.992 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.589 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 7.8 p90 -110.68 120.41 42.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.882 0.848 . . . . 0.0 110.995 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.681 ' CE2' HG13 ' A' ' 29' ' ' VAL . 57.4 m-85 -113.91 -174.13 2.41 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.293 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.03 -63.44 1.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.586 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.2 m -122.73 -179.57 4.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HG2' ' CE3' ' A' ' 27' ' ' TRP . 39.2 mt-30 -79.04 -1.26 34.8 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.76 -21.08 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.247 0.546 . . . . 0.0 110.341 170.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.498 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 6.4 m-20 -72.62 -16.8 61.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.418 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.679 HG22 ' NE1' ' A' ' 27' ' ' TRP . 49.1 t -44.62 -28.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.448 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 5.7 t -82.23 -52.22 7.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.878 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -141.23 17.21 2.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 43' ' ' ASP . . . -69.21 117.28 7.76 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.161 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m 72.19 -41.32 0.5 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.669 0.787 . . . . 0.0 113.046 175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 26.6 mmmt 67.8 11.19 8.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.865 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.19 131.8 10.73 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.512 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.8 p -142.77 146.21 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.093 HG23 HG21 ' A' ' 73' ' ' ILE . 9.0 mt -87.52 134.87 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.919 168.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HE3' HD11 ' A' ' 34' ' ' ILE . 40.8 mtpt -108.92 89.28 2.94 Favored 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.537 173.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.725 ' HB2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -74.15 -21.36 59.89 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.468 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -63.32 -38.13 89.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.159 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.7 m -91.72 -15.19 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.783 0.801 . . . . 0.0 110.688 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.584 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 87.3 m -132.56 -145.27 0.25 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.243 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.561 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.7 tp10 -125.81 146.8 49.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.078 0.854 . . . . 0.0 112.221 -170.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.725 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -95.64 134.64 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 172.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.622 ' HG3' HG23 ' A' ' 72' ' ' ILE . 23.3 mtmt -117.16 147.35 42.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.014 0.435 . . . . 0.0 110.371 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.604 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m . . . . . 0 C--N 1.313 -1.0 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 44.3 p . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.62 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 59.0 ttt180 -159.28 109.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.492 . . . . 0.0 109.796 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.619 ' HG2' HD11 ' A' ' 93' ' ' LEU . 1.9 mpp? -130.08 171.22 13.05 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -148.58 155.31 40.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.035 0.445 . . . . 0.0 110.906 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.848 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -130.35 129.76 43.56 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.25 0.548 . . . . 0.0 111.461 174.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.622 HG23 ' HG3' ' A' ' 60' ' ' LYS . 1.5 pp -111.91 113.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.093 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -133.67 166.27 30.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.706 -174.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.761 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 Cg_endo -59.63 130.03 33.55 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.294 2.662 . . . . 0.0 114.228 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 -25.04 9.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.594 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.83 69.53 0.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -80.85 97.22 7.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.522 0.677 . . . . 0.0 110.144 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -175.29 88.0 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.934 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.2 m-85 -144.97 97.23 2.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.722 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 88.3 m-85 -102.87 127.25 50.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -147.73 141.71 25.91 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.678 0.752 . . . . 0.0 112.833 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 67' ' ' THR . 39.6 ttpt -105.6 138.78 41.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.916 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 161.9 13.69 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.576 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.716 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -48.69 -45.36 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.79 176.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.61 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 38.3 m-80 -136.93 -175.79 4.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.589 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -79.66 -43.02 23.56 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.537 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.88 -17.71 62.7 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.56 173.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.716 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 26.6 tp10 -67.91 -44.13 77.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.728 ' O ' HD22 ' A' ' 93' ' ' LEU . 17.2 ttt180 -55.13 -52.3 63.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.69 171.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 94' ' ' VAL . 20.3 tp60 -51.6 -56.55 12.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.909 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.863 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 61.8 mtt180 -37.28 -42.36 0.46 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.591 1.157 . . . . 0.0 113.457 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.552 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 93.0 m95 -72.43 -56.49 5.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.881 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -51.83 -37.37 51.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.5 176.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 90' ' ' GLN . 33.1 t -56.23 -63.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.17 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.63 79.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.867 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.494 ' HB3' HG21 ' A' ' 59' ' ' ILE . 83.1 mt -52.56 -55.25 23.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.37 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.59 -20.42 64.0 Favored Glycine 0 C--O 1.204 -1.741 0 C-N-CA 119.085 -1.531 . . . . 0.0 112.603 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -59.75 -34.68 73.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.91 1.355 . . . . 0.0 109.978 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -91.4 -32.73 15.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.187 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 1.1 tttt . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.484 0 CA-C-O 121.355 0.598 . . . . 0.0 112.588 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.7 t80 -154.04 97.82 2.1 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.922 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 8.9 tpt -122.73 111.07 16.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 122.025 0.917 . . . . 0.0 110.838 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.446 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.36 147.93 45.68 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.44 -171.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.7 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.21 167.09 13.26 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.503 172.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.414 HG13 ' H ' ' A' ' 12' ' ' VAL . 2.0 m -65.36 137.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.448 0.642 . . . . 0.0 111.575 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 13' ' ' LEU . 3.7 tp -124.05 119.05 28.37 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -73.46 87.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.4 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 15.1 tmtt? . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 0.0 111.629 -169.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 N--CA 1.46 -0.471 0 CA-C-O 121.276 0.448 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HD3' ' OH ' ' A' ' 37' ' ' TYR . 98.8 mtt180 -123.16 157.09 33.74 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.715 ' NE1' HG22 ' A' ' 44' ' ' VAL . 74.0 t-105 -81.96 132.58 35.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.422 0.63 . . . . 0.0 111.546 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.514 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -129.44 142.47 50.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.137 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.63 HG13 ' HE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -151.6 132.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 122.581 1.181 . . . . 0.0 112.786 167.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.9 tm? -94.75 123.11 38.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.594 -2.093 . . . . 0.0 109.713 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -154.44 141.18 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 171.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.18 27.02 16.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.999 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 86.89 -28.74 5.34 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.133 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.554 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -77.14 124.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.532 0.682 . . . . 0.0 111.083 178.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.634 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -101.21 106.97 18.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 m -103.14 155.09 18.65 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.481 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.455 ' OH ' ' HD3' ' A' ' 26' ' ' ARG . 21.3 t80 -109.72 132.4 54.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.594 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.63 ' HE2' HG13 ' A' ' 29' ' ' VAL . 29.1 m-85 -139.66 179.55 6.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.27 -61.48 1.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.638 0.256 . . . . 0.0 110.916 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.3 m -132.41 -176.76 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' HG3' ' CE3' ' A' ' 27' ' ' TRP . 0.7 OUTLIER -73.29 -3.31 26.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.18 -20.47 23.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.257 0.551 . . . . 0.0 110.385 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 7.5 m-20 -82.29 -15.61 52.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.525 -175.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.715 HG22 ' NE1' ' A' ' 27' ' ' TRP . 70.3 t -41.16 -37.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -172.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 p -68.78 -51.82 36.87 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.079 -0.388 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -124.59 -68.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.073 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.63 -132.6 52.63 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.83 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.5 m -77.01 -8.49 57.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.747 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.8 tptt 73.93 -37.62 0.37 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.067 0.854 . . . . 0.0 112.485 176.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.99 129.91 42.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.195 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.1 p -139.7 139.07 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.367 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.013 HG23 HG21 ' A' ' 73' ' ' ILE . 13.7 mt -88.51 133.77 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.41 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.554 ' HE3' HD11 ' A' ' 34' ' ' ILE . 38.1 mtpt -110.99 94.18 4.86 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.916 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.893 ' HB2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -76.66 -1.05 25.82 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.753 0.311 . . . . 0.0 110.439 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.01 -47.95 9.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.874 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.6 m -80.81 -16.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.034 0.921 . . . . 0.0 109.641 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.614 ' HB3' HD12 ' A' ' 72' ' ' ILE . 41.0 m -133.88 -154.84 0.62 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.835 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.6 tp10 -124.35 144.37 50.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 113.23 -167.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.893 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -90.9 115.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 171.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HG3' HG23 ' A' ' 72' ' ' ILE . 23.8 mmmt -97.47 139.08 33.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.568 -172.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.452 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m . . . . . 0 C--N 1.314 -0.939 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.744 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.1 p . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 121.46 0.648 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.69 120.12 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.873 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.585 ' HE1' ' HB2' ' A' ' 92' ' ' TRP . 9.4 ptm -170.16 151.95 4.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.735 -172.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -155.51 166.89 32.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.848 0.356 . . . . 0.0 110.325 -175.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.91 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -136.98 131.23 32.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.006 0.431 . . . . 0.0 111.102 175.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.679 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.2 pp -115.5 118.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.013 HG21 HG23 ' A' ' 52' ' ' ILE . 1.9 pp -138.47 166.06 28.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.581 -174.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.787 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 37.3 Cg_endo -60.29 136.91 71.41 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.597 2.864 . . . . 0.0 114.437 -172.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.19 -45.07 2.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.664 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.79 80.04 1.01 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.106 0.479 . . . . 0.0 111.121 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.422 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 8.8 pt20 -81.43 95.87 7.19 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.399 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -166.61 87.41 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.303 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.8 m-85 -136.55 96.01 3.26 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.486 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 65.0 m-85 -103.83 117.06 33.47 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -142.52 147.6 36.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.384 0.611 . . . . 0.0 111.483 -172.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.744 ' HG2' ' O ' ' A' ' 67' ' ' THR . 48.1 mtmt -110.53 176.69 4.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -127.41 173.13 10.06 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.577 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.791 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -50.06 -39.52 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.609 0.719 . . . . 0.0 111.073 174.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.443 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 12.8 t-20 -149.01 -176.17 5.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.383 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -86.14 -37.21 19.0 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.795 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -74.52 -15.15 60.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.113 0.959 . . . . 0.0 109.429 171.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.791 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.04 -52.46 55.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.614 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -47.99 -48.05 32.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.506 170.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.747 ' NE2' HG21 ' A' ' 94' ' ' VAL . 14.6 tm0? -51.74 -62.31 1.71 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.879 0.872 . . . . 0.0 111.127 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.922 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 69.7 mtt180 -35.17 -41.78 0.16 Allowed 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.57 1.169 . . . . 0.0 113.694 175.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.585 ' HB2' ' HE1' ' A' ' 69' ' ' MET . 96.9 m95 -73.36 -56.63 4.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.74 -36.42 57.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.792 0.806 . . . . 0.0 110.078 177.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.747 HG21 ' NE2' ' A' ' 90' ' ' GLN . 30.4 t -60.64 -53.58 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.621 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.85 46.08 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.624 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.427 ' CD1' HD13 ' A' ' 59' ' ' ILE . 77.3 mt -51.49 -53.59 35.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.774 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.83 -4.26 90.13 Favored Glycine 0 C--O 1.207 -1.535 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.624 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.572 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.7 t -69.09 -34.4 75.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.507 1.154 . . . . 0.0 109.243 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.3 t -89.51 -29.12 19.18 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.027 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 39.8 tttt . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 54.0 t80 -153.8 98.22 2.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.892 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 5.5 tpt -126.31 118.12 24.42 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.344 0.592 . . . . 0.0 111.017 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -126.2 153.13 45.09 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.533 -173.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.693 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 142.03 161.16 8.63 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.671 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.31 132.17 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.748 0.785 . . . . 0.0 111.12 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 83' ' ' ALA . 10.5 tp -122.03 118.65 29.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.557 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 8.8 m-30 -61.06 148.26 40.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 37.1 mtmt . . . . . 0 C--N 1.311 -1.075 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.832 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 44.3 Cg_endo . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.264 0.443 . . . . 0.0 112.966 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -116.46 139.67 50.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.693 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 64.3 t-105 -72.49 125.69 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.747 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.3 m-85 -121.15 143.16 49.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.045 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -152.47 129.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 122.445 1.117 . . . . 0.0 112.45 166.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -94.85 122.97 38.03 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 112.636 -2.074 . . . . 0.0 109.496 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -153.18 136.94 16.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.21 0.528 . . . . 0.0 110.301 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 61.12 24.26 14.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.207 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.654 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 91.76 -25.16 17.28 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.582 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.15 120.91 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-O 121.517 0.675 . . . . 0.0 111.064 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.715 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -100.21 108.21 20.25 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.423 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . 25.3 t -103.87 149.78 24.76 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.519 -0.738 . . . . 0.0 110.896 -172.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.429 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 22.8 p90 -113.58 130.55 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.492 0.663 . . . . 0.0 111.225 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.532 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 6.7 m-85 -130.36 179.06 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.144 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.88 -54.38 3.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.79 0.328 . . . . 0.0 110.235 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.5 p -131.56 178.33 6.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -72.36 -9.31 58.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.377 0.608 . . . . 0.0 110.595 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -85.69 -20.93 28.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.439 0.638 . . . . 0.0 110.335 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.09 -14.89 57.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.181 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.615 HG22 ' NE1' ' A' ' 27' ' ' TRP . 94.5 t -44.68 -27.14 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 t -73.16 -41.41 63.95 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.634 -0.666 . . . . 0.0 111.039 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -113.05 -71.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA3' ' CD2' ' A' ' 38' ' ' TYR . . . 65.44 52.4 40.11 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.231 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m 64.23 2.76 1.57 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.847 0.356 . . . . 0.0 111.921 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 31.4 mmmt 61.33 24.01 14.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.592 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 124.73 7.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.949 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.92 156.48 47.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.739 0.78 . . . . 0.0 111.729 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.094 HG23 HG21 ' A' ' 73' ' ' ILE . 13.4 mt -92.0 131.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.293 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HE3' HD11 ' A' ' 34' ' ' ILE . 33.5 mtpt -103.79 89.12 3.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.317 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.654 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -76.22 -3.7 37.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.65 -175.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.15 -41.81 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.204 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.4 m -83.92 -15.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.969 0.89 . . . . 0.0 109.466 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.643 ' HB3' HD12 ' A' ' 72' ' ' ILE . 51.9 m -133.47 -155.35 0.67 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.02 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.416 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.4 tp10 -121.54 144.01 48.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.621 1.1 . . . . 0.0 113.354 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.531 HD13 HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -89.33 114.37 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 171.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.693 ' HG3' HG23 ' A' ' 72' ' ' ILE . 22.0 mmmt -95.77 136.97 35.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.139 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.541 HG11 ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.317 -0.834 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.444 ' OG1' ' HE3' ' A' ' 82' ' ' LYS . 3.3 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.962 0.411 . . . . 0.0 111.815 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -135.99 131.28 34.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.188 0.518 . . . . 0.0 110.718 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.912 ' HG3' ' SD ' ' A' ' 81' ' ' MET . 8.2 ptm -170.16 153.95 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.164 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.49 167.54 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.048 0.451 . . . . 0.0 110.832 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.877 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.84 134.7 39.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 175.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.693 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.3 pp -119.85 120.7 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.094 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -139.43 165.98 27.69 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.077 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.765 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.51 146.23 95.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.27 2.647 . . . . 0.0 114.121 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.11 -45.63 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.806 -0.634 . . . . 0.0 113.122 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -148.05 66.8 1.09 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.272 0.558 . . . . 0.0 110.943 -176.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.54 95.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.446 0.641 . . . . 0.0 110.859 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 179.87 87.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.957 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.461 ' CG ' HD11 ' A' ' 52' ' ' ILE . 91.9 m-85 -131.56 98.41 4.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.425 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -108.3 109.63 21.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.912 ' SD ' ' HG3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -128.82 171.43 12.26 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.748 -178.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 73.3 tttt -131.15 150.32 52.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -98.48 158.69 15.44 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.276 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.761 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.1 t -50.8 -43.87 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.342 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.444 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 47.4 m-80 -143.01 -171.46 3.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.573 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.46 -41.22 15.58 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.649 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.94 -16.68 61.54 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.168 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.761 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -66.23 -53.06 41.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 170.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.598 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 15.3 ttt180 -48.1 -49.17 32.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.924 171.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 51.6 tp60 -54.98 -58.39 7.84 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.848 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.892 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 41.9 mtt180 -37.8 -42.62 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 113.809 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 92.2 m95 -72.37 -53.77 11.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.381 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.541 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.84 -37.37 60.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.719 0.771 . . . . 0.0 110.246 176.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 98' ' ' SER . 24.5 t -60.05 -56.61 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.659 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.12 65.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.683 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 59' ' ' ILE . 81.4 mt -52.99 -56.04 19.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.668 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.32 -2.92 88.26 Favored Glycine 0 C--O 1.205 -1.689 0 C-N-CA 119.695 -1.24 . . . . 0.0 112.473 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 21.7 t -68.29 -41.27 81.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.536 1.168 . . . . 0.0 108.931 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.7 t -80.7 -38.2 29.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.914 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 28.9 tttt . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -174.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.03 56.38 3.05 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.549 2.833 . . . . 0.0 112.714 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.443 ' C ' ' HB3' ' A' ' 102' ' ' CYS . 2.7 pt? -176.88 -26.83 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.44 -141.58 12.18 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.579 ' O ' ' HA ' ' A' ' 99' ' ' SER . 30.7 t -92.27 119.75 67.99 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.06 85.84 0.25 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.331 2.02 . . . . 0.0 111.771 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -87.69 165.31 15.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.364 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 84.5 t80 -153.15 97.34 2.17 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.773 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.7 ttt -124.69 137.25 54.36 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.396 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 7.2 pt-20 -134.93 147.97 49.93 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.197 0.522 . . . . 0.0 112.205 -173.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.727 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 155.21 166.34 15.33 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.523 174.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -68.9 133.01 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.413 0.625 . . . . 0.0 111.825 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 83' ' ' ALA . 4.7 tp -118.34 120.05 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -74.52 93.11 2.44 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.14 0.576 . . . . 0.0 110.89 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 29.4 mtmt -92.98 146.0 23.95 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.681 0.753 . . . . 0.0 112.412 -168.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.559 ' CZ2' ' HA ' ' A' ' 19' ' ' TYR . 39.3 t-105 -93.61 98.6 11.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.355 175.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.2 p -86.77 -33.61 19.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.03 0.443 . . . . 0.0 110.558 -175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -159.08 165.88 32.89 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.559 ' HA ' ' CZ2' ' A' ' 16' ' ' TRP . 50.6 t80 -58.28 -41.95 85.49 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.018 0.437 . . . . 0.0 110.486 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 48.9 mt -64.47 -53.64 44.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.862 0.839 . . . . 0.0 110.758 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.0 p -107.31 89.42 2.99 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.707 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 23' ' ' TRP . . . -108.95 -174.31 21.37 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 172.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.479 ' HB3' ' O ' ' A' ' 22' ' ' GLY . 17.8 t90 73.84 -9.19 1.26 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 117.259 0.53 . . . . 0.0 112.202 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.403 ' HB3' ' HE ' ' A' ' 26' ' ' ARG . 86.8 mm-40 -49.56 102.32 0.31 Allowed Pre-proline 0 N--CA 1.472 0.645 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -171.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.86 107.84 2.51 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.173 1.249 . . . . 0.0 109.941 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HE ' ' HB3' ' A' ' 24' ' ' GLN . 22.6 mmt180 -124.26 142.87 50.9 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.727 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 67.7 t-105 -74.11 129.03 37.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.305 0.574 . . . . 0.0 110.596 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.453 ' CE2' HD13 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -129.68 142.2 50.77 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.197 -177.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.699 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -151.06 133.57 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 122.161 0.981 . . . . 0.0 112.557 172.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -92.98 119.72 32.54 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.694 -174.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -131.3 111.0 11.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 57.17 26.68 12.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.716 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.604 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.54 -28.34 15.37 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.368 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.64 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.01 108.78 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 121.932 0.872 . . . . 0.0 110.463 178.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.453 HD13 ' CE2' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -94.81 107.6 19.61 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.47 179.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 m -103.25 160.36 14.74 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.45 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -108.43 133.21 52.92 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.345 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.456 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 22.8 m-85 -139.82 165.34 27.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.992 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.33 6.75 22.62 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.394 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 t -173.6 164.55 4.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.172 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -77.28 -13.62 59.9 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.086 0.469 . . . . 0.0 111.181 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -90.48 -16.93 28.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.501 0.667 . . . . 0.0 109.996 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.533 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 26.6 t0 -79.7 -15.05 58.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.757 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.622 HG22 ' NE1' ' A' ' 27' ' ' TRP . 94.3 t -45.62 -29.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 p -69.82 -37.14 76.13 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -122.79 -58.69 1.65 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.851 0.358 . . . . 0.0 110.665 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.533 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -148.33 49.51 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.315 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.0 m -89.08 2.31 54.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.8 mptt 75.29 -34.66 0.26 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.762 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.91 141.3 44.96 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.002 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.7 p -147.11 150.0 34.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.359 0.599 . . . . 0.0 111.431 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.069 HG23 HG21 ' A' ' 73' ' ' ILE . 10.8 mt -87.63 123.98 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.321 176.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.64 ' HE3' HD11 ' A' ' 34' ' ' ILE . 30.8 mtpt -96.05 88.08 4.76 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.735 172.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.604 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -79.53 -9.6 59.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.748 -172.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -80.81 -38.4 28.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.11 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.624 ' HA ' ' H ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -86.26 -17.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 122.246 1.022 . . . . 0.0 109.619 -174.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.652 ' HB3' HD12 ' A' ' 72' ' ' ILE . 96.3 m -128.69 -153.09 0.55 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.081 -1.418 . . . . 0.0 107.659 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.447 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.6 tp10 -120.81 142.98 49.11 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 119.247 0.931 . . . . 0.0 112.982 -168.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.425 HD11 HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -92.64 115.84 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 170.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.57 ' HG3' HG23 ' A' ' 72' ' ' ILE . 20.8 mmmt -94.29 130.73 40.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.608 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.8 m -141.17 128.5 21.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -145.37 -73.61 0.24 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.383 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' A' ' 68' ' ' ARG . 44.2 m -16.56 109.99 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 O-C-N 125.079 1.487 . . . . 0.0 113.28 -167.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 57.66 0.7 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.423 -169.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -166.54 -159.35 0.36 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 24.2 p-10 -69.49 152.46 44.83 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.639 ' CA ' ' HD3' ' A' ' 89' ' ' ARG . 80.4 p 54.72 95.97 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.102 0 O-C-N 123.405 0.44 . . . . 0.0 111.484 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' A' ' 63' ' ' SER . 0.0 OUTLIER -140.08 117.13 11.13 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.609 -0.682 . . . . 0.0 111.704 174.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.731 ' SD ' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -172.38 153.68 3.02 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -159.65 164.79 33.77 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 113.938 -1.483 . . . . 0.0 107.595 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.859 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -133.09 130.32 39.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.192 0.52 . . . . 0.0 111.265 177.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.652 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.2 pp -115.96 120.49 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.069 HG21 HG23 ' A' ' 52' ' ' ILE . 2.5 pp -137.1 176.85 2.48 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.744 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 50.0 Cg_exo -54.79 137.03 73.98 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 124.004 3.136 . . . . 0.0 114.426 -175.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.14 -46.56 3.0 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.887 175.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 13.6 pt-20 -139.46 106.36 5.41 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.595 0.712 . . . . 0.0 110.884 -177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -99.84 97.18 8.12 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.939 177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.404 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 0.4 OUTLIER -177.62 86.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.49 -178.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CG ' HD11 ' A' ' 52' ' ' ILE . 87.6 m-85 -140.42 96.45 3.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.172 0.511 . . . . 0.0 109.635 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -101.75 121.56 42.29 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.526 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.9 ptt? -151.08 137.57 18.66 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.642 -0.823 . . . . 0.0 111.161 -172.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.634 ' HA ' ' CZ ' ' A' ' 89' ' ' ARG . 35.5 ttpt -102.41 177.98 4.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -124.06 169.72 11.39 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.274 -175.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.802 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.66 -38.02 12.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 O-C-N 123.793 0.683 . . . . 0.0 110.983 173.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -157.66 -170.07 3.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.584 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 66' ' ' ASN . . . -83.36 -48.91 9.88 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.995 -172.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' A' ' 90' ' ' GLN . . . -67.59 -17.87 64.79 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.554 0.692 . . . . 0.0 109.487 176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.802 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.35 -54.4 29.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.475 -1.239 . . . . 0.0 107.739 171.273 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.731 ' HG3' ' SD ' ' A' ' 69' ' ' MET . 3.4 ttt180 -58.49 -34.51 71.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.765 176.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.49 ' HA ' HD22 ' A' ' 93' ' ' LEU . 47.7 tp60 -62.91 -56.94 12.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 123.437 0.695 . . . . 0.0 111.044 175.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.773 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 65.3 mtt180 -34.71 -47.06 0.32 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.685 1.194 . . . . 0.0 113.149 174.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.524 ' HB2' ' CE ' ' A' ' 69' ' ' MET . 97.0 m95 -66.56 -53.63 32.51 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.35 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.607 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -49.97 -40.86 45.42 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.612 0.72 . . . . 0.0 109.96 175.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.635 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 52.5 t -55.85 -64.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 114.155 -1.384 . . . . 0.0 112.088 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 -50.49 71.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.37 -176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.463 ' CD2' ' HG2' ' A' ' 54' ' ' MET . 70.2 mt -52.65 -62.78 1.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.117 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.689 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -75.31 -1.81 65.59 Favored Glycine 0 C--O 1.222 -0.642 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.799 -175.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.9 t -90.33 -32.65 16.4 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.564 0.682 . . . . 0.0 109.67 168.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 5' ' ' SER . 31.8 t -83.56 -28.09 28.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.032 -178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 17.8 tttt -100.72 1.31 40.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.384 0.611 . . . . 0.0 110.629 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -56.77 -21.16 26.46 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -168.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.443 ' HB3' ' C ' ' A' ' 3' ' ' LEU . 45.2 t -90.89 -13.74 33.03 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.932 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' A' ' 107' ' ' ARG . 1.1 mm? -90.26 100.93 13.67 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.977 0.418 . . . . 0.0 110.015 177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 42.0 p -89.24 -24.02 22.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.134 0.493 . . . . 0.0 110.267 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -111.1 -72.15 0.73 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.878 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 56' ' ' VAL . 85.4 m -160.03 131.79 6.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.116 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.624 ' H ' ' HA ' ' A' ' 56' ' ' VAL . 14.7 tpt180 -69.13 99.03 1.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.25 1.121 0 CA-C-O 119.459 -0.305 . . . . 0.0 110.664 -178.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 111.871 -0.492 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.35 78.24 2.35 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.873 2.382 . . . . 0.0 112.277 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 pp -136.8 148.06 46.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.164 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.57 166.77 17.18 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.364 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.9 p -60.25 139.3 91.67 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 122.387 0.275 . . . . 0.0 111.06 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.56 93.73 0.77 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.613 2.209 . . . . 0.0 112.117 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 9.7 tp10 -77.24 168.56 19.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.656 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 30.4 t80 -150.87 98.54 2.61 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.857 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 4.0 tpt -123.91 129.68 51.37 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.885 0.374 . . . . 0.0 111.355 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.721 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.0 pt-20 -134.84 143.73 47.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.365 0.602 . . . . 0.0 112.56 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.679 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 160.41 170.18 24.66 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.497 173.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.7 m -73.49 141.18 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-O 121.353 0.597 . . . . 0.0 112.276 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.553 HD11 HH21 ' A' ' 89' ' ' ARG . 0.3 OUTLIER -121.96 118.57 29.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 177.08 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.16 116.53 21.11 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.263 0.625 . . . . 0.0 112.103 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HG2' ' C ' ' A' ' 80' ' ' TYR . 25.5 tptt -153.98 168.48 26.28 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 173.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 35.9 t-105 -52.71 140.77 22.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 113.379 -1.737 . . . . 0.0 110.198 169.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.516 HG21 ' HB2' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -128.96 61.43 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -172.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 61.02 60.3 1.85 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.349 170.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.47 ' HA ' ' CZ2' ' A' ' 16' ' ' TRP . 80.7 t80 72.1 -63.29 0.43 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 168.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.1 mt -46.85 -56.72 5.82 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 123.334 0.654 . . . . 0.0 111.276 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.5 p -110.75 128.0 55.56 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.298 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' TRP . . . -65.74 -40.01 95.53 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.078 -173.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.647 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 39.5 p-90 -155.26 136.97 14.34 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.516 ' HB2' HG21 ' A' ' 17' ' ' THR . 84.4 mm-40 -145.99 119.82 5.31 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.647 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 19.9 Cg_endo -63.76 108.14 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 121.059 1.173 . . . . 0.0 110.72 167.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -112.13 149.39 32.24 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.679 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -80.4 130.84 35.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.468 0.652 . . . . 0.0 111.444 -172.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.599 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -124.86 145.17 49.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.49 -179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.721 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.5 p -156.76 132.68 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 122.329 1.062 . . . . 0.0 112.798 168.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.1 tm? -94.36 118.29 31.4 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.725 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.18 130.22 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.086 0.469 . . . . 0.0 109.914 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 57.52 22.15 7.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.841 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.664 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 97.21 -22.82 38.68 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.273 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.525 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -80.54 120.09 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.625 0 CA-C-O 121.465 0.65 . . . . 0.0 111.157 177.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.604 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.67 106.84 18.82 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 8.3 t -105.16 162.38 13.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.013 0.435 . . . . 0.0 111.973 -167.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.694 ' HH ' ' HD1' ' A' ' 79' ' ' PHE . 39.3 m-85 -106.81 137.59 44.56 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.593 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.524 ' HE2' HG13 ' A' ' 29' ' ' VAL . 22.0 m-85 -149.28 164.47 34.76 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -98.0 -39.98 8.68 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.431 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 m -130.5 166.35 20.74 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.8 -5.82 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.848 0.356 . . . . 0.0 111.649 -173.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -92.24 -18.29 23.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.274 0.559 . . . . 0.0 110.109 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.7 -14.8 59.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.943 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.575 HG22 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -44.39 -22.12 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -173.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 2.7 p -83.0 -57.69 3.18 Favored 'General case' 0 C--N 1.315 -0.926 0 O-C-N 121.413 -0.805 . . . . 0.0 112.273 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 45' ' ' CYS . 39.8 mmtm -133.58 27.78 4.01 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.59 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.85 132.77 11.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.762 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.9 m 74.04 -34.0 0.27 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.2 mptt 68.54 6.43 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 123.68 0.792 . . . . 0.0 112.727 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 137.54 13.43 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.882 -178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 34' ' ' ILE . 12.0 p -146.83 142.67 27.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -173.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.124 HG23 HG21 ' A' ' 73' ' ' ILE . 9.8 mt -89.24 136.22 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 C-N-CA 124.465 1.106 . . . . 0.0 111.197 172.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.525 ' HE3' HD11 ' A' ' 34' ' ' ILE . 31.4 mtpt -106.73 89.78 3.12 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-O 120.993 0.425 . . . . 0.0 110.669 173.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.664 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.17 -1.16 31.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.621 -177.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.31 -48.47 8.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.04 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.448 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.7 m -80.7 -15.95 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.177 0.989 . . . . 0.0 109.501 -175.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.586 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 54.1 m -131.64 -155.39 0.69 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.082 -1.417 . . . . 0.0 107.956 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.564 ' O ' HG13 ' A' ' 72' ' ' ILE . 7.8 tp10 -123.11 146.4 47.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 119.463 1.029 . . . . 0.0 113.194 -165.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.565 HD13 HD13 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -88.22 121.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 173.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 5.6 mttt -96.41 135.61 38.03 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.106 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.532 HG12 HD11 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -138.31 158.27 31.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 175.24 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -138.2 94.78 2.91 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.108 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.0 m -78.62 78.06 5.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.197 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.62 33.93 0.27 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.756 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 16.9 t70 -170.61 -29.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.828 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 18.9 m120 83.29 -11.95 0.89 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.662 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p -135.72 44.2 2.53 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.107 0.479 . . . . 0.0 111.54 175.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 89' ' ' ARG . 12.5 mmm180 -123.12 124.4 43.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.052 0.453 . . . . 0.0 111.357 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.601 ' HE3' ' NH2' ' A' ' 89' ' ' ARG . 5.1 ttm -155.76 160.88 40.66 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.538 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 4.9 mt-10 -152.4 168.03 26.78 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.907 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -129.72 140.1 51.18 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.828 0.347 . . . . 0.0 110.269 171.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 58' ' ' GLU . 1.7 pp -120.87 117.05 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.124 HG21 HG23 ' A' ' 52' ' ' ILE . 1.7 pp -136.36 168.87 15.19 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.073 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.774 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 87.5 Cg_exo -29.79 117.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.362 1.264 0 C-N-CA 124.94 3.76 . . . . 0.0 116.185 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.4 -21.38 6.2 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 114.273 168.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 78' ' ' HIS . 14.9 pt-20 -151.76 115.33 4.84 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 112.322 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 3.0 pt20 -103.13 97.26 7.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.482 0.658 . . . . 0.0 110.103 173.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.46 ' CD2' ' HB2' ' A' ' 76' ' ' GLU . 1.2 p80 -175.47 87.15 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.674 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.694 ' HD1' ' HH ' ' A' ' 37' ' ' TYR . 96.6 m-85 -138.2 97.02 3.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.642 ' C ' ' HG2' ' A' ' 15' ' ' LYS . 69.0 m-85 -87.99 140.61 29.32 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.311 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.597 ' HA ' ' HB2' ' A' ' 15' ' ' LYS . 8.3 ptt? -170.53 142.31 2.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 171.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HA ' HH12 ' A' ' 89' ' ' ARG . 37.5 ttmt -104.64 170.17 8.04 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.461 ' H ' ' HG2' ' A' ' 82' ' ' LYS . . . -119.55 165.49 14.36 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 118.514 0.597 . . . . 0.0 110.994 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.81 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.81 -42.2 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 123.57 0.544 . . . . 0.0 111.082 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.456 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 6.2 m120 -148.82 -172.27 4.07 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.631 -176.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.86 -40.51 15.88 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.656 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.0 -18.8 63.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.608 0.718 . . . . 0.0 109.14 172.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.81 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -68.61 -52.15 34.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 171.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.61 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -48.07 -47.59 33.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.876 170.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.4 tp60 -55.78 -55.51 31.56 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.671 178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.857 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 8.1 mtp180 -35.51 -44.84 0.32 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 124.599 1.187 . . . . 0.0 113.614 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.599 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 97.2 m95 -76.1 -51.03 13.08 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -53.16 -35.87 60.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 121.641 0.734 . . . . 0.0 109.889 175.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' A' ' 91' ' ' ARG . 19.6 t -55.86 -65.3 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.343 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.857 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -63.11 -55.77 22.48 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.002 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.565 HD13 HD13 ' A' ' 59' ' ' ILE . 83.3 mt -50.44 -60.21 3.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.525 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.738 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -87.39 -1.67 83.51 Favored Glycine 0 C--O 1.221 -0.71 0 CA-C-O 119.23 -0.761 . . . . 0.0 114.331 -173.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -90.04 -37.56 14.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 118.427 1.113 . . . . 0.0 109.517 169.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.7 t -72.81 -41.76 64.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.966 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 21.1 tttt -88.22 -1.48 58.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.25 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -56.42 -35.44 67.82 Favored 'General case' 0 C--N 1.317 -0.816 0 O-C-N 121.882 -0.511 . . . . 0.0 112.227 -172.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 35.5 t -86.09 -17.1 36.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.099 0.476 . . . . 0.0 110.705 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.501 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 7.7 tp -78.72 -27.76 44.94 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.3 p 60.87 -81.83 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.829 1.252 . . . . 0.0 112.836 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -121.41 -66.42 1.05 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.712 0.291 . . . . 0.0 110.983 -175.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.2 p -95.52 150.79 19.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.812 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -81.35 165.95 20.9 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.132 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.249 1.048 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 175.511 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.452 ' O ' ' HB ' ' A' ' 108' ' ' THR . 71.5 Cg_endo -76.25 65.09 7.16 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 123.056 2.504 . . . . 0.0 112.588 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.0 tp -177.38 152.27 0.83 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.524 ' HA3' ' SG ' ' A' ' 102' ' ' CYS . . . -149.65 -101.53 0.24 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.29 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 99' ' ' SER . 14.7 m -71.11 114.69 29.45 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.556 0.217 . . . . 0.0 111.194 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 4.9 Cg_exo -79.1 83.69 2.21 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.878 2.386 . . . . 0.0 110.74 175.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 95' ' ' ALA . 7.6 tp10 -76.9 161.25 28.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.05 -174.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 81.2 t80 -150.57 99.0 2.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.037 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.94 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 3.7 tpt -127.48 120.5 28.47 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.291 0.567 . . . . 0.0 110.795 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -126.86 155.73 42.5 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.851 -173.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.737 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 143.87 167.31 11.76 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.725 175.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 27' ' ' TRP . 1.5 m -64.46 132.99 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.53 0.681 . . . . 0.0 111.208 -177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 83' ' ' ALA . 8.1 tp -126.32 116.94 22.0 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 8.4 m-85 -66.25 161.07 23.01 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.6 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 67.6 mmtt -133.43 159.65 39.7 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.446 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 75.9 t-105 -117.58 102.13 8.92 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.0 p -74.4 -61.95 1.69 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.998 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -163.47 -68.17 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -152.76 -65.27 0.16 Allowed 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.694 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.3 mt -51.12 -67.64 0.23 Allowed 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.647 0.737 . . . . 0.0 111.271 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.6 p -97.87 41.17 1.13 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.504 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 16' ' ' TRP . . . -44.52 -64.23 2.15 Favored Glycine 0 CA--C 1.5 -0.861 0 CA-C-N 114.657 -1.156 . . . . 0.0 113.266 -174.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.623 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 36.5 p-90 -88.65 128.53 35.6 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -144.57 105.74 4.65 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.491 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.623 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 36.4 Cg_endo -70.46 109.6 2.49 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 120.919 1.079 . . . . 0.0 112.071 174.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -113.75 135.75 53.6 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.737 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 49.5 t-105 -71.07 132.92 45.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.419 -175.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -129.05 145.08 51.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.389 -177.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -151.6 131.16 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 122.276 1.036 . . . . 0.0 112.654 170.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.7 tm? -93.69 113.09 25.09 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.399 -1.728 . . . . 0.0 109.784 -176.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.19 100.18 7.17 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.51 177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 58.4 29.25 17.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.852 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.684 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 104.1 -23.29 32.5 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.131 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.554 HG23 ' HB2' ' A' ' 51' ' ' SER . 0.9 OUTLIER -82.3 100.21 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-O 122.138 0.971 . . . . 0.0 109.662 175.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -93.99 102.29 14.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.307 -1.315 . . . . 0.0 108.883 -177.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.4 t -105.33 155.4 19.13 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.443 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.577 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.7 p90 -114.04 141.24 47.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.132 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.59 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 38.7 m-85 -137.03 155.72 49.33 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.44 -4.26 59.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.766 0.317 . . . . 0.0 111.214 -174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.6 m -159.9 161.27 34.3 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.712 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -75.47 -17.44 60.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.208 0.527 . . . . 0.0 110.643 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.16 -16.95 28.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.322 0.582 . . . . 0.0 109.984 174.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -79.0 -16.03 57.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.548 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.59 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 65.3 t -47.31 -43.41 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 t -51.85 -43.56 63.26 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.89 55.56 0.31 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.263 0.554 . . . . 0.0 111.83 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -121.5 0.73 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.815 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 m -64.46 -30.65 71.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.205 0.526 . . . . 0.0 110.865 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HA ' ' HD2' ' A' ' 49' ' ' LYS . 29.6 mmmt 71.26 -25.07 0.17 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.999 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -54.93 134.62 47.57 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.554 ' HB2' HG23 ' A' ' 34' ' ' ILE . 32.5 p -140.87 150.62 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.948 0.88 . . . . 0.0 113.114 -171.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.069 HG23 HG21 ' A' ' 73' ' ' ILE . 12.7 mt -88.67 131.52 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.662 171.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' HE3' HD11 ' A' ' 34' ' ' ILE . 26.1 mtpt -101.23 89.56 3.83 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-O 121.045 0.45 . . . . 0.0 110.439 172.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.84 ' HE3' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -78.46 3.8 14.92 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.354 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.04 -43.4 13.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.035 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 106' ' ' THR . 2.0 m -87.1 -18.35 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.724 0.773 . . . . 0.0 110.25 -173.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 55.3 m -136.0 -173.36 3.36 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.921 -175.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.563 ' O ' HG13 ' A' ' 72' ' ' ILE . 9.9 tp10 -105.99 144.39 32.78 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -161.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.618 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -94.51 128.23 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 175.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 15.9 mmmt -109.87 144.29 38.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -174.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.689 ' CG1' ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -141.61 142.3 28.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.6 ' CE1' ' HA ' ' A' ' 64' ' ' ALA . 0.0 OUTLIER 67.52 -43.04 0.45 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 165.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.5 t 63.05 -80.85 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -170.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HA ' ' CE1' ' A' ' 62' ' ' HIS . . . -153.45 16.82 0.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.08 0.467 . . . . 0.0 110.784 169.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.65 -179.72 3.78 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.789 177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.659 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 94.0 m-20 -84.0 -80.98 0.18 Allowed 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 16.2 p -73.86 73.29 1.6 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.447 0.641 . . . . 0.0 111.113 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -148.03 143.74 27.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.743 175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.523 ' HG3' ' HG3' ' A' ' 81' ' ' MET . 4.5 ptm -170.29 154.99 5.07 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -148.57 166.9 26.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.025 0.44 . . . . 0.0 110.154 -176.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.945 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.94 124.53 23.67 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.276 0.56 . . . . 0.0 110.772 171.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.619 ' O ' ' HB3' ' A' ' 57' ' ' CYS . 2.0 pp -105.31 114.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 173.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.069 HG21 HG23 ' A' ' 52' ' ' ILE . 1.7 pp -136.38 163.35 50.61 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.067 -174.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 9.5 Cg_exo -14.6 -115.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.303 1 C-N-CA 126.857 5.038 . . . . 0.0 118.407 -169.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.33 3.18 59.55 Favored Glycine 0 CA--C 1.507 -0.423 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.652 -171.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.489 ' HG2' HD11 ' A' ' 73' ' ' ILE . 1.6 pm0 -144.2 63.74 1.32 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.219 0.533 . . . . 0.0 111.395 -177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.457 ' HA ' ' H ' ' A' ' 73' ' ' ILE . 15.8 pt20 -78.02 96.55 5.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.396 0.617 . . . . 0.0 110.213 178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 178.67 88.71 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.194 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 71.0 m-85 -137.36 96.23 3.23 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -98.46 132.48 43.86 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.443 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.523 ' HG3' ' HG3' ' A' ' 69' ' ' MET . 17.1 ptt? -157.58 165.59 35.15 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.309 0.576 . . . . 0.0 111.059 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 67' ' ' THR . 41.1 ttmt -131.2 157.91 41.95 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -112.35 162.02 16.01 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.89 -177.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.796 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.0 -41.27 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.259 175.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.435 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 7.3 m-80 -147.02 -176.16 5.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.887 177.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -83.4 -36.82 23.99 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.622 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.589 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.23 -19.15 61.76 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.613 0.72 . . . . 0.0 109.173 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.796 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -67.77 -51.84 44.26 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.659 ' HD3' ' O ' ' A' ' 66' ' ' ASN . 23.6 ttp180 -50.3 -45.72 54.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.914 171.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 8.0 tp60 -54.91 -59.19 5.07 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.563 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.94 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 14.6 mtt180 -36.33 -44.61 0.43 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 124.64 1.176 . . . . 0.0 113.466 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.482 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 95.0 m95 -70.9 -55.43 8.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.689 ' HG ' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -53.03 -37.38 61.49 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.71 0.767 . . . . 0.0 110.15 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 98' ' ' SER . 19.0 t -56.97 -57.99 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 114.141 -1.39 . . . . 0.0 111.294 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -69.28 -43.55 73.65 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.938 -175.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.482 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 66.7 mt -54.06 -60.73 2.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.785 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.771 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -77.17 -1.18 73.45 Favored Glycine 0 C--O 1.203 -1.838 0 C-N-CA 119.259 -1.448 . . . . 0.0 112.106 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 39.4 t -75.1 -41.75 58.03 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.435 1.117 . . . . 0.0 108.615 171.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' SER . 8.6 t -79.64 -37.79 35.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.603 177.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.84 ' HB2' ' HE3' ' A' ' 54' ' ' MET . 34.5 tttt -84.38 -7.93 59.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.832 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -53.29 -26.26 17.8 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.651 0.739 . . . . 0.0 110.769 -176.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.524 ' SG ' ' HA3' ' A' ' 4' ' ' GLY . 56.1 m -101.94 5.33 40.76 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.283 -174.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.713 HD23 ' HA ' ' A' ' 100' ' ' LYS . 1.4 mm? -83.77 -79.47 0.2 Allowed 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.1 174.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.9 p 48.37 39.64 12.94 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.601 0.563 . . . . 0.0 111.643 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -166.16 -81.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.185 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 8.2 p -135.26 -90.57 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.763 -0.199 . . . . 0.0 111.413 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.509 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -174.86 178.93 1.74 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 178.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 2' ' ' PRO . 2.9 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.06 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -62.48 115.45 2.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.453 2.102 . . . . 0.0 112.065 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.9 mt 61.34 30.78 19.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.389 178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.49 145.97 5.33 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.368 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -111.92 131.89 22.24 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.91 74.11 3.5 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.705 2.27 . . . . 0.0 112.997 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 43.2 mm-40 -81.96 162.66 22.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.975 176.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 73.2 t80 -154.02 99.45 2.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.813 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 10.1 ttt -132.22 136.15 46.8 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.089 -0.644 . . . . 0.0 111.636 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.751 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 4.8 pt-20 -136.31 144.38 44.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.362 0.601 . . . . 0.0 112.294 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.677 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.5 168.16 22.99 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.399 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 12' ' ' VAL . 2.0 m -67.06 140.83 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.646 0.736 . . . . 0.0 112.299 -175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.9 tp -125.12 118.93 27.2 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.6 m-30 -67.37 87.76 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.31 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 43.2 tttm -99.49 143.97 29.12 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -70.17 126.19 28.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.037 171.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 p -100.16 -57.99 2.01 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.15 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -165.73 158.19 15.04 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -60.05 -15.65 24.67 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 20' ' ' LEU . 40.8 mt -73.14 -71.04 0.33 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.536 0.684 . . . . 0.0 111.306 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.2 p -83.2 -11.53 57.76 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.204 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.67 -107.98 2.36 Favored Glycine 0 CA--C 1.505 -0.571 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.561 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.827 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 29.5 p-90 -108.41 139.89 42.5 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -143.75 125.89 8.46 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.827 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 6.3 Cg_endo -53.52 109.04 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.71 1.607 . . . . 0.0 112.012 175.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' NH1' ' HA ' ' A' ' 39' ' ' ASP . 29.4 tpt180 -102.67 129.2 49.2 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.677 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 54.4 t-105 -72.02 129.69 39.15 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.683 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.6 m-85 -125.28 140.79 52.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.048 -177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.751 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.4 p -149.52 125.87 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-O 122.292 1.044 . . . . 0.0 112.27 171.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.9 tm? -92.81 113.3 25.54 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-N 113.236 -1.802 . . . . 0.0 108.96 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -137.26 131.73 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.068 0.461 . . . . 0.0 109.925 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 62.94 16.65 9.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.42 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.0 -28.43 14.61 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.891 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.7 OUTLIER -77.4 122.21 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 CA-C-O 121.446 0.641 . . . . 0.0 110.812 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.544 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.84 104.76 16.66 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 15.0 m -103.79 138.79 39.9 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.952 0.406 . . . . 0.0 110.388 -173.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.418 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 9.5 p90 -110.79 137.5 48.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.5 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.582 ' CD2' ' HA ' ' A' ' 44' ' ' VAL . 53.3 m-85 -135.8 169.93 16.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.409 -176.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 20.5 t70 -63.37 -61.66 2.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.044 0.45 . . . . 0.0 110.347 178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.508 ' HB2' ' OD1' ' A' ' 42' ' ' ASP . 18.3 m -139.9 -175.55 4.26 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.606 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.73 -17.28 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.161 0.505 . . . . 0.0 111.398 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.508 ' OD1' ' HB2' ' A' ' 40' ' ' SER . 6.0 p-10 -86.37 -17.46 34.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.287 0.565 . . . . 0.0 110.571 178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.537 ' OD1' ' HA3' ' A' ' 47' ' ' GLY . 26.0 t70 -85.23 -20.2 30.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.338 -176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.582 ' HA ' ' CD2' ' A' ' 38' ' ' TYR . 50.5 t -44.47 -44.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 124.329 1.052 . . . . 0.0 113.709 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' A' ' 46' ' ' LYS . 5.1 p -58.42 -57.76 11.49 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.057 -0.52 . . . . 0.0 112.234 -172.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -152.18 29.87 0.56 Allowed 'General case' 0 N--CA 1.469 0.481 0 O-C-N 121.954 -0.466 . . . . 0.0 111.788 -173.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA3' ' OD1' ' A' ' 43' ' ' ASP . . . -86.16 -96.5 0.8 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.811 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.3 m -62.44 -38.19 88.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.898 0.38 . . . . 0.0 111.984 -173.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt 70.72 -30.43 0.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.36 129.03 39.81 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.322 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.471 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.1 p -136.51 140.92 43.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.862 0.839 . . . . 0.0 113.264 -172.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.085 HG23 HG21 ' A' ' 73' ' ' ILE . 12.6 mt -89.86 135.78 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 114.297 -1.32 . . . . 0.0 111.766 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.574 ' HE3' HD11 ' A' ' 34' ' ' ILE . 36.5 mtpt -109.27 93.06 4.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.834 171.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.862 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -76.22 -3.12 34.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.882 -176.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.01 -49.74 9.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.984 0.421 . . . . 0.0 112.088 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.494 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.9 m -78.35 -17.0 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 122.271 1.034 . . . . 0.0 109.327 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.696 ' HB3' HD12 ' A' ' 72' ' ' ILE . 56.9 m -131.87 -149.73 0.39 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.305 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.2 tp10 -132.09 145.27 51.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 120.093 1.315 . . . . 0.0 113.793 -168.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.638 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -89.88 112.4 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 168.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.601 ' HG3' HG23 ' A' ' 72' ' ' ILE . 18.0 mmmt -93.76 147.33 23.15 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.682 -176.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.55 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.3 m -135.85 152.23 30.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.898 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 68' ' ' ARG . 53.8 t-80 -120.56 90.38 3.31 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.1 m -90.75 70.71 6.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.488 0.661 . . . . 0.0 111.413 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HB3' ' CE1' ' A' ' 62' ' ' HIS . . . -147.38 28.45 0.98 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.592 175.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 66' ' ' ASN . 4.4 p-10 -172.68 -13.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.496 -174.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 18.0 m120 80.37 -10.58 1.25 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.731 0.812 . . . . 0.0 113.036 173.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -130.58 13.26 5.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -172.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' HB3' ' HB3' ' A' ' 62' ' ' HIS . 4.9 tpp180 -121.86 138.36 54.42 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.761 -174.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.495 ' HA ' ' HA ' ' A' ' 61' ' ' VAL . 4.2 ptp -153.19 177.0 11.31 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -150.31 161.43 42.47 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -175.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.92 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -130.39 124.34 31.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.257 0.551 . . . . 0.0 111.021 173.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.696 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.2 pp -109.73 118.27 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.085 HG21 HG23 ' A' ' 52' ' ' ILE . 2.1 pp -138.39 167.06 21.23 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.433 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 39.0 Cg_endo -60.8 144.72 99.6 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 123.132 2.555 . . . . 0.0 113.987 -172.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.81 -49.16 4.1 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.428 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 12.9 pt-20 -150.42 89.65 1.59 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.284 0.564 . . . . 0.0 111.3 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.44 97.0 10.22 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.336 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -170.1 87.25 0.13 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.748 0.785 . . . . 0.0 110.312 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.6 m-85 -139.02 98.08 3.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.591 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.469 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 46.5 m-85 -103.98 121.11 42.47 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.087 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.496 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.9 ptt? -149.37 142.4 24.88 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.695 0.76 . . . . 0.0 111.679 -174.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -105.03 151.65 23.7 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -99.79 155.73 17.49 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.339 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.753 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -49.48 -40.22 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.721 177.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.434 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 10.7 t-20 -146.43 -174.03 4.35 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.91 -44.64 14.04 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.895 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.561 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.02 -15.66 62.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.873 0.844 . . . . 0.0 109.361 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.753 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.06 -52.27 56.7 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 169.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.421 ' O ' HD22 ' A' ' 93' ' ' LEU . 10.0 ttp180 -54.42 -46.03 73.11 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.77 173.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.73 ' NE2' HG21 ' A' ' 94' ' ' VAL . 15.3 tm0? -49.12 -62.43 1.54 Allowed 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 123.557 0.743 . . . . 0.0 110.628 175.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.813 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 71.8 mtt180 -35.06 -48.13 0.4 Allowed 'General case' 0 N--CA 1.434 -1.27 0 O-C-N 124.75 1.281 . . . . 0.0 113.137 175.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.501 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 95.6 m95 -71.46 -52.33 19.02 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.55 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -51.48 -38.67 55.04 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.793 0.806 . . . . 0.0 109.769 176.219 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.73 HG21 ' NE2' ' A' ' 90' ' ' GLN . 39.7 t -61.86 -63.04 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.783 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.1 86.57 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.484 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 59' ' ' ILE . 69.2 mt -58.27 -58.89 6.47 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.247 0.546 . . . . 0.0 111.035 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.708 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -81.77 -0.98 90.05 Favored Glycine 0 C--O 1.22 -0.753 0 CA-C-N 115.694 -0.684 . . . . 0.0 114.02 -175.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.3 t -87.75 -31.41 19.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 166.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.552 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 30.3 t -81.73 -34.27 30.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.102 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.862 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 28.5 tttt -91.33 0.8 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.199 0.523 . . . . 0.0 110.564 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -59.74 -12.8 7.85 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -170.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.4 t -98.45 -12.67 21.11 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.27 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -102.37 138.36 39.41 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.868 0.366 . . . . 0.0 110.354 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 68.0 p -112.08 -36.76 5.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.113 0.482 . . . . 0.0 110.62 176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -133.37 -61.9 0.8 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.3 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.8 p -101.88 158.45 16.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.667 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 20.0 ptt180 -81.07 107.47 13.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.543 176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.143 -0.932 . . . . 0.0 112.052 177.92 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.811 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.63 5.94 5.97 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.983 2.455 . . . . 0.0 113.131 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp -102.38 -1.57 30.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.247 0.546 . . . . 0.0 109.546 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.3 48.88 0.41 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.905 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.504 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 10.8 m -80.08 170.77 14.43 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-O 119.089 -0.481 . . . . 0.0 109.706 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 5' ' ' SER . 78.4 Cg_exo -43.88 134.72 7.86 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.856 2.371 . . . . 0.0 112.694 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 7.6 pt-20 -144.39 70.66 1.29 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.221 0.534 . . . . 0.0 112.039 -170.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 32.2 t80 -151.51 97.58 2.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.814 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 5.8 tpt -130.12 128.84 42.64 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.749 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.57 158.16 40.05 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.347 0.594 . . . . 0.0 112.406 -173.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.779 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 139.96 162.42 9.11 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.983 174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.7 136.32 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-O 121.265 0.555 . . . . 0.0 111.433 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 83' ' ' ALA . 3.9 tp -123.59 118.5 27.46 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.635 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 20.1 m-85 -74.63 93.69 2.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 123.012 0.525 . . . . 0.0 110.881 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -94.08 134.38 36.57 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 118.926 -1.11 . . . . 0.0 112.087 -171.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -80.02 110.45 15.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 p -68.91 -56.19 8.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.622 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -175.71 -60.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.628 0.251 . . . . 0.0 111.24 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -168.62 -49.34 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.33 -175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.6 mt -55.52 -70.78 0.1 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.358 0.599 . . . . 0.0 112.354 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.7 p -84.16 -14.12 51.04 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.783 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.12 -85.08 0.59 Allowed Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.027 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.683 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 37.6 p-90 -128.56 140.19 51.91 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -172.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -147.09 108.33 3.95 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.55 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.683 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 62.4 Cg_endo -75.53 109.67 2.95 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.314 1.343 . . . . 0.0 112.098 173.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -110.86 146.84 35.78 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.779 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 56.3 t-105 -67.35 118.72 11.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.071 0.462 . . . . 0.0 109.783 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.65 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -108.5 144.48 36.08 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.984 -176.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.606 HG13 ' HE2' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -154.54 129.72 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 122.514 1.15 . . . . 0.0 112.667 167.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -93.64 124.58 37.73 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 112.76 -2.018 . . . . 0.0 109.647 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.9 141.58 15.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.982 0.42 . . . . 0.0 109.873 173.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.47 23.04 13.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.273 -173.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.85 -13.24 37.97 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.23 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.527 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -90.71 141.38 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 C-N-CA 123.445 0.698 . . . . 0.0 111.216 175.149 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.612 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -118.15 110.01 17.08 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.463 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.462 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 15.0 m -105.39 152.6 22.76 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.571 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.613 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 6.0 p90 -112.02 138.05 49.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.272 0.558 . . . . 0.0 111.55 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HE2' HG13 ' A' ' 29' ' ' VAL . 11.1 m-85 -134.46 178.4 7.02 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.011 -175.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.77 -63.89 1.11 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.851 0.358 . . . . 0.0 110.441 174.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 27' ' ' TRP . 5.7 t -146.76 -166.84 2.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.147 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -70.46 -11.74 61.12 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.972 0.415 . . . . 0.0 111.415 -174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -90.39 -17.16 27.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.462 0.648 . . . . 0.0 110.717 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.621 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 24.4 t70 -90.53 -14.51 32.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.854 -175.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.667 HG22 ' NE1' ' A' ' 27' ' ' TRP . 59.7 t -43.49 -32.12 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -173.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 11.6 t -70.31 -38.68 74.98 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.725 -175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -123.2 -72.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.73 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.621 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 67.6 -151.23 52.06 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.402 -176.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 50' ' ' GLY . 50.1 m -74.07 -11.04 60.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.312 0.577 . . . . 0.0 109.807 176.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 30.2 tptt 71.2 -9.92 0.83 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.466 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 48' ' ' SER . . . -66.04 141.56 41.72 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 174.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.457 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.7 p -146.56 142.32 27.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.243 0.544 . . . . 0.0 112.056 -173.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.073 HG23 HG21 ' A' ' 73' ' ' ILE . 62.6 mt -89.16 144.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.764 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.527 ' HE3' HD11 ' A' ' 34' ' ' ILE . 34.6 mtpt -113.56 90.46 3.35 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.331 173.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.707 ' HB3' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -73.09 -24.61 60.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.569 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -59.75 -36.61 76.96 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.486 HG22 ' HD3' ' A' ' 74' ' ' PRO . 2.0 m -94.97 -15.4 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.666 0.746 . . . . 0.0 111.07 -171.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 72' ' ' ILE . 81.5 m -134.01 -145.76 0.25 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.544 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.624 ' O ' HG13 ' A' ' 72' ' ' ILE . 4.8 tp10 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 119.322 0.965 . . . . 0.0 112.313 -170.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.619 ' O ' HG13 ' A' ' 59' ' ' ILE . 0.5 OUTLIER -97.66 125.67 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 170.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.705 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 34.4 mtmt -104.71 97.76 7.6 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 121.361 0.601 . . . . 0.0 110.522 -172.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -114.35 89.83 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-O 121.64 0.733 . . . . 0.0 110.814 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.468 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 21.1 t-80 -76.18 107.71 8.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.178 -173.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 t -61.41 122.58 15.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.234 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -165.85 -70.27 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.267 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -124.68 -164.77 1.3 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.091 173.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.596 ' HA ' ' NH1' ' A' ' 89' ' ' ARG . 49.9 m-80 -95.07 167.44 11.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.026 0.441 . . . . 0.0 111.78 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.4 p 52.13 44.48 29.59 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.824 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.725 ' HD2' ' O ' ' A' ' 68' ' ' ARG . 3.2 ppt_? -123.56 134.89 53.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.045 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' A' ' 81' ' ' MET . 1.7 ptm -171.49 158.06 5.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.063 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 4.8 mt-10 -150.25 167.12 27.89 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.207 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.818 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -135.51 125.72 26.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.616 171.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.1 pp -110.38 120.07 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.073 HG21 HG23 ' A' ' 52' ' ' ILE . 1.1 pp -133.72 163.39 51.45 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.61 -167.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 17.8 Cg_endo -53.77 -63.19 0.24 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.095 3.197 . . . . 0.0 115.253 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.93 -20.49 62.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.559 -174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 179.95 103.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.33 0.586 . . . . 0.0 111.162 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HA ' ' H ' ' A' ' 73' ' ' ILE . 16.9 pt20 -84.39 97.55 9.56 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.942 -0.474 . . . . 0.0 111.051 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -177.47 87.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.669 0.747 . . . . 0.0 110.211 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 82.9 m-85 -139.98 97.79 3.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.672 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -101.24 135.62 42.42 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.533 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 8.8 ptt? -156.26 151.15 26.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.933 0.873 . . . . 0.0 112.718 -177.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 40.3 ttmt -111.84 137.58 49.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 113.756 -1.565 . . . . 0.0 108.099 176.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -90.49 157.99 17.26 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.731 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.755 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.0 OUTLIER -46.51 -49.06 6.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.134 175.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.508 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 12.0 m120 -134.88 -174.49 3.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.905 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.617 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -87.7 -37.15 16.95 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.109 -0.637 . . . . 0.0 111.825 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -76.51 -14.99 59.99 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.878 0.847 . . . . 0.0 109.249 171.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.755 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.02 -53.25 48.9 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 168.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.665 ' O ' HD13 ' A' ' 93' ' ' LEU . 32.7 ttp180 -47.72 -51.24 22.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.793 170.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.698 ' NE2' HG21 ' A' ' 94' ' ' VAL . 17.1 tm0? -49.1 -64.12 0.9 Allowed 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 123.701 0.8 . . . . 0.0 111.036 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.814 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 34.2 mtt180 -35.74 -45.13 0.37 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.65 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 94.2 m95 -70.65 -55.3 9.08 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 121.263 -0.175 . . . . 0.0 111.439 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.753 ' CD1' HG11 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -51.8 -41.0 61.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.949 0.88 . . . . 0.0 110.292 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.698 HG21 ' NE2' ' A' ' 90' ' ' GLN . 25.5 t -56.85 -51.56 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.007 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.4 -51.35 10.95 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.759 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.676 HD22 ' HE2' ' A' ' 54' ' ' MET . 92.3 mt -50.84 -55.78 15.31 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.674 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -81.31 -3.22 90.69 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.334 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.634 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 42.5 t -66.47 -57.06 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.885 0.842 . . . . 0.0 109.622 176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 7' ' ' GLU . 13.9 t -79.77 -29.43 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.743 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.595 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -100.22 0.91 41.29 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -173.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -45.87 -53.81 9.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -174.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 72.1 m -106.62 19.34 20.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.595 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 9.2 tp -80.09 -141.87 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.641 -173.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 40.0 p 53.26 26.59 5.29 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.614 0.766 . . . . 0.0 111.742 -172.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -120.84 -55.24 2.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.521 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.5 p -82.74 -42.17 18.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.245 175.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.47 ' HA ' ' HE ' ' A' ' 107' ' ' ARG . 2.9 mmp_? -104.65 109.75 21.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.794 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.251 1.176 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.469 -179.715 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.9 -41.22 38.65 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.592 2.195 . . . . 0.0 112.172 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.6 tp -78.07 94.61 4.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.49 -80.21 0.47 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 113.346 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' SER . 18.5 m -82.84 118.64 72.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.751 0.31 . . . . 0.0 111.202 -175.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -87.83 104.57 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.966 2.444 . . . . 0.0 112.28 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 99' ' ' SER . 6.0 tp10 -107.55 159.31 16.53 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.149 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 75.4 t80 -150.45 99.59 2.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -172.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.787 ' CE ' ' HB3' ' A' ' 91' ' ' ARG . 2.9 tpt -122.79 133.34 54.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.308 -175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.7 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 5.4 pt-20 -135.67 149.94 49.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.544 0.688 . . . . 0.0 112.746 -173.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.738 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 151.31 162.98 11.08 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.206 174.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -66.11 132.14 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 121.361 0.601 . . . . 0.0 111.39 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 83' ' ' ALA . 3.5 tp -121.23 118.95 30.89 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.422 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 25' ' ' PRO . 85.4 m-85 -76.79 90.6 3.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.005 -175.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 0.0 OUTLIER -95.7 158.49 15.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.513 0.673 . . . . 0.0 112.686 -171.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -81.96 131.54 35.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.192 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.442 HG21 ' HG3' ' A' ' 24' ' ' GLN . 13.4 p -101.76 -175.46 2.85 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.763 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.4 91.93 0.28 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.0 t80 71.64 -57.47 0.61 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.976 0.91 . . . . 0.0 112.478 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.41 167.16 21.83 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.428 ' C ' ' H ' ' A' ' 23' ' ' TRP . 19.8 p 39.08 100.11 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 125.07 1.481 . . . . 0.0 114.12 177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.21 25.34 0.85 Allowed Glycine 0 C--N 1.329 0.186 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.293 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.61 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 17.6 p-90 -170.89 125.9 0.69 Allowed 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.442 ' HG3' HG21 ' A' ' 17' ' ' THR . 77.9 mm-40 -145.32 109.99 4.6 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 171.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 30.8 Cg_endo -68.77 107.93 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 120.807 1.005 . . . . 0.0 111.506 177.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.56 ' HA ' ' NE ' ' A' ' 26' ' ' ARG . 1.4 tpm_? -112.34 129.28 56.35 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.738 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 62.4 t-105 -67.26 119.41 12.1 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.528 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.527 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.7 OUTLIER -113.71 137.0 52.23 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.643 -177.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.7 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.9 p -150.53 130.85 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-O 122.409 1.099 . . . . 0.0 112.457 168.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.748 HD21 ' HE3' ' A' ' 54' ' ' MET . 2.7 tm? -93.37 117.98 30.74 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 112.894 -1.957 . . . . 0.0 109.756 -173.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -141.28 124.44 16.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.684 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 58.21 31.23 20.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.425 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.579 ' HA2' ' CE ' ' A' ' 54' ' ' MET . . . 91.55 -25.49 15.45 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.024 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.552 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -83.93 113.24 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 CA-C-O 121.746 0.784 . . . . 0.0 111.238 -178.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.495 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -95.25 105.88 17.86 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.57 178.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.4 t -104.31 160.43 14.9 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.082 0.468 . . . . 0.0 111.279 -169.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.555 ' OH ' HG13 ' A' ' 52' ' ' ILE . 1.6 m-85 -108.71 128.15 54.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.984 -173.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 18.4 m-85 -131.47 160.39 35.33 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.13 -62.92 1.38 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.908 0.385 . . . . 0.0 110.084 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.8 t -142.9 -173.16 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.44 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -65.42 -19.91 66.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.174 0.511 . . . . 0.0 111.438 -177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.16 -16.9 34.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.0 110.66 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.757 ' OD2' ' HA2' ' A' ' 47' ' ' GLY . 22.6 t0 -87.32 -14.24 41.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.096 -174.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.592 HG22 ' NE1' ' A' ' 27' ' ' TRP . 85.6 t -41.47 -33.11 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -176.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 15.0 t -63.83 -36.84 85.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.87 0.366 . . . . 0.0 111.055 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -118.24 -76.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.001 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.757 ' HA2' ' OD2' ' A' ' 43' ' ' ASP . . . 71.11 -176.51 37.21 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.855 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 m -66.95 122.17 17.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -78.54 51.95 1.12 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.937 0.875 . . . . 0.0 111.59 -172.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -134.92 159.75 24.06 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 172.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.486 ' OG ' HG23 ' A' ' 34' ' ' ILE . 4.5 t -159.78 158.51 31.29 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.151 0.977 . . . . 0.0 112.836 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 73' ' ' ILE . 9.8 mt -90.49 128.2 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.409 171.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HE3' HD11 ' A' ' 34' ' ' ILE . 37.9 mtpt -104.37 88.7 3.03 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.235 173.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.783 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.96 -21.8 60.81 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.793 -177.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -65.71 -28.67 69.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.284 -174.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.457 HG13 ' HB3' ' A' ' 53' ' ' LYS . 1.5 m -98.56 -14.49 7.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.706 0.765 . . . . 0.0 110.931 -172.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.635 ' HB3' HD12 ' A' ' 72' ' ' ILE . 86.1 m -136.43 -142.99 0.18 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' O ' HG13 ' A' ' 72' ' ' ILE . 8.5 tp10 -128.4 146.34 50.82 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 119.302 0.955 . . . . 0.0 112.376 -170.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -93.91 135.17 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 9.7 mmtt -114.1 146.15 40.65 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.598 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.9 m -141.43 128.42 20.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 O-C-N 122.001 -0.437 . . . . 0.0 109.939 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -80.15 99.85 7.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.9 m -82.91 48.24 1.32 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.561 -171.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.05 15.18 1.17 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.58 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -145.7 160.04 42.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.851 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 97.8 m-20 -91.74 -23.78 19.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.668 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 82' ' ' LYS . 24.7 p -138.39 46.89 2.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -176.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -135.88 122.93 21.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.082 0.468 . . . . 0.0 111.498 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.644 ' HG2' HD11 ' A' ' 93' ' ' LEU . 1.3 mpp? -141.1 172.32 12.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -151.57 166.76 30.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.184 0.516 . . . . 0.0 111.261 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.846 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -137.2 137.3 38.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.016 173.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 57' ' ' CYS . 1.9 pp -115.93 115.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.023 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -135.72 164.98 39.52 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.814 -175.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.767 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.29 132.25 45.52 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.513 2.809 . . . . 0.0 114.664 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.88 -29.81 7.63 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.539 170.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -156.97 58.41 0.53 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.987 0.423 . . . . 0.0 111.698 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -68.29 98.74 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.605 0.717 . . . . 0.0 110.719 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -178.94 88.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.143 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.1 m-85 -138.32 99.0 3.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.826 0.346 . . . . 0.0 110.838 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -101.2 127.63 47.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 13.9 ptt? -151.58 142.42 22.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.665 0.745 . . . . 0.0 111.77 -176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 67' ' ' THR . 77.8 tttt -105.12 136.89 43.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.037 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.66 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -89.41 155.82 19.08 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.978 -0.689 . . . . 0.0 111.705 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.767 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -47.56 -46.19 10.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.662 176.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.532 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 25.5 m-80 -139.16 -170.2 2.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.667 177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -88.05 -40.26 13.98 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.361 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.26 -18.73 61.79 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 171.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.767 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -62.78 -53.16 58.48 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.702 ' O ' HD22 ' A' ' 93' ' ' LEU . 36.8 ttt-85 -45.13 -53.53 7.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.826 170.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 6.2 tp60 -54.46 -58.36 7.75 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.362 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.787 ' HB3' ' CE ' ' A' ' 9' ' ' MET . 36.6 mtt180 -37.36 -41.86 0.45 Allowed 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 124.562 1.164 . . . . 0.0 113.575 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.527 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 91.8 m95 -72.89 -54.42 8.78 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.664 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -53.19 -38.2 62.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.434 0.635 . . . . 0.0 110.343 176.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 90' ' ' GLN . 25.4 t -54.4 -63.82 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.028 175.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.416 ' HA ' ' HG2' ' A' ' 7' ' ' GLU . . . -61.08 -53.79 52.77 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.021 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.521 ' HB3' HG21 ' A' ' 59' ' ' ILE . 58.7 mt -53.38 -53.81 45.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.34 -177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.764 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -89.31 -1.07 79.16 Favored Glycine 0 C--O 1.222 -0.647 0 CA-C-O 119.472 -0.627 . . . . 0.0 113.808 -175.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.2 t -89.98 -41.47 11.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 117.861 0.83 . . . . 0.0 109.818 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 7' ' ' GLU . 8.8 t -75.81 -38.2 58.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.329 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.783 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 2.7 tttt -88.47 -1.82 58.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.092 0.473 . . . . 0.0 110.908 177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.764 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -56.91 -25.29 56.88 Favored 'General case' 0 C--N 1.318 -0.777 0 O-C-N 121.973 -0.454 . . . . 0.0 111.803 -175.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 35.3 t -83.46 -13.67 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.273 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.424 ' HB2' ' HG2' ' A' ' 100' ' ' LYS . 1.4 mm? -92.85 133.22 36.29 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.181 0.515 . . . . 0.0 110.609 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.6 p -111.07 -30.05 7.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.295 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -123.73 -71.75 0.71 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.41 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.9 p -140.53 173.86 11.09 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.067 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -106.53 32.16 4.7 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 111.064 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 74.4 p . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.558 178.129 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 111.99 -0.444 . . . . 0.0 111.99 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.604 ' O ' HD11 ' A' ' 103' ' ' LEU . 30.0 Cg_exo -62.34 -43.13 24.34 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.731 2.287 . . . . 0.0 112.358 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.452 HD21 HH11 ' A' ' 107' ' ' ARG . 50.0 mt -148.03 147.66 29.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.027 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.7 -32.7 45.0 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 175.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.9 t -166.03 145.69 5.21 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.39 -62.61 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 121.83 1.687 . . . . 0.0 111.25 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 69.16 142.01 0.04 OUTLIER 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.963 0.887 . . . . 0.0 112.344 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 61.5 t80 -154.66 97.26 1.97 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.031 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.91 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 3.6 tpt -120.2 125.24 47.67 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.955 0.407 . . . . 0.0 111.163 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.702 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 8.2 pt-20 -131.87 151.78 51.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.532 0.682 . . . . 0.0 112.257 -173.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.714 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.97 159.73 8.72 Favored Glycine 0 N--CA 1.441 -0.99 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.309 174.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.7 m -60.08 131.82 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 83' ' ' ALA . 10.2 tp -122.58 118.61 28.61 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.62 ' O ' ' HB2' ' A' ' 81' ' ' MET . 10.1 m-30 -59.3 149.15 29.66 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' TRP . 45.1 mmtm -119.57 151.58 38.41 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.669 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -95.82 99.37 11.19 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 174.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.6 p -88.05 -47.4 8.54 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.374 -172.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -166.61 165.83 16.44 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -55.84 -39.43 71.4 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.201 0.524 . . . . 0.0 110.645 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.24 -66.03 0.6 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.31 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 63.5 p -78.01 -18.03 56.39 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.533 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.87 -109.25 2.11 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.864 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.844 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 33.6 p-90 -100.65 144.19 29.93 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.861 -0.67 . . . . 0.0 110.877 -170.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -143.45 111.57 5.44 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.275 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.844 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 42.8 Cg_endo -70.04 114.7 3.83 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 121.758 1.639 . . . . 0.0 112.597 178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -132.95 143.45 49.48 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.714 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 72.6 t-105 -70.43 139.41 51.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.365 0.603 . . . . 0.0 111.345 -169.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.486 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.1 OUTLIER -138.96 142.95 38.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.036 -178.2 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.702 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 1.7 p -154.55 133.46 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 122.297 1.046 . . . . 0.0 112.67 170.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 2.3 tm? -94.42 126.0 39.41 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 113.117 -1.856 . . . . 0.0 109.97 -174.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -138.27 113.38 9.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.792 0.33 . . . . 0.0 110.779 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 58.06 30.91 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.237 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 98.06 -29.81 10.58 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.53 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.438 HG13 ' HG2' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -75.95 106.83 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 121.705 0.764 . . . . 0.0 110.075 177.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -94.36 108.94 20.82 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.177 -179.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 14.8 t -103.4 155.17 18.68 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.92 -170.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -109.22 134.85 51.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.109 -172.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.457 ' CD2' ' HD1' ' A' ' 27' ' ' TRP . 18.0 m-85 -143.73 169.14 18.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.132 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -82.74 -65.53 1.0 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.75 0.31 . . . . 0.0 110.547 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -123.78 179.92 4.62 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -73.5 -7.6 52.49 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.304 0.573 . . . . 0.0 111.109 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -84.57 -20.98 30.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.774 0.797 . . . . 0.0 110.298 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.423 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 3.0 m-20 -78.84 -16.24 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.829 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.68 HG22 ' NE1' ' A' ' 27' ' ' TRP . 65.1 t -45.15 -39.1 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.2 p -61.7 -55.68 27.79 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.41 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -124.9 -76.83 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.552 -178.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.86 -143.24 48.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.016 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -69.79 -21.54 63.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.25 0.548 . . . . 0.0 110.8 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.8 tptt 62.73 13.72 6.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.34 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.78 129.51 9.18 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' SER . 12.3 p -128.98 141.4 51.27 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -171.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.045 HG23 HG21 ' A' ' 73' ' ' ILE . 13.0 mt -89.01 133.1 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.965 171.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.438 ' HG2' HG13 ' A' ' 34' ' ' ILE . 40.5 mtpt -111.69 89.47 3.07 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.823 ' SD ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -72.03 -11.42 60.75 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.156 0.503 . . . . 0.0 109.964 -176.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.14 -26.8 53.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.411 -174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.477 HG21 ' HG3' ' A' ' 74' ' ' PRO . 2.0 m -98.79 -16.13 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.748 0.785 . . . . 0.0 110.147 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.733 ' HB3' HD12 ' A' ' 72' ' ' ILE . 97.9 m -133.4 -142.71 0.21 Allowed 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -177.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.512 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.4 tp10 -131.06 146.18 52.28 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.802 1.183 . . . . 0.0 112.756 -170.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.774 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -89.13 130.28 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 171.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.568 ' HG3' HG23 ' A' ' 72' ' ' ILE . 10.1 mmmt -105.01 136.04 45.23 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.187 0.517 . . . . 0.0 110.913 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.7 m -140.29 126.94 22.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 173.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -97.74 121.88 40.17 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.545 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.8 p -84.95 73.06 10.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.669 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -142.45 -83.27 0.18 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -86.41 136.01 33.28 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.53 ' OD1' ' HB1' ' A' ' 86' ' ' ALA . 10.9 t-20 -53.7 -54.53 36.64 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.92 -171.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.477 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 14.2 p -75.21 53.49 0.64 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.184 0.516 . . . . 0.0 112.315 -177.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -125.78 120.86 31.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.52 0.676 . . . . 0.0 110.476 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.47 ' CE ' ' HB2' ' A' ' 92' ' ' TRP . 8.2 ptm -155.07 152.4 29.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.919 -172.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.401 ' HG2' ' C ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -157.25 168.08 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.739 0.304 . . . . 0.0 110.534 -175.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.824 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.29 134.13 39.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.067 0.461 . . . . 0.0 110.856 175.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.733 HD12 ' HB3' ' A' ' 57' ' ' CYS . 2.1 pp -116.82 119.21 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.045 HG21 HG23 ' A' ' 52' ' ' ILE . 2.6 pp -134.71 178.33 1.81 Allowed Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.731 -175.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.757 ' CD ' ' HB ' ' A' ' 73' ' ' ILE . 38.9 Cg_endo -76.37 143.38 24.83 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.197 1.931 . . . . 0.0 113.34 -170.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.74 -49.17 3.99 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.631 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -144.82 80.12 1.62 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.332 0.587 . . . . 0.0 111.048 -176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -84.39 96.44 9.07 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -171.8 87.55 0.09 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.728 0.775 . . . . 0.0 110.352 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.531 ' CG ' HD11 ' A' ' 52' ' ' ILE . 92.7 m-85 -129.8 97.06 4.39 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.097 174.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -107.35 118.19 36.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 10.7 ptt? -143.23 176.79 8.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.283 0.564 . . . . 0.0 111.623 -171.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 41.7 ttmt -140.79 157.83 44.85 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -105.08 160.0 15.4 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.906 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.708 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -51.33 -31.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.042 176.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.56 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 13.0 t-20 -157.62 -175.75 5.56 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -77.45 -48.73 16.43 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -172.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -71.43 -14.55 62.19 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.624 0.726 . . . . 0.0 109.678 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.708 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 27.2 tp10 -65.6 -40.85 93.1 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 170.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.537 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 2.4 tmt_? -62.37 -44.21 96.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.755 -1.112 . . . . 0.0 109.261 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.776 ' NE2' HG21 ' A' ' 94' ' ' VAL . 15.8 tm0? -53.34 -62.66 1.51 Allowed 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.103 174.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.91 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 69.0 mtt180 -33.11 -46.74 0.17 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 124.689 1.243 . . . . 0.0 113.857 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.486 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 93.3 m95 -71.92 -54.37 10.24 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.607 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -54.2 -36.76 63.8 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.92 0.867 . . . . 0.0 109.611 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.776 HG21 ' NE2' ' A' ' 90' ' ' GLN . 31.3 t -59.32 -55.8 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 CA-C-N 113.992 -1.458 . . . . 0.0 111.8 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.98 -43.64 71.07 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.472 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.458 ' HB3' HG21 ' A' ' 59' ' ' ILE . 78.0 mt -54.33 -55.67 26.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.059 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.664 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -81.23 -3.57 90.63 Favored Glycine 0 C--O 1.205 -1.718 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.241 177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 48.3 t -67.72 -41.37 83.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.272 1.036 . . . . 0.0 108.826 173.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.451 ' OG ' HD22 ' A' ' 3' ' ' LEU . 9.7 t -80.49 -38.95 28.89 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.637 176.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.823 ' HB2' ' SD ' ' A' ' 54' ' ' MET . 29.1 tttt -87.19 1.66 52.39 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -60.74 -22.88 64.47 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 121.607 -0.683 . . . . 0.0 111.441 -174.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 48.8 t -100.24 6.19 44.69 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.52 0.676 . . . . 0.0 110.286 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.604 HD11 ' O ' ' A' ' 2' ' ' PRO . 7.9 mp -110.51 111.5 22.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.415 -175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.4 p -93.32 -34.08 13.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.692 0.282 . . . . 0.0 111.547 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -127.85 -69.23 0.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.157 0.504 . . . . 0.0 111.547 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 56' ' ' VAL . 73.1 m -152.86 128.03 9.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.216 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.47 ' HB2' HD21 ' A' ' 103' ' ' LEU . 59.9 ttp180 -64.97 130.37 43.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.858 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--O 1.249 1.029 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.99 179.19 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 111.936 -0.466 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.44 -36.87 92.61 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.873 2.382 . . . . 0.0 111.937 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.58 165.59 27.17 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.461 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 99' ' ' SER . . . -99.27 103.59 2.74 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.309 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.42 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 29.3 m -73.35 -49.86 6.58 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 5' ' ' SER . 62.6 Cg_endo -71.88 0.61 6.86 Favored 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.166 1.911 . . . . 0.0 113.489 -175.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.66 122.24 20.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.009 0.433 . . . . 0.0 110.822 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 7.2 t80 -152.43 96.82 2.2 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.863 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 6.4 tpt -115.85 112.64 22.23 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.853 0.835 . . . . 0.0 110.306 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.664 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.85 137.94 52.53 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.944 -1.48 . . . . 0.0 112.957 -172.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.794 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 161.44 170.46 26.14 Favored Glycine 0 N--CA 1.436 -1.313 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.204 172.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG13 ' H ' ' A' ' 12' ' ' VAL . 1.6 m -62.59 138.31 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-O 121.472 0.653 . . . . 0.0 111.729 -176.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 81' ' ' MET . 1.7 tp -128.24 116.93 20.63 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 25' ' ' PRO . 62.4 m-85 -72.98 90.16 1.47 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.784 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 22.8 ttpp -94.06 135.5 35.35 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 122.117 0.96 . . . . 0.0 112.326 -170.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.523 ' CZ2' ' HA ' ' A' ' 19' ' ' TYR . 74.7 t-105 -80.12 98.23 7.2 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.91 -1.496 . . . . 0.0 109.838 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.513 ' H ' ' HA2' ' A' ' 22' ' ' GLY . 25.5 p -83.93 60.39 5.8 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.012 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 69.44 165.11 0.26 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.978 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.523 ' HA ' ' CZ2' ' A' ' 16' ' ' TRP . 29.4 p90 -68.65 -6.47 26.13 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.734 -171.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.0 mt -67.39 -55.29 14.32 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 121.564 0.697 . . . . 0.0 110.597 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.5 p -116.15 -81.02 0.61 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.011 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.513 ' HA2' ' H ' ' A' ' 17' ' ' THR . . . 79.0 176.67 48.69 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.382 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.483 ' HB3' ' O ' ' A' ' 22' ' ' GLY . 27.5 t90 75.67 -17.35 0.52 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -55.16 104.77 0.45 Allowed Pre-proline 0 N--CA 1.468 0.47 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -168.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 14' ' ' TYR . 72.8 Cg_endo -81.89 108.75 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.037 1.825 . . . . 0.0 112.164 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -107.34 152.52 24.04 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.794 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 65.7 t-105 -74.23 105.43 5.42 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.084 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 37' ' ' TYR . 0.9 OUTLIER -96.48 136.39 37.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.972 -177.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.681 HG13 ' CE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -142.91 128.98 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.865 0.84 . . . . 0.0 111.994 172.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.8 tm? -96.13 123.45 39.76 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.058 -1.428 . . . . 0.0 110.239 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.24 140.49 14.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.109 0.48 . . . . 0.0 110.379 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 61.25 27.73 17.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.421 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.503 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 86.27 -22.49 12.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.114 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.552 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.6 OUTLIER -86.3 134.15 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.604 0 CA-C-O 121.342 0.591 . . . . 0.0 111.259 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.464 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -108.7 106.27 16.24 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 177.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 51' ' ' SER . 35.9 m -104.17 147.18 27.74 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.961 -0.462 . . . . 0.0 110.992 -174.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.589 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 7.8 p90 -110.68 120.41 42.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.882 0.848 . . . . 0.0 110.995 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.681 ' CE2' HG13 ' A' ' 29' ' ' VAL . 57.4 m-85 -113.91 -174.13 2.41 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.293 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -96.03 -63.44 1.15 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.586 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.2 m -122.73 -179.57 4.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.464 ' HG2' ' CE3' ' A' ' 27' ' ' TRP . 39.2 mt-30 -79.04 -1.26 34.8 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -91.76 -21.08 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.247 0.546 . . . . 0.0 110.341 170.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.498 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 6.4 m-20 -72.62 -16.8 61.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.418 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.679 HG22 ' NE1' ' A' ' 27' ' ' TRP . 49.1 t -44.62 -28.46 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.448 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 5.7 t -82.23 -52.22 7.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.878 -175.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -141.23 17.21 2.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -172.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 43' ' ' ASP . . . -69.21 117.28 7.76 Favored Glycine 0 C--N 1.321 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.161 -176.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 m 72.19 -41.32 0.5 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.669 0.787 . . . . 0.0 113.046 175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 26.6 mmmt 67.8 11.19 8.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.865 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.19 131.8 10.73 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.512 ' HB2' HG23 ' A' ' 34' ' ' ILE . 13.8 p -142.77 146.21 34.04 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.093 HG23 HG21 ' A' ' 73' ' ' ILE . 9.0 mt -87.52 134.87 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.919 168.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.552 ' HE3' HD11 ' A' ' 34' ' ' ILE . 40.8 mtpt -108.92 89.28 2.94 Favored 'General case' 0 N--CA 1.422 -1.849 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.537 173.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.725 ' HB2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -74.15 -21.36 59.89 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.468 ' HA ' ' HG3' ' A' ' 100' ' ' LYS . . . -63.32 -38.13 89.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.159 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.7 m -91.72 -15.19 8.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.783 0.801 . . . . 0.0 110.688 -171.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.584 ' SG ' ' HD3' ' A' ' 74' ' ' PRO . 87.3 m -132.56 -145.27 0.25 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.243 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.561 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.7 tp10 -125.81 146.8 49.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 119.078 0.854 . . . . 0.0 112.221 -170.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.725 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -95.64 134.64 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 172.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.622 ' HG3' HG23 ' A' ' 72' ' ' ILE . 23.3 mtmt -117.16 147.35 42.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.014 0.435 . . . . 0.0 110.371 -177.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.604 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m -141.79 127.65 18.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -86.63 129.23 34.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.967 0.413 . . . . 0.0 111.431 -170.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.3 t -85.17 176.65 8.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.052 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 72.47 11.72 5.65 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.236 0.614 . . . . 0.0 111.962 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.411 ' OD1' ' HB3' ' A' ' 68' ' ' ARG . 2.9 p30 -168.49 173.0 7.81 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -117.14 167.78 10.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.302 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 44.3 p 48.69 57.07 6.72 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.62 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 59.0 ttt180 -159.28 109.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.134 0.492 . . . . 0.0 109.796 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.619 ' HG2' HD11 ' A' ' 93' ' ' LEU . 1.9 mpp? -130.08 171.22 13.05 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.718 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -148.58 155.31 40.93 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.035 0.445 . . . . 0.0 110.906 -174.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.848 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -130.35 129.76 43.56 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.25 0.548 . . . . 0.0 111.461 174.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.622 HG23 ' HG3' ' A' ' 60' ' ' LYS . 1.5 pp -111.91 113.66 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.093 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -133.67 166.27 30.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.706 -174.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.761 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 35.9 Cg_endo -59.63 130.03 33.55 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.294 2.662 . . . . 0.0 114.228 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.82 -25.04 9.04 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.81 -0.632 . . . . 0.0 113.594 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.83 69.53 0.54 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 0.0 111.528 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -80.85 97.22 7.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.522 0.677 . . . . 0.0 110.144 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -175.29 88.0 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.934 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.718 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 93.2 m-85 -144.97 97.23 2.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.722 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' O ' ' HG3' ' A' ' 15' ' ' LYS . 88.3 m-85 -102.87 127.25 50.14 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.559 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -147.73 141.71 25.91 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.678 0.752 . . . . 0.0 112.833 -174.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 67' ' ' THR . 39.6 ttpt -105.6 138.78 41.23 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.916 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 161.9 13.69 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.576 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.716 ' HB ' ' HG2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -48.69 -45.36 15.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.79 176.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.61 ' H ' ' HB3' ' A' ' 88' ' ' GLU . 38.3 m-80 -136.93 -175.79 4.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.589 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -79.66 -43.02 23.56 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.537 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -70.88 -17.71 62.7 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.56 173.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.716 ' HG2' ' HB ' ' A' ' 84' ' ' VAL . 26.6 tp10 -67.91 -44.13 77.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.728 ' O ' HD22 ' A' ' 93' ' ' LEU . 17.2 ttt180 -55.13 -52.3 63.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.69 171.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 94' ' ' VAL . 20.3 tp60 -51.6 -56.55 12.93 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.909 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.863 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 61.8 mtt180 -37.28 -42.36 0.46 Allowed 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 124.591 1.157 . . . . 0.0 113.457 175.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.552 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 93.0 m95 -72.43 -56.49 5.35 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.881 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -51.83 -37.37 51.57 Favored 'General case' 0 C--N 1.343 0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.5 176.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 90' ' ' GLN . 33.1 t -56.23 -63.62 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-N 114.283 -1.326 . . . . 0.0 111.17 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -47.63 79.27 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.867 -175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.494 ' HB3' HG21 ' A' ' 59' ' ' ILE . 83.1 mt -52.56 -55.25 23.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.37 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.589 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -81.59 -20.42 64.0 Favored Glycine 0 C--O 1.204 -1.741 0 C-N-CA 119.085 -1.531 . . . . 0.0 112.603 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.9 t -59.75 -34.68 73.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.91 1.355 . . . . 0.0 109.978 178.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.457 ' HA ' ' HA3' ' A' ' 4' ' ' GLY . 1.9 p -91.4 -32.73 15.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.187 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 1.1 tttt -101.46 1.33 38.11 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -176.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -54.38 -42.26 70.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.433 0.635 . . . . 0.0 111.095 -175.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.7 m -93.68 14.85 17.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.16 -178.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 55' ' ' ALA . 2.2 tp -98.71 -78.48 0.49 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.344 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.8 p 50.21 36.25 12.12 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.104 0.562 . . . . 0.0 112.062 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -160.3 171.31 19.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.9 m -79.72 82.67 5.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.256 0.55 . . . . 0.0 110.049 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 107' ' ' ARG . 15.5 ttp85 -66.01 130.23 42.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.25 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.045 -0.978 . . . . 0.0 112.42 178.201 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.89 -12.13 14.86 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.986 2.457 . . . . 0.0 112.085 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.9 pt? -103.58 -176.15 3.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.722 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.79 -113.84 2.84 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.98 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.0 m -104.44 165.88 12.56 Favored Pre-proline 0 C--N 1.326 -0.454 0 C-N-CA 122.389 0.276 . . . . 0.0 110.926 -175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.83 140.97 46.71 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.001 2.467 . . . . 0.0 111.248 171.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -134.87 125.91 27.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.355 0.598 . . . . 0.0 112.588 -169.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 4.7 t80 -154.04 97.82 2.1 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 171.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.922 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 8.9 tpt -122.73 111.07 16.27 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 122.025 0.917 . . . . 0.0 110.838 178.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.36 147.93 45.68 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.44 -171.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.7 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 148.21 167.09 13.26 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.503 172.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.414 HG13 ' H ' ' A' ' 12' ' ' VAL . 2.0 m -65.36 137.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-O 121.448 0.642 . . . . 0.0 111.575 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 13' ' ' LEU . 3.7 tp -124.05 119.05 28.37 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -73.46 87.95 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.4 -177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 15.1 tmtt? -101.62 143.06 32.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.164 0.507 . . . . 0.0 111.629 -169.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -70.22 118.32 12.89 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.705 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.0 p -76.61 -165.91 0.59 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.513 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -67.17 -52.06 46.04 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.274 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.7 p90 177.76 -19.99 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.344 0.403 . . . . 0.0 111.72 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 mp -46.13 -69.29 0.14 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.7 p -105.14 -6.75 19.58 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 121.185 0.517 . . . . 0.0 111.474 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.24 -88.45 1.37 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.979 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.678 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 54.2 p-90 -100.38 141.72 32.84 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.318 -0.441 . . . . 0.0 109.984 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -149.06 115.37 3.7 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.883 -0.144 . . . . 0.0 111.147 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.678 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 35.3 Cg_endo -68.94 108.58 1.95 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 121.354 1.369 . . . . 0.0 111.271 170.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HD3' ' OH ' ' A' ' 37' ' ' TYR . 98.8 mtt180 -123.16 157.09 33.74 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.715 ' NE1' HG22 ' A' ' 44' ' ' VAL . 74.0 t-105 -81.96 132.58 35.26 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.422 0.63 . . . . 0.0 111.546 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.514 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 0.3 OUTLIER -129.44 142.47 50.78 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.137 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.63 HG13 ' HE2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -151.6 132.44 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 122.581 1.181 . . . . 0.0 112.786 167.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.9 tm? -94.75 123.11 38.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.594 -2.093 . . . . 0.0 109.713 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -154.44 141.18 19.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 171.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 60.18 27.02 16.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.999 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 86.89 -28.74 5.34 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.133 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.554 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -77.14 124.09 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.532 0.682 . . . . 0.0 111.083 178.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.634 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -101.21 106.97 18.25 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 177.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 m -103.14 155.09 18.65 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.481 -172.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.455 ' OH ' ' HD3' ' A' ' 26' ' ' ARG . 21.3 t80 -109.72 132.4 54.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.594 -174.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.63 ' HE2' HG13 ' A' ' 29' ' ' VAL . 29.1 m-85 -139.66 179.55 6.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.171 -177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.27 -61.48 1.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.638 0.256 . . . . 0.0 110.916 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 46.3 m -132.41 -176.76 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' HG3' ' CE3' ' A' ' 27' ' ' TRP . 0.7 OUTLIER -73.29 -3.31 26.18 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -90.18 -20.47 23.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.257 0.551 . . . . 0.0 110.385 173.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 7.5 m-20 -82.29 -15.61 52.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.525 -175.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.715 HG22 ' NE1' ' A' ' 27' ' ' TRP . 70.3 t -41.16 -37.24 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -172.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.1 p -68.78 -51.82 36.87 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.079 -0.388 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -124.59 -68.33 0.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.073 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 58.63 -132.6 52.63 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.83 175.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.5 m -77.01 -8.49 57.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.617 -0.291 . . . . 0.0 111.747 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.8 tptt 73.93 -37.62 0.37 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.067 0.854 . . . . 0.0 112.485 176.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.99 129.91 42.97 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.427 -0.416 . . . . 0.0 112.195 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.1 p -139.7 139.07 36.5 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.64 0.733 . . . . 0.0 112.367 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.013 HG23 HG21 ' A' ' 73' ' ' ILE . 13.7 mt -88.51 133.77 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.41 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.554 ' HE3' HD11 ' A' ' 34' ' ' ILE . 38.1 mtpt -110.99 94.18 4.86 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.916 173.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.893 ' HB2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -76.66 -1.05 25.82 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.753 0.311 . . . . 0.0 110.439 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.01 -47.95 9.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.874 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 ' HD3' ' A' ' 74' ' ' PRO . 1.6 m -80.81 -16.65 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 122.034 0.921 . . . . 0.0 109.641 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.614 ' HB3' HD12 ' A' ' 72' ' ' ILE . 41.0 m -133.88 -154.84 0.62 Allowed 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 113.87 -1.514 . . . . 0.0 107.835 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 72' ' ' ILE . 6.6 tp10 -124.35 144.37 50.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.62 1.1 . . . . 0.0 113.23 -167.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.893 HG22 ' HB2' ' A' ' 54' ' ' MET . 0.2 OUTLIER -90.9 115.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 171.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.679 ' HG3' HG23 ' A' ' 72' ' ' ILE . 23.8 mmmt -97.47 139.08 33.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.568 -172.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.452 HG11 ' HG ' ' A' ' 93' ' ' LEU . 1.4 m -139.89 126.07 22.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.747 ' O ' ' HD3' ' A' ' 68' ' ' ARG . 23.6 t-80 -87.76 170.7 11.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.1 p -118.35 -166.0 1.17 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 76.7 -79.06 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.709 0.804 . . . . 0.0 112.265 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -73.65 178.43 4.75 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.971 0.415 . . . . 0.0 111.21 -176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -99.75 163.31 12.53 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.744 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.1 p 50.4 56.22 8.27 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.46 0.648 . . . . 0.0 110.813 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.747 ' HD3' ' O ' ' A' ' 62' ' ' HIS . 0.3 OUTLIER -122.69 120.12 32.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.873 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.585 ' HE1' ' HB2' ' A' ' 92' ' ' TRP . 9.4 ptm -170.16 151.95 4.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.735 -172.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -155.51 166.89 32.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.848 0.356 . . . . 0.0 110.325 -175.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.91 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -136.98 131.23 32.65 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.006 0.431 . . . . 0.0 111.102 175.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.679 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.2 pp -115.5 118.64 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.013 HG21 HG23 ' A' ' 52' ' ' ILE . 1.9 pp -138.47 166.06 28.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.581 -174.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.787 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 37.3 Cg_endo -60.29 136.91 71.41 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.597 2.864 . . . . 0.0 114.437 -172.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.19 -45.07 2.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.664 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -155.79 80.04 1.01 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.106 0.479 . . . . 0.0 111.121 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.422 ' HB2' ' HB ' ' A' ' 72' ' ' ILE . 8.8 pt20 -81.43 95.87 7.19 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.399 178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -166.61 87.41 0.32 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.303 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 94.8 m-85 -136.55 96.01 3.26 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.486 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 65.0 m-85 -103.83 117.06 33.47 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.582 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 10.4 ptt? -142.52 147.6 36.26 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.384 0.611 . . . . 0.0 111.483 -172.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.744 ' HG2' ' O ' ' A' ' 67' ' ' THR . 48.1 mtmt -110.53 176.69 4.94 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -127.41 173.13 10.06 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.133 -0.627 . . . . 0.0 111.577 -176.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.791 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 0.9 OUTLIER -50.06 -39.52 15.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.609 0.719 . . . . 0.0 111.073 174.303 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.443 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 12.8 t-20 -149.01 -176.17 5.24 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.383 -177.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.614 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -86.14 -37.21 19.0 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.795 -177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -74.52 -15.15 60.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.113 0.959 . . . . 0.0 109.429 171.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.791 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -65.04 -52.46 55.77 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.614 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -47.99 -48.05 32.74 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.506 170.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.747 ' NE2' HG21 ' A' ' 94' ' ' VAL . 14.6 tm0? -51.74 -62.31 1.71 Allowed 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.879 0.872 . . . . 0.0 111.127 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.922 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 69.7 mtt180 -35.17 -41.78 0.16 Allowed 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 124.57 1.169 . . . . 0.0 113.694 175.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.585 ' HB2' ' HE1' ' A' ' 69' ' ' MET . 96.9 m95 -73.36 -56.63 4.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.74 -36.42 57.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.792 0.806 . . . . 0.0 110.078 177.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.747 HG21 ' NE2' ' A' ' 90' ' ' GLN . 30.4 t -60.64 -53.58 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.621 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -47.85 46.08 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.624 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.427 ' CD1' HD13 ' A' ' 59' ' ' ILE . 77.3 mt -51.49 -53.59 35.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.774 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -82.83 -4.26 90.13 Favored Glycine 0 C--O 1.207 -1.535 0 C-N-CA 119.666 -1.254 . . . . 0.0 112.624 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.572 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 22.7 t -69.09 -34.4 75.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.507 1.154 . . . . 0.0 109.243 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.3 t -89.51 -29.12 19.18 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.027 176.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 39.8 tttt -99.31 -2.28 36.84 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -55.46 -28.99 57.85 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.612 -0.68 . . . . 0.0 112.086 -173.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 45.0 t -110.54 5.62 21.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.025 0.44 . . . . 0.0 110.941 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 11.7 tp -84.55 150.21 25.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.152 0.501 . . . . 0.0 111.928 -169.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 32.5 p -68.03 149.1 50.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.491 173.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -52.96 -51.95 59.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.01 0.433 . . . . 0.0 111.143 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.3 m -104.7 81.03 1.72 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.762 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -91.94 74.55 5.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.085 0.469 . . . . 0.0 110.267 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.417 HG22 ' HB ' ' A' ' 56' ' ' VAL . 39.2 p . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.675 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 112.23 -0.348 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 3' ' ' LEU . 37.0 Cg_exo -57.32 124.34 15.92 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.706 2.27 . . . . 0.0 111.855 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 2' ' ' PRO . 7.7 mp 72.17 -56.43 0.65 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.794 0.684 . . . . 0.0 110.671 -175.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.86 62.22 4.56 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.018 -0.61 . . . . 0.0 111.704 176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 m -88.21 133.27 37.25 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.26 105.62 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.72 2.28 . . . . 0.0 112.048 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 120.3 37.24 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 54.0 t80 -153.8 98.22 2.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.892 ' HE1' ' HB3' ' A' ' 91' ' ' ARG . 5.5 tpt -126.31 118.12 24.42 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.344 0.592 . . . . 0.0 111.017 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.477 ' HB3' ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -126.2 153.13 45.09 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.533 -173.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.693 ' HA2' ' CZ3' ' A' ' 27' ' ' TRP . . . 142.03 161.16 8.63 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.671 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.31 132.17 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-O 121.748 0.785 . . . . 0.0 111.12 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 83' ' ' ALA . 10.5 tp -122.03 118.65 29.3 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.557 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 8.8 m-30 -61.06 148.26 40.94 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 81' ' ' MET . 37.1 mtmt -111.99 141.03 46.15 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.832 170.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.423 ' H ' ' HA ' ' A' ' 81' ' ' MET . 70.1 t-105 -85.57 104.4 15.29 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.011 0.434 . . . . 0.0 109.976 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.3 p -80.65 152.53 28.43 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 173.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -70.97 83.82 0.68 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.668 0.271 . . . . 0.0 111.327 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.5 t80 74.48 -51.63 0.68 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.572 173.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.0 mt -47.43 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -170.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.6 p -91.26 4.21 52.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.068 -174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.72 -92.17 0.15 Allowed Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.01 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.865 ' CZ3' ' HD3' ' A' ' 25' ' ' PRO . 42.4 p-90 -119.85 145.08 46.99 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -173.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -142.26 112.66 6.13 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.865 ' HD3' ' CZ3' ' A' ' 23' ' ' TRP . 44.3 Cg_endo -69.41 117.94 5.37 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.059 1.839 . . . . 0.0 112.966 -178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -116.46 139.67 50.19 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 174.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.693 ' CZ3' ' HA2' ' A' ' 11' ' ' GLY . 64.3 t-105 -72.49 125.69 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.747 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HB3' ' CH2' ' A' ' 92' ' ' TRP . 1.3 m-85 -121.15 143.16 49.26 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.045 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 10' ' ' GLU . 0.6 OUTLIER -152.47 129.61 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-O 122.445 1.117 . . . . 0.0 112.45 166.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 1.7 tm? -94.85 122.97 38.03 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 112.636 -2.074 . . . . 0.0 109.496 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -153.18 136.94 16.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.21 0.528 . . . . 0.0 110.301 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 61.12 24.26 14.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.207 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.654 ' O ' ' HG3' ' A' ' 54' ' ' MET . . . 91.76 -25.16 17.28 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.937 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.582 HD11 ' HE3' ' A' ' 53' ' ' LYS . 0.8 OUTLIER -81.15 120.91 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-O 121.517 0.675 . . . . 0.0 111.064 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.715 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -100.21 108.21 20.25 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.423 ' HB3' ' OH ' ' A' ' 38' ' ' TYR . 25.3 t -103.87 149.78 24.76 Favored 'General case' 0 C--N 1.311 -1.081 0 O-C-N 121.519 -0.738 . . . . 0.0 110.896 -172.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.429 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 22.8 p90 -113.58 130.55 56.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.492 0.663 . . . . 0.0 111.225 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.532 ' CD1' ' HD1' ' A' ' 27' ' ' TRP . 6.7 m-85 -130.36 179.06 6.13 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.144 -175.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -90.88 -54.38 3.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.79 0.328 . . . . 0.0 110.235 175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 79.5 p -131.56 178.33 6.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -72.36 -9.31 58.35 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.377 0.608 . . . . 0.0 110.595 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -85.69 -20.93 28.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.439 0.638 . . . . 0.0 110.335 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.09 -14.89 57.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.181 -177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.615 HG22 ' NE1' ' A' ' 27' ' ' TRP . 94.5 t -44.68 -27.14 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -171.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.0 t -73.16 -41.41 63.95 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 121.634 -0.666 . . . . 0.0 111.039 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -113.05 -71.18 0.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA3' ' CD2' ' A' ' 38' ' ' TYR . . . 65.44 52.4 40.11 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.231 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.0 m 64.23 2.76 1.57 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.847 0.356 . . . . 0.0 111.921 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.449 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 31.4 mmmt 61.33 24.01 14.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.592 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 124.73 7.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.949 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.92 156.48 47.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.739 0.78 . . . . 0.0 111.729 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.094 HG23 HG21 ' A' ' 73' ' ' ILE . 13.4 mt -92.0 131.58 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.293 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.582 ' HE3' HD11 ' A' ' 34' ' ' ILE . 33.5 mtpt -103.79 89.12 3.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.317 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.654 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -76.22 -3.7 37.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.65 -175.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' A' ' 107' ' ' ARG . . . -88.15 -41.81 12.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.204 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.431 ' HA ' ' HB ' ' A' ' 106' ' ' THR . 1.4 m -83.92 -15.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.969 0.89 . . . . 0.0 109.466 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.643 ' HB3' HD12 ' A' ' 72' ' ' ILE . 51.9 m -133.47 -155.35 0.67 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.02 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.416 ' O ' HG13 ' A' ' 72' ' ' ILE . 5.4 tp10 -121.54 144.01 48.96 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.621 1.1 . . . . 0.0 113.354 -166.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.531 HD13 HD13 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -89.33 114.37 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 171.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.693 ' HG3' HG23 ' A' ' 72' ' ' ILE . 22.0 mmmt -95.77 136.97 35.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.139 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.541 HG11 ' HG ' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -140.36 148.8 21.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 177.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -149.26 162.94 39.04 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.504 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.8 p -79.78 -79.06 0.15 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.431 ' CB ' ' HG3' ' A' ' 68' ' ' ARG . . . 67.19 -61.79 0.33 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.628 0.771 . . . . 0.0 110.791 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -152.23 -65.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.671 -0.241 . . . . 0.0 110.489 174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.505 ' OD1' HG23 ' A' ' 67' ' ' THR . 7.1 p30 -160.65 -17.29 0.05 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.505 HG23 ' OD1' ' A' ' 66' ' ' ASN . 3.3 p -128.61 70.66 1.38 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.962 0.411 . . . . 0.0 111.815 -177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' HG3' ' CB ' ' A' ' 64' ' ' ALA . 18.5 mmt180 -135.99 131.28 34.83 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.188 0.518 . . . . 0.0 110.718 176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.912 ' HG3' ' SD ' ' A' ' 81' ' ' MET . 8.2 ptm -170.16 153.95 4.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.164 -170.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.49 167.54 30.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.048 0.451 . . . . 0.0 110.832 -174.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.877 ' HG ' HG21 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -135.84 134.7 39.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.513 175.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.693 HG23 ' HG3' ' A' ' 60' ' ' LYS . 2.3 pp -119.85 120.7 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 172.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.094 HG21 HG23 ' A' ' 52' ' ' ILE . 2.0 pp -139.43 165.98 27.69 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.077 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.765 ' HD2' ' HB ' ' A' ' 73' ' ' ILE . 36.7 Cg_endo -59.51 146.23 95.7 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.27 2.647 . . . . 0.0 114.121 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.11 -45.63 3.49 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.806 -0.634 . . . . 0.0 113.122 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -148.05 66.8 1.09 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.272 0.558 . . . . 0.0 110.943 -176.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -72.54 95.77 1.86 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.446 0.641 . . . . 0.0 110.859 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 179.87 87.7 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.957 176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.461 ' CG ' HD11 ' A' ' 52' ' ' ILE . 91.9 m-85 -131.56 98.41 4.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.425 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -108.3 109.63 21.02 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.912 ' SD ' ' HG3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -128.82 171.43 12.26 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.748 -178.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 73.3 tttt -131.15 150.32 52.2 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 88' ' ' GLU . . . -98.48 158.69 15.44 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.276 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.761 ' HB ' ' HG3' ' A' ' 88' ' ' GLU . 1.1 t -50.8 -43.87 25.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.342 176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.444 ' H ' ' CB ' ' A' ' 88' ' ' GLU . 47.4 m-80 -143.01 -171.46 3.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.573 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 89' ' ' ARG . . . -85.46 -41.22 15.58 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.649 -174.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.484 ' O ' ' HB3' ' A' ' 90' ' ' GLN . . . -72.94 -16.68 61.54 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.168 173.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.761 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -66.23 -53.06 41.65 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 170.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.598 ' HB3' ' O ' ' A' ' 86' ' ' ALA . 15.3 ttt180 -48.1 -49.17 32.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 113.727 -1.579 . . . . 0.0 109.924 171.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 87' ' ' ALA . 51.6 tp60 -54.98 -58.39 7.84 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.848 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.892 ' HB3' ' HE1' ' A' ' 9' ' ' MET . 41.9 mtt180 -37.8 -42.62 0.61 Allowed 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 113.809 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . 0.569 ' CH2' ' HB3' ' A' ' 28' ' ' PHE . 92.2 m95 -72.37 -53.77 11.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 121.151 -0.219 . . . . 0.0 111.381 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.541 ' HG ' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -52.84 -37.37 60.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.719 0.771 . . . . 0.0 110.246 176.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 98' ' ' SER . 24.5 t -60.05 -56.61 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 114.364 -1.289 . . . . 0.0 111.659 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.05 -46.12 65.66 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.683 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.531 HD13 HD13 ' A' ' 59' ' ' ILE . 81.4 mt -52.99 -56.04 19.04 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.668 177.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -79.32 -2.92 88.26 Favored Glycine 0 C--O 1.205 -1.689 0 C-N-CA 119.695 -1.24 . . . . 0.0 112.473 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 94' ' ' VAL . 21.7 t -68.29 -41.27 81.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 118.536 1.168 . . . . 0.0 108.931 175.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.7 t -80.7 -38.2 29.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.914 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 100' ' ' LYS . 28.9 tttt -91.81 0.85 57.47 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -174.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 97' ' ' GLY . . . -57.21 -35.1 69.22 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.058 0.456 . . . . 0.0 111.379 -174.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.5 m -107.91 15.68 24.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.209 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 100' ' ' LYS . 1.1 mp -86.35 74.46 9.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.967 0.413 . . . . 0.0 110.751 -177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 41.2 p -72.95 -37.66 67.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.993 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -116.59 36.57 4.08 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.84 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.431 ' HB ' ' HA ' ' A' ' 56' ' ' VAL . 82.5 p 54.99 -169.35 0.07 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.966 -177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.486 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 77.7 ttt180 -142.2 109.84 5.74 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.212 -0.305 . . . . 0.0 110.212 -174.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.0 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.556 -0.735 . . . . 0.0 111.151 -178.675 . . . . . . . . 0 0 . 1 stop_ save_